Computer Task Group

!

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 FORM 10-K

(Mark One)
☒

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020

OR

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 
1934

For the Transition period from                      to                    

Commission File No. 1-9410

COMPUTER TASK GROUP, INCORPORATED

(Exact name of registrant as specified in its charter)

New York
(State or other jurisdiction of incorporation or organization)
300 Corporate Parkway, Suite 214N, Amherst, New York
(Address of principal executive offices)

16-0912632
(I.R.S. Employer Identification No.)
14226
(Zip Code)

Registrant’s telephone number, including area code: (716) 882-8000 

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class of Stock
Common Stock, par value $0.01 per share

Trading Symbol
CTG

Name of each exchange on which registered
The NASDAQ Stock Market, LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    YES ☐    NO ☒
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    YES ☐    NO ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 

1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such 
filing requirements for the past 90 days.    YES ☒    NO ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 

405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit 
such files).    YES ☒    NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting 

company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “an 
emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer

Non-accelerated filer

☐

☐ 

Accelerated filer

Smaller reporting company

Emerging growth company

☒

☒

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with 

any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its 

internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that 
prepared or issued its audit report.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    YES ☐    NO ☒
The aggregate market value of the registrant’s voting and non-voting common equity held by non-affiliates, computed by reference to the price at 
which the common equity was last sold on the last business day of the registrant’s most recently completed second quarter was $60.4 million. Solely for 
the purposes of this calculation, all persons who are or may be executive officers or directors of the registrant have been deemed to be affiliates.

The total number of shares of Common Stock of the Registrant outstanding at March 5, 2021 was 15,192,845.

DOCUMENTS INCORPORATED BY REFERENCE

None.

 
 
 
 
Page

3
9
15
15
15
15

16
18
19
32
33
72
72
74

75
78
92
93
93

95
97
99

SEC Form 10-K Index

Section

Business

Part I
Item 1.
Item 1A. Risk Factors
Item 1B. Unresolved Staff Comments
Item 2.
Item 3.
Item 4.

Properties
Legal Proceedings
Mine Safety Disclosures

Part II
Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity 
Securities
Selected Financial Data
Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 6.
Item 7.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Item 8.
Item 9.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
Item 9A. Controls and Procedures
Item 9B. Other Information

Part III
Item 10. Directors, Executive Officers and Corporate Governance
Item 11. Executive Compensation
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13. Certain Relationships and Related Transactions, and Director Independence
Item 14. Principal Accounting Fees and Services

Part IV
Item 15. Exhibits, Financial Statement Schedules
Item 16.

Form 10-K Summary
Signatures

2

 
 
 
 
 
As used in this annual report on Form 10-K, references to “CTG,” “the Company” or “the Registrant” refer to 

Computer Task Group, Incorporated and its subsidiaries, unless the context suggests otherwise.

Forward-Looking Statements

PART I

This annual report on Form 10-K contains forward-looking statements made by the management of Computer Task 

Group, Incorporated (“CTG,” the “Company” or the “Registrant”) that are subject to a number of risks and uncertainties. 
These forward-looking statements are based on information as of the date of this report. The Company assumes no 
obligation to update these statements based on information from and after the date of this report. Generally, forward-
looking statements include words or phrases such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” 
“projects,” “could,” “may,” “might,” “should,” “will” and words and phrases of similar impact. The forward-looking 
statements include, but are not limited to, statements regarding future operations, industry trends or conditions and the 
business environment, and statements regarding future levels of or trends in business strategy and expectations, new 
business opportunities, cost control initiatives, business wins, market demand, revenue, operating expenses, capital 
expenditures, and financing. The forward-looking statements are made pursuant to safe harbor provisions of the Private 
Securities Litigation Reform Act of 1995. Numerous factors could cause actual results to differ materially from those in the 
forward-looking statements, including the following: (i) the availability to CTG of qualified professional staff, (ii) domestic 
and foreign industry competition for clients and talent, including technical, sales and management personnel, (iii) 
increased bargaining power of large clients, (iv) the Company's ability to protect confidential client data, (v) the partial or 
complete loss of the revenue the Company generates from International Business Machines Corporation (IBM) and other 
significant clients, (vi) the uncertainty of clients' implementations of cost reduction projects, (vii) the effect of healthcare 
reform and initiatives, (viii) the mix of revenue between staffing and solutions, (ix) currency exchange risks, (x) risks 
associated with operating in foreign jurisdictions, (xi) renegotiations, nullification, or breaches of contracts with clients, 
vendors, subcontractors or other parties, (xii) the impact of current and future laws and government regulation, as well as 
repeal or modification of such, affecting the information technology (IT) solutions and staffing industry, taxes and the 
Company's operations in particular, (xiii) industry and economic conditions, including fluctuations in demand for IT 
services, (xiv) consolidation among the Company's competitors or clients, (xv) the need to supplement or change our IT 
services in response to new offerings in the industry or changes in client requirements for IT products and solutions, (xvi) 
the risks associated with acquisitions, (xvii) actions of activist shareholders, (xviii) the effects of the COVID-19 pandemic 
and the regulatory, social, and business responses thereto on the Company’s business, operations, employees, 
contractors, and clients, and (xix) the risks described in Item 1A of this annual report on Form 10-K and from time to time 
in the Company's reports filed with the Securities and Exchange Commission (SEC).

Item 1.

Business

Overview

CTG was incorporated in Buffalo, New York on March 11, 1966, and its corporate headquarters are located at 300 

Corporate Parkway, Suite 214N, Amherst, New York 14226 (716-882-8000). CTG is an information and technology 
solutions company with operations in North and South America, Western Europe, and India. CTG’s employees and 
billable subcontractors total approximately 3,900 people worldwide at December 31, 2020. During 2020, the Company 
had thirteen operating subsidiaries: Computer Task Group of Canada, Inc. and La Societe de Tests StarDust Inc., 
providing services in Canada; Computer Task Group Belgium N.V., CTG ITS S.A., Computer Task Group IT Solutions, 
S.A., Computer Task Group Luxembourg PSF S.A., Computer Task Group (U.K.) Limited, CTG Health Solutions N.V., 
Soft Company SAS (“CTG France”), and StarDust SAS, each primarily providing services in Europe; Computer Task 
Information Technology Private Services Limited, providing services in India and CTG LATAM SAS, providing services in 
Colombia. The parent corporation, CTG, Inc., and CTG Federal Systems, LLC primarily provide services in North 
America.

The Company operates in one industry segment, providing information technology and related services to its clients. 

These services include information and technology-related solutions, including supplemental staffing as a solution. With 
solution services, the Company generally takes responsibility for the deliverables and some level of project and staff 
management, and services may include high-end advisory or business-related consulting. When providing staffing 
services, including managed staffing, staff augmentation, and volume staffing, personnel are provided to clients, who 
then, in turn, take their direction from the clients’ managers. 

3

Services

CTG is a leading provider of IT solutions and services, serving as a catalyst for our clients’ digital transformation. We 

increase project momentum and the speed at which our clients achieve their desired outcomes. Our solutions portfolio 
addresses critical challenges for clients in North America, South America, Western Europe, and India in high-growth 
industries. Clients we typically support are organizations with large, complex technology, information, and data 
requirements. Some have begun their digital transformation and are struggling to drive their desired results, while many 
are just starting to define their transformation needs and strategy. 

CTG's Digital Transformation Solutions portfolio spans three areas that collectively address many of our clients' 
most pressing transformation challenges and are designed to address their unique business, technology, and operational 
needs. Our capabilities ensure that our clients utilize the right information technology to meet their business needs, 
maximize their IT systems' value, and operate efficiently and effectively. The following describes the typical services 
provided:

(cid:129) Business Process Transformation Solutions ensure clients can meet today's challenges, map to tomorrow's 
growth, and align their organizations' technology solutions to their business objectives. We combine strategic 
advisory services, technologies and platforms, and implementation and integration processes to accelerate 
business outcomes, improve workflows, and drive efficiencies. These solutions services include Advisory, Data 
Strategy, Digital Workplace, Enterprise Platforms, Information Disclosure, and Regulatory and Compliance. 

(cid:129)

Technology Transformation Solutions accelerate digital transformation by keeping our clients ahead of the 
digital curve and delivering the sustainable business value they expect from their technology investments. CTG's 
Technology Transformation Solutions also help our clients stay ahead of their competition by rapidly adopting 
digital technologies with confidence through solutions that include Application Development, Automation, Cloud, 
Data Management, Enterprise Platform Implementation, and Testing.

(cid:129) Operations Transformation Solutions ensure our clients have the correct operations infrastructure in place to 
achieve the organizational agility necessary to accelerate their business velocity. Our Global Delivery Network 
supports our Operations Transformation Solutions, enabling cost-effective solutions delivery at optimal staffing 
levels to ensure exceptional customer service while reducing client costs. These solutions include Application 
support, IT Operations support, Cloud, and Infrastructure.

CTG’s staffing services address a range of information and technology resource needs, from filling specific talent 
gaps to managing high-volume staffing programs. CTG recruits, retains, and manages IT talent for its clients, which are 
primarily large technology service providers and other companies with multiple locations and a significant need for high-
volume professional IT resources. 

IT solutions and IT and other staffing revenue as a percentage of consolidated revenue for the three years ended 

December 31, 2020, 2019, and 2018 is as follows:

IT solutions
IT and other staffing

Total

Capabilities

2020

2019

2018

38%   
62%   
100%   

36%   
64%   
100%   

31%
69%
100%

Our expertise in key technologies–what we call Digital Accelerators–underpins our solutions and ensure our clients 

get the most value from their digital technologies and methodologies. CTG's Digital Accelerators evolve to meet market 
needs and address the most innovative technology platforms and thinking. These Digital Accelerators include Agile and 
DevSecOps, Internet of Things (IoT), Intelligent Automation, Data and Analytics, Cloud, and Automated Testing. 

As the pace of change accelerates, CTG accelerates our clients' digital environment through a unique combination 

of Transformation Solutions, Digital Accelerators, leading industry talent, domain expertise, innovative tools and 
methodologies, a partner ecosystem, and a Global Delivery Network. 

(cid:129)

Industry-leading Digital and Technology Talent. CTG cultivates a workplace that attracts, develops, and 
retains the best digital and technology experts. Being Great Place to Work® Certified validates our workplace 
culture that has made CTG a leading IT and digital solutions and services company for more than 50 years.

4

 
 
 
 
 
 
 
   
   
   
(cid:129) Deep Domain Expertise. CTG serves clients in high-growth sectors across the globe and brings industry 
experience that we leverage to build and deliver digital solutions customized for the unique challenges, 
requirements, and regulations companies face in each industry we serve. CTG serves clients in high-growth 
global sectors, such as healthcare, energy, manufacturing, financial services, technology service providers, and 
other general markets. 

(cid:129)

(cid:129)

Innovative Tools and Methodologies. CTG leverages up-to-date best practices, technologies, and 
methodologies (e.g., Agile, SAFe, DASA, ITIL) to support our clients' need for greater speed-to-market, 
innovation, continuous improvement, and to support today's high-performance IT teams. CTG also builds and 
provides a number of proprietary tools and platforms (e.g., We Are Testers, BugTrapp) designed to meet the 
unique needs of our clients.

Partner Ecosystem. Given our clients' specialized and evolving needs and the accelerated pace at which new 
technologies emerge, we know that we must leverage industry partnerships to increase the value we provide to 
our clients. Our strong partner network, representing today's leading technologies, allows our clients to access 
and utilize today's leading technologies, coupled with our supporting Solutions, methodologies, and industry 
experience. 

(cid:129) Global Delivery Network. Through established operations in North and South America, Western Europe, and 
India, CTG's delivery centers leverage a centralized model to deliver a broad spectrum of high-quality, cost-
effective services and solutions.

Vertical Markets

The Company provides a majority of its services through five vertical market focus areas: technology service 
providers, financial services, healthcare (which includes services provided to healthcare providers, health insurers 
(payers), and life sciences companies), manufacturing, and energy. The remainder of CTG’s revenue is derived from 
general markets.

CTG’s revenue by vertical market as a percentage of consolidated revenue for the three years ended December 31, 

2020, 2019, and 2018 is as follows:

Technology service providers
Financial services
Healthcare
Manufacturing
Energy
General markets

Total

2020

2019

2018

32.7%   
15.7%   
14.9%   
13.5%   
6.3%   
16.9%   
100.0%   

32.2%   
13.8%   
16.6%   
16.8%   
5.2%   
15.4%   
100.0%   

32.4%
15.2%
16.2%
19.5%
4.7%
12.0%
100.0%

Revenue for the Company's technology service providers vertical market as a percentage of consolidated revenue 

increased slightly in 2020 as compared with 2019. Overall, the Company’s revenue decreased in 2020 as the global 
COVID-19 pandemic reduced demand for the Company’s staffing services. However, demand from our largest staffing 
client, IBM, which is included in this vertical market, decreased at a rate consistent with the Company’s overall decrease 
in revenue. The revenue as a percentage of consolidated revenue decrease in 2019 as compared with 2018 was due to a 
change in business mix as the Company focused on selling its IT Solutions services, which are not included in this vertical 
market.

Revenue for the Company’s financial services vertical market as a percentage of consolidated revenue increased in 

2020 as compared with 2019 due to acquisitions completed by the Company in 2019 and 2020. Revenue decreased in 
2019 as compared to 2018 due to lower demand in this vertical market throughout our European operations. 

In 2020, the demand from our healthcare clients decreased at a rate that was above the overall revenue decrease 

for the Company, which caused the percentage of total revenue to decrease. Additionally, a significant project in this 
vertical market was essentially complete by the end of 2019 and was not replaced in 2020. This was a reversal of the 
trend of an increase in 2019 as compared with 2018 as revenue increased in that year due to the large project previously 
mentioned.

5

 
 
 
 
 
 
 
   
   
   
   
   
   
   
The revenue in our manufacturing vertical market is primarily generated from several large staffing clients, including 

Lenovo (through SDI as a vendor manager for Lenovo), which is our second largest client. Revenue from Lenovo and 
other large clients decreased in 2020 as compared with 2019, and in 2019 as compared with 2018, as the demand for 
these services, which include some non-IT staffing, decreased in recent years. Additionally, the Company continues to 
disengage from its lowest margin staffing business, which is generally included in this vertical market. 

Revenue for the Company's energy vertical market increased as a percentage of consolidated revenue in both 

2020 and 2019 given strong demand for our services in this vertical market.

For the year ended December 31, 2020, CTG provided its services to 601 clients, primarily in North America and 

Europe. In North America, the Company operates in the United States and Canada, with about 99% of 2020 North 
American revenue generated in the United States. In Europe, the Company operates in Belgium, Luxembourg, France, 
and the United Kingdom. Of total 2020 consolidated revenue of $366.1 million, approximately 56% was generated in 
North America and 44% in Europe. Revenue generated in India and Colombia was insignificant. One client, IBM, 
accounted for greater than 10% of CTG’s consolidated revenue in 2020.

Revenue Recognition and Backlog

The Company recognizes revenue when control of the promised good or service is transferred to clients, in an 
amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. For 
time-and-material contracts, revenue is recognized as hours are incurred and costs are expended. For contracts with 
progress billing schedules, primarily monthly, revenue is recognized as services are rendered to the client. Revenue for 
fixed-price contracts is recognized over time using an input-based approach. Over time revenue recognition best portrays 
the Company’s performance in transferring control of the goods or services to the client. On most fixed-price contracts, 
revenue recognition is supported through contractual clauses that require the client to pay for work performed to date, 
including cost plus a reasonable profit margin, for goods or services that have no alternative use to the Company. On 
certain contracts, revenue recognition is supported through contractual clauses that indicate the client controls the asset, 
or work in process, as the Company creates or enhances the asset. On a given project, actual salary and indirect labor 
costs incurred are measured and compared with the total estimate of costs of such items at the completion of the project. 
Revenue is recognized based upon the percentage-of-completion calculation of total incurred costs to total estimated 
costs. The Company infrequently works on fixed-price projects that include significant amounts of material or other non-
labor related costs that could distort the percent complete within a percentage-of-completion calculation. The Company’s 
estimate of the total labor costs it expects to incur over the term of the contract is based on the nature of the project and 
our experience on similar projects, and includes management judgments and estimates that affect the amount of revenue 
recognized on fixed-price contracts in any accounting period. Losses on fixed-price projects are recorded when identified.

The Company’s revenue from contracts accounted for under time-and-material, progress billing, and percentage-of-
completion methods as a percentage of consolidated revenue for the three years ended December 31, 2020, 2019, and 
2018 is as follows:

Time-and-material
Progress billing
Percentage-of-completion

Total

2020

2019

2018

81.0%   
15.9%   
3.1%   
100.0%   

79.6%   
10.2%   
10.2%   
100.0%   

84.7%
10.5%
4.8%
100.0%

As of December 31, 2020 and 2019, the backlog for fixed-price and all managed-support contracts was 

approximately $50.9 million and $53.6 million, respectively. Approximately 70% or $35.7 million of the December 31, 2020 
backlog is expected to be earned in 2021. Approximately 56% of the $53.6 million of backlog at December 31, 2019, or 
$30.3 million, was earned in 2020. Revenue is subject to slight seasonal variations, with a minor slowdown and a 
decrease in billable resource utilization in months of high vacation and legal holidays (July, August, and December). 
Backlog does not tend to be seasonal; however, it does fluctuate based upon the timing of entry into long-term contracts.

Competition

The IT services market, for both information and technology solutions and IT and professional staffing services, is 

highly competitive. The market is also highly fragmented with many providers and no single competitor maintaining clear 
market leadership. Competition varies by location, the type of service, and the client to whom services are provided. The 
Company’s competition comes from four major channels: large national or international companies, including major 

6

 
 
 
 
 
 
 
   
   
   
   
accounting and consulting firms and large companies headquartered in India; hardware vendors and suppliers of 
packaged software systems; small local firms or individuals specializing in specific programming services or applications; 
and from a client’s internal IT staff. CTG competes against all four of these channels for its share of the market. The 
Company believes that to compete successfully, it is necessary to have a local geographic presence, offer appropriate IT 
solutions, provide skilled professional resources, and price its services competitively.

Intellectual Property

The Company has registered its symbol and logo with the U.S. Patent and Trademark Office and has taken steps to 

preserve its rights in other countries where it operates. We regard patents, trademarks, copyrights and other intellectual 
property as important to our success, and we rely on them in the United States and foreign countries to protect our 
investments in products and technology. Our patents expire at various times, but we believe that the loss or expiration of 
any individual patent would not materially affect our business. We, like any other company, may be subject to claims of 
alleged infringement of the patents, trademarks and other intellectual property rights of third parties from time to time in 
the ordinary course of business. CTG has entered into agreements with various software and hardware vendors from time 
to time in the normal course of business, and has capitalized certain costs under software development projects.

Human Capital Resources

Employees

CTG’s business depends on the Company’s ability to attract, develop and retain qualified professional staff to 
execute our strategy and provide services to its clients. The Company has a structured recruiting organization that works 
with its clients to meet their requirements by recruiting, retaining, and providing high quality, motivated staff. As the 
Company works with a number of subcontractors within CTG France, which was acquired on February 15, 2018, the 
Company now includes subcontractors in its total headcount, which equals approximately 3,900 total resources 
worldwide, with approximately 2,450 in the United States and Canada and 1,450 in Europe, as of December 31, 2020. Of 
these resources, approximately 91% are IT professionals and 9% are individuals who work in sales, recruiting, delivery, 
administrative and support positions. The Company believes that its relationship with its employees is good and supported 
by the Company’s 2020 recognition as a Great Place to Work® in North America, Belgium, and Luxembourg. No 
employees are covered by a collective bargaining agreement or are represented by a labor union. CTG is an equal 
opportunity employer.

COVID-19 Response

The health, well-being and safety of our employees, clients and communities is our top priority. The Company began 

to focus on COVID-19 as a potentially significant issue during the first quarter of 2020 as we followed global 
developments and observed the impacts of COVID-19 in several European markets where we operate. Our senior 
management team initiated regular COVID-19 planning sessions to address the critical safety, operational and business 
risks associated with the pandemic. With our continued commitment to monitor, assess and implement guidance and best 
practices for the Company as recommended by the World Health Organization (WHO) and Centers for Disease Control 
and Prevention (CDC), we have been able to maintain the continuity of the essential services that we provide to our 
clients, while also managing the impact of the spread of the virus within our business, as well as promoting the health, 
well-being and safety of our employees, clients and communities. 

7

Financial Information About Geographic Areas

The following table sets forth certain financial information relating to the performance of the Company for the three 

years ended December 31, 2020, 2019, and 2018. This information should be read in conjunction with the audited 
consolidated financial statements and notes thereto included in Item 8, “Financial Statements and Supplementary Data” 
included in this report.

(amounts in thousands)
Revenue from External Clients:

United States
Luxembourg (1)
Belgium (2)
Other countries

Total foreign revenue
Total revenue

Operating Income (loss):

United States - pre-allocation
Allocation to other countries (5)

United States - post-allocation

Belgium (2)
Luxembourg (1)
United Kingdom (4)
France (3)
Other countries

Total foreign operating income - pre-allocation
Allocation from the United States (5)

Total foreign operating income - post-allocation

Total operating income

Total Assets:

United States
Luxembourg (1)
Belgium (2)
France (3)
Other countries

Total foreign assets
Total assets

2020

2019

2018

203,495    $
66,411     
59,851     
36,334     
162,596     
366,091    $

241,038    $
64,852     
52,468     
35,812     
153,132     
394,170    $

232,178 
44,660 
48,585 
33,346 
126,591 
358,769 

(1,223)   $
1,840     
617     
4,411     
3,491     
1,203     
776     
472     
10,353     
(1,840)    
8,513     
9,130    $

50,075    $
47,047     
39,164     
33,035     
6,932     
126,178     
176,253    $

733    $
1,566     
2,299     
1,159     
2,363     
1,199     
1,346     
112     
6,179     
(1,566)    
4,613     
6,912    $

(3,083)
942 
(2,141)
1,528 
1,731 
671 
1,129 
104 
5,163 
(942)
4,221 
2,080 

54,043    $
42,943     
30,159     
26,500     
5,061     
104,663     
158,706    $

39,488 
26,355 
27,128 
27,425 
3,725 
84,633 
124,121  

  $

  $

  $

  $

  $

  $

(1) Revenue, operating income, and assets for our Luxembourg operations have been disclosed separately as they 

exceed 10% of the consolidated balances in at least one of the years presented.

(2) Revenue, operating income, and assets for our Belgium operations have been disclosed separately as they exceed 

10% of the consolidated balances in at least one of the years presented.

(3) Operating income and assets for our France operations have been disclosed separately as they exceed 10% of the 

consolidated balances in at least one of the years presented.

(4) Operating income for our United Kingdom operations has been disclosed separately as it exceeds 10% of the 

consolidated balance in at least one of the years presented.

(5) During 2020, 2019 and 2018, the Company allocated support costs primarily for management, finance and 

information technology services from the United States to our foreign operations to reflect costs that are recorded in 
the United States but support our foreign operations. 

Available Company Information

The Company’s annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all 
amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 
(Exchange Act), and reports pertaining to the Company filed under Section 16 of the Exchange Act are available without 

8

 
 
   
   
 
 
 
    
 
    
 
  
   
      
      
  
   
   
   
   
   
      
      
  
   
   
   
   
   
  
   
   
   
   
   
      
      
  
   
   
   
   
   
charge on the Company’s website at www.ctg.com as soon as reasonably practicable after the Company electronically 
files the information with, or furnishes it to, the SEC. The SEC’s website, www.sec.gov, contains reports, proxy and 
information statements, and other information regarding issuers that file electronically with the SEC. The Company’s code 
of ethics (Code of Conduct), committee charters and governance policies (including a fraud and insider trading policy) are 
also available without charge on the Company’s website at http://investors.ctg.com/corporate-governance/governance-
documents. If applicable, the Company intends to disclose future amendments to, or waivers from, certain provisions of 
the Code of Conduct on the Company's website or in a current report on Form 8-K.

Item 1A.

Risk Factors

The following risk factors should be read carefully in connection with evaluating our business and the forward-
looking information contained in this Annual Report on Form 10-K. The risk factors below represent what we believe are 
the known material risk factors with respect to the Company and our business. Any of the following risks could materially 
adversely affect our business, operations, financial position or future financial results.

Global Pandemic and Related Risks

The impact of the COVID-19 pandemic has had, and is expected to continue to have, an adverse effect on 

our business and our financial results.

The COVID-19 pandemic has negatively affected the global economy, disrupted consumer spending and global 
supply chains, and created significant volatility and disruption of financial markets. The COVID-19 pandemic has had and 
is expected to continue to have an adverse effect on our business and financial performance. The extent of the impact of 
the COVID-19 pandemic, including our ability to execute our business strategies as planned, will depend on future 
developments, including the duration and severity of the pandemic, which are highly uncertain and cannot be predicted.

The future impact of COVID-19 on our business and financial results will depend on, among other factors, the 
duration and spread of the pandemic, the implementation or recurrence of shelter in place or similar orders in the future, 
new information that may emerge concerning the severity of new strains of the virus, and the effectiveness of vaccines. 
Therefore, we cannot reasonably estimate the full extent of the COVID-19 pandemic’s impact on our future business and 
financial results.

Business Related Risks

Our business depends on the availability of a large number of highly qualified IT professionals, sales and 

management personnel, and our ability to recruit and retain these individuals.

We actively compete with many other IT service providers for qualified personnel, including professional IT staff, 
recruiters, sales and business development specialists, and management. The availability of qualified personnel may 
affect our ability to provide services and meet the requirements of our clients. An inability to fulfill client requirements at 
agreed-upon rates due to a lack of available qualified personnel may adversely affect our revenue and operating results in 
the future.

Decreases in demand for IT Solutions and IT and Other Staffing services in the future would have an 

adverse effect on our revenue and operating results.

The Company’s revenue and operating results are significantly impacted by changes in demand for its services. In 

the past, when the world economy deteriorated, there was a significant decline in demand for the Company’s services that 
negatively affected the Company’s revenue and operating results as compared with prior years. Declines in demand for 
the requirement for our IT services in 2021 or future years would adversely affect our revenue and operating results as it 
has in the past.

9

Our client contracts generally have a short term or are terminable on short notice, and a significant number 

of failures to renew contracts in place, or early terminations or renegotiations of our existing client contracts 
could adversely affect our results of operations.

Our clients typically retain us on a non-exclusive, engagement-by-engagement basis, rather than under exclusive 

long-term contracts. We performed 81.0% of our services on a time-and-materials basis during 2020. As such, our clients 
generally have the right to terminate a contract with us upon written notice without the payment of any financial penalty. 
Client projects may involve multiple engagements or stages, and there is a risk that a client may choose not to retain us 
for additional stages of a project, or that a client will cancel or delay additional planned engagements. These terminations, 
cancellations, or delays could result from factors that are beyond our control and are unrelated to our work product or the 
progress of the project but could be related to business or financial conditions of the client, changes in client strategies or 
the economy in general. When contracts are terminated, we lose the anticipated future revenue and we may not be able 
to eliminate the associated costs that would have been required to support those contracts in a timely manner. 
Consequently, our operating results in subsequent periods may be lower than expected. Our clients can cancel or reduce 
the scope of their engagements with us on short notice. If they do so, we may be unable to reassign our professionals to 
new engagements without delay. The cancellation or reduction in scope of an engagement could, therefore, reduce the 
utilization rate of our professionals, which would have a negative impact on our business, financial condition, and results 
of operations. As a result of these and other factors, our past financial performance should not be relied on as a 
guarantee of similar or improved future performance. Due to these factors, we believe that our results from operations in 
the future may fluctuate from period to period.

Competition Related Risks

Increased competition and the bargaining power of our large clients may cause our billing rates to decline, 

which would have an adverse effect on our revenue and, if we are unable to control our personnel costs 
accordingly, on our margins and operating results.

We have experienced reductions in the rates we bill a number of our larger clients for services due to highly 

competitive market conditions. Additionally, we actively compete against many other companies for business at both new 
and existing clients. Billing rate reductions or competitive pressures may lead to a decline in revenue. When faced with 
such pressures, if we are unable to make commensurate reductions in our personnel costs, our margins and operating 
results would be adversely affected.

Existing and potential clients may outsource or consider outsourcing their IT requirements to foreign 
countries in which we may not currently have operations, which could have an adverse effect on our ability to 
retain existing clients or obtain new clients.

In recent years, more companies are using, or are considering using, low-cost offshore outsourcing centers to 

perform technology-related work and complete projects. Currently, we have partnered with clients to perform services 
outside of North America in both India and Colombia to mitigate and reduce this risk to our Company. However, the risk of 
additional outsourcing of IT solutions overseas to countries where we do not have operations could have a material, 
adverse impact on our future operations.

The IT services industry is highly competitive and fragmented, which means that our clients have a number 

of choices for providers of IT services and we may not be able to compete effectively.

The market for our services is highly competitive. The market is fragmented, and no company holds a dominant 

position. Consequently, our competition for client requirements and experienced personnel varies significantly by 
geographic area and by the type of service provided. Some of our competitors are larger and have greater technical, 
financial, and marketing resources, and greater name recognition than we have in the markets we collectively serve. In 
addition, clients may elect to increase their internal IT system resources to satisfy their custom software development and 
integration needs. Finally, our industry is being impacted by the growing use of lower-cost offshore delivery capabilities 
(primarily India and other parts of Asia). There can be no assurance that we will be able to continue to compete 
successfully with existing or future competitors or that future competition will not have a material adverse effect on our 
results of operations and financial condition.

10

The introduction of new IT services or changes in client requirements for IT services may render our 
existing IT Solutions or IT and Other Staffing offerings obsolete or unnecessary, which, if we are unable to keep 
pace with these corresponding changes, could have an adverse effect on our business.

Our success depends, in part, on our ability to implement and deliver IT Solutions or IT and other staffing services 

that anticipate and keep pace with rapid and continuing changes in technology, industry standards, and client preferences 
and requirements. We may not be successful in anticipating or responding to these developments on a timely basis, and 
our offerings may not be successful in the marketplace. Also, services, solutions, and technologies developed by our 
competitors may make our solutions or staffing offerings uncompetitive or obsolete. Any one of these circumstances could 
have a material adverse effect on our ability to obtain and successfully complete client engagements.

Operations Related Risks

We derive a significant portion of our revenue from one client, and a significant reduction in the amount of 

requirements requested by this client would have an adverse effect on our revenue and operating results.

IBM is CTG’s largest client, and we provide services to various IBM divisions in a number of locations. During the 

fourth quarter of 2020, the National Technical Services Agreement (NTS Agreement) with IBM was renewed and now 
expires on October 27, 2023. In 2020, 2019, and 2018, IBM accounted for $77.5 million or 21.2%, $84.9 million or 21.5%, 
and $80.6 million or 22.5% of the Company’s consolidated revenue, respectively. The Company’s accounts receivable 
from IBM at December 31, 2020 and 2019 totaled $11.3 million and $23.0 million, respectively. 

If we are unable to bill for our services or collect our receivables, our results of operations, financial 

condition, and cash flows could be adversely affected.

Our business depends on our ability to obtain payment from our clients of the amounts they owe us for work 
performed. We evaluate the financial condition of our clients and typically bill and collect on reasonable cycles. However, 
we might not accurately assess the creditworthiness of our clients, or macroeconomic conditions could result in financial 
difficulties for our clients, including bankruptcy and insolvency. In certain industries, some clients have requested longer 
payment terms, which has adversely affected, and may continue to adversely affect, our cash flows. The timely collection 
of client balances also depends on our ability to complete our contractual commitments as required. If we are unable to 
meet our commitments or bill our clients on a timely basis, our results of operations and cash flows could be adversely 
affected. We have established allowances for losses of receivables and unbilled services where we deem amounts to be 
uncollectible. The uncollectible amounts due to the Company from clients could differ from those that we currently 
anticipate.

If we repatriate our cash balances from our foreign operations, we may be subject to additional tax 

liabilities.

We earn a portion of our operating income outside of the United States, and any repatriation or deemed repatriation 

of funds currently held in foreign jurisdictions to the United States may result in additional tax liabilities for the Company. 
In addition, there have been changes to the tax laws in the United States that impact how United States-based 
multinational corporations are taxed on foreign earnings. Any further changes in these tax laws could have a material 
adverse impact on our tax expense and cash flows.

Ineffective internal controls could affect the Company's business and operating results. 

The Company's internal control over financial reporting may not prevent or detect misstatements because of the 
inherent limitations of internal controls, including the possibility of human error, the circumvention or overriding of controls, 
poorly designed or ineffective controls, or fraud. Internal controls that are deemed to be effective can provide only 
reasonable assurance with respect to the preparation and fair presentation of the Company's consolidated financial 
statements. If the Company fails to maintain the adequacy of its internal controls, including the failure to implement new or 
improve existing controls, or fails to properly execute or properly test these controls, the Company's business and 
operating results could be adversely impacted and the Company could fail to meet its financial reporting obligations.

Changing economic conditions and the effect of such changes on accounting estimates could have a 

material impact on our results of operations.

The Company has also made a number of estimates and assumptions relating to the reporting of its assets and 
liabilities and the disclosure of contingent assets and liabilities to prepare its consolidated financial statements pursuant to 
the rules and regulations of the SEC and other accounting rulemaking authorities. Such estimates primarily relate to the 
valuation of stock options for recording equity-based compensation expense, allowances for doubtful accounts receivable, 

11

investment valuation, discount rates associated with pension plans, incurred but not recorded claims related to the 
Company's self-insured medical plan, valuation allowances for deferred tax assets, goodwill, acquisition and related 
accounting, legal matters, other contingencies and estimates of progress toward completion and direct profit or loss on 
contracts, as applicable. As future events and their effects cannot be determined with precision, actual results could differ 
from these estimates. Changes in the economic climates in which the Company operates may affect these estimates and 
will be reflected in the Company’s consolidated financial statements in the event they occur. Such changes could result in 
a material impact on the Company’s results of operations.

Cyber Related Risks

We could be subject to liability and damage to our reputation resulting from cyber-attacks or data breaches.

Cyber risks for companies providing global information technology (IT) and professional services, especially in 
regulated industries, continue to increase. This increase in risk may be attributed to the increasing value and dependence 
on data, including organizations’ intellectual property and citizens’ personal data that could be misused for identity theft 
and fraud. While the value and dependence of data has increased, likewise the reliance on electronic communications, 
mobile technologies, social networking, hybrid and cloud-based resources, smart devices, and emerging technologies 
continues to grow. In some regions, the regulatory compliance requirements surrounding data protection and privacy have 
also increased. In addition, the sophistication, motivation, and organization of cyber attacks continues to evolve, as does 
the sophistication of threat actors such as organized crime, hackers, terrorists, activists, insider threats, foreign 
governments, and third parties.

The Company’s business, operations, and its clients rely on the secure processing, transmission, storage, integrity, 

and availability of data, services, and resources provided by its IT environments and operational processes. The 
Company’s complex IT environments support a variety of technologies, industries, delivery services, regulatory 
compliance requirements, and clients globally.

Although the Company has not experienced any prior material data breaches, regulatory non-compliance incidents, 
or cyber security incidents, its environments may be impacted by cyber attacks or cyber security incidents caused via the 
aforementioned threat actors or the Company's personnel. These incidents could result in data loss, result in the 
disruption of the Company's internal or client-supporting operations and services, adversely affect its adherence with 
regulatory requirements, or result in a data breach. Data losses and data breaches could include the unauthorized 
disclosure, misuse, loss, and destruction of both the Company’s and its clients’ intellectual property, financial information, 
or other regulated or privacy-related information.  This includes but is not limited to United States personally identifiable 
information (PII), personal data under the European General Data Protection Regulation (GDPR), data covered under 
Luxembourg Law on the Financial Sector, and protected health information (PHI) under the United States Health 
Insurance Portability and Accountability Act of 1996 (HIPAA).

The Company’s failure to protect sensitive data and address the regulatory compliance requirements of data and 

associated internal or delivery services under the Company’s control could result in reputational damage, fines and 
penalties, litigation costs, external investigations, compensation costs including reimbursement and monetary awards, 
prohibition of providing services in a region or industry, and/or additional compliance costs that could have a material, 
adverse impact on the Company's operations. It could also have an adverse impact on the Company’s ability to maintain 
and execute new contracts with clients that produce or work with similar data, and make it more difficult to retain and 
recruit qualified personnel to perform its services in the future. As the cyber threat and regulatory compliance landscape 
continues to evolve and the Company’s risk profile changes, it will be required to expend additional resources to enhance 
and implement new risk mitigation strategies.

Regulatory or Legislative Related Risks

The foreign currency exchange, legislative, tax, regulatory and economic risks associated with international 

operations could have an adverse effect on our operating results if we are unable to mitigate or hedge these 
risks.

We have operations in the United States and Canada in North America, in Belgium, Luxembourg, France, and the 

United Kingdom in Europe, in India, and in Colombia. Although our foreign operations conduct their business in their local 
currencies, these operations are subject to their own currency fluctuations, legislation, employment and tax law changes, 
and economic climates. These factors as they relate to our foreign operations are different from those of the United 
States. Although we actively manage these foreign operations with local management teams, our overall operating results 
may be negatively affected by local economic conditions, changes in foreign currency exchange rates, or tax, regulatory 
or other economic changes beyond our control.

12

In addition, any widespread outbreak of an illness, pandemic or other local or global health issue (including COVID-

19), natural disasters, climate change impacts, or uncertain political climates, international hostilities, or any terrorist 
activities, could adversely affect customer demand, the Company’s operations, and its ability to source and deliver 
services to its customers, which could have a material adverse effect on the Company’s financial results. For instance, the 
U.K. referendum to exit from the European Union, commonly referred to as “Brexit,” has caused global economic, trade 
and regulatory uncertainty. The Company continues to monitor the impact that the United Kingdom’s exit from the 
European Union (Brexit) has had on its operations. To date, there has been a nominal impact on the Company’s operating 
results from Brexit. As the total revenue generated by our British subsidiary is immaterial as compared with the 
Company’s total consolidated revenue, we do not expect the nominal impact the exit has had on the Company’s 
operations to date to change in the foreseeable future.

Government cuts in healthcare programs, such as Medicare, and delays in legislative or regulatory 
healthcare mandates could cause a reduction in IT spending by our healthcare clients, which could materially 
and adversely affect our revenue and results of operations.

The Company’s growth efforts include a focus on the healthcare market. Growth in this market depends on 

continued spending by our healthcare clients on IT projects. Cuts in government healthcare programs, such as 
sequestration, which has periodically cut Medicare reimbursements to hospitals and health systems, may result in 
reduced expenditures by our healthcare clients on IT projects. If additional government cuts in healthcare programs occur, 
whether due to the failure of Congress to adopt a budget, pass appropriations bills or raise the U.S. debt ceiling or for 
other reasons, there may be delays, reductions or cessation of funding to our clients, which could cause our clients to 
purchase less IT services from us, and materially and adversely affect our revenue and results of operations.

In addition, delays in implementation of legislative or regulatory healthcare mandates could adversely affect the IT 

spending by our healthcare clients to implement such mandates. If the implementation of existing or contemplated 
legislative or regulatory healthcare mandates are deferred, the resulting reduction in IT spending by our healthcare clients 
could materially and adversely affect our revenue and results of operations.

Changes in government regulations and laws affecting the IT services industry, and the industries in which 
our clients operate, including accounting principles and interpretations, and the taxation of domestic operations 
could adversely affect our results of operations.

Changing laws, regulations and standards relating to corporate governance and public disclosure, including the 

Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the Patient Protection 
and Affordable Care Act (PPACA), and new SEC regulations, create uncertainty for companies such as ours. These laws, 
regulations, and standards are subject to varying interpretations which, in many instances, is due to their lack of 
specificity. As a result, the application of these standards and regulations in practice may evolve over time as new 
guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance 
matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We are committed to 
maintaining high standards of corporate governance and public disclosure. As a result, our efforts to comply with evolving 
laws, tax regulations and other standards have resulted in, and are likely to continue to result in, increased general and 
administrative expenses and a diversion of management time and attention from revenue-generating activities to 
compliance activities. 

The Financial Accounting Standards Board (FASB), the SEC, and the Public Company Accounting Oversight Board 

(PCAOB) or other accounting rule making authorities have issued and may continue to issue new accounting rules or 
auditing standards that are different from those that we presently apply to our financial results. Such new accounting rules 
or auditing standards could require significant changes from the way we currently report our financial condition, results of 
operations or cash flows.

U.S. generally accepted accounting principles have been the subject of frequent changes in interpretations, and the 

frequency of future accounting policy changes may accelerate. Such future changes in financial accounting standards 
may have a significant effect on our reported results of operations, including results of transactions entered into before the 
effective date of the changes.

We are subject to income and other taxes in the United States (federal and state) and numerous foreign 

jurisdictions. Our provisions for income and other taxes and our tax liabilities in the future could be adversely affected by 
numerous factors. These factors include, but are not limited to, income before taxes being lower than anticipated in 
countries with lower statutory tax rates and higher than anticipated in countries with higher statutory tax rates, changes in 
the valuation of deferred tax assets and liabilities, and changes in various federal, state and international tax laws, 

13

(cid:85)(cid:72)(cid:74)(cid:88)(cid:79)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:68)(cid:70)(cid:70)(cid:82)(cid:88)(cid:81)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:83)(cid:85)(cid:76)(cid:81)(cid:70)(cid:76)(cid:83)(cid:79)(cid:72)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:83)(cid:85)(cid:72)(cid:87)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:85)(cid:72)(cid:82)(cid:73)(cid:15)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:70)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:68)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:79)(cid:92)(cid:3)(cid:76)(cid:80)(cid:83)(cid:68)(cid:70)(cid:87)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)
(cid:82)(cid:73)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:73)(cid:79)(cid:82)(cid:90)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:86)(cid:17)(cid:3)

(cid:36)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:53)(cid:76)(cid:86)(cid:78)(cid:86)

Risks to the Company from acquisitions include integration challenges, disruptions of the Company's core 

business, a failure to achieve objectives, and the assumption of liabilities.  

(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:85)(cid:72)(cid:74)(cid:88)(cid:79)(cid:68)(cid:85)(cid:79)(cid:92)(cid:3)(cid:72)(cid:89)(cid:68)(cid:79)(cid:88)(cid:68)(cid:87)(cid:72)(cid:86)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:76)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:10)(cid:86)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)(cid:76)(cid:81)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:73)(cid:76)(cid:87)(cid:86)(cid:3)(cid:69)(cid:92)(cid:3)(cid:72)(cid:91)(cid:83)(cid:68)(cid:81)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)

(cid:86)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:82)(cid:73)(cid:73)(cid:72)(cid:85)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:74)(cid:72)(cid:82)(cid:74)(cid:85)(cid:68)(cid:83)(cid:75)(cid:76)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:70)(cid:79)(cid:76)(cid:72)(cid:81)(cid:87)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:17)(cid:3)(cid:36)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:82)(cid:73)(cid:87)(cid:72)(cid:81)(cid:3)
(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:3)(cid:70)(cid:75)(cid:68)(cid:79)(cid:79)(cid:72)(cid:81)(cid:74)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:85)(cid:76)(cid:86)(cid:78)(cid:86)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:74)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:85)(cid:72)(cid:3)(cid:70)(cid:68)(cid:81)(cid:3)(cid:69)(cid:72)(cid:3)(cid:81)(cid:82)(cid:3)
(cid:68)(cid:86)(cid:86)(cid:88)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:80)(cid:68)(cid:81)(cid:68)(cid:74)(cid:72)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:86)(cid:88)(cid:70)(cid:70)(cid:72)(cid:86)(cid:86)(cid:73)(cid:88)(cid:79)(cid:79)(cid:92)(cid:15)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:10)(cid:86)(cid:3)(cid:70)(cid:82)(cid:85)(cid:72)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:69)(cid:72)(cid:3)
(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:79)(cid:92)(cid:3)(cid:71)(cid:76)(cid:86)(cid:85)(cid:88)(cid:83)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:73)(cid:87)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:86)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:79)(cid:76)(cid:93)(cid:72)(cid:71)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:74)(cid:76)(cid:70)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:83)(cid:83)(cid:82)(cid:85)(cid:87)(cid:88)(cid:81)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:69)(cid:72)(cid:3)(cid:68)(cid:89)(cid:68)(cid:76)(cid:79)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:82)(cid:81)(cid:3)(cid:68)(cid:70)(cid:70)(cid:72)(cid:83)(cid:87)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)(cid:87)(cid:72)(cid:85)(cid:80)(cid:86)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:85)(cid:76)(cid:86)(cid:78)(cid:86)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:68)(cid:81)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:73)(cid:68)(cid:76)(cid:79)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:70)(cid:75)(cid:76)(cid:72)(cid:89)(cid:72)(cid:3)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:74)(cid:76)(cid:70)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:81)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:73)(cid:76)(cid:87)(cid:3)(cid:76)(cid:80)(cid:83)(cid:85)(cid:82)(cid:89)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:69)(cid:82)(cid:85)(cid:85)(cid:82)(cid:90)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:3)(cid:68)(cid:80)(cid:82)(cid:88)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:80)(cid:82)(cid:81)(cid:72)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:73)(cid:88)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)
(cid:70)(cid:85)(cid:72)(cid:68)(cid:87)(cid:72)(cid:86)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:85)(cid:72)(cid:86)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:10)(cid:86)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:68)(cid:86)(cid:3)(cid:90)(cid:72)(cid:79)(cid:79)(cid:3)(cid:68)(cid:86)(cid:3)(cid:73)(cid:68)(cid:76)(cid:79)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:85)(cid:72)(cid:87)(cid:68)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:78)(cid:72)(cid:92)(cid:3)(cid:83)(cid:72)(cid:85)(cid:86)(cid:82)(cid:81)(cid:81)(cid:72)(cid:79)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:71)(cid:3)
(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:17)(cid:3)(cid:36)(cid:71)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:79)(cid:92)(cid:15)(cid:3)(cid:73)(cid:68)(cid:76)(cid:79)(cid:88)(cid:85)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:72)(cid:72)(cid:87)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:81)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:70)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:79)(cid:72)(cid:68)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:76)(cid:80)(cid:83)(cid:68)(cid:76)(cid:85)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:70)(cid:75)(cid:68)(cid:85)(cid:74)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:76)(cid:81)(cid:87)(cid:68)(cid:81)(cid:74)(cid:76)(cid:69)(cid:79)(cid:72)(cid:3)
(cid:68)(cid:86)(cid:86)(cid:72)(cid:87)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:74)(cid:82)(cid:82)(cid:71)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:76)(cid:81)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:86)(cid:17)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:79)(cid:79)(cid:92)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:86)(cid:86)(cid:88)(cid:80)(cid:83)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:79)(cid:76)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:79)(cid:76)(cid:87)(cid:76)(cid:74)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:79)(cid:72)(cid:74)(cid:68)(cid:79)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:72)(cid:71)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)
(cid:76)(cid:81)(cid:89)(cid:82)(cid:79)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:71)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:3)(cid:85)(cid:76)(cid:86)(cid:78)(cid:17)

(cid:38)(cid:68)(cid:83)(cid:76)(cid:87)(cid:68)(cid:79)(cid:3)(cid:53)(cid:72)(cid:86)(cid:82)(cid:88)(cid:85)(cid:70)(cid:72)(cid:86)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:53)(cid:76)(cid:86)(cid:78)(cid:86)

We may require additional capital to support our business, and this capital may not be available to us on 

acceptable terms, if at all.

(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:68)(cid:3)(cid:70)(cid:85)(cid:72)(cid:71)(cid:76)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:86)(cid:72)(cid:70)(cid:88)(cid:85)(cid:76)(cid:87)(cid:92)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:11)(cid:87)(cid:75)(cid:72)(cid:3)(cid:179)(cid:38)(cid:85)(cid:72)(cid:71)(cid:76)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:54)(cid:72)(cid:70)(cid:88)(cid:85)(cid:76)(cid:87)(cid:92)(cid:3)(cid:36)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:180)(cid:12)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:69)(cid:68)(cid:81)(cid:78)(cid:15)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)
(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:68)(cid:3)(cid:87)(cid:75)(cid:85)(cid:72)(cid:72)(cid:16)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:85)(cid:72)(cid:89)(cid:82)(cid:79)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:85)(cid:72)(cid:71)(cid:76)(cid:87)(cid:3)(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:81)(cid:3)(cid:68)(cid:74)(cid:74)(cid:85)(cid:72)(cid:74)(cid:68)(cid:87)(cid:72)(cid:3)(cid:83)(cid:85)(cid:76)(cid:81)(cid:70)(cid:76)(cid:83)(cid:68)(cid:79)(cid:3)(cid:68)(cid:80)(cid:82)(cid:88)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:7)(cid:23)(cid:24)(cid:17)(cid:19)(cid:3)(cid:80)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:79)(cid:76)(cid:80)(cid:76)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:7)(cid:20)(cid:19)(cid:17)(cid:19)(cid:3)(cid:80)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:79)(cid:72)(cid:87)(cid:87)(cid:72)(cid:85)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:70)(cid:85)(cid:72)(cid:71)(cid:76)(cid:87)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:85)(cid:72)(cid:71)(cid:76)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:54)(cid:72)(cid:70)(cid:88)(cid:85)(cid:76)(cid:87)(cid:92)(cid:3)(cid:36)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:68)(cid:80)(cid:72)(cid:81)(cid:71)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:21)(cid:22)(cid:15)(cid:3)(cid:21)(cid:19)(cid:20)(cid:28)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:91)(cid:87)(cid:72)(cid:81)(cid:71)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)
(cid:87)(cid:72)(cid:85)(cid:80)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:85)(cid:72)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:81)(cid:82)(cid:90)(cid:3)(cid:72)(cid:91)(cid:83)(cid:76)(cid:85)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:21)(cid:19)(cid:21)(cid:21)(cid:17)(cid:3)(cid:36)(cid:87)(cid:3)(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:22)(cid:20)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:75)(cid:68)(cid:71)(cid:3)(cid:81)(cid:82)(cid:3)(cid:69)(cid:82)(cid:85)(cid:85)(cid:82)(cid:90)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:82)(cid:88)(cid:87)(cid:86)(cid:87)(cid:68)(cid:81)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)
(cid:82)(cid:88)(cid:85)(cid:3)(cid:85)(cid:72)(cid:89)(cid:82)(cid:79)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:85)(cid:72)(cid:71)(cid:76)(cid:87)(cid:3)(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:69)(cid:72)(cid:3)(cid:71)(cid:72)(cid:83)(cid:72)(cid:81)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:81)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:85)(cid:72)(cid:89)(cid:82)(cid:79)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:85)(cid:72)(cid:71)(cid:76)(cid:87)(cid:3)(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:72)(cid:72)(cid:87)(cid:3)(cid:90)(cid:82)(cid:85)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:68)(cid:83)(cid:76)(cid:87)(cid:68)(cid:79)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)
(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:70)(cid:70)(cid:72)(cid:86)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:76)(cid:86)(cid:3)(cid:71)(cid:72)(cid:83)(cid:72)(cid:81)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:81)(cid:15)(cid:3)(cid:68)(cid:80)(cid:82)(cid:81)(cid:74)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:76)(cid:81)(cid:74)(cid:86)(cid:15)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:79)(cid:76)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:68)(cid:83)(cid:83)(cid:79)(cid:76)(cid:70)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)
(cid:70)(cid:82)(cid:89)(cid:72)(cid:81)(cid:68)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:73)(cid:76)(cid:91)(cid:72)(cid:71)(cid:3)(cid:70)(cid:75)(cid:68)(cid:85)(cid:74)(cid:72)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:74)(cid:72)(cid:3)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:15)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:72)(cid:68)(cid:85)(cid:81)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:69)(cid:72)(cid:73)(cid:82)(cid:85)(cid:72)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:72)(cid:86)(cid:87)(cid:15)(cid:3)(cid:87)(cid:68)(cid:91)(cid:72)(cid:86)(cid:15)(cid:3)(cid:71)(cid:72)(cid:83)(cid:85)(cid:72)(cid:70)(cid:76)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)
(cid:68)(cid:80)(cid:82)(cid:85)(cid:87)(cid:76)(cid:93)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:11)(cid:40)(cid:37)(cid:44)(cid:55)(cid:39)(cid:36)(cid:12)(cid:3)(cid:87)(cid:68)(cid:85)(cid:74)(cid:72)(cid:87)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:3)(cid:79)(cid:76)(cid:80)(cid:76)(cid:87)(cid:3)(cid:82)(cid:81)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:72)(cid:91)(cid:83)(cid:72)(cid:81)(cid:71)(cid:76)(cid:87)(cid:88)(cid:85)(cid:72)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:83)(cid:85)(cid:82)(cid:83)(cid:72)(cid:85)(cid:87)(cid:92)(cid:15)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:87)(cid:15)(cid:3)(cid:72)(cid:84)(cid:88)(cid:76)(cid:83)(cid:80)(cid:72)(cid:81)(cid:87)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:68)(cid:83)(cid:76)(cid:87)(cid:68)(cid:79)(cid:76)(cid:93)(cid:72)(cid:71)(cid:3)
(cid:86)(cid:82)(cid:73)(cid:87)(cid:90)(cid:68)(cid:85)(cid:72)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:73)(cid:76)(cid:91)(cid:72)(cid:71)(cid:3)(cid:70)(cid:75)(cid:68)(cid:85)(cid:74)(cid:72)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:74)(cid:72)(cid:3)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:3)(cid:76)(cid:86)(cid:3)(cid:82)(cid:81)(cid:79)(cid:92)(cid:3)(cid:87)(cid:72)(cid:86)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:73)(cid:3)(cid:68)(cid:89)(cid:68)(cid:76)(cid:79)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:82)(cid:81)(cid:3)(cid:68)(cid:3)(cid:80)(cid:72)(cid:68)(cid:86)(cid:88)(cid:85)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:3)(cid:76)(cid:86)(cid:3)(cid:69)(cid:72)(cid:79)(cid:82)(cid:90)(cid:3)(cid:68)(cid:3)(cid:87)(cid:75)(cid:85)(cid:72)(cid:86)(cid:75)(cid:82)(cid:79)(cid:71)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)
(cid:68)(cid:80)(cid:82)(cid:88)(cid:81)(cid:87)(cid:3)(cid:68)(cid:89)(cid:68)(cid:76)(cid:79)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:69)(cid:82)(cid:85)(cid:85)(cid:82)(cid:90)(cid:76)(cid:81)(cid:74)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:89)(cid:82)(cid:79)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:85)(cid:72)(cid:71)(cid:76)(cid:87)(cid:3)(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:70)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:69)(cid:72)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:79)(cid:92)(cid:3)(cid:85)(cid:72)(cid:71)(cid:88)(cid:70)(cid:72)(cid:71)(cid:3)(cid:71)(cid:88)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:82)(cid:82)(cid:85)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)
(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:17)(cid:3)(cid:36)(cid:81)(cid:92)(cid:3)(cid:79)(cid:82)(cid:86)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:71)(cid:88)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:70)(cid:70)(cid:72)(cid:86)(cid:86)(cid:3)(cid:73)(cid:88)(cid:81)(cid:71)(cid:86)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:89)(cid:82)(cid:79)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:85)(cid:72)(cid:71)(cid:76)(cid:87)(cid:3)
(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:70)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:81)(cid:72)(cid:74)(cid:68)(cid:87)(cid:76)(cid:89)(cid:72)(cid:79)(cid:92)(cid:3)(cid:76)(cid:80)(cid:83)(cid:68)(cid:70)(cid:87)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:79)(cid:76)(cid:84)(cid:88)(cid:76)(cid:71)(cid:76)(cid:87)(cid:92)(cid:17)

(cid:53)(cid:76)(cid:86)(cid:78)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:36)(cid:70)(cid:87)(cid:76)(cid:89)(cid:76)(cid:86)(cid:87)(cid:3)(cid:54)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)

Actions of activist stockholders could cause us to incur substantial costs, divert management’s and the 

board’s attention and resources, and have an adverse effect on our business and stock price.

(cid:41)(cid:85)(cid:82)(cid:80)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:69)(cid:72)(cid:3)(cid:86)(cid:88)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:85)(cid:82)(cid:83)(cid:82)(cid:86)(cid:68)(cid:79)(cid:86)(cid:3)(cid:69)(cid:92)(cid:3)(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:3)(cid:88)(cid:85)(cid:74)(cid:76)(cid:81)(cid:74)(cid:3)(cid:88)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:68)(cid:78)(cid:72)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:68)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:68)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:17)(cid:3)(cid:44)(cid:73)(cid:3)

(cid:68)(cid:70)(cid:87)(cid:76)(cid:89)(cid:76)(cid:86)(cid:87)(cid:3)(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:68)(cid:70)(cid:87)(cid:76)(cid:89)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:72)(cid:81)(cid:86)(cid:88)(cid:72)(cid:15)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:70)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:69)(cid:72)(cid:3)(cid:68)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:86)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:85)(cid:82)(cid:91)(cid:92)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:72)(cid:86)(cid:87)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)
(cid:85)(cid:72)(cid:68)(cid:70)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:68)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:69)(cid:92)(cid:3)(cid:68)(cid:70)(cid:87)(cid:76)(cid:89)(cid:76)(cid:86)(cid:87)(cid:3)(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:3)(cid:70)(cid:68)(cid:81)(cid:3)(cid:69)(cid:72)(cid:3)(cid:70)(cid:82)(cid:86)(cid:87)(cid:79)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:16)(cid:70)(cid:82)(cid:81)(cid:86)(cid:88)(cid:80)(cid:76)(cid:81)(cid:74)(cid:15)(cid:3)(cid:71)(cid:76)(cid:86)(cid:85)(cid:88)(cid:83)(cid:87)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:71)(cid:76)(cid:89)(cid:72)(cid:85)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:68)(cid:87)(cid:87)(cid:72)(cid:81)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:80)(cid:68)(cid:81)(cid:68)(cid:74)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:69)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)(cid:71)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:15)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:82)(cid:73)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:70)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:73)(cid:72)(cid:85)(cid:72)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:72)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:74)(cid:76)(cid:70)(cid:3)
(cid:83)(cid:79)(cid:68)(cid:81)(cid:17)(cid:3)(cid:58)(cid:72)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:69)(cid:72)(cid:3)(cid:85)(cid:72)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:85)(cid:72)(cid:87)(cid:68)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:89)(cid:68)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:73)(cid:72)(cid:86)(cid:86)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:71)(cid:89)(cid:76)(cid:86)(cid:72)(cid:3)(cid:88)(cid:86)(cid:3)(cid:82)(cid:81)(cid:3)(cid:68)(cid:70)(cid:87)(cid:76)(cid:89)(cid:76)(cid:86)(cid:87)(cid:3)(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:80)(cid:68)(cid:87)(cid:87)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)
(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:79)(cid:72)(cid:74)(cid:68)(cid:79)(cid:15)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:88)(cid:81)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:68)(cid:71)(cid:89)(cid:76)(cid:86)(cid:82)(cid:85)(cid:86)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:86)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:68)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:17)(cid:3)(cid:44)(cid:81)(cid:3)
(cid:68)(cid:71)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:70)(cid:72)(cid:76)(cid:89)(cid:72)(cid:71)(cid:3)(cid:88)(cid:81)(cid:70)(cid:72)(cid:85)(cid:87)(cid:68)(cid:76)(cid:81)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:71)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:74)(cid:92)(cid:3)(cid:82)(cid:85)(cid:3)(cid:79)(cid:72)(cid:68)(cid:71)(cid:72)(cid:85)(cid:86)(cid:75)(cid:76)(cid:83)(cid:3)(cid:70)(cid:85)(cid:72)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:86)(cid:3)(cid:68)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:84)(cid:88)(cid:72)(cid:81)(cid:70)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:70)(cid:87)(cid:76)(cid:89)(cid:76)(cid:86)(cid:87)(cid:3)
(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:76)(cid:81)(cid:76)(cid:87)(cid:76)(cid:68)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:79)(cid:82)(cid:86)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:83)(cid:82)(cid:87)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:79)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:82)(cid:83)(cid:83)(cid:82)(cid:85)(cid:87)(cid:88)(cid:81)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:75)(cid:68)(cid:85)(cid:80)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:87)(cid:87)(cid:85)(cid:68)(cid:70)(cid:87)(cid:3)(cid:81)(cid:72)(cid:90)(cid:3)(cid:76)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:82)(cid:85)(cid:86)(cid:15)(cid:3)
(cid:70)(cid:79)(cid:76)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:83)(cid:85)(cid:76)(cid:70)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:91)(cid:83)(cid:72)(cid:85)(cid:76)(cid:72)(cid:81)(cid:70)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:89)(cid:82)(cid:79)(cid:68)(cid:87)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:82)(cid:85)(cid:3)(cid:86)(cid:87)(cid:68)(cid:74)(cid:81)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:17)

(cid:54)(cid:75)(cid:68)(cid:85)(cid:72)(cid:3)(cid:51)(cid:85)(cid:76)(cid:70)(cid:72)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:53)(cid:76)(cid:86)(cid:78)(cid:86)

Our share price could fluctuate and be difficult to predict.

(cid:50)(cid:88)(cid:85)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:3)(cid:83)(cid:85)(cid:76)(cid:70)(cid:72)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:73)(cid:79)(cid:88)(cid:70)(cid:87)(cid:88)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:68)(cid:86)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:76)(cid:81)(cid:88)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:73)(cid:79)(cid:88)(cid:70)(cid:87)(cid:88)(cid:68)(cid:87)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:86)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:89)(cid:68)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:15)(cid:3)

(cid:69)(cid:82)(cid:87)(cid:75)(cid:3)(cid:72)(cid:91)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:29)

(cid:129)

(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:80)(cid:68)(cid:70)(cid:85)(cid:82)(cid:72)(cid:70)(cid:82)(cid:81)(cid:82)(cid:80)(cid:76)(cid:70)(cid:3)(cid:82)(cid:85)(cid:3)(cid:83)(cid:82)(cid:79)(cid:76)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:88)(cid:81)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:74)(cid:72)(cid:82)(cid:74)(cid:85)(cid:68)(cid:83)(cid:75)(cid:76)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:90)(cid:72)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:30)

(cid:20)(cid:23)

(cid:129)

(cid:129)

(cid:129)

(cid:129)

(cid:129)

(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:3)(cid:82)(cid:85)(cid:3)(cid:76)(cid:81)(cid:71)(cid:88)(cid:86)(cid:87)(cid:85)(cid:92)(cid:16)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:76)(cid:70)(cid:3)(cid:80)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:3)(cid:70)(cid:82)(cid:81)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:80)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:86)(cid:30)

(cid:82)(cid:88)(cid:85)(cid:3)(cid:73)(cid:68)(cid:76)(cid:79)(cid:88)(cid:85)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:72)(cid:72)(cid:87)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)(cid:82)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:11)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:15)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:80)(cid:68)(cid:85)(cid:74)(cid:76)(cid:81)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:72)(cid:68)(cid:85)(cid:81)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:83)(cid:72)(cid:85)(cid:3)
(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:3)(cid:87)(cid:68)(cid:85)(cid:74)(cid:72)(cid:87)(cid:86)(cid:12)(cid:30)

(cid:82)(cid:88)(cid:85)(cid:3)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:73)(cid:79)(cid:82)(cid:90)(cid:3)(cid:87)(cid:82)(cid:3)(cid:85)(cid:72)(cid:87)(cid:88)(cid:85)(cid:81)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:87)(cid:82)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:3)(cid:68)(cid:87)(cid:3)(cid:75)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:86)(cid:3)(cid:72)(cid:91)(cid:83)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)
(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:30)

(cid:68)(cid:81)(cid:81)(cid:82)(cid:88)(cid:81)(cid:70)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:69)(cid:92)(cid:3)(cid:88)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:87)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:68)(cid:69)(cid:82)(cid:88)(cid:87)(cid:3)(cid:71)(cid:72)(cid:89)(cid:72)(cid:79)(cid:82)(cid:83)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:83)(cid:85)(cid:82)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:86)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)

(cid:83)(cid:85)(cid:82)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:88)(cid:79)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:68)(cid:69)(cid:82)(cid:88)(cid:87)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:80)(cid:72)(cid:71)(cid:76)(cid:68)(cid:3)(cid:82)(cid:85)(cid:3)(cid:76)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:68)(cid:79)(cid:92)(cid:86)(cid:87)(cid:86)(cid:17)

Item 1B.

Unresolved Staff Comments

(cid:49)(cid:82)(cid:81)(cid:72)(cid:17)

Item 2.

Properties

(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:83)(cid:85)(cid:72)(cid:89)(cid:76)(cid:82)(cid:88)(cid:86)(cid:79)(cid:92)(cid:3)(cid:82)(cid:90)(cid:81)(cid:72)(cid:71)(cid:3)(cid:68)(cid:3)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:69)(cid:88)(cid:76)(cid:79)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:87)(cid:3)(cid:26)(cid:19)(cid:19)(cid:3)(cid:39)(cid:72)(cid:79)(cid:68)(cid:90)(cid:68)(cid:85)(cid:72)(cid:3)(cid:36)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)

(cid:75)(cid:72)(cid:68)(cid:71)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:86)(cid:3)(cid:68)(cid:87)(cid:3)(cid:27)(cid:19)(cid:19)(cid:3)(cid:39)(cid:72)(cid:79)(cid:68)(cid:90)(cid:68)(cid:85)(cid:72)(cid:3)(cid:36)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:15)(cid:3)(cid:79)(cid:82)(cid:70)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:37)(cid:88)(cid:73)(cid:73)(cid:68)(cid:79)(cid:82)(cid:15)(cid:3)(cid:49)(cid:72)(cid:90)(cid:3)(cid:60)(cid:82)(cid:85)(cid:78)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:86)(cid:82)(cid:79)(cid:71)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:26)(cid:19)(cid:19)(cid:3)(cid:39)(cid:72)(cid:79)(cid:68)(cid:90)(cid:68)(cid:85)(cid:72)(cid:3)(cid:36)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)
(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:68)(cid:71)(cid:80)(cid:76)(cid:81)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:69)(cid:88)(cid:76)(cid:79)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)(cid:3)(cid:41)(cid:72)(cid:69)(cid:85)(cid:88)(cid:68)(cid:85)(cid:92)(cid:3)(cid:21)(cid:19)(cid:20)(cid:27)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:7)(cid:20)(cid:17)(cid:27)(cid:3)(cid:80)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:82)(cid:82)(cid:78)(cid:3)(cid:89)(cid:68)(cid:79)(cid:88)(cid:72)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:7)(cid:20)(cid:17)(cid:25)(cid:3)(cid:80)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:72)(cid:71)(cid:3)
(cid:68)(cid:81)(cid:3)(cid:76)(cid:80)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:74)(cid:68)(cid:76)(cid:81)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:68)(cid:79)(cid:72)(cid:17)(cid:3)(cid:39)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:3)(cid:86)(cid:72)(cid:70)(cid:82)(cid:81)(cid:71)(cid:3)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:86)(cid:82)(cid:79)(cid:71)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:27)(cid:19)(cid:19)(cid:3)(cid:39)(cid:72)(cid:79)(cid:68)(cid:90)(cid:68)(cid:85)(cid:72)(cid:3)(cid:36)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)
(cid:75)(cid:72)(cid:68)(cid:71)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:86)(cid:17)(cid:3)(cid:36)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:68)(cid:79)(cid:72)(cid:3)(cid:83)(cid:85)(cid:76)(cid:70)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:88)(cid:76)(cid:79)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:7)(cid:21)(cid:17)(cid:24)(cid:3)(cid:80)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:82)(cid:82)(cid:78)(cid:3)(cid:89)(cid:68)(cid:79)(cid:88)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:88)(cid:76)(cid:79)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:91)(cid:76)(cid:80)(cid:68)(cid:87)(cid:72)(cid:79)(cid:92)(cid:3)
(cid:7)(cid:20)(cid:17)(cid:25)(cid:3)(cid:80)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:72)(cid:71)(cid:3)(cid:68)(cid:3)(cid:74)(cid:68)(cid:76)(cid:81)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:68)(cid:79)(cid:72)(cid:3)(cid:68)(cid:73)(cid:87)(cid:72)(cid:85)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:72)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:69)(cid:82)(cid:88)(cid:87)(cid:3)(cid:7)(cid:19)(cid:17)(cid:27)(cid:3)(cid:80)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:3)(cid:86)(cid:72)(cid:70)(cid:82)(cid:81)(cid:71)(cid:3)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:17)

(cid:36)(cid:79)(cid:79)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:80)(cid:68)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:79)(cid:82)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:87)(cid:82)(cid:87)(cid:68)(cid:79)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:91)(cid:76)(cid:80)(cid:68)(cid:87)(cid:72)(cid:79)(cid:92)(cid:3)(cid:21)(cid:24)(cid:3)(cid:86)(cid:76)(cid:87)(cid:72)(cid:86)(cid:15)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:79)(cid:72)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:17)(cid:3)(cid:48)(cid:82)(cid:86)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)

(cid:68)(cid:85)(cid:72)(cid:3)(cid:79)(cid:82)(cid:70)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:56)(cid:81)(cid:76)(cid:87)(cid:72)(cid:71)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:72)(cid:86)(cid:15)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:20)(cid:20)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:79)(cid:82)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:40)(cid:88)(cid:85)(cid:82)(cid:83)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:88)(cid:81)(cid:87)(cid:85)(cid:76)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:37)(cid:72)(cid:79)(cid:74)(cid:76)(cid:88)(cid:80)(cid:15)(cid:3)(cid:47)(cid:88)(cid:91)(cid:72)(cid:80)(cid:69)(cid:82)(cid:88)(cid:85)(cid:74)(cid:15)(cid:3)(cid:41)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:56)(cid:81)(cid:76)(cid:87)(cid:72)(cid:71)(cid:3)(cid:46)(cid:76)(cid:81)(cid:74)(cid:71)(cid:82)(cid:80)(cid:15)(cid:3)(cid:90)(cid:75)(cid:72)(cid:85)(cid:72)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:40)(cid:88)(cid:85)(cid:82)(cid:83)(cid:72)(cid:68)(cid:81)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:79)(cid:82)(cid:70)(cid:68)(cid:87)(cid:72)(cid:71)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:82)(cid:81)(cid:72)(cid:3)(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:76)(cid:81)(cid:3)(cid:38)(cid:68)(cid:81)(cid:68)(cid:71)(cid:68)(cid:15)(cid:3)(cid:44)(cid:81)(cid:71)(cid:76)(cid:68)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:38)(cid:82)(cid:79)(cid:82)(cid:80)(cid:69)(cid:76)(cid:68)(cid:17)(cid:3)
(cid:55)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:86)(cid:72)(cid:85)(cid:89)(cid:72)(cid:3)(cid:68)(cid:86)(cid:3)(cid:86)(cid:68)(cid:79)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:86)(cid:88)(cid:83)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:76)(cid:85)(cid:3)(cid:86)(cid:76)(cid:93)(cid:72)(cid:3)(cid:89)(cid:68)(cid:85)(cid:76)(cid:72)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:81)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:82)(cid:73)(cid:3)(cid:83)(cid:72)(cid:82)(cid:83)(cid:79)(cid:72)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:71)(cid:3)(cid:68)(cid:87)(cid:3)
(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:15)(cid:3)(cid:85)(cid:68)(cid:81)(cid:74)(cid:76)(cid:81)(cid:74)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:91)(cid:76)(cid:80)(cid:68)(cid:87)(cid:72)(cid:79)(cid:92)(cid:3)(cid:21)(cid:19)(cid:19)(cid:3)(cid:87)(cid:82)(cid:3)(cid:21)(cid:22)(cid:15)(cid:19)(cid:19)(cid:19)(cid:3)(cid:86)(cid:84)(cid:88)(cid:68)(cid:85)(cid:72)(cid:3)(cid:73)(cid:72)(cid:72)(cid:87)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:79)(cid:72)(cid:68)(cid:86)(cid:72)(cid:3)(cid:87)(cid:72)(cid:85)(cid:80)(cid:86)(cid:3)(cid:89)(cid:68)(cid:85)(cid:92)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:79)(cid:72)(cid:86)(cid:86)(cid:3)
(cid:87)(cid:75)(cid:68)(cid:81)(cid:3)(cid:68)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:87)(cid:82)(cid:3)(cid:73)(cid:76)(cid:73)(cid:87)(cid:72)(cid:72)(cid:81)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:92)(cid:83)(cid:76)(cid:70)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:73)(cid:79)(cid:72)(cid:91)(cid:76)(cid:69)(cid:79)(cid:72)(cid:3)(cid:85)(cid:72)(cid:81)(cid:72)(cid:90)(cid:68)(cid:79)(cid:3)(cid:82)(cid:83)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:69)(cid:72)(cid:79)(cid:76)(cid:72)(cid:89)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:79)(cid:72)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:73)(cid:68)(cid:70)(cid:76)(cid:79)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)
(cid:68)(cid:71)(cid:72)(cid:84)(cid:88)(cid:68)(cid:87)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:88)(cid:83)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:70)(cid:88)(cid:85)(cid:85)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:81)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:81)(cid:72)(cid:72)(cid:71)(cid:86)(cid:17)

Item 3.

Legal Proceedings

(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:76)(cid:81)(cid:89)(cid:82)(cid:79)(cid:89)(cid:72)(cid:71)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:89)(cid:68)(cid:85)(cid:76)(cid:82)(cid:88)(cid:86)(cid:3)(cid:79)(cid:72)(cid:74)(cid:68)(cid:79)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:72)(cid:71)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:68)(cid:85)(cid:76)(cid:86)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:82)(cid:85)(cid:71)(cid:76)(cid:81)(cid:68)(cid:85)(cid:92)(cid:3)

(cid:70)(cid:82)(cid:88)(cid:85)(cid:86)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:17)(cid:3)(cid:36)(cid:79)(cid:87)(cid:75)(cid:82)(cid:88)(cid:74)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:82)(cid:88)(cid:87)(cid:70)(cid:82)(cid:80)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:79)(cid:68)(cid:90)(cid:86)(cid:88)(cid:76)(cid:87)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:72)(cid:71)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:76)(cid:81)(cid:89)(cid:82)(cid:79)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:76)(cid:72)(cid:86)(cid:3)
(cid:70)(cid:68)(cid:81)(cid:81)(cid:82)(cid:87)(cid:3)(cid:69)(cid:72)(cid:3)(cid:83)(cid:85)(cid:72)(cid:71)(cid:76)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:68)(cid:76)(cid:81)(cid:87)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:80)(cid:82)(cid:88)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:79)(cid:76)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:70)(cid:82)(cid:88)(cid:79)(cid:71)(cid:3)(cid:68)(cid:85)(cid:76)(cid:86)(cid:72)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:79)(cid:68)(cid:90)(cid:86)(cid:88)(cid:76)(cid:87)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)
(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:72)(cid:71)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:70)(cid:68)(cid:81)(cid:81)(cid:82)(cid:87)(cid:3)(cid:69)(cid:72)(cid:3)(cid:83)(cid:85)(cid:72)(cid:71)(cid:76)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:70)(cid:70)(cid:88)(cid:85)(cid:68)(cid:87)(cid:72)(cid:79)(cid:92)(cid:15)(cid:3)(cid:80)(cid:68)(cid:81)(cid:68)(cid:74)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:71)(cid:82)(cid:72)(cid:86)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:72)(cid:91)(cid:83)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:80)(cid:68)(cid:87)(cid:87)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)(cid:76)(cid:73)(cid:3)(cid:68)(cid:81)(cid:92)(cid:15)(cid:3)(cid:87)(cid:82)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)
(cid:68)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:72)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:83)(cid:82)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:73)(cid:79)(cid:82)(cid:90)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:17)

Item 4.

Mine Safety Disclosures

(cid:49)(cid:82)(cid:87)(cid:3)(cid:68)(cid:83)(cid:83)(cid:79)(cid:76)(cid:70)(cid:68)(cid:69)(cid:79)(cid:72)(cid:17)

(cid:20)(cid:24)

PART II

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity 
Securities

Stock Market Information

The Company’s common stock is traded on The NASDAQ Stock Market LLC under the symbol CTG. The following 
table sets forth the high and low sales prices for the Company’s common stock for each quarter of the previous two years.

Stock Price
Year Ended December 31, 2020
Fourth Quarter
Third Quarter
Second Quarter
First Quarter
Year Ended December 31, 2019
Fourth Quarter
Third Quarter
Second Quarter
First Quarter

High

Low

7.30    $
5.38    $
4.61    $
6.48    $

6.23    $
5.82    $
4.89    $
4.78    $

4.68 
4.01 
3.50 
2.86 

4.70 
3.98 
3.99 
3.90  

  $
  $
  $
  $

  $
  $
  $
  $

On March 5, 2021, there were 1,226 holders of record of the Company’s common shares. The Company currently 
does not pay a dividend. A dividend was last paid in the 2016 fourth quarter. At December 31, 2020, under the terms of 
the Company's revolving credit facility, the Company is required to meet certain financial covenants in order to pay 
dividends. The Company was in compliance with these financial covenants at both December 31, 2020 and 2019. For 
additional information regarding these financial covenants, see Item 7, "Management's Discussion and Analysis of 
Financial Condition and Results of Operations - Financial Condition and Liquidity." The determination of the timing, 
amount and the payment of dividends, if any, on the Company’s common stock in the future is at the discretion of the 
Board of Directors and will depend upon, among other things, the Company’s profitability, liquidity, financial condition, 
capital requirements, and compliance with the covenants under the Company's Credit and Security agreement. The 
Company currently has no intention to pay a dividend in the foreseeable future.

For information concerning common stock issued in connection with the Company’s equity compensation plans, see 

Item 12, “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”

Issuer Purchases of Equity Securities

The Company’s Board of Directors has authorized the repurchase of its stock up to a total of $30.0 million. As of 
March 12, 2021, the Company had repurchased approximately $22.3 million shares pursuant to the authorization, leaving 
a remaining authorization of approximately $7.7 million. No shares were purchased during 2020 under this authorization.

The information below for the fiscal fourth quarter of 2020 does not include shares withheld by or surrendered to the 

Company either to satisfy the exercise cost for the cashless exercise of employee stock options, or to satisfy tax 
withholding obligations associated with employee equity awards as the number of shares is minor.

Period
September 26 - October 31
November 1 - November 30
December 1 - December 31

Total

*  Excludes broker commissions

Total
Number
of Shares
Purchased

Average
Price
Paid per
Share*

  Total Number

of Shares
  Purchased as  
  Part of Publicly  
  Announced Plans 
or Programs

Maximum

  Dollar Amount
that May Yet
  be Purchased  
  Under the Plans  
  Or Programs  
7,727,724 
7,727,724 
7,727,724 

—    $
—    $
—    $
—       

—    $
—    $
—    $
—    $

—     
—     
—     
—     

16

 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
   
 
 
   
 
 
 
 
 
 
   
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
 
 
     
       
       
       
 
     
       
       
       
 
Company Performance Graph

The following graph displays a five-year comparison of cumulative total shareholder returns for the Company’s 
common stock, the S&P 500 Index, and the Dow Jones U.S. Computer Services Index, assuming a base index of $100 at 
the end of 2015. The cumulative total return for each annual period within the five years presented is measured by 
dividing (1) the sum of (A) the cumulative amount of dividends for the period, assuming dividend reinvestment, and (B) the 
difference between the Company’s share price at the end and the beginning of the period by (2) the share price at the 
beginning of the period. The calculations were made excluding trading commissions and taxes.

Comparison of Cumulative Five Year Total Return 

Computer Task Group, Inc.
S&P 500 Index
Dow Jones U.S. Computer Services Index

Base
Period

Indexed Returns
Years Ending

  December     December     December     December     December     December  

2015

2016

2017

2018

2019

2020

  $ 100.00    $
79.95 
  $ 100.00    $ 111.96    $ 136.40 
  $ 100.00    $ 117.44    $ 129.69 

66.00    $

 $
63.96 
 $ 130.42 
 $ 114.14 

 $
81.21 
 $ 171.49 
 $ 143.98 

 $
95.94 
 $ 203.04 
 $ 164.56  

The information included under this section entitled “Company Performance Graph” is deemed not to be “soliciting 

material” or “filed” with the SEC, is not subject to the liabilities of Section 18 of the Exchange Act, and shall not be deemed 
incorporated by reference into any of the filings previously made or made in the future by the Company under the 
Exchange Act or the Securities Act of 1933, except to the extent the Company specifically incorporates any such 
information into a document that is filed.

17

 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 6.

Selected Financial Data

Consolidated Summary—Five-Year Selected Financial Information

The selected operating data and financial position information set forth below for each of the years in the five-year 
period ended December 31, 2020 has been derived from the Company’s audited consolidated financial statements. This 
information should be read in conjunction with the audited consolidated financial statements and notes thereto in Item 8, 
“Financial Statements and Supplementary Data” included in this report.

(amounts in millions, except per-share data)  
Operating Data
  $
Revenue
  $
Operating income (loss)
Net income (loss)
  $
Basic net income (loss) per share   $
Diluted net income (loss) per share   $
  $
Cash dividend per share

Financial Position
Working capital
Total assets
Long-term debt
Shareholders’ equity

  $
  $
  $
  $

2020
(1)

2019
(2)

2018
(3)

2017
(4)

2016
(5)

366.1    $
9.1    $
7.6    $
0.56    $
0.53    $
—    $

52.0    $
176.3    $
0.0    $
79.5    $

394.2    $
6.9    $
4.1    $
0.31    $
0.29    $
—    $

45.0    $
158.7    $
5.3    $
66.2    $

358.8    $
2.1    $
(2.8)   $
(0.20)   $
(0.20)   $
—    $

51.9    $
124.1    $
3.6    $
64.2    $

301.2    $
3.9    $
0.8    $
0.05    $
0.05    $
—    $

50.8    $
127.6    $
4.4    $
78.6    $

324.9 
(33.3)
(34.6)
(2.22)
(2.22)
0.18 

53.7 
126.9 
4.7 
78.8  

(1) During 2020, the Company incurred acquisition-related legal and consulting fees, adjustments to the fair value of 
earn-out liabilities, and amortization of intangible assets of approximately $1.6 million, and severance charges of 
$0.6 million.  These expenses were offset with a gain from a sale of a building of $0.8 million, and gains from non-
taxable life insurance from former executives that passed away of $1.0 million. These items increased net income by 
approximately $0.2 million, or $0.01 basic and diluted earnings per share.

(2) During 2019, the Company incurred acquisition-related legal and consulting fees, adjustments to the fair value of 

earn-out liabilities, and amortization of intangible assets of approximately $2.3 million.  These expenses reduced net 
income by approximately $1.5 million, or $0.11 basic and diluted earnings per share.

(3) During 2018, the Company recorded a valuation allowance against its U.S. deferred tax assets for $4.1 million 

based on the history of U.S. losses for tax purposes and uncertain profitability in future years. The Company 
incurred acquisition-related legal and consulting fees, adjustments to the fair value of the earn-out liability, and 
amortization of intangible assets of approximately $2.0 million. The Company also recorded severance of 
approximately $0.7 million for former executives. Finally, the Company recorded a $0.8 million gain from non-taxable 
life insurance for a former executive that passed away. These expenses increased the net loss by a net amount of 
$6.0 million and basic and diluted loss per share by $0.43.

(4) During 2017, the Company incurred expenses of $1.2 million for unexpected costs associated with the Company’s 

self-insured medical plan, and $0.8 million for severance charges for former executives, which reduced operating 
income by a total of $2.0 million. Additionally, the Company was impacted by the enactment of the Tax Cuts and 
Jobs Act, which resulted in the Company recording an additional $1.7 million of tax expense upon enactment. 
Finally, the Company recorded a $0.4 million gain from non-taxable life insurance for a former executive that passed 
away in 2017. These charges decreased net income by a net amount of $2.5 million and basic and diluted loss per 
share by $0.17.

(5) During 2016, the Company incurred expenses of $37.3 million related to goodwill impairment charges, and $1.5 

million for severance charges for two former executives, which reduced operating income by a total of $38.8 million.  
These charges increased net loss by $38.3 million and basic and diluted loss per share by $2.45.

18

 
 
   
   
   
   
 
   
   
   
   
 
   
      
      
      
      
  
 
   
      
      
      
      
  
   
      
      
      
      
  
Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This annual report on Form 10-K contains forward-looking statements made by the management of Computer Task 

Group, Incorporated (“CTG,” the “Company” or the “Registrant”) that are subject to a number of risks and uncertainties. 
These forward-looking statements are based on information as of the date of this report. The Company assumes no 
obligation to update these statements based on information from and after the date of this report. Generally, forward-
looking statements include words or phrases such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” 
“projects,” “could,” “may,” “might,” “should,” “will” and words and phrases of similar impact. The forward-looking 
statements include, but are not limited to, statements regarding future operations, industry trends or conditions and the 
business environment, and statements regarding future levels of or trends in business strategy and expectations, new 
business opportunities, cost control initiatives, business wins, market demand, revenue, operating expenses, capital 
expenditures, and financing. The forward-looking statements are made pursuant to safe harbor provisions of the Private 
Securities Litigation Reform Act of 1995. Numerous factors could cause actual results to differ materially from those in the 
forward-looking statements, including the following: (i) the availability to CTG of qualified professional staff, (ii) domestic 
and foreign industry competition for clients and talent, including technical, sales and management personnel, (iii) 
increased bargaining power of large clients, (iv) the Company's ability to protect confidential client data, (v) the partial or 
complete loss of the revenue the Company generates from International Business Machines Corporation (IBM) and other 
significant clients, (vi) the uncertainty of clients' implementations of cost reduction projects, (vii) the effect of healthcare 
reform and initiatives, (viii) the mix of revenue between staffing and solutions, (ix) currency exchange risks, (x) risks 
associated with operating in foreign jurisdictions, (xi) renegotiations, nullification, or breaches of contracts with clients, 
vendors, subcontractors or other parties, (xii) the impact of current and future laws and government regulation, as well as 
repeal or modification of such, affecting the information technology (IT) solutions and staffing industry, taxes and the 
Company's operations in particular, (xiii) industry and economic conditions, including fluctuations in demand for IT 
services, (xiv) consolidation among the Company's competitors or clients, (xv) the need to supplement or change our IT 
services in response to new offerings in the industry or changes in client requirements for IT products and solutions, (xvi) 
the risks associated with acquisitions, (xvii) actions of activist shareholders, (xviii) the effects of the COVID-19 pandemic 
and the regulatory, social, and business responses thereto on the Company’s business, operations, employees, 
contractors, and clients, and (xix) the risks described in Item 1A of the Company’s most recently filed annual report on 
Form 10-K, and from time to time, in the Company's reports filed with the Securities and Exchange Commission (SEC).

Industry Trends

The market demand for the Company’s services is heavily dependent on information and technology-related 
spending by major corporations, organizations and government entities in the markets and regions that we serve. The 
pace of technology advances, changes in business requirements, and the practices of our clients all have a significant 
impact on the demand for the services we provide. Competition for new engagements and pricing pressure has been 
strong as there are numerous competitors. The demand for the Company's information and technology-related solutions 
business, primarily in our healthcare vertical market in North America, improved in 2018 and 2019. In 2020, demand was 
significantly reduced, primarily in our staffing business, as the COVID-19 global pandemic (“Pandemic”) had a significant 
negative impact on the economies of the countries and the markets we serve. To offset this decrease in demand, the 
Company took action to reduce its expenses, including a full-time furlough for certain employees and a 20% furlough for 
nearly all other non-billable employees, including the senior management team. This furlough was in place for about six 
months, and ended with the close of the Company’s fiscal third quarter.

The Company also actively participated in government-sponsored programs in its European operations, including 

Belgium, France and Luxembourg, that partially reimbursed the Company for the costs of employees that were made idle 
by the Pandemic.  This primarily included employees that were previously billable on an engagement, but the client made 
a decision to stop or end a project prior to completion. The Company is continuing to participate in these programs, but 
the benefit to the Company’s European operations was diminished subsequent to August 2020 as the respective 
governments reduced the reimbursement under these programs at that time. The Company believes that if these 
employees had remained billable throughout 2020, the revenue they would have generated would have approximated the 
reimbursements received from the various governments.

The Company operates in one industry segment, providing information technology and related services to its clients. 

These services include information and technology-related solutions, including supplemental staffing as a solution. With 
solution services, the Company generally takes responsibility for the deliverables and some level of project and staff 
management, and services may include high-end advisory or business-related consulting. When providing staffing 

19

services, including managed staffing, staff augmentation, and volume staffing, personnel are provided to clients, who 
then, in turn, take their direction from the clients’ managers. 

IT solutions and IT and other staffing revenue as a percentage of consolidated revenue for the three years ended 

December 31, 2020, 2019, and 2018 is as follows:

IT solutions
IT and other staffing

Total

2020

2019

2018

38%   
62%   
100%   

36%   
64%   
100%   

31%
69%
100%

The Company provides a majority of its services in five vertical market focus areas: technology service providers, 

financial services, healthcare (which includes services provided to healthcare providers, health insurers (payers), and life 
sciences companies), manufacturing, and energy. The remainder of CTG’s revenue is derived from general markets.

CTG’s revenue by vertical market as a percentage of consolidated revenue for the three years ended December 31, 

2020, 2019, and 2018 is as follows:

Technology service providers
Financial services
Healthcare
Manufacturing
Energy
General markets

Total

2020

2019

2018

32.7%   
15.7%   
14.9%   
13.5%   
6.3%   
16.9%   
100.0%   

32.2%   
13.8%   
16.6%   
16.8%   
5.2%   
15.4%   
100.0%   

32.4%
15.2%
16.2%
19.5%
4.7%
12.0%
100.0%

The IT services industry is extremely competitive and characterized by continuous changes in client requirements 

and improvements in technologies. Our competition varies significantly by geographic region, as well as by the type of 
service provided. Many of our competitors are larger than CTG, and have greater financial, technical, sales, and 
marketing resources. In addition, the Company frequently competes with a client’s own internal IT staff. Our industry is 
impacted by the growing use of lower-cost offshore delivery capabilities (primarily India and other parts of Asia). There 
can be no assurance that we will be able to continue to compete successfully with existing or future competitors or that 
future competition will not have a material adverse effect on our results of operations and financial condition.

Revenue Recognition

The Company recognizes revenue when control of the promised good or service is transferred to clients in an 
amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. For 
time-and-material contracts, revenue is recognized as hours are incurred and costs are expended. For contracts with 
progress billing schedules, primarily monthly, revenue is recognized as services are rendered to the client. Revenue for 
fixed-price contracts is recognized over time using an input-based approach. Over time revenue recognition best portrays 
the Company’s performance in transferring control of the goods or services to the client. On most fixed price contracts, 
revenue recognition is supported through contractual clauses that require the client to pay for work performed to date, 
including cost plus a reasonable profit margin, for goods or services that have no alternative use to the Company. On 
certain contracts, revenue recognition is supported through contractual clauses that indicate the client controls the asset, 
or work in process, as the Company creates or enhances the asset. On a given project, actual salary and indirect labor 
costs incurred are measured and compared with the total estimate of costs of such items at the completion of the project. 
Revenue is recognized based upon the percentage-of-completion calculation of total incurred costs to total estimated 
costs. The Company infrequently works on fixed-price projects that include significant amounts of material or other non-
labor related costs that could distort the percent complete within a percentage-of-completion calculation. The Company’s 
estimate of the total labor costs it expects to incur over the term of the contract is based on the nature of the project and 
our experience on similar projects, and includes management judgments and estimates that affect the amount of revenue 
recognized on fixed-price contracts in any accounting period. Losses on fixed-price projects are recorded when identified

20

 
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
   
   
   
   
   
   
   
The Company’s revenue from contracts accounted for under time-and-material, progress billing, and percentage-of-
completion methods as a percentage of consolidated revenue for the three years ended December 31, 2020, 2019, and 
2018 is as follows:

Time-and-material
Progress billing
Percentage-of-completion

Total

Results of Operations

2020

2019

2018

81.0%   
15.9%   
3.1%   
100.0%   

79.6%   
10.2%   
10.2%   
100.0%   

84.7%
10.5%
4.8%
100.0%

The table below sets forth percentage information calculated as a percentage of consolidated revenue as reported 

on the Company’s consolidated statements of operations as included in Item 8, “Financial Statements and Supplementary 
Data” in this report.

Year Ended December 31,
(percentage of revenue)
Revenue
Direct costs
Selling, general and administrative expenses
Operating income
Interest and other income (expense), net
Income before income taxes
Provision for income taxes
Net income (loss)

2020

2019

2018

100.0%   
79.0%   
18.5%   
2.5%   
0.4%   
2.9%   
0.8%   
2.1%   

100.0%    
80.9%    
17.3%    
1.8%    
(0.2)%   
1.6%    
0.6%    
1.0%    

100.0%
80.9%
18.5%
0.6%
0.1%
0.7%
1.5%
(0.8)%

2020 as compared with 2019

The Company recorded revenue in 2020 and 2019 as follows:

Year Ended December 31,
(dollars in thousands)
North America
Europe
Total

  % of total

2020

    % of total

2019

Year-Over-
Year Change 

55.8%  $ 204,264     
44.2%    161,827     
100.0%  $ 366,091     

61.5%  $ 242,218     
38.5%    151,952     
100.0%  $ 394,170     

(15.7)%
6.5%
(7.1)%

The Company’s strategy throughout its operations is to expand the amount of IT solutions services it provides to its 
clients as compared with IT staffing services, and to focus on delivering digital solutions. IT Solutions provide significant 
value to our clients, and drive higher bill rates and margins for the Company. Our existing solutions include business, 
technology, and operations solutions that aid our clients in digitally transforming their company, and ultimately meet the 
needs of their clients. The digital services the Company delivers includes the Internet of Things, Intelligent Automation, 
Data and Analytics, Cloud and Automated Testing.

 The revenue decrease in North America in 2020 as compared with 2019 was primarily due to a significant decrease 

in demand for the Company's IT staffing business due to the impact the Pandemic had on the economies in the markets 
we serve. Additionally, the Company continues to disengage from its lowest margin staffing services as part of its 
strategy. Demand in some areas of our IT solutions business, primarily in our healthcare vertical market, also declined 
driven by the impact of the Pandemic. The revenue increase in Europe was primarily due to strong demand for the 
Company’s services in the European markets we serve, and the acquisition of StarDust on March 3, 2020, which at the 
time of acquisition had estimated annual revenue of approximately $6 million. Reimbursable expenses billed to clients and 
included in revenue totaled $1.9 million and $2.6 million in 2020 and 2019, respectively.

On a consolidated basis, IT solutions revenue decreased $3.0 million or 2.1% in 2020 as compared with 2019. The 
decrease is primarily due to a decrease in IT solutions services in North America in our healthcare vertical market. In our 
European operations, IT solutions revenue remained strong and was complemented by the acquisition of StarDust, a 

21

 
 
 
 
 
 
 
   
   
   
   
 
 
 
 
 
 
   
 
 
   
 
 
   
 
 
   
   
   
   
   
   
   
   
 
 
 
 
   
   
  
   
      
  
   
      
  
   
   
   
company that provides crowd testing and quality assurance services in France and Canada. As a percentage of 
consolidated revenue, IT solutions revenue increased 2.0% to 37.8% of total revenue. 

Also on a consolidated basis, IT and other staffing revenue decreased $25.1 million or 9.9% during 2020 as 

compared with 2019. The IT staffing revenue decrease was again primarily due to a significant decrease in demand 
resulting from the Pandemic. Additionally, given the Company’s strategic focus on becoming a digital solutions company, 
starting in the second half of 2019 the Company critically evaluated each significant staffing engagement as it came up for 
renewal to determine if the Company would continue to provide those services to its client. These decisions are based on, 
among other factors, critically evaluating the work performed, the availability of the resources, the client, the long-term 
opportunities for the services provided at the client, and the revenue and profit associated with the engagement. The 
Company made a decision to disengage from several small engagements and a large staffing engagement late in 2019. 
While these decisions negatively affected revenue during 2020, the Company believes the reallocation of resources away 
from these engagements to other higher margin, IT solutions services will positively impact the Company’s operations in 
the long-term, and aid in the execution of the strategy to become a digital transformation solution provider.  

Following the acquisition of CTG France (formerly Soft Company) in 2018, which relies heavily on billable 
subcontractors (non-employees), the Company revised how it defines and calculates headcount in order to report all 
billable consultants, including both employees and subcontractors. Accordingly, the Company’s total headcount was 
approximately 3,900 at December 31, 2020, which was a 1.3% decrease from approximately 3,950 at December 31, 
2019.  Approximately 91% of this headcount is for technical resources and 9% for support positions. 

The increase in revenue in the Company’s European operations in 2020 as compared with 2019 was in part due to 

the strength relative to the U.S. dollar of the currencies in Belgium, Luxembourg, France, and the United Kingdom, the 
countries in which the Company’s European subsidiaries operate. In Belgium, Luxembourg, and France, the functional 
currency is the Euro, while in the United Kingdom the functional currency is the British Pound. In 2020 as compared with 
2019, the average value of the Euro increased 2.0%, and the average value of the British Pound increased 0.5%. A 
significant portion of the Company's revenue from its European operations is recorded in Belgium, Luxembourg, and 
France. Had there been no change in these exchange rates from 2019 to 2020, total European revenue would have been 
approximately $3.0 million lower, or $158.8 million as compared with the $161.8 million reported. When considering the 
year-over-year change in revenue in constant currencies, revenue from our European operations increased 5.1%. 
Operating income was positively impacted by $0.1 million in 2020 as compared with 2019 given the increase in the 
exchange rates year-over-year.

The Company continues to monitor the impact that the United Kingdom’s exit from the European Union (Brexit) has 

had on its operations. To date, there has been a nominal impact on the Company’s operating results from Brexit. As the 
total revenue generated by our British subsidiary is immaterial as compared with the Company’s total consolidated 
revenue, we do not expect the nominal impact the exit has had on the Company’s operations to date to change in the 
foreseeable future. 

International Business Machines Corporation (IBM) was CTG’s largest client and accounted for $77.5 million or 

21.2% and $84.9 million or 21.5% of the Company’s consolidated revenue in 2020 and 2019, respectively. The National 
Technical Services Agreement with IBM was renewed and now expires on October 27, 2023. As part of the National 
Technical Services Agreement, the Company provides its services as a predominant supplier primarily to IBM’s Integrated 
Technology Services and the Systems and Technology Group business units. This agreement accounted for 
approximately 66% of all of the services provided to IBM by the Company in 2020. The Company’s accounts receivable 
from IBM at December 31, 2020 and 2019 totaled $11.3 million and $23.0 million, respectively. 

We expect to continue to derive a significant portion of our revenue from IBM in future years; however, a significant 

decline or the loss of the revenue from this client would have a significant negative effect on our operating results. No 
other client accounted for more than 10% of the Company’s revenue in 2020 or 2019.

Direct costs, defined as costs for billable staff including billable out-of-pocket expenses, were 79.0% and 80.9% of 

consolidated revenue in 2020 and 2019, respectively. In 2020, direct costs as a percentage of revenue fell as the 
Company’s strategy to focus on selling IT solutions, which has lower direct costs as a percentage of revenue, had an 
increasing impact on the Company’s overall financial results as the percentage of solutions revenue grew. Additionally, 
the decision to disengage from a large, low margin staffing engagement, as well as other smaller engagements late in 
2019, had a modest impact on the year’s direct cost percentage.

Selling, general and administrative (SG&A) expenses were 18.5% of revenue in 2020 as compared with 17.3% of 

revenue in 2019. The increase in SG&A expenses as a percentage of revenue in 2020 as compared with 2019 is primarily 

22

due to the loss of operating leverage from lower revenue, and the continued investment in business development, 
solutions, recruiting and marketing that support IT solutions services in order to focus on the Company’s long-term growth.

Operating income was 2.5% of revenue in 2020 as compared with 1.8% of revenue in 2019. Operating income from 

the North American operations was $0.6 million in 2020 after allocations of $1.8 million to foreign operations, compared 
with operating income of $2.3 million in 2019 after allocations of $1.6 million. Operating income from our European 
operations was $8.5 million in 2020 after allocations of $1.8 million from our North American operations, compared with 
$4.6 million in 2019 after allocations of $1.6 million.

Other income (expense) was 0.4% of revenue in 2020 and (0.2)% of revenue in 2019. In 2020, the Company 
recorded non-taxable life insurance gains of approximately $1.0 million as two of its former executives passed away, and 
gains of approximately $0.8 million from the sale of a building. 

The Company’s effective tax rate (ETR) is calculated based upon the full year's operating results and various tax 
related items. The ETR in 2020 was 28.3%, while the 2019 ETR was 34.4%. The ETR in 2020 was impacted by a number 
of items, including non-taxable life insurance gains, a one-time tax benefit of approximately $0.08 per share for a change 
in tax legislation, offset by higher effective tax rates in the Company’s European operations where the Company 
generated most of its income in 2020.

Net income for 2020 was 2.1% of revenue or $0.53 per diluted share, compared with 1.0% of revenue or $0.29 per 
diluted share in 2019. Diluted earnings per share were calculated using 14.4 million weighted-average equivalent shares 
outstanding in 2020 and 14.0 million in 2019. 

2019 as compared with 2018

The Company recorded revenue in 2019 and 2018 as follows:

Year Ended December 31,
(dollars in thousands)
North America
Europe
Total

  % of total

2019

    % of total

2018

Year-Over-
Year Change 

61.5%  $ 242,218     
38.5%    151,952     
100.0%  $ 394,170     

64.9%  $ 232,695     
35.1%    126,074     
100.0%  $ 358,769     

4.1%
20.5%
9.9%

The revenue increase in North America in 2019 as compared with 2018 was primarily due to a significant increase in 

demand for the Company's IT solutions business, primarily in our healthcare vertical market, and a modest increase in 
demand for our IT and other staffing business, primarily in our technology services provider vertical market. The revenue 
increase in Europe is primarily due to strong demand for the Company’s services in the European markets we serve, and 
the acquisition of Tech-IT on February 6, 2019, which at the time of acquisition had estimated annual revenue of 
approximately $20 million. Reimbursable expenses billed to clients and included in revenue totaled $2.6 million and $3.2 
million in 2019 and 2018, respectively.

On a consolidated basis, IT solutions revenue increased $28.2 million or 24.9% in 2019 as compared with 2018. The 

increase was primarily due to an increase in IT solutions services in both North America and Europe and the addition of 
Tech-IT, which conducts its operations in Luxembourg. In North America, we continue to shift our focus to IT solutions 
services, as the profit on those engagements is significantly higher than the profit on our IT staffing services. In our 
European operations, greater than 50% of the services we provide to clients are IT solutions, and those operations have 
consistently grown organically at a rate that far exceeds the growth rate for IT services of 3-5% in the markets in which we 
conduct business. The acquisition of Tech-IT expanded our IT solutions services by adding software and hardware 
services, including consulting, infrastructure and software design and development, infrastructure integration, project 
management, and training.

Also on a consolidated basis, IT and other staffing revenue increased $7.2 million or 2.9% during 2019 as compared 

with 2018. The IT staffing revenue increase was primarily due to growth in IT staffing in North America with our largest 
client, IBM.

Additionally, given the Company’s strategic focus on becoming a more solutions-centric company, a decision was 

made, starting in the second half of 2019, to critically evaluate each significant staffing engagement as it comes up for 
renewal to determine if the Company wants to continue to provide those services to its client. Those decisions are based 

23

 
 
 
 
   
   
  
   
      
  
   
      
  
   
   
   
on, among other factors, critically evaluating the work performed, the availability of the resources, the client, the long-term 
opportunities for the service provided at the client, and the revenue and profit associated with the engagement. 
Accordingly, the Company made a decision to disengage from several small engagements and a large staffing 
engagement late in 2019. While these decisions negatively affected revenue during 2020, the Company believes the 
reallocation of resources away from these engagements to other higher margin, IT solutions services will positively impact 
the Company in the long-term, and aid in the transformation to a more solutions-centric IT services provider.

Following the acquisition of CTG France (Soft Company) in 2018, which relies heavily on billable subcontractors 

(non-employees), we revised how we define and calculate headcount in order to report all billable consultants, including 
both employees and subcontractors. Accordingly, the Company’s billable consultants were approximately 3,950 at 
December 31, 2019, which was a 4.8% decrease from approximately 4,150 billable consultants at December 31, 2018.  
Approximately 91% of this headcount was for technical resources and 9% for support positions. The decrease in 
headcount year-over-year was due to disengaging from several IT staffing projects late in 2019.

The significant increase in revenue in the Company’s European operations in 2019 as compared with 2018 was due 
to an increase in demand for the Company’s IT solutions services across a number of the vertical markets we serve. The 
weakness relative to the U.S. dollar of the currencies in Belgium, Luxembourg, France, and the United Kingdom, the 
countries in which the Company’s European subsidiaries operate, offset this significant increase. In Belgium, 
Luxembourg, and France, the functional currency is the Euro, while in the United Kingdom the functional currency is the 
British Pound. In 2019 as compared with 2018, the average value of the Euro decreased 5.2%, and the average value of 
the British Pound decreased 4.3%. A significant portion of the Company's revenue from its European operations is 
recorded in Belgium, Luxembourg, and France. Had there been no change in these exchange rates from 2018 to 2019, 
total European revenue would have been approximately $8.4 million higher, or $160.3 million as compared with the 
$152.0 million reported. When considering the year-over-year change in revenue in constant currencies, revenue from our 
European operations increased 27.2%. Operating income was negatively impacted by $0.3 million in 2019 as compared 
with 2018 given the decrease in the exchange rates year-over-year.

The Company continues to assess the potential impact, if any, that the United Kingdom’s exit from the European 

Union will have its operations. As the total revenue generated by our British subsidiary is immaterial when compared with 
the Company’s total consolidated revenue, we do not expect the impact of the pending exit to have a material impact on 
the Company’s operations, and we have not experienced any material impact to date. 

International Business Machines Corporation (IBM) was CTG’s largest client and accounted for $84.9 million or 
21.5% and $80.6 million or 22.5% of the Company’s consolidated revenue in 2019 and 2018, respectively. At December 
31, 2019, the National Technical Services Agreement with IBM was extended for four months to May 1, 2020. The 
contract extension was later signed in 2020, and now expires in October 2023. As part of the National Technical Services 
Agreement, the Company provides its services as a predominant supplier primarily to IBM’s Integrated Technology 
Services and the Systems and Technology Group business units. This agreement accounted for approximately 70% of all 
of the services provided to IBM by the Company in 2019. The Company’s accounts receivable from IBM at December 31, 
2019 and 2018 totaled $23.0 million and $22.1 million, respectively. No other client accounted for more than 10% of the 
Company’s revenue in 2019 or 2018.

Direct costs, defined as costs for billable staff including billable out-of-pocket expenses, were 80.9% of consolidated 

revenue in both 2019 and 2018. In 2019, direct costs as a percentage of revenue fell throughout the year from a high of 
81.8% in the first quarter to a low of 79.6% in the fourth quarter as the Company’s strategy to focus on selling IT solutions 
had an increasing impact on the Company’s financial results as the year went on. Additionally, the decision to disengage 
from a large, low margin staffing engagement, as well as other smaller engagements late in 2019, had a modest impact 
on the year’s direct cost percentage.

Selling, general and administrative (SG&A) expenses were 17.3% of revenue in 2019 as compared with 18.5% of 

revenue in 2018. The decrease in SG&A expenses as a percentage of revenue in 2019 as compared with 2018 was 
primarily due to a concerted effort to reduce certain support costs while continuing to invest in sales and other resources 
that support IT solutions services in order to focus on the Company’s long-term growth. Additionally, SG&A in 2019 
included acquisition-related costs of $2.3 million, primarily the amortization of intangible assets resulting from our recent 
acquisitions. SG&A in 2018 includes acquisition-related costs totaling $2.0 million, and $0.7 million in severance.

Operating income was 1.8% of revenue in 2019 as compared with 0.6% of revenue in 2018. Operating income from 
the North American operations was $0.8 million in 2019 before allocations of $1.6 million to foreign operations, compared 
with a loss of $2.4 million in 2018 before allocations of $0.9 million.  The 2018 loss was impacted by investments in 
business development, recruiting, and marketing, totaling approximately $3.5 million.

24

Operating income from our European operations was $6.1 million in 2019 before allocations of $1.6 million from our 

North American operations, compared with $6.3 million in 2018 before allocations of $0.9 million.

Other income (expense) was (0.2)% of revenue in 2019 and 0.1% of revenue in 2018. In 2018, the Company 

recorded a non-taxable life insurance gain of approximately $0.8 million as one of its former executives passed away.

The Company’s effective tax rate (ETR) is calculated based upon the full year's operating results and various tax 

related items. The ETR in 2019 was 34.4%, while the 2018 ETR was 224.2%.

The ETR in 2019 was impacted as a large portion of the Company’s profits result from the Company’s European 
operations where the effective tax rates are generally higher than in the U.S. Additionally, the ETR was higher in 2019 
primarily due to non-deductible acquisition costs related to the Tech-IT and Soft Company acquisitions.

The ETR was high in 2018 primarily due to the Company recording a valuation allowance for its deferred tax assets 
in the U.S. totaling $3.8 million as the Company had recurring pre-tax losses in recent years and uncertainty as to income 
in future years.  The Company also incurred approximately $0.7 million of tax associated with the GILTI provisions of the 
2017 Tax Cut and Jobs Act, and $0.3 million of tax from non-deductible acquisition-related costs in our European 
operations.  These items, which caused additional tax expense, were offset by a non-taxable life insurance gain, the 
reversal of the valuation for deferred tax assets in the United Kingdom, the Tax Cuts and Jobs Act which reduced the US 
federal corporate tax rate to 21%, and tax benefits for the Work Opportunity Tax Credit (WOTC) and Research and 
Development tax credit (R&D).

Net income for 2019 was 1.0% of revenue or $0.29 per diluted share, compared with net loss of (0.8)% of revenue 

or $(0.20) per diluted share in 2018. Diluted earnings per share were calculated using 14.0 million weighted-average 
equivalent shares outstanding in 2019 and 13.8 million in 2018. 

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with U.S. generally accepted 
accounting principles requires the Company’s management to make estimates, judgments and assumptions that affect 
the amounts reported in the consolidated financial statements and accompanying notes. The Company’s significant 
accounting policies are included in Note 1 to the consolidated financial statements contained in this annual report on Form 
10-K under Item 8, “Financial Statements and Supplementary Data.” These policies, along with the underlying 
assumptions and judgments made by the Company’s management in their application, have a significant impact on the 
Company’s consolidated financial statements. The Company identifies its most critical accounting policies as those that 
are the most pervasive and important to the portrayal of the Company’s financial position and results of operations, and 
that require the most difficult, subjective and/or complex judgments by management regarding estimates about matters 
that are inherently uncertain. The Company’s critical accounting policies are related to the valuation allowance for 
deferred income taxes, and the valuation of goodwill.

Income Taxes—Valuation Allowances on Deferred Tax Assets

At December 31, 2020, the Company had a total of approximately $0.4 million of deferred tax assets, and 

approximately $2.2 million of deferred tax liabilities recorded on its consolidated balance sheet. The deferred tax assets, 
net, primarily consist of deferred compensation, loss carryforwards, and state taxes. The changes in deferred tax assets 
and liabilities from period to period are determined based upon the changes in the differences between the basis of assets 
and liabilities for financial reporting purposes and the basis of assets and liabilities for tax purposes, as measured by the 
enacted tax rates when these differences are estimated to reverse. The Company has made certain assumptions 
regarding the timing of the reversal of these assets and liabilities, and whether taxable income in future periods will be 
sufficient to recognize all or a part of any gross deferred tax asset of the Company.

At December 31, 2020, the Company had deferred tax assets recorded resulting from net operating losses in 
previous years totaling approximately $0.4 million. The Company has analyzed each jurisdiction’s tax position, including 
forecasting potential taxable income in future periods and the expiration of the net operating loss carryforwards as 
applicable, and determined that it is unclear whether all of these deferred tax assets will be realized at any point in the 
future. Accordingly, at December 31, 2020, the Company had offset a portion of these assets with a valuation allowance 
totaling approximately $0.2 million, resulting in a net deferred tax asset from net operating loss carryforwards of 
approximately $0.2 million.

25

In assessing the realizability of deferred tax assets, management considers, within each taxing jurisdiction, whether 
it is more likely than not that all or some portion of the deferred tax assets will be realized, or that a valuation allowance is 
required. Management considers all available evidence, both positive and negative, in assessing realizability of its 
deferred tax assets. A key component of this assessment is management’s critical evaluation of current and future 
impacts of business and economic factors on the Company’s ability to generate future taxable income. Factors that may 
affect the Company’s ability to generate taxable income include, but are not limited to increased competition, a decline in 
revenue or margins, a loss of market share, the availability of qualified professional staff, and a decrease in demand for 
the Company’s services. The Company had a total of $5.2 million of deferred tax assets in its North American operations 
that were fully offset by a valuation allowance at December 31, 2020.

The Company’s deferred tax assets and their potential realizability are evaluated each quarter to determine if any 

changes should be made to the valuation allowance. Any change in the valuation allowance in the future could result in a 
change in the Company’s ETR. A 1% change in the ETR in 2020 would have increased or decreased net income by 
approximately $107,000, or less than $0.01 per diluted share.

Goodwill Valuation

As of December 31, 2020, goodwill recorded on the Company's consolidated balance sheet totaled $21.3 million, 

which relates to the acquisitions completed by the Company in 2018, 2019, and 2020. The acquisition of Soft Company in 
2018 and StarDust in 2020 are in the France reporting unit, while the 2019 acquisition of Tech-IT is in the Luxembourg 
reporting unit. In connection with our annual goodwill impairment test, we make various assumptions to determine the 
estimated fair value of the reporting units to which the goodwill relates. We perform the annual impairment review in the 
fourth quarter of each year.

The goodwill impairment test is performed at least annually, unless indicators of an impairment exist in interim 
periods. The Company compared the estimated fair value of a reporting unit with goodwill to its carrying value. If the 
carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is 
recognized in an amount equal to the excess.

As of October 2020 fiscal month-end, we performed our annual goodwill impairment test in conjunction with an 
external consultant and estimated the fair value of our reporting units based on a combination of the income (estimates of 
future discounted cash flows) and the market approach (market multiples for similar companies). The income approach 
uses a discounted cash flow (DCF) method that utilizes the present value of cash flows to estimate fair value of the 
reporting unit. The future cash flows for the reporting units were projected based upon on our estimates of future revenue, 
operating income and other factors such as working capital and capital expenditures. As part of our projections, we took 
into account expected industry and market conditions for the industries in which the reporting units operate, as well as 
trends currently impacting the reporting units. The market approach utilizes multiples of earnings before interest expense, 
taxes, depreciation and amortization (EBITDA) to estimate the fair value of the reporting unit. The market multiples used 
for our reporting units were based on competitor industry data, along with the market multiples for the Company and other 
factors.

As part of our DCF analysis, we projected revenue and operating profits, and assumed a long-term revenue growth 
rates in the “terminal year” for both of the reporting units. We also utilized a weighted-average cost of capital (WACC) of 
16.0% for the France reporting unit and 15.0% for the Luxembourg reporting unit. The carrying value as of October 2020 
was approximately $17.6 million and $13.2 million for the France and Luxembourg reporting units, respectively.  

Finally, we compared our estimates of fair value to the consolidated Company’s October 2020 month-end total 
public market capitalization, which included factoring in the business operations that do not have goodwill, and assessed 
implied control premiums. Based on the results of this analysis, we concluded that the estimated fair value determined 
under our approach for the annual goodwill impairment test for our France and Luxembourg reporting units was 
reasonable. 

We concluded that the goodwill assigned to the France and Luxembourg reporting units as of October 2020 were 
not impaired. However, the estimates and assumptions on which the Company’s evaluations are based involve judgments 
and are based on current available information, any of which could prove wrong or inaccurate when made, or become 
wrong or inaccurate as a result of subsequent events. In the event the business significantly under achieves its goals for 
revenue and profit growth in the future, the carrying value for this business unit may not be supportable using a 
discounted cash flow projection, and an impairment charge may exist.

26

Other Estimates

The Company has also made a number of estimates and assumptions relating to the reporting of its assets and 

liabilities and the disclosure of contingent assets and liabilities to prepare the consolidated financial statements pursuant 
to the rules and regulations of the SEC, the FASB, and other regulatory authorities. Such estimates primarily relate to the 
valuation of stock options for recording equity-based compensation expense, allowances for doubtful accounts receivable, 
investment valuation, discount rates associated with pension plans, incurred but not reported healthcare claims, 
acquisition and related accounting, legal matters, and estimates of progress toward completion and direct profit or loss on 
contracts, as applicable. As future events and their effect on the Company's operating results cannot be determined with 
precision, actual results could differ from these estimates. Changes in the economic climates in which the Company 
operates may affect these estimates and will be reflected in the Company’s financial statements in the event they occur. 

Financial Condition and Liquidity

Cash provided by (used in) operating activities was $30.7 million, $8.5 million, and $(0.3) million in 2020, 2019, and 

2018, respectively. In 2020, net income was $7.6 million, while other non-cash adjustments, primarily consisting of 
depreciation and amortization expense, equity-based compensation, deferred income taxes, non-taxable life insurance 
gains, a gain from a sale of a building, impairment of capitalized software, and deferred compensation totaled $4.4 million. 
In 2019 and 2018, net income (loss) was $4.1 million and $(2.8) million, respectively, while the corresponding non-cash 
adjustments netted to $4.3 million and $6.3 million, respectively. 

Accounts receivable balances decreased $17.0 million in 2020 as compared with 2019, increased $3.6 million in 

2019 as compared with 2018, and increased $8.7 million in 2018 as compared with 2017. The decrease in the accounts 
receivable balance in 2020 resulted from a decrease in the Company’s days sales outstanding (DSO) as compared with 
2019. DSO is calculated by dividing accounts receivable obtained from the consolidated balance sheet by average daily 
revenue for the fourth quarter of the respective year. DSO was 74 days at December 31, 2020 as compared with 85 days 
December 31, 2019. The decrease in DSO was primarily driven by the Company entering into an arrangement with its 
largest customer to factor outstanding receivables, which decreases the time of payment from 90 days to as little as 15 
days based upon the Company’s direction. DSO was 85 days at December 31, 2019 as compared with DSO at 
December 31, 2018 of 82 days. 

The cash surrender value of life insurance policies decreased $0.7 million in 2020, decreased $1.0 million in 2019, 
and increased $1.4 million in 2018. The increase or decrease in each of the years was due to normal appreciation of the 
existing cash surrender value of the outstanding policies at each respective point in time, which in turn was reduced by 
the benefits paid upon the death of former executives in 2020 (two) and 2018 (one). Accounts payable decreased $0.6 
million in 2020, increased $3.9 million in 2019, and increased less than 0.1 million in 2018. The decrease in 2020 was 
primarily due to the timing of certain payments near year-end, while the increase in 2019 was primarily due to the growth 
in the size of the Company and the timing of payments made near year-end. Accrued compensation decreased $3.1 
million in 2020 primarily due to the US operations reducing its payroll lag from two weeks in 2019 to one week in 2020, 
and increased $2.2 million in 2019 primarily due to significant growth in the Company’s operations and higher incentives 
for 2019 paid early in 2020. Accrued compensation increased $2.6 million in 2018 primarily due to significant growth in the 
Company’s operations and headcount. Income taxes receivable increased by $1.3 million in 2020 due to a change in tax 
legislation which created a one-time benefit of approximately $1.1 million, and increased $0.2 million in 2019 due to 
refunds received from the federal government and higher taxable income. Income taxes receivable decreased $0.5 million 
in 2018 due to refunds received from the federal government. Deferred payroll taxes increased $6.7 million in 2020. The 
increase was due to the Company’s participation in a U.S. government program that allows companies under the CARES 
ACT to defer the payment of the employer portion of payroll taxes until 2021 and 2022. Advance billings increased $1.3 
million in 2020, decreased $2.8 million in 2019, and increased $0.2 million in 2018. The change in advance billings in any 
given period is determined by the nature and type of existing projects, and the advance payments, if any, associated with 
those projects. 

Investing activities used $5.0 million, $11.5 million, and $12.6 million of cash in 2020, 2019, and 2018, respectively. 
Cash paid for the acquisition of StarDust, net of cash acquired, was approximately $4.3 million. In 2019, net cash paid for 
the acquisition of Tech-IT totaled $8.5 million, while in 2018, cash paid for the acquisition of Soft Company was $13.8 
million. The Company also used cash for additions to property, equipment and capitalized software of $2.9 million in 2020, 
$2.4 million in 2019, and $2.2 million in 2018. The Company expects the amount to be spent in 2021 on additions to 
property, equipment and capitalized software to be similar to the amount spent in 2020. The Company has no material 
commitments for future capital expenditures. The Company received approximately $1.8 million of proceeds from the sale 
of its corporate administrative building in the first quarter of 2018. As the carrying value of the building was $1.6 million, 

27

the Company recorded a gain of $0.1 million after applicable fees. During the 2020 second quarter, the Company sold its 
remaining owned real estate for $2.5 million. As the book value of the building was approximately $1.6 million, the 
Company recorded a gain of approximately $0.8 million, after fees. The Company paid premiums for life insurance totaling 
$0.6 million in both 2020 and 2019, and $0.7 million for life insurance in 2018. The Company received a total of $0.4 
million of proceeds from life insurance policies on former executives in the 2020. Net cash received from the Company's 
deferred compensation plans was less than $0.1 million in 2020, and $0.2 million in 2019 and 2018.

Financing activities provided (used) $(5.7) million, $1.8 million, and $14.6 million of cash in 2020, 2019, and 2018, 
respectively. Net cash received (paid) under the Company’s revolving credit agreement was $(5.3) million in 2020, $1.7 
million in 2019, and $(0.8) million in 2018. Payments made to taxing authorities that represent the value of shares 
withheld for taxes in employee equity-based compensation transactions totaled $0.2 million in both 2020 and 2019, and 
$0.3 million in 2018. Cash overdrafts relate to the amount of outstanding checks at a point in time, and netted to $(0.4) 
million, less than $0.1 million, and $(0.5) million in the 2020, 2019, and 2018 periods, respectively. In 2018, the Company 
borrowed $29.3 million against the cash surrender value of its life insurance policies, primarily to return capital to 
shareholders through the “Dutch Auction” tender offer, fund the acquisition of Soft Company, and for general working 
capital purposes. The Company also used $14.9 million to purchase 1,767,000 shares for treasury under its buyback 
program in the 2018 period, including 1,530,990 shares purchased under the “Dutch Auction” tender offer in the 2018 
second quarter. As of December 31, 2020, $7.7 million was available under the Company's authorization to purchase 
shares in future periods. The Company recorded $0.0 million, $0.1 million, and $1.8 million during 2020, 2019, and 2018, 
respectively, from the proceeds from stock option exercises. 

No dividends were paid in 2020, 2019, or 2018.

The Company’s Credit and Security Agreement provides for a three-year revolving credit facility in an aggregate 

principal amount of $45.0 million, including a sublimit of $10.0 million for letters of credit.

The Credit and Security Agreement expires in December 2022, and has interest rates ranging from 150 to

200 basis points over LIBOR or the greater of (i) the prime rate, (ii) the federal funds effective rate plus 50 basis points, 
and (iii) adjusted LIBOR plus 100 basis points plus a spread ranging from 50 to 100 basis points based on the amounts 
outstanding under the Credit and Security Agreement. The Company can borrow under the agreement with either rate at 
its discretion. 

There was $0.0 million, $5.3 million, and $3.6 million outstanding under the Company’s lines of credit at 

December 31, 2020, 2019, and 2018, respectively. The Company borrows or repays its debt as needed based upon its 
working capital obligations, including the timing of the U.S. bi-weekly payroll. 

The maximum amount outstanding under its credit agreements in 2020, 2019, and 2018 was $12.0 million, $22.3 

million, and $12.8 million, respectively. The average amounts outstanding during 2020, 2019, and 2018 were $6.4 million, 
$10.4 million, and $4.1 million, respectively, and carried weighted-average interest rates of 1.9%, 2.8%, and 3.4%, 
respectively. Total commitment fees incurred in 2020 totaled $0.2 million, and $0.3 million in both 2019 and 2018, while 
interest paid in 2020 totaled $0.2 million, $0.4 million in 2019, and $0.2 million in 2018.

Under the Credit and Security Agreement, the Company is required to meet certain financial covenants in order to 
maintain borrowings under its revolving credit line, pay dividends, and make acquisitions. The covenants are measured 
quarterly, and at December 31, 2020, included a fixed charge coverage ratio, which must be less than 1.10 to 1.00, 
consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA), adjusted for equity-based 
compensation and severance expense, must be no less than $5.0 million for the trailing twelve months, and capital 
expenditures for property, plant, equipment, and capitalized software must be no more than $5.0 million in any annual 
period. The fixed charge coverage ratio is only tested if availability on a measurement date is less than approximately 
$5.6 million. Actual borrowings by CTG under the Credit and Security Agreement are subject to a borrowing base, which 
is a formula based on certain eligible receivables and reserves. Total availability as of December 31, 2020 was 
approximately $21.2 million.  The Company was in compliance with these covenants at December 31, 2020 as EBITDA, 
as defined above, was $15.4 million and capital expenditures for property, equipment and capitalized software were $2.0 
million in 2020.  The Company was also in compliance with its covenants at December 31, 2019 and December 31, 2018.

Of the total cash and cash equivalents reported on the consolidated balance sheet at December 31, 2020 of $32.9 

million, approximately $26.3 million is held by the Company’s foreign operations and is considered to be indefinitely 
reinvested in those operations. The Company has not repatriated any of its cash and cash equivalents from its foreign 
operations in the past five years, and has no intention of doing so in the foreseeable future as the funds are generally 
required to meet the working capital needs of its foreign operations.

28

At December 31, 2020, the Company believes existing internally available funds, cash potentially generated from 

future operations, and funds potentially available under the Company's revolving line of credit (subject to collateral limits) 
totaling $20.0 million, will be sufficient to meet foreseeable working capital and capital expenditure needs, fund stock 
repurchases, pay a dividend (if any), fund acquisitions, and allow for future internal growth and expansion.

Off-Balance Sheet Arrangements

The Company did not have off-balance sheet arrangements or transactions in 2020, 2019, and 2018 other than 
guarantees in our European operations which support office leases and performance under government contracts. These 
guarantees totaled approximately $3.2 million at December 31, 2020. Also, the Company has purchase obligations in 
2021, 2022, and 2023 for certain software, recruiting and other services totaling $2.5 million.

Quantitative and Qualitative Disclosures about Market Risk

The Company’s primary market risk exposure consists of foreign currency exchange risk associated with the 
Company’s European operations. See Item 7A, “Quantitative and Qualitative Disclosures about Market Risk” in this report.

Recently Issued Accounting Standards

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842),” which sets out the principles for the 
recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). 
The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases 
based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will 
determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the 
term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases 
with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be 
accounted for similar to existing guidance for operating leases today. Topic 842 supersedes the previous leases standard, 
ASC 840, Leases. This guidance is effective for reporting periods beginning after December 15, 2018. On January 1, 
2019, the Company adopted the new lease standard using the modified retrospective transition approach and elected the 
transition method to apply the new lease standard as of the January 1, 2019 adoption date. Results for the reporting 
periods beginning after January 1, 2019 are presented under Topic 842, while prior period amounts are not adjusted and 
continue to be reported in accordance with accounting under Topic 840. In addition, the Company elected the package of 
practical expedients, which permits the Company not to reassess under the new standard prior conclusions about lease 
identification, lease classification, and initial direct costs. The Company has also elected the practical expedient to 
separate lease and non-lease components for its office leases and has elected to group lease and non-lease components 
for its vehicle leases. Upon adoption of Topic 842 on January 1, 2019, the Company recorded approximately $13.1 million 
of operating lease right-of-use assets and lease liabilities. The adoption of Topic 842 did not have a significant impact on 
the Company’s consolidated statements of income, comprehensive income (loss), or its consolidated statements of cash 
flows. The new lease standard does not affect the Company’s compliance with financial covenants associated with its 
Credit and Security Agreement.

In January 2018, the FASB issued ASU 2018-02, “Income Statement – Reporting Comprehensive Income (Topic 

220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI)”, which gives 
entities the option to reclassify to retained earnings the tax effects resulting from the Act related to items in AOCI that the 
FASB refers to as having been stranded in AOCI. The guidance required new disclosures regarding a company’s 
accounting policy for releasing the tax effects in AOCI and permit the company the option to reclassify to retained 
earnings the tax effects resulting from the Act that are stranded in AOCI. The Company reclassified approximately $0.3 
million to retained earnings due to the adoption of ASU 2018-02 in the 2018 fourth quarter.

In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”, 
which requires the immediate recognition of estimated credit losses expected to occur over the remaining life of many 
financial assets, including trade receivables. The allowance for credit losses will be the difference between the amortized 
cost balance of a financial asset and the amount of amortized cost expected to be collected over the remaining 
contractual life. When determining the allowance, expected credit losses over the contractual term of the financial assets 
will be estimated considering relevant information about past events, current conditions, and reasonable and supportable 
forecasts that affect the collectability of the reported amount.  Subsequent changes in the allowance will be recorded 
through the income statement as an expense adjustment. This guidance is effective for reporting periods beginning after 
December 15, 2019; however, early adoption is permitted. The Company adopted the new credit loss standard on 
January 1, 2020. The Company estimated its allowance for credit losses by pooling assets with similar risk characteristics, 

29

reviewing historical losses within the last five years and taking into consideration any reasonable supportable forecasts of 
future economic conditions. The Company cannot guarantee that the rate of future credit losses will be similar to past 
experience, but considers all available information when assessing the adequacy of its allowance for credit losses each 
quarter. As the impact from this standard on the Company was immaterial, no adjustment was made to the beginning 
retained earnings balance.

In January 2017, the FASB issued ASU 2017-04,”Simplifying the Test for Goodwill Impairment”, which simplifies 

how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. This 
guidance is effective for reporting periods beginning after December 15, 2019; however, early adoption is permitted. The 
Company adopted the new standard on January 1, 2020 for the year ending December 31, 2020 on a prospective basis 
and the adoption did not have a material impact on the Company’s operations. 

In August 2018, the FASB issued ASU 2018-15, “Customer’s Accounting for Implementation Costs Incurred in a 
Cloud Computing Arrangement That Is a Service Contract”, which helps entities evaluate the accounting for fees paid in a 
cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement 
includes a software license. This guidance is effective for fiscal years beginning after December 15, 2019; however, early 
adoption is permitted. The Company adopted the new standard on January 1, 2020 for the year ending December 31, 
2020 on a prospective basis and the adoption did not have a material impact on the Company’s operations.

In August 2018, the FASB issued ASU 2018-14, "Compensation - Retirement Benefits - Defined Benefit Plans - 

General (Subtopic 715-20)". The amendments in this update modify the disclosure requirements for employers that 
sponsor defined benefit pension or other post-retirement plans by removing disclosures that no longer are considered cost 
beneficial, clarifying the specific requirements of disclosures, and adding disclosure requirements identified as relevant. 
The new ASU is effective for fiscal years ending after December 15, 2020, and early adoption is permitted. The Company 
adopted this new standard retrospectively for the year ending December 31, 2020, and the adoption did not have a 
material impact on its consolidated financial statements and associated disclosures.

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform - Facilitation of the Effects of Reference 

Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for accounting contracts, 
hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments 
apply only to contracts, hedging relationships and other transactions that reference the London Interbank Offering Rate 
(“LIBOR”) or another reference rate expected to be discontinued due to the reference rate reform. It is effective for all 
entities between March 12, 2020 and December 31, 2022. The Company does not expect a significant impact from the 
adoption of this standard as provisions have been made in our Credit and Security Agreement to use an alternate 
benchmark interest rate when the use of LIBOR is discontinued.

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for 

Income Taxes.” Among other clarifications and simplifications related to income tax accounting, the new standard 
simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax 
allocation, the methodology for calculating income taxes in an interim period, hybrid taxes and the recognition of deferred 
tax liabilities for outside basis differences. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal 
years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently reviewing the provisions 
of this new pronouncement, but does not expect adoption of this guidance to have a material impact on its consolidated 
financial statements.

30

Contractual Obligations

The Company intends to satisfy its contractual obligations from operating cash flows, and, if necessary, from draws 

on its demand credit line. A summary of the Company’s contractual obligations at December 31, 2020 is as follows:

(in millions)
Long-term debt
Operating lease obligations
Purchase obligations
Deferred compensation benefits (U.S.)
Deferred compensation benefits (Netherlands)
Deferred compensation benefits (Belgium)
Deferred compensation benefits (France)
Other long-term liabilities
Contingent consideration (StarDust)

Total

Payments Due by Period

Total

Less
than
1 year

Years
2-3

Years
4-5

More
than
5 years

  A   $
  B    
  C    
  D    
  E    
  F    
  G   
  H    
  I    
    $

—    $
23.1     
2.5     
3.9     
3.7     
2.5     
0.1     
0.1     
0.5     
36.4    $

—    $
6.5     
1.6     
0.5     
0.3     
0.1     
—     
—     
0.4     
9.4    $

—    $
8.7     
0.9     
1.0     
0.6     
0.2 
— 
0.1 
0.1 
11.6    $

—    $
3.8     
—     
0.8     
0.7     
0.9     
—     
—     
—     
6.2    $

— 
4.1 
— 
1.6 
2.1 
1.3 
0.1 
— 
— 
9.2  

A

B

C

D

E

F

G

H

I

On December 21, 2017, the Company entered into the Credit and Security Agreement which provides for a three-
year revolving credit facility in an aggregate principal amount of $45.0 million. The agreement was amended on 
December 23, 2019 for three years and now expires in December 2022. The Company uses this Credit and Security 
Agreement to fund its working capital obligations as needed, primarily funding the U.S. bi-weekly payroll. There were 
no borrowings outstanding under the Credit and Security Agreement as of December 31, 2020.

Operating lease obligations relate to the rental of office space, office equipment, and automobiles leased by the 
Company. Total rental expense under operating leases in 2020, 2019, and 2018 was approximately $6.4 million, 
$6.8 million, and $6.6 million, respectively.

The Company’s purchase obligations in 2021, 2022 and 2023 total approximately $2.5 million, including $1.1 million 
for software maintenance, support and related fees, $0.3 million for telecommunications, $0.3 million for recruiting 
services, $0.3 million for professional organization memberships, and $0.5 million for computer-based training 
courses.

The Company is committed to the Executive Supplemental Benefit Plan (ESBP) in the U.S. that provides certain 
former key executives with deferred compensation benefits. The ESBP was amended as of November 30, 1994 to 
freeze benefits for participants at that time. At December 31, 2020, 14 individuals were receiving benefits under this 
plan. The ESBP is deemed to be unfunded as the Company has not specifically identified Company assets to be 
used to discharge the deferred compensation benefit liabilities.

The Company retained a contributory defined-benefit plan for its previous employees located in the Netherlands 
when the Company disposed of its subsidiary, CTG Nederland B.V. This plan was curtailed on January 1, 2003 for 
additional contributions. The Company does not anticipate making additional contributions to fund the plan in future 
years.

The Company maintains a fully funded pension plan for its CTG Belgium and CTG Health Solutions (Belgium) 
employees. The Company will continue to make contributions to fund the plan as needed in future years.

As a result of the acquisition of Soft Company on February 15, 2018, the Company maintains an unfunded pension 
plan related to the current Soft Company employees (FDBP). The Company will make payments as needed in the 
future. 

The Company has other long-term liabilities including payments for a postretirement benefit plan for several retired 
employees and their spouses, totaling fewer than 10 participants.

The Company has a contingent consideration liability related to an earn-out provision of which a portion will be 
payable in each period subject to the achievement by StarDust of certain consolidated direct profit targets for fiscal 
years 2020 and 2021. The Company expects to pay $0.4 million related to the achievement of these targets for fiscal 
year 2020 and $0.1 million related to fiscal year 2021.

31

 
 
   
 
 
   
   
   
   
   
 
  
  
  
  
 
Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

The Company’s primary market risk exposure consists of foreign currency exchange risk associated with the 

Company’s European operations.

During 2020, revenue was impacted by the year-over-year foreign currency exchange rate changes of Belgium, 

Luxembourg, France, and the United Kingdom, the countries in which the Company’s European subsidiaries operate. In 
Belgium, Luxembourg, and France, the functional currency is the Euro, while in the United Kingdom the functional 
currency is the British Pound. Had there been no change in these exchange rates from 2019 to 2020, total European 
revenue would have been approximately $3.0 million lower in 2020, or $158.8 million as compared with the $161.8 million 
reported. Operating income in the Company’s European operations would have been $0.1 million lower if there had been 
no change in foreign currency exchange rates year-over-year.

The Company has historically not used any market rate sensitive instruments to hedge its foreign currency 

exchange risk as it conducts its foreign operations in local currencies, which generally limits risk. The Company believes 
the market risk related to intercompany balances in future periods will not have a material effect on its results of 
operations.

32

Item 8.

Financial Statements and Supplementary Data

Report of Independent Registered Public Accounting Firm

Board of Directors and Shareholders
Computer Task Group, Incorporated

Opinion on the financial statements 

We have audited the accompanying consolidated balance sheets of Computer Task Group, Incorporated (a New York 
corporation) and subsidiaries (the “Company”) as of December 31, 2020 and 2019, the related consolidated statements of 
operations, comprehensive income (loss), shareholders’ equity, and cash flows for each of the two years in the period 
ended December 31, 2020, and the related notes and financial statement schedule included under Item 15(a) (collectively 
referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the 
financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows 
for each of the two years in the period ended December 31, 2020, in conformity with accounting principles generally 
accepted in the United States of America. 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United 
States) (“PCAOB”), the Company’s internal control over financial reporting as of December 31, 2020, based on criteria 
established in the 2013 Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of 
the Treadway Commission (“COSO”), and our report dated March 12, 2021 expressed an unqualified opinion.

Basis for opinion 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an 
opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the 
PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities 
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and 
perform the audit to obtain reasonable assurance about whether the financial statements are free of material 
misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material 
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those 
risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the 
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made 
by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits 
provide a reasonable basis for our opinion.

Critical audit matters 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements 
that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or 
disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex 
judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, 
taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the 
critical audit matters or on the accounts or disclosures to which they relate. 

Goodwill impairment assessment

The Company’s consolidated goodwill balance was $21.3 million as of December 31, 2020.  As described in Note 1 to the 
consolidated financial statements, the Company evaluates goodwill impairment for each reporting unit every fourth 
quarter, or on an interim basis if an indicator of impairment is present. If management determines that it is more likely than 
not that the fair value of a reporting unit is less than its carrying value, then quantitative impairment testing is performed 
utilizing a combination of the income and market approach. If the book value of a reporting unit is greater than its fair 
value, an impairment loss is recorded for the excess. The fair value of a reporting unit is judgmental and requires 
assumptions and estimates of many critical factors such as forecasted revenue, operating income margins, long-term 
discount rate, and estimated valuation multiples.  We identified the estimation of the fair value of each reporting unit 
included in the Company’s annual goodwill impairment assessment as a critical audit matter.  

33

The principal considerations for our determination that performing procedures relating to the goodwill impairment 
assessment is a critical audit matter are (1) there was significant judgment and estimation by management when 
developing the fair value measurement of the reporting units and (2) a high degree of auditor judgment, subjectivity, and 
effort in performing procedures and evaluating audit evidence related to management’s cash flow projections and 
significant assumptions for certain of the reporting units, including forecasted revenue, operating income margins, long-
term discount rate and estimated valuation multiples to other public companies.

Our audit procedures related to the goodwill impairment analysis of certain reporting units included the following, among 
others. We tested the design and operating effectiveness of key controls over the Company's goodwill impairment 
assessment process including controls over the development and review of significant assumptions used in the 
determination of the fair value of each reporting unit. We tested the significant assumptions discussed above by assessing 
the reasonableness of management’s forecasts compared to current results and forecasted industry trends. We 
performed sensitivity analyses of certain assumptions to evaluate changes in the fair value that would result from changes 
in the assumptions. With the assistance of our valuation specialists, we evaluated the selection of the long-term discount 
rate and perpetual growth rate, including testing the underlying source information and the mathematical accuracy of the 
calculations by developing a range of independent estimates and comparing those to the rates selected by management. 
We also involved our valuation specialists to evaluate the market approach, including evaluating the reasonableness of 
estimated valuation multiples.

Assessment of realizability of deferred tax assets

As disclosed in Note 5 to the consolidated financial statements, the Company records a deferred tax valuation allowance 
based on the assessment of the realizability of the Company’s deferred tax assets. For the year ended December 31, 
2020, the Company had U.S. deferred tax assets before valuation allowances of $5.2 million. We identified the 
assessment of the realizability of the Company’s U.S. deferred tax assets as a critical audit matter. 

The principal consideration for our determination that the assessment of the realizability of deferred tax assets is a critical 
audit matter is the significant judgment and estimation by management in determining whether sufficient future taxable 
income, including projected pre-tax income, will be generated to support the realization of the existing U.S. deferred tax 
assets. 

Our audit procedures related to the assessment of realizability of U.S. deferred tax assets included the following, among 
others. We tested the design and operating effectiveness of key controls related to the realizability of U.S. deferred tax 
assets, including controls over management’s projection of pre-tax income. We evaluated the assumptions used by the 
Company to develop projections of future taxable income, including the pre-tax income by jurisdiction and tested the 
completeness and accuracy of the underlying data used in the projections. We compared the projections of pre-tax 
income with the actual results of prior periods, as well as management’s consideration of current industry and economic 
trends, including the impact of COVID-19. We compared the projections of future pre-tax income with other forecasted 
financial information prepared by the Company. We also performed a sensitivity analysis of future taxable income to 
evaluate the recoverability of deferred tax assets resulting from changes in assumptions.

/s/ GRANT THORNTON LLP

Cleveland, Ohio
March 12, 2021

We have served as the Company’s auditor since 2019.

34

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors
Computer Task Group, Incorporated:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated statements of operations, comprehensive income (loss), cash flows, 
and shareholders’ equity of Computer Task Group, Incorporated and subsidiaries (the Company) for the year ended 
December 31, 2018, and the related notes and financial statement schedule (collectively, the consolidated financial 
statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the results of 
operations of the Company and its cash flows for the year ended December 31, 2018, in conformity with U.S. generally 
accepted accounting principles.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to 
express an opinion on these consolidated financial statements based on our audit. We are a public accounting firm 
registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be 
independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and 
regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and 
perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material 
misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material 
misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that 
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and 
disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used 
and significant estimates made by management, as well as evaluating the overall presentation of the consolidated 
financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ KPMG LLP

We served as the Company’s auditor from 2003 to 2019.

Rochester, New York
March 15, 2019

35

Consolidated Statements of Operations

Year Ended December 31,

(amounts in thousands, except per-share data)
Revenue
Direct costs
Selling, general and administrative expenses
Operating income
Interest and other income
Gain on sale of building
Non-taxable life insurance gain
Interest and other expense
Income before income taxes
Provision for income taxes
Net income (loss)
Net income (loss) per share:

Basic
Diluted

Weighted average shares outstanding:

Basic
Diluted

  $

  $

  $
  $

2020

2019

2018

366,091    $
289,133     
67,828     
9,130     
506     
824     
987     
786     
10,661     
3,022     
7,639    $

394,170    $
319,135     
68,123     
6,912     
311     
—     
—     
934     
6,289     
2,164     
4,125    $

358,769 
290,282 
66,407 
2,080 
223 
— 
807 
841 
2,269 
5,086 
(2,817)

0.56    $
0.53    $

0.31    $
0.29    $

(0.20)
(0.20)

13,621     
14,427     

13,450     
13,997     

13,805 
13,805  

The accompanying notes are an integral part of these consolidated financial statements.

36

 
 
 
 
 
 
 
 
 
   
 
 
     
 
 
   
   
   
   
   
   
   
   
   
     
       
       
 
     
       
       
 
   
   
(2,817)

(2,059)
(263)

1,387 
(935)

(3,752)

Year Ended December 31,
(amounts in thousands)
Net income (loss)

Consolidated Statements of Comprehensive Income (Loss)

2020

2019

2018

  $

7,639    $

4,125    $

Foreign currency translation adjustment, net of taxes
Implementation of accounting standards
Change in pension loss, net of taxes of $455, $265, and $0, in
   2020, 2019 and 2018, respectively

Other comprehensive income (loss)

5,461     
—     

(2,286)    
3,175     

(1,084)    
—     

(2,847)    
(3,931)    

Comprehensive income (loss)

  $

10,814    $

194    $

The accompanying notes are an integral part of these consolidated financial statements.

37

 
   
   
 
 
 
 
   
 
 
   
 
 
 
 
     
       
       
 
   
   
   
   
 
     
       
       
 
Consolidated Balance Sheets

December 31,
(amounts in thousands, except share balances)
Assets
Current Assets:

Cash and cash equivalents
Accounts receivable, net of allowances of $561 and $84 in 2020 and 2019, 
respectively
Prepaid and other current assets
Income taxes receivable
Total current assets

Property, equipment and capitalized software, net
Operating lease right-of-use assets
Deferred income taxes
Acquired intangibles, net
Goodwill
Cash surrender value of life insurance
Other assets
Investments

Total assets

Liabilities and Shareholders’ Equity
Current Liabilities:

Accounts payable
Accrued compensation
Advance billings on contracts
Short-term operating lease liabilities
Short-term deferred payroll taxes
Other current liabilities

Total current liabilities

Long-term debt
Deferred compensation benefits
Long-term operating lease liabilities
Deferred payroll taxes
Deferred income taxes
Other long-term liabilities
Total liabilities
Shareholders’ Equity:

Common stock, par value $0.01 per share, 150,000,000 shares authorized;
   27,017,824 shares issued in both periods
Capital in excess of par value
Retained earnings
Less: Treasury stock of 11,841,960 and 12,311,010 shares at cost, at 
December 31, 2020 and 2019, respectively
Accumulated other comprehensive loss

Total shareholders’ equity
Total liabilities and shareholders’ equity

2020

2019

  $

32,865    $

10,781 

76,892   
2,207   
1,174   
113,138   
5,515   
22,116   
393   
9,097   
21,275   
3,587   
924   
208   
176,253    $

18,784    $
21,968   
3,102   
6,427   
3,329   
7,535   
61,145   
—   
14,420   
15,564   
3,329   
2,174   
113   
96,745   

270   
109,407   
94,312   

(109,114)  
(15,367)  
79,508   
176,253    $

88,772 
2,064 
231 
101,848 
6,379 
21,253 
453 
8,439 
16,681 
3,133 
328 
192 
158,706 

18,612 
23,538 
1,704 
5,904 
— 
7,096 
56,854 
5,290 
12,346 
15,349 
— 
2,101 
530 
92,470 

270 
112,096 
86,673 

(114,261)
(18,542)
66,236 
158,706  

  $

  $

  $

The accompanying notes are an integral part of these consolidated financial statements.

38

 
 
 
 
 
   
   
   
 
 
   
   
   
 
 
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
 
 
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Statements of Cash Flows

Year Ended December 31,
(amounts in thousands)
Cash flow from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by 
(used in) operating activities:

2020

2019

2018

  $

7,639    $

4,125    $

(2,817)

Depreciation and amortization expense
Equity-based compensation expense
Deferred income taxes
Deferred compensation benefits
Gain on the sale of property and equipment
Impairment of capitalized software
Non-taxable life insurance gain
Changes in assets and liabilities that provide (use) cash, excluding 
the effects of acquisitions:
Accounts receivable
Prepaid and other current assets
Other long-term assets
Cash surrender value of life insurance
Accounts payable
Accrued compensation
Income taxes payable / receivable
Deferred payroll taxes
Advance billings on contracts
Other current liabilities
Other long-term liabilities

Net cash provided by (used in) operating activities
Cash flow from investing activities:

Cash paid for acquisitions, net of cash received
Additions to property and equipment
Additions to capitalized software
Proceeds from the sale of property and equipment
Premiums paid for life insurance
Proceeds from life insurance
Deferred compensation plan investments, net

Net cash used in investing activities
Cash flow from financing activities:
Proceeds from long-term debt
Payments on long-term debt
Proceeds from stock option plan exercises
Proceeds from life insurance loans
Taxes remitted for shares withheld from equity-based 
compensation transactions
Proceeds from Employee Stock Purchase Plan
Change in cash overdraft, net
Purchase of stock for treasury

Net cash provided by (used in) financing activities
Effect of exchange rates on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year

3,309     
2,483     
(370)    
(108)    
(799)    
855     
(987)    

16,961     
(65)    
(596)    
749     
(577)    
(3,081)    
(1,304)    
6,658     
1,267     
(818)    
(478)    
30,738     

(4,324)    
(1,780)    
(1,105)    
2,442     
(616)    
400     
—     
(4,983)    

3,268     
1,748     
(294)    
(427)    
—     
—     
—     

(3,627)    
952     
84     
961     
3,864     
2,203     
(186)    
—     
(2,830)    
(1,061)    
(250)    
8,530     

(8,461)    
(1,773)    
(669)    
—     
(618)    
—     
—     
(11,521)    

2,537 
2,353 
3,070 
(729)
(108)
— 
(807)

(8,724)
174 
847 
(1,406)
30 
2,580 
497 
— 
210 
2,508 
(518)
(303)

(13,782)
(2,011)
(234)
1,724 
(702)
2,151 
209 
(12,645)

40,845     
(46,135)    
—     
—     

170,920     
(169,270)    
91     
—     

134,386 
(135,181)
1,848 
29,268 

(168)    
143     
(370)    
—     
(5,685)    
2,014     
22,084     
10,781     
32,865    $

(172)    
147     
78     
—     
1,794     
(453)    
(1,650)    
12,431     
10,781    $

(329)
93 
(528)
(14,945)
14,612 
(403)
1,261 
11,170 
12,431  

  $

The accompanying notes are an integral part of these consolidated financial statements.

39

 
 
 
 
 
 
 
 
 
   
 
 
   
 
 
 
     
       
       
 
     
       
       
 
   
   
   
   
   
   
   
     
       
       
 
   
   
   
   
   
   
   
   
   
   
   
   
     
       
       
 
   
   
   
   
   
   
   
   
     
       
       
 
   
   
   
   
   
   
   
   
   
   
   
   
Consolidated Statements of Shareholders’ Equity

Common Stock

    Capital in     
    Excess of     Retained    
  Amount     Par Value     Earnings     Shares  

  Shares  

Treasury Stock

    Accumulated      
Other

Total

    Comprehensive     Shareholders’  

  Amount

Income (loss)    

Equity

(amounts in thousands)
Balances as of December 31, 2017
Implementation of Accounting Standards
Employee Stock Purchase Plan share
   issuance
Stock Option Plan share issuance, net
Restricted stock plan share
   issuance/forfeiture
Deferred compensation plan share
   issuance
Purchase of stock
Equity-based compensation
Net loss
Foreign currency adjustment
Pension loss adjustment, net of tax
Balances as of December 31, 2018
Employee Stock Purchase Plan share
   issuance
Stock Option Plan share issuance, net
Restricted stock plan share
   issuance/forfeiture
Deferred compensation plan share
   issuance
Equity-based compensation
Net income
Foreign currency adjustment
Pension loss adjustment, net of tax
Balances as of December 31, 2019

(continued on next page)

(13,676 )   $
(263 )    

78,624  
73  

—     
—     

—     

—     
—     
—     
—     
(2,059 )    
1,387      
(14,611 )   $

—     
—     

—     

—     
—     
—     

(1,084 )
(2,847 )    
(18,542 )   $

93  
1,849  

(1,849 )

1,519  
(14,945 )
2,353  
(2,817 )
(2,059 )
1,387  
64,228  

147  
91  

(172 )

— 
1,748  
4,125  
(1,084 )
(2,847 )
66,236  

    27,018  
— 

 $

270    $ 120,247    $ 85,029       11,754     $ (113,246 )   $
—     
336      

—     

—     

—    

— 
— 

— 

—    
—    

—    

(109 )    
(1,589 )    

(4,475 )    

—     
—     

—     

(21 )    
(366 )    

202  
3,438  

(229 )    

2,626  

— 
— 
— 
— 
— 
— 
    27,018  

— 
— 

— 

— 
— 
— 
— 
— 
    27,018  

 $

 $

—    
—    
—    
—    
—    
—    

—     
—     
—     
(2,817 )    
—     
—     
270    $ 116,427    $ 82,548       12,746     $ (120,406 )   $

—     
—     
2,353      
—     
—     
—     

(159 )    
1,767      
—     
—     
—     
—     

1,519  
(14,945 )   

— 
— 
— 
— 

—    
—    

—    

(152 )    
(663 )    

(3,230 )    

—     
—     

—     

(32 )    
(45 )    

299  
754  

(143 )    

3,058  

—    
—    
—    
—    
—    

—     
—     
4,125      
— 
—     
270    $ 112,096    $ 86,673       12,311     $ (114,261 )   $

(2,034 )    
1,748      
—     
— 
—     

(215 )    
—     
—     
— 
—     

2,034  
— 
— 
— 
— 

40

 
   
 
 
  
 
    
 
    
 
     
 
 
  
 
 
 
 
   
 
 
  
 
 
     
 
 
  
 
   
   
 
 
 
 
   
 
   
  
  
     
  
  
      
  
  
  
  
      
  
   
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
  
  
  
  
   
  
  
Common Stock

    Capital in     
   Excess of     Retained  
  Amount     Par Value     Earnings  

  Shares  

Treasury Stock

  Shares  

  Amount

    Accumulated  
Other
   Comprehensive  
Income (loss)  

Total
 Shareholders’  
Equity

(amounts in thousands)
Balances as of December 31, 2019
Employee Stock Purchase Plan share
   issuance
Stock Option Plan share issuance, net
Restricted stock plan share
   issuance/forfeiture
Equity-based compensation
Net income
Foreign currency adjustment
Pension loss adjustment, net of tax
Balances as of December 31, 2020

    27,018  

 $

270    $ 112,096    $ 86,673       12,311     $ (114,261 )  $

(18,542 )   $

66,236  

— 
— 

—    
—    

(128 )    
(193 )    

—     
—     

(29 )    
(6 )    

271  
193  

— 
— 
— 
— 
— 
    27,018  

 $

—    
—    
—    
—    
—    

—     
—     
7,639      
—     
—     
270    $ 109,407    $ 94,312       11,842     $ (109,114 )  $

(4,851 )    
2,483      
—     
—     
—     

(434 )    
—     
—     
—     
—     

4,683  
— 
— 
— 
— 

—     
—     

—     
—     
—     
5,461      
(2,286 )    
(15,367 )   $

143  
— 

(168 )
2,483  
7,639  
5,461  
(2,286 )
79,508  

The accompanying notes are an integral part of these consolidated financial statements.

41

 
  
 
 
  
 
    
 
    
 
 
  
 
 
  
 
  
 
 
 
  
 
 
  
 
 
 
  
 
 
  
 
   
 
 
 
 
 
 
 
   
 
 
   
 
 
  
 
    
 
     
 
     
 
     
 
    
 
     
 
 
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
Notes to Consolidated Financial Statements

1.

Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

The consolidated financial statements include the accounts of Computer Task Group, Incorporated, and its 

subsidiaries (the “Company” or “CTG”), located primarily in North and South America, Western Europe, and India. There 
are no unconsolidated entities, or off-balance sheet arrangements other than certain guarantees supporting office leases 
and the performance under government contracts in the Company's European operations, and purchase obligations for 
certain software, recruiting and other services. All inter-company accounts have been eliminated. Management of the 
Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the 
disclosure of contingent assets and liabilities to prepare these consolidated financial statements in conformity with U.S. 
generally accepted accounting principles. Such estimates primarily relate to the valuation allowances for deferred tax 
assets, actuarial assumptions including discount rates and expected rates of return, as applicable, for the Company’s 
defined benefit plans, the allowance for doubtful accounts receivable, assumptions underlying stock option valuation, 
investment valuation, estimates of progress toward completion and direct profit or loss on contracts, acquisition and 
related accounting, legal matters, and other contingencies. The current economic environments in the United States, 
Canada, Colombia, Western Europe, and India where the Company has operations have increased the degree of 
uncertainty inherent in these estimates and assumptions. Actual results could differ from those estimates.

The Company operates in one industry segment, providing information and technology-related services to its clients. 

These services include information and technology-related solutions, including supplemental staffing as a solution. CTG 
provides these services to all of the markets that it serves. The services provided typically encompass the IT business 
solution life cycle, including phases for planning, developing, implementing, managing, and ultimately maintaining the IT 
solution. A typical client is an organization with large, complex information and data processing requirements. The 
Company provides a majority of its services in five vertical market focus areas: technology service providers, financial 
services, healthcare (which includes services provided to healthcare providers, health insurers (payers), and life sciences 
companies), manufacturing, and energy. The Company focuses on these five vertical areas as it believes that these areas 
are either higher growth markets than the general IT services market and the general economy, or are areas that provide 
greater potential for the Company’s growth due to the size of the vertical market. The remainder of CTG’s revenue is 
derived from general markets.

CTG’s revenue by vertical market as a percentage of consolidated revenue for the three years ended December 31, 

2020, 2019, and 2018 is as follows:

Technology service providers
Financial services
Healthcare
Manufacturing
Energy
General markets

Total

Revenue and Cost Recognition

2020

2019

2018

32.7%   
15.7%   
14.9%   
13.5%   
6.3%   
16.9%   
100.0%   

32.2%   
13.8%   
16.6%   
16.8%   
5.2%   
15.4%   
100.0%   

32.4%
15.2%
16.2%
19.5%
4.7%
12.0%
100.0%

The Company recognizes revenue when control of the promised good or service is transferred to clients, in an 
amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. For 
time-and-material contracts, revenue is recognized as hours are incurred and costs are expended. For contracts with 
progress billing schedules, primarily monthly, revenue is recognized as services are rendered to the client. Revenue for 
fixed-price contracts is recognized over time using an input-based approach. Over time revenue recognition best portrays 
the Company’s performance in transferring control of the goods or services to the client. On most fixed price contracts, 
revenue recognition is supported through contractual clauses that require the client to pay for work performed to date, 
including cost plus a reasonable profit margin, for goods or services that have no alternative use to the Company. On 
certain contracts, revenue recognition is supported through contractual clauses that indicate the client controls the asset, 
or work in process, as the Company creates or enhances the asset. On a given project, actual salary and indirect labor 

42

 
 
 
 
 
 
 
   
   
   
   
   
   
   
costs incurred are measured and compared with the total estimate of costs of such items at the completion of the project. 
Revenue is recognized based upon the percentage-of-completion calculation of total incurred costs to total estimated 
costs. The Company infrequently works on fixed-price projects that include significant amounts of material or other non-
labor related costs that could distort the percent complete within a percentage-of-completion calculation. The Company’s 
estimate of the total labor costs it expects to incur over the term of the contract is based on the nature of the project and 
our experience on similar projects, and includes management judgments and estimates that affect the amount of revenue 
recognized on fixed-price contracts in any accounting period.  Losses on fixed-price projects are recorded when identified. 

The Company’s revenue from contracts accounted for under time-and-material, progress billing, and percentage-of-
completion methods as a percentage of consolidated revenue for the three years ended December 31, 2020, 2019, and 
2018 is as follows:

Time-and-material
Progress billing
Percentage-of-completion

Total

2020

2019

2018

81.0%   
15.9%   
3.1%   
100.0%   

79.6%   
10.2%   
10.2%   
100.0%   

84.7%
10.5%
4.8%
100.0%

The Company recorded revenue for fiscal years ended 2020 compared to 2019 and 2019 compared to 2018 as 

follows:

Year Ended December 31,
(dollars in thousands)
North America
Europe
Total

Year Ended December 31,
(dollars in thousands)
North America
Europe
Total

  % of total

2020

    % of total

2019

Year-Over-
Year Change 

55.8%  $ 204,264     
44.2%    161,827     
100.0%  $ 366,091     

61.5%  $ 242,218     
38.5%    151,952     
100.0%  $ 394,170     

(15.7)%
6.5%
(7.1)%

  % of total

2019

    % of total

2018

Year-Over-
Year Change 

61.5%  $ 242,218     
38.5%    151,952     
100.0%  $ 394,170     

64.9%  $ 232,695     
35.1%    126,074     
100.0%  $ 358,769     

4.1%
20.5%
9.9%

The Company includes billable expenses in its accounts as both revenue and direct costs. These billable expenses 

totaled $1.9 million, $2.6 million, and $3.2 million in 2020, 2019, and 2018, respectively. 

Significant Judgments

With the exception of cost estimates on certain fixed-price projects, there are no other significant judgments used to 
determine the timing of satisfaction of performance obligations or determining transaction price and amounts allocated to 
performance obligations. The Company allocates the transaction price based on standalone selling prices for contracts 
with clients that include more than one performance obligation. Standalone selling prices are based on the expected cost 
of the good or service plus margin approach. Certain clients may qualify for discounts and rebates, which we account for 
as variable consideration. The Company estimates variable consideration and reduces revenue recognized based on the 
amount it expects to provide to clients.

Contract Balances

 For time-and-material and progress billing contracts, the timing of the Company’s satisfaction of its performance 
obligations is consistent with the timing of payment. For these contracts, the Company has the right to payment in the 
amount that corresponds directly with the value of the Company’s performance to date. The Company uses the right to 
invoice practical expedient that allows the Company to recognize revenue in the amount for which it has the right to 
invoice for time-and-material and progress billing contracts. Bill schedules for fixed-price contracts are generally 
consistent with the Company’s performance in transferring control of the goods or services to the client. There are no 
significant financing components in our contracts with clients. Advance billings represent contract liabilities for cash 

43

 
 
 
 
 
 
 
   
   
   
   
 
 
 
 
   
   
  
   
      
  
   
      
  
   
   
   
 
 
 
 
   
   
  
   
      
  
   
      
  
   
   
   
 
payments received in advance of our performance. Unbilled receivables are reported within “accounts receivable” on the 
consolidated balance sheet. Accounts receivable and contract liability balances fluctuate based on the timing of the 
client’s billing schedule and the Company’s period-end date. There are no significant costs to obtain or fulfill contracts with 
clients.

Transaction Price Allocated to Remaining Performance Obligations

As of December 31, 2020, the aggregate transaction price allocated to unsatisfied or partially unsatisfied 

performance obligations for fixed-price and all progress billing contracts was approximately $9.9 million and $41.0 million, 
respectively. Approximately $35.7 million of the transaction price allocated to unsatisfied or partially unsatisfied 
performance obligations is expected to be earned in 2021. Approximately $15.2 million of the transaction price allocated 
to unsatisfied or partially unsatisfied performance obligations is expected to be earned in 2022 and beyond. The Company 
uses the right to invoice practical expedient. Therefore, no disclosure is required for unsatisfied performance obligations 
for contracts in which we recognize revenue at the amount to which we have the right to invoice for services performed.

Taxes Collected from Clients

In instances where the Company collects taxes from its clients for remittance to governmental authorities, primarily 

in its international locations, taxes are recorded in the Company's accounts on a net basis.

Fair Value

Fair value is defined as the exchange price that would be received for an asset or paid for a liability in the principal 

or most advantageous market for the asset or liability, in an orderly transaction between market participants. The 
Company utilizes a fair value hierarchy for its assets and liabilities, as applicable, based upon three levels of input, which 
are:

Level 1—quoted prices in active markets for identical assets or liabilities (observable)

Level 2—inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar 

assets or liabilities, quoted prices in inactive markets, or other inputs that are observable or can be supported by 
observable market data for essentially the full term of the asset or liability (observable)

Level 3—unobservable inputs that are supported by little or no market activity, but are significant to determining the 

fair value of the asset or liability (unobservable)

At December 31, 2020 and 2019, the carrying amounts of the Company’s cash of $32.9 million and $10.8 million, 

respectively, approximated fair value.

As described in Note 3 of the consolidated financial statements, the Company acquired 100% of the equity of 

StarDust in the first quarter of 2020, Tech-IT in the first quarter of 2019, and Soft Company in the first quarter of 2018. 
Level 3 inputs were used to estimate the fair values of the assets acquired and liabilities assumed. The valuation 
techniques used to assign fair values to intangible assets included the relief-from-royalty method and excess earnings 
method.

 The Company had a contingent consideration liability related to the earn-out provision of which a portion was 
payable in each period subject to the achievement by Soft Company of certain revenue and EBIT targets for fiscal 2017, 
2018, and 2019. There is no payout if the achievement on either target is below a certain target threshold. The fair value 
of this contingent consideration is determined using level 3 inputs. The fair value assigned to the contingent consideration 
liability is determined using the real options method, which requires inputs such as revenue forecasts, EBIT forecasts, 
discount rate, and other market variables to assess the probability of Soft Company achieving the revenue and EBIT 
targets. The fair value as of the February 15, 2018 acquisition date was determined to be $2.0 million. In the 2018 second 
quarter, the Company paid approximately $0.9 million relating to the earn-out based on the achievement by Soft Company 
of certain revenue and EBIT targets for fiscal 2017. In the 2019 third quarter, the Company paid approximately $1.2 
million relating to the earn-out based on the achievement by Soft Company of certain revenue and EBIT targets for fiscal 
2018. In the 2020 fourth quarter, the Company paid approximately $0.9 million relating to the earn-out based on the 
achievement by Soft Company of certain revenue and EBIT targets for fiscal 2019. There is no remaining contingent 
consideration liability related to Soft Company’s earn-out as it has been fully paid as of December 31, 2020.

44

 
The Company has a contingent consideration liability related to the earn-out provision of which a portion will be 
payable in each period subject to the achievement by Tech-IT of direct profit targets for fiscal 2019 and 2020. There is no 
payout if the achievements are below the target thresholds. The fair value of this contingent consideration liability is 
determined using the real options method, which requires inputs such as expected direct profit forecasts, discount rate, 
and other market variables to assess the probability of Tech-IT achieving the direct profit targets. The fair value as of the 
February 6, 2019 acquisition date was determined to be $0.6 million. In the 2020 fourth quarter, the Company paid 
approximately $0.3 million relating to the earn-out based on the achievement by Tech-IT of the direct profit targets for 
fiscal year 2019. The fair value of the remaining contingent consideration liability was determined to be zero as of 
December 31, 2020 as the direct profit target threshold was not met by Tech-IT for the fiscal year 2020. 

In addition, the Company has a contingent consideration liability related to the earn-out provision of which a portion 
will be payable in each period subject to the achievement by StarDust of consolidated direct profit targets for fiscal 2020 
and 2021. There is no payout if the achievement on either target is below a certain target threshold. The fair value of this 
contingent consideration is determined using level 3 inputs. The fair value assigned to the contingent consideration liability 
is determined using the real options method, which requires inputs such as consolidated direct profit forecasts, discount 
rate, and other market variables to assess the probability of StarDust achieving the revenue and EBIT targets. The fair 
value as of the March 3, 2020 acquisition date was determined to be $0.1 million. The fair value of the remaining 
contingent consideration liability was determined to be approximately $0.5 million as of December 31, 2020. As such, the 
Company recorded $0.4 million of selling, general, and administrative expense during the 2020 year-to-date period. 
Approximately $0.4 million and $0.1 million of the remaining contingent consideration liability is recorded in “other current 
liabilities” and “other long-term liabilities”, respectively, on the December 31, 2020 consolidated balance sheet.

As of December 31, 2020, goodwill recorded on the Company's consolidated balance sheet totaled $21.3 million, 

which relates to the acquisitions completed by the Company in 2018, 2019, and 2020. The acquisition of Soft Company in 
2018 and StarDust in 2020 are in the France reporting unit, while the 2019 acquisition of Tech-IT is in the Luxembourg 
reporting unit. In connection with our annual goodwill impairment test, we make various assumptions to determine the 
estimated fair value of the reporting units to which the goodwill relates. We perform the annual impairment review in the 
fourth quarter of each year. The goodwill impairment test is performed at least annually, unless indicators of an 
impairment exist in interim periods. The Company compared the estimated fair value of a reporting unit with goodwill to its 
carrying value. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an 
impairment loss is recognized in an amount equal to the excess.

As of October 2020 fiscal month-end, we performed our annual goodwill impairment test in conjunction with an 
external consultant and estimated the fair value of our reporting units based on a combination of the income (estimates of 
future discounted cash flows) and the market approach (market multiples for similar companies). The income approach 
uses a discounted cash flow (DCF) method that utilizes the present value of cash flows and other Level 3 inputs to 
estimate the fair value of the reporting unit. The future cash flows for the reporting units were projected based upon on our 
estimates of future revenue, a terminal growth rate, operating income and other factors such as working capital and 
capital expenditures. As part of our projections, we took into account expected industry and market conditions for the 
industries in which the reporting units operate, as well as trends currently impacting the reporting units. As part of our DCF 
analysis, we projected revenue and operating profits, and assumed a long-term revenue growth rates in the “terminal 
year” for both of the reporting units. We also utilized a weighted-average cost of capital (WACC) of 16.0% for the France 
reporting unit and 15.0% for the Luxembourg reporting unit. These projections are based upon our judgment and may 
change in the future based upon the inherent uncertainty in predicting future results. The market approach utilizes 
multiples of earnings before interest expense, taxes, depreciation and amortization (EBITDA) to estimate the fair value of 
the reporting unit. The market multiples used for our reporting units were based on competitor industry data, along with 
the market multiples for the Company and other factors.

The carrying value as of October 2020 was approximately $17.6 million and $13.2 million for the France and 

Luxembourg reporting units, respectively.  

The Company is also allowed to elect an irrevocable option to measure, on a contract-by-contract basis, specific 
financial instruments and certain other items that are currently not being measured at fair value. The Company did not 
elect to apply the fair value provisions of this standard for any specific contracts during the years ended December 31, 
2020 and 2019.

45

Life Insurance Policies

The Company has purchased life insurance on the lives of a number of former employees who are plan participants 

in the non-qualified defined benefit Executive Supplemental Benefit Plan. In total, there are policies on 16 individuals, 
whose average age is 77 years old. These policies have generated cash surrender value and the Company has taken 
loans against the policies. At December 31, 2020, these insurance policies have a gross cash surrender value of $27.1 
million, outstanding loans and interest totaling $24.4 million, and a net cash surrender value of $2.7 million. At 
December 31, 2019, these insurance policies had a gross cash surrender value of $29.7 million, outstanding loans and 
interest totaling $27.2 million, and a net cash surrender value of $2.5 million. 

At December 31, 2020 and 2019, the total death benefit for the remaining policies was approximately $35.0 million 

and $37.7 million, respectively. Currently, upon the death of all of the plan participants, the Company would expect to 
receive approximately $10.3 million, and under current tax regulations, would record a non-taxable gain of approximately 
$7.6 million.

During both, the 2020 second and third quarters, a participant in the plan passed away. Upon their deaths, the 
Company recorded a non-taxable life insurance gain totaling approximately $1.0 million, which it has recorded on its 
consolidated statements of operations. Also, a former employee covered by these policies passed away in the 2018 third 
quarter and the Company recorded a non-taxable gain of approximately $0.8 million during 2018.

Cash and Cash Equivalents, and Cash Overdrafts

For purposes of the statement of cash flows, cash and cash equivalents are defined as cash on hand, demand 
deposits, and short-term, highly liquid investments with a maturity of three months or less. As the Company does not fund 
its bank accounts for the checks it has written until the checks are presented to the bank for payment, the "change in cash 
overdraft, net" line item as presented on the consolidated statement of cash flows represents the increase or decrease in 
outstanding checks for a given period. The cash in the Company’s U.S. banks is insured by the Federal Deposit Insurance 
Corporation up to the insurable limit of $250,000. As of December 31, 2020, the Company has multiple accounts that 
carry balances in excess of this insurable limit. The Company’s cash in its foreign bank accounts is not insured. 

Accounts Receivable Factoring

As part of our working capital management, the Company entered into a factoring agreement during the 2020 first 

quarter to sell certain trade accounts receivables on a non-recourse basis to third-party financial institutions. We account 
for these transactions as sales of receivables and present cash proceeds as cash provided by operating activities in the 
consolidated statements of cash flows. Total trade accounts receivable sold under the factoring agreement was 
approximately $64.0 million in 2020. Factoring fees for the sale of receivables were recorded in direct costs and were $0.1 
million for the year ended December 31, 2020. There were no accounts receivable factoring activities during 2019.

Property, Equipment and Capitalized Software Costs

Property and equipment are generally stated at historical cost less accumulated depreciation. Depreciation is 

computed using the straight-line method based on estimated useful lives of one year to ten years, and begins after an 
asset has been placed into service. Leasehold improvements are generally depreciated over the shorter of the term of the 
lease or the useful life of the improvement. The cost of property or equipment sold or otherwise disposed of, along with 
related accumulated depreciation, is eliminated from the accounts, and the resulting gain or loss, if any, is reflected in 
current earnings. Maintenance and repairs are charged to expense when incurred, while significant improvements to 
existing assets are capitalized. Depreciation expense for the Company totaled $1.9 million in both 2020 and 2019, and 
$1.8 million in 2018. 

As of December 31, 2020 and 2019, the Company had capitalized costs relating to software projects developed for 

internal use. Amortization periods for these projects range from three to five years, and begin when the software, or 
enhancements thereto, is available for its intended use. Amortization periods are evaluated annually for propriety.

46

Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the 
carrying amount of an asset may not be recoverable. When such circumstances exist, the recoverability of assets to be 
held and used is measured by a comparison of the carrying amount of an asset to future cash flows expected to be 
generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the 
amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of by sale, 
if any, are reported at the lower of the carrying amount or fair value less costs to sell. During the 2020 fourth quarter, the 
Company recorded an adjustment of $0.8 million to reduce capital software for an asset that was being developed in the 
United Kingdom. The Company does not have any other long-lived assets that are impaired as of December 31, 2020.

During the 2020 second quarter, the Company sold its corporate headquarters located in Buffalo, NY. As the sale 

price of the building was $2.5 million, and the book value of the building was approximately $1.6 million, the Company 
recorded a profit on the sale after related fees of about $0.8 million in the 2020 second quarter.

Leases

The Company is obligated under a number of short and long-term operating leases for office space and office 
equipment, and for automobiles leased in Europe. On January 1, 2019, the Company adopted Topic 842 using the 
modified retrospective transition approach and elected the transition method to apply the new lease standard as of the 
January 1, 2019 adoption date. Results for the reporting periods beginning after January 1, 2019 are presented under 
Topic 842, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s 
historic accounting under Topic 840.

Goodwill

The goodwill recorded on the Company's consolidated balance sheet at December 31, 2020 relates to the 
acquisition of Soft Company in the 2018 first quarter, Tech-IT in the 2019 first quarter, and StarDust in the 2020 first 
quarter. In accordance with current accounting guidance for “Intangibles - Goodwill and Other,” the Company performs 
goodwill impairment testing at least annually (in the Company’s fourth quarter), unless indicators of impairment exist in 
interim periods. If impairment indicators are present and the estimated future undiscounted cash flows are less than the 
carrying value of the long-lived assets, the carrying value would be reduced to the estimated fair value. There were no 
impairments recorded in the Company’s consolidated financial statements during 2020, 2019, or 2018. 

The changes in the carrying amount of goodwill for the years ended December 31, 2020 and 2019 are as follows:

 (amounts in thousands)
Balance at December 31, 2018
Acquired goodwill
Foreign currency translation
Balance at December 31, 2019
Acquired goodwill
Foreign currency translation
Balance at December 31, 2020

Acquired Intangibles Assets

Acquired intangible assets at December 31, 2020 consist of the following:

$

$

$

11,664 
5,331 
(314)
16,681 
2,757 
1,837 
21,275  

 (amounts in thousands)
Trademarks
Technology
Customer relationships

Total

Estimated
Economic Life  
2 years
10 years
7-13 years    
  $

  $

Gross Carrying
Amount

Accumulated
Amortization  

Foreign 
Currency 
Translation    

Net Carrying
Amount

1,532    $
591     
10,496     
12,619    $

1,456    $
54     
2,331     
3,841    $

50    $
59     
210     
319    $

126 
596 
8,375 
9,097  

47

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
   
 
   
Acquired intangible assets at December 31, 2019 consisted of the following:

 (amounts in thousands)
Trademarks
Customer relationships

Total

Estimated
Economic Life  
2 years

  $
8-13 years    
  $

Gross Carrying
Amount

Accumulated
Amortization    

Foreign 
Currency 
Translation    

Net Carrying
Amount

1,432    $
9,905     
11,337    $

911    $
1,191     
2,102    $

(86)   $
(710)    
(796)   $

435 
8,004 
8,439  

Amortization expense for our acquired intangibles was $1.4 million in both 2020 and 2019, and $0.7 million in 2018.

Estimated amortization expense for the next five fiscal years, and thereafter, is as follows (amounts in thousands):

Year
2021
2022
2023
2024
2025
Thereafter
Total

Annual
Amortization

1,225 
1,117 
1,108 
1,108 
1,108 
3,431 
9,097  

$

$

48

 
   
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income Taxes

The Company provides for deferred income taxes for the temporary differences between the financial reporting basis 

and the tax basis of the Company’s assets and liabilities. In assessing the realizability of deferred tax assets, 
management considers within each tax jurisdiction, whether it is more likely than not that some portion or all of the 
deferred tax assets will be realized, or that a valuation allowance is required. Management considers all available 
evidence, both positive and negative, in assessing realizability of its deferred tax assets. A key component of this 
assessment is management’s critical evaluation of current and future impacts of business and economic factors on the 
Company’s ability to generate future taxable income. Factors that may affect the Company’s ability to generate taxable 
income include, but are not limited to increased competition, a decline in revenue or margins, a loss of market share, the 
availability of qualified professional staff, and a decrease in demand for the Company’s services. The Company elected to 
use the incremental cash tax savings approach when considering GILTI in its assessment of the realizability of its U.S. 
deferred tax assets. The Company generated U.S. book and tax income during 2019 and 2020 but incurred significant 
losses in 2018 resulting in a cumulative near break-even position for the three years ended December 31, 2020. The 
Company believes its financial outlook remains positive; however, the COVID-19 pandemic has created a high level of 
uncertainty. Because of difficulties with forecasting U.S. financial results historically, and due to the uncertainties 
associated with the COVID-19 pandemic, the Company maintained a full valuation allowance on its U.S. deferred tax 
assets at December 31, 2020. The analysis that the Company prepared to determine the valuation allowance required 
significant judgment and assumptions regarding future market conditions as well as forecasts for profits, taxable income, 
and taxable income by jurisdiction. Due to the sensitivity of the analysis, changes to the assumptions in subsequent 
periods could have a material effect on the valuation allowance. Additionally, management has determined that a 
valuation allowance is required against its Netherlands deferred taxes. The total valuation allowance recorded against 
these deferred tax assets is $7.7 million, a net increase of $2.0 million during the year, which was recorded as income tax 
expense in the consolidated statement of operations. The Company recognizes, as applicable, accrued interest and 
penalties related to unrecognized tax benefits (if any) in tax expense.

The Company establishes an unrecognized tax benefit based upon the anticipated outcome of tax positions taken 

for financial statement purposes compared with positions taken on the Company’s tax returns. The Company records the 
benefit for unrecognized tax benefits only when it is more likely than not that the position will be sustained upon 
examination by the taxing authorities. The Company reviews its unrecognized tax benefits on a quarterly basis. Such 
reviews include consideration of factors such as the cause of the action, the degree of probability of an unfavorable 
outcome, the Company’s ability to estimate the liability, and the timing of the liability and how it will impact the Company’s 
other tax attributes.

Equity-Based Compensation

The Company records the fair value of equity-based compensation expense for all equity-based compensation 

awards granted and recognizes the cost in the Company’s income statement over the periods in which an employee or 
director is required to provide the services for the award. Compensation cost is not recognized for employees or directors 
that do not render the requisite services. The Company recognized the expense for equity-based compensation in its 
2020, 2019, and 2018 consolidated statements of operations on a straight-line basis based upon awards that are 
ultimately expected to vest. See Note 10, “Equity-Based Compensation.”

49

Net Income (Loss) Per Share

Basic and diluted earnings (loss) per share (EPS) for the years ended December 31, 2020, 2019, and 2018 are as 

follows:

For the year ended
(amounts in thousands, except per-share data)
December 31, 2020
Basic EPS
Dilutive effect of outstanding equity instruments
Diluted EPS
December 31, 2019
Basic EPS
Dilutive effect of outstanding equity instruments
Diluted EPS
December 31, 2018
Basic EPS
Dilutive effect of outstanding equity instruments
Diluted EPS

Net
Income (loss)

Weighted
Average
Shares

Earnings
(loss) per
Share

  $

  $

  $

  $

  $

  $

7,639     
—     
7,639     

4,125     
—     
4,125     

(2,817)    
—     
(2,817)    

13,621    $
806     
14,427    $

13,450    $
547     
13,997    $

13,805    $
—     
13,805    $

0.56 
(0.03)
0.53 

0.31 
(0.02)
0.29 

(0.20)
— 
(0.20)

Weighted-average shares represent the average number of issued shares less treasury shares, and for the basic 

EPS calculations, unvested restricted stock.

Certain options representing 0.6 million, 0.7 million, and 1.1 million shares of common stock were outstanding at 
December 31, 2020, 2019, and 2018, respectively, but were not included in the computation of diluted earnings per share 
as their effect on the computation would have been anti-dilutive.

Accumulated Other Comprehensive Loss

The components that comprised accumulated other comprehensive loss on the consolidated balance sheets at 

December 31, 2020 and 2019 are as follows:

 (amounts in thousands)
Foreign currency translation adjustment, net of taxes
Pension loss, net of tax of $455 in 2020 and $265 in 2019

Accumulated other comprehensive loss

  $

  $

2020

2019

(3,645)   $
(11,722)    
(15,367)   $

(9,106)
(9,436)
(18,542)

During 2020, 2019, and 2018, actuarial losses were amortized to expense as follows:

 (amounts in thousands)
Amortization of actuarial losses
Income tax

Net of tax

2020

2019

2018

  $

  $

298    $
1     
297    $

185    $
—     
185    $

277 
— 
277  

The amortization of actuarial losses is included in determining net periodic pension cost. See Note 7, "Deferred 

Compensation Benefits" for additional information.

Foreign Currency

The functional currency of the Company’s foreign subsidiaries is the applicable local currency. The translation of the 
applicable foreign currencies into U.S. dollars is performed for assets and liabilities using current exchange rates in effect 
at the balance sheet date, for equity accounts using historical exchange rates, and for revenue and expense activity using 
the applicable month’s average exchange rates. The Company recorded a nominal amount of expense in 2020, 2019, and 
2018 from foreign currency transactions for balances settled during the year or intended to be settled as of each 
respective year-end.

50

 
   
   
 
 
 
    
 
    
 
  
   
      
      
  
   
   
      
      
  
   
   
      
      
  
   
 
   
 
   
 
   
 
 
 
   
Guarantees

The Company has a number of guarantees in place in our European operations which support office leases and 

performance under government projects. These guarantees totaled approximately $3.2 million and $3.0 million at 
December 31, 2020 and 2019, respectively, and generally have expiration dates ranging from January 2021 through 
October 2034.

Recently Issued Accounting Standards

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842),” which sets out the principles for the 
recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). 
The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases 
based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will 
determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the 
term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases 
with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be 
accounted for similar to existing guidance for operating leases today. Topic 842 supersedes the previous leases standard, 
ASC 840, Leases. This guidance is effective for reporting periods beginning after December 15, 2018. On January 1, 
2019, the Company adopted the new lease standard using the modified retrospective transition approach and elected the 
transition method to apply the new lease standard as of the January 1, 2019 adoption date. Results for the reporting 
periods beginning after January 1, 2019 are presented under Topic 842, while prior period amounts are not adjusted and 
continue to be reported in accordance with accounting under Topic 840. In addition, the Company elected the package of 
practical expedients, which permits the Company not to reassess under the new standard prior conclusions about lease 
identification, lease classification, and initial direct costs. The Company has also elected the practical expedient to 
separate lease and non-lease components for its office leases and has elected to group lease and non-lease components 
for its vehicle leases. Upon adoption of Topic 842 on January 1, 2019, the Company recorded approximately $13.1 million 
of operating lease right-of-use assets and lease liabilities. The adoption of Topic 842 did not have a significant impact on 
the Company’s consolidated statements of income, comprehensive income (loss), or its consolidated statements of cash 
flows. The new lease standard does not affect the Company’s compliance with financial covenants associated with its 
Credit and Security Agreement.

In January 2018, the FASB issued ASU 2018-02, “Income Statement – Reporting Comprehensive Income (Topic 

220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI)”, which gives 
entities the option to reclassify to retained earnings the tax effects resulting from the Act related to items in AOCI that the 
FASB refers to as having been stranded in AOCI. The guidance required new disclosures regarding a company’s 
accounting policy for releasing the tax effects in AOCI and permit the company the option to reclassify to retained 
earnings the tax effects resulting from the Act that are stranded in AOCI. The Company reclassified approximately $0.3 
million to retained earnings due to the adoption of ASU 2018-02 in the 2018 fourth quarter.

In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments”, 
which requires the immediate recognition of estimated credit losses expected to occur over the remaining life of many 
financial assets, including trade receivables. The allowance for credit losses will be the difference between the amortized 
cost balance of a financial asset and the amount of amortized cost expected to be collected over the remaining 
contractual life. When determining the allowance, expected credit losses over the contractual term of the financial assets 
will be estimated considering relevant information about past events, current conditions, and reasonable and supportable 
forecasts that affect the collectability of the reported amount.  Subsequent changes in the allowance will be recorded 
through the income statement as an expense adjustment. This guidance is effective for reporting periods beginning after 
December 15, 2019; however, early adoption is permitted. The Company adopted the new credit loss standard on 
January 1, 2020. The Company estimated its allowance for credit losses by pooling assets with similar risk characteristics, 
reviewing historical losses within the last five years and taking into consideration any reasonable supportable forecasts of 
future economic conditions. The Company cannot guarantee that the rate of future credit losses will be similar to past 
experience, but considers all available information when assessing the adequacy of its allowance for credit losses each 
quarter. As the impact from this standard on the Company was immaterial, no adjustment was made to the beginning 
retained earnings balance.

In January 2017, the FASB issued ASU 2017-04,”Simplifying the Test for Goodwill Impairment”, which simplifies 

how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. This 
guidance is effective for reporting periods beginning after December 15, 2019; however, early adoption is permitted. The 

51

Company adopted the new standard on January 1, 2020 for the year ending December 31, 2020 on a prospective basis 
and the adoption did not have a material impact on the Company’s operations. 

In August 2018, the FASB issued ASU 2018-15, “Customer’s Accounting for Implementation Costs Incurred in a 
Cloud Computing Arrangement That Is a Service Contract”, which helps entities evaluate the accounting for fees paid in a 
cloud computing arrangement (hosting arrangement) by providing guidance for determining when the arrangement 
includes a software license. This guidance is effective for fiscal years beginning after December 15, 2019; however, early 
adoption is permitted. The Company adopted the new standard on January 1, 2020 for the year ending December 31, 
2020 on a prospective basis and the adoption did not have a material impact on the Company’s operations.

In August 2018, the FASB issued ASU 2018-14, "Compensation - Retirement Benefits - Defined Benefit Plans - 

General (Subtopic 715-20)". The amendments in this update modify the disclosure requirements for employers that 
sponsor defined benefit pension or other post-retirement plans by removing disclosures that no longer are considered cost 
beneficial, clarifying the specific requirements of disclosures, and adding disclosure requirements identified as relevant. 
The new ASU is effective for fiscal years ending after December 15, 2020, and early adoption is permitted. The Company 
adopted this new standard retrospectively for the year ending December 31, 2020, and the adoption did not have a 
material impact on its consolidated financial statements and associated disclosures.

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform - Facilitation of the Effects of Reference 

Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for accounting contracts, 
hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments 
apply only to contracts, hedging relationships and other transactions that reference the London Interbank Offering Rate 
(“LIBOR”) or another reference rate expected to be discontinued due to the reference rate reform. It is effective for all 
entities between March 12, 2020 and December 31, 2022. The Company does not expect a significant impact from the 
adoption of this standard as provisions have been made in our Credit and Security Agreement to use an alternate 
benchmark interest rate when the use of LIBOR is discontinued.

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for 

Income Taxes.” Among other clarifications and simplifications related to income tax accounting, the new standard 
simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax 
allocation, the methodology for calculating income taxes in an interim period, hybrid taxes and the recognition of deferred 
tax liabilities for outside basis differences. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal 
years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently reviewing the provisions 
of this new pronouncement, but does not expect adoption of this guidance to have a material impact on its consolidated 
financial statements.

Subsequent Event

The Company has evaluated all subsequent events through the filing date of this Form 10-K with the SEC and there 

were no subsequent events which required recognition, adjustment to or disclosure in the consolidated financial 
statements.  

2.

Property, Equipment and Capitalized Software

Property, equipment and capitalized software at December 31, 2020 and 2019 are summarized as follows:

December 31,
(amounts in thousands)
Land
Buildings
Equipment
Furniture
Capitalized software
Other software
Leasehold improvements

Accumulated depreciation and amortization

Useful Life
(years)

2020

2019

—    $
30     
1-5     
5-10     
3-5     
1-5     
3-10     

     $

—    $
—     
6,136     
1,490     
2,397     
2,139     
2,381     
14,543     
(9,028)    
5,515    $

50 
1,808 
5,533 
2,214 
2,147 
1,722 
3,910 
17,384 
(11,005)
6,379  

52

 
   
   
 
 
   
 
    
 
  
   
   
 
 
 
 
 
 
   
      
   
      
 
   
The Company capitalizes software projects developed for commercial use. The Company recorded capitalized 

software costs during 2020 and 2019 as follows:

(amounts in thousands)
Capitalized software, beginning balance
Additions
Impairment
Capitalized software

For the year ended December 31,

2020

2019

  $

  $

2,147    $
1,105   
(855)  
2,397    $

1,864 
283 
— 
2,147  

Capitalized software amortization periods range from three to five years, and are evaluated periodically for propriety. 

Amortization expense and accumulated amortization for these projects at December 31, 2020 and 2019 are as follows:

(amounts in thousands)
Accumulated amortization, beginning balance
Amortization expense
Accumulated amortization

3.

Acquisitions

StarDust SAS (“StarDust”)

For the year ended December 31,

2020

2019

866    $
414   
1,280    $

745 
121 
866  

  $

  $

On March 3, 2020, the Company acquired 100% of the equity of StarDust, for approximately $6.1 million (€5.5 

million based on a EUR into USD exchange rate of 1.1145). The acquisition was funded using cash on hand and 
borrowings under the Credit and Security Agreement. The France-based StarDust, is a leading provider of testing and 
quality assurance for digital services with offices in Marseille, France, and Montreal, Canada. StarDust offers a complete 
range of testing services, including functional, multilingual, operational, environmental, regression, and application 
benchmarking, covering digital services and website, software, mobile applications, and Internet of Things connected 
objects. The acquisition is expected to expand the Company’s global testing capabilities.

The results of operations of StarDust have been included in the Company’s consolidated financial results since the 
date of acquisition. As the Company has determined that the acquisition is not material to its existing operations, certain 
disclosures, including pro forma financial information, have not been included in this annual report on Form 10-K.

An earn-out of up to $1.1 million (€1.0 million based on a EUR into USD exchange rate of 1.1145) can be earned, a 

portion of which will be payable in each period subject to the achievement of consolidated direct profit targets for fiscal 
2020 and 2021. Additionally, for each €10,000 of consolidated direct profit achieved above the target, an additional €1,000 
can be earned, with no maximum limit. There is no payout if the achievement is below the target threshold. The fair value 
as of the March 3, 2020 acquisition date was determined to be $0.1 million, and was $0.5 million as of December 31, 
2020. As such, the Company recorded $0.4 million in selling, general, and administrative expenses during 2020 related to 
this earn-out. Approximately $0.4 million and $0.1 million of the remaining contingent consideration liability is recorded in 
“other current liabilities” and “other long-term liabilities” on the December 31, 2020 consolidated balance sheet, 
respectively.

The acquisition date fair value of the consideration for the acquisition of StarDust consisted of the following as of 

March 3, 2020:

(amounts in thousands)
Cash consideration
Fair value of contingent consideration
Fair value of purchase consideration

$

$

6,122 
111 
6,233  

53

 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
The following table summarizes the allocation of the aggregate purchase consideration to the fair value of the assets 

acquired and liabilities assumed as of March 3, 2020:

(amounts in thousands)
Assets Acquired:
Cash
Accounts receivable
Prepaids & other
Property & equipment, net
Acquired intangibles
Goodwill
Total assets acquired

Liabilities Assumed:
Accounts payable
Accrued compensation
Taxes payable
Other liabilities
Deferred income taxes
Total liabilities assumed
Net assets acquired

$

$

$

$

1,798 
1,303 
71 
327 
1,282 
2,757 
7,538 

285 
307 
222 
163 
328 
1,305 
6,233  

The purchase consideration for the acquisition was allocated to the assets acquired and liabilities assumed based 
upon their respective fair values. The excess consideration was recorded as goodwill, which is not deductible for income 
tax purposes.

(amounts in thousands)
Trademarks
Technology
Customer relationships
Fair value of purchase consideration

Fair Value

$

$

100   
591   
591   
1,282   

Estimated
Economic Life
2 years
10 years
7 years

The Company incurred acquisition-related legal and consulting fees, adjustments to the fair value of the earn-out 

liability, and amortization of intangible assets of approximately $0.6 million in 2020, which were recorded as a component 
of selling, general, and administrative expenses in the consolidated statements of operations. The purchase price 
allocation for this acquisition has been finalized.

Tech-IT PSF S.A. (“Tech-IT”)

On February 6, 2019, the Company acquired 100% of the equity of Tech-IT for approximately $9.7 million. The 
acquisition was funded using cash on hand and borrowings under the Credit and Security Agreement. Tech-IT, located in 
Bertrange, Luxembourg, is a leading provider of software and hardware services, including consulting, infrastructure and 
software design and development, infrastructure integration, project management, and training. The acquisition of Tech-IT 
is expected to enable the Company to strengthen its market position in Luxembourg and broaden its portfolio to offer end-
to-end IT solutions.

The results of operations of Tech-IT have been included in the Company’s consolidated financial results since the 
date of acquisition. As the Company has determined that the acquisition is not material to its existing operations, certain 
disclosures, including pro forma financial information, have not been included in this annual report on Form 10-K.

An earn-out of up to a maximum of $1.7 million (€1.5 million based on a EUR into USD exchange rate of 1.1386 at 

the time of acquisition) can be earned, a portion of which will be payable in each period subject to the achievement of 
direct profit targets for fiscal 2019 and 2020.  There is no payout if the achievement is below the target threshold. The fair 
value as of the February 6, 2019 acquisition date was determined to be $0.6 million. In the 2020 fourth quarter, the 
Company paid approximately $0.3 million relating to the earn-out based on the achievement by Tech-IT of direct profit 
targets for the fiscal year 2019. The fair value of the remaining contingent consideration liability was determined to be zero 
as of December 31, 2020 as the direct profit target threshold was not met by Tech-IT for the fiscal year 2020. 

54

   
 
   
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
The acquisition date fair value of the consideration for the above transaction consisted of the following as of 

February 6, 2019:

 (amounts in thousands)
Cash consideration
Fair value of contingent consideration
Fair value of purchase consideration

$

$

9,678 
569 
10,247  

The following table summarizes the allocation of the aggregate purchase consideration to the fair value of the assets 

acquired and liabilities assumed as of February 6, 2019:

 (amounts in thousands)
Assets Acquired:
Cash
Accounts receivable
Prepaids & other
Property & equipment, net
Acquired intangibles
Goodwill
Total assets acquired

Liabilities Assumed:
Accounts payable
Accrued compensation
Other short-term liabilities
Deferred income taxes
Total liabilities assumed
Net assets acquired

$

$

$

$

1,217 
4,491 
1,122 
98 
4,099 
5,331 
16,358 

2,378 
172 
2,447 
1,114 
6,111 
10,247  

The purchase consideration for the acquisition was allocated to the assets acquired and liabilities assumed based 
upon their respective fair values. The excess consideration was recorded as goodwill, which is not deductible for income 
tax purposes.

The intangible assets acquired in this acquisition consisted of the following:

 (amounts in thousands)
Trademarks
Customer relationships
Fair value of purchase consideration

Fair Value

$

$

683   
3,416   
4,099   

Estimated
Economic Life
2 years
8 years

The Company incurred acquisition-related legal and consulting fees, adjustments to the fair value of the earn-out 

liability, and amortization of intangible assets of approximately $0.4 million and $0.8 million in 2020 and 2019, 
respectively, which were recorded as a component of selling, general, and administrative expenses in the consolidated 
statements of operations. The purchase price allocation for this acquisition has been finalized.

Soft Company SAS (“Soft Company”)

On February 15, 2018, the Company acquired 100% of the equity of Soft Company for approximately $16.9 million 
(€13.6 million based on a EUR into USD exchange rate of 1.2392 at the time of acquisition). The acquisition was funded 
using cash on hand and borrowings under the Company’s existing credit agreement. Soft Company, located in Paris, 
France, is an IT consulting company that specializes in providing IT services to finance, insurance, telecom, and media 
services companies. The acquisition of Soft Company enabled the Company to expand its position in Europe and 
enhance its service offerings.

55

 
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
   
 
 
 
 
 
The Company had a contingent consideration liability related to an earn-out provision of which a portion was payable 
in each period subject to the achievement by Soft Company of certain revenue and EBIT targets for fiscal 2017, 2018, and 
2019. There is no payout if the achievement on either target is below a certain target threshold. The fair value as of the 
February 15, 2018 acquisition date was determined to be $2.0 million. In the 2018 second quarter, the Company paid 
approximately $0.9 million relating to the earn-out based on the achievement by Soft Company of certain revenue and 
EBIT targets for fiscal 2017. In the 2019 third quarter, the Company paid approximately $1.2 million relating to the earn-
out based on the achievement by Soft Company of certain revenue and EBIT targets for fiscal 2018. In the 2020 fourth 
quarter, the Company paid approximately $0.9 million relating to the earn-out based on the achievement by Soft Company 
of certain revenue and EBIT targets for fiscal 2019. There is no remaining contingent consideration liability related to Soft 
Company’s earn-out as it has been fully paid as of December 31, 2020.

The acquisition date fair value of the consideration for the above transaction consisted of the following as of 

February 15, 2018:

 (amounts in thousands)
Cash consideration
Fair value of contingent consideration
Fair value of purchase consideration

$

$

16,910 
1,997 
18,907  

The following tables summarizes the allocation of the aggregate purchase consideration to the fair values of the 

assets acquired and liabilities assumed as of February 15, 2018:

 (amounts in thousands)
Assets Acquired:
Cash
Accounts receivable
Prepaids & other
Property & equipment, net
Acquired intangibles
Goodwill
Total assets acquired

Liabilities Assumed:
Accounts payable
Accrued compensation
Other short-term liabilities
Deferred income taxes
Other long-term liabilities
Total liabilities assumed
Net assets acquired

$

$

$

$

4,059 
5,551 
243 
53 
7,238 
12,720 
29,864 

4,085 
2,669 
2,006 
1,827 
370 
10,957 
18,907  

The purchase consideration for the acquisition was allocated to the assets acquired and liabilities assumed based 
upon their respective fair values. The excess consideration was recorded as goodwill, which is not deductible for income 
tax purposes.

The intangible assets acquired in this acquisition consisted of the following:

 (amounts in thousands)
Trademarks
Customer relationships
Fair value of purchase consideration

  $

  $

Fair Value

749   
6,489   
7,238   

Estimated
Economic Life
2 years
13 years

The results of operations of Soft Company have been included in the Company’s consolidated financial results since 

the date of acquisition. The Company incurred acquisition-related legal and consulting fees, adjustments to the fair value 
of the earn-out liability, and amortization of intangible assets of approximately $0.6 million in 2020 and $1.3 million in 

56

 
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
   
 
 
 
2019, which were recorded as a component of selling, general, and administrative expenses in the consolidated 
statement of operations.

4.

Debt

The Company has a credit and security agreement (the “Credit and Security Agreement”) with its bank, which 
provides for a three-year revolving credit facility in an aggregate principal amount of $45.0 million, including a sublimit of 
$10.0 million for letters of credit. The Credit and Security Agreement expires in December 2022. The Credit and Security 
Agreement has interest rates ranging from 150 to 200 basis points over LIBOR or the greater of (i) the prime rate, (ii) the 
federal funds effective rate plus 50 basis points, and (iii) adjusted LIBOR plus 100 basis points plus a spread ranging from 
50 to 100 basis points based on the amounts outstanding under the Credit and Security Agreement. The Company can 
borrow under the agreement with either rate at its discretion.

At December 31, 2020 and 2019, there was $0.0 million and $5.3 million, respectively, outstanding under the Credit 
and Security Agreement. The Company borrows or repays its debt as needed based upon its working capital obligations, 
including the timing of the U.S. bi-weekly payroll.    

The maximum amount outstanding under its credit agreements in 2020 and 2019 was $12.0 million and $22.3 

million, respectively. In 2020 and 2019, the average amounts outstanding were $6.4 million and $10.4 million, 
respectively, and carried weighted-average interest rates of 1.9% and 2.8%, respectively. Total commitment fees incurred 
in 2020 totaled approximately $0.2 million, and $0.3 million in both 2019 and 2018, while interest paid in 2020, 2019, and 
2018 totaled $0.2 million, $0.4 million, and $0.2 million, respectively.

Under the Credit and Security Agreement, the Company is required to meet certain financial covenants in order to 
maintain borrowings under its revolving credit line, pay dividends, and make acquisitions. The covenants are measured 
quarterly, and at December 31, 2020, included a fixed charge coverage ratio, which must be less than 1.10 to 1.00, 
consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA), adjusted for equity-based 
compensation and severance expense, must be no less than $5.0 million for the trailing twelve months, and capital 
expenditures for property, plant, equipment, and capitalized software must be no more than $5.0 million in any annual 
period. The fixed charge coverage ratio is only tested if availability on a measurement date is less than approximately 
$5.6 million. Actual borrowings by CTG under the Credit and Security Agreement are subject to a borrowing base, which 
is a formula based on certain eligible receivables and reserves. Total availability as of December 31, 2020 was 
approximately $21.2 million. The Company was in compliance with these covenants at December 31, 2020 as EBITDA, 
as defined above, was $15.4 million and capital expenditures for property, equipment and capitalized software were $2.0 
million in 2020. The Company was also in compliance with its covenants at December 31, 2019 and December 31, 
2018.          

5.

Income Taxes

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. The 
CARES Act is a relief package intended to assist many aspects of the American economy and includes provisions relating 
to refundable payroll tax credits, deferral of certain payment requirements for the employer portion of Social Security 
taxes, net operating loss carryback periods and temporarily increasing the amount of net operating losses that 
corporations can use to offset income, alternative minimum tax (“AMT”) credit refunds, modifications to the net interest 
deduction limitations, and technical corrections to tax depreciation methods for qualified improvement property.

On July 20, 2020, the Department of the Treasury and the Internal Revenue Service issued final regulations 

addressing the treatment of income earned by certain foreign corporations that is subject to a high rate of foreign tax. The 
final regulations allow taxpayers to exclude certain high-taxed income of a controlled foreign corporation from their Global 
Intangible Low Taxed Income (GILTI) computation on an elective basis (“the GILTI High Tax Exclusion election” or “the 
Election”). Taxpayers make the election on an annual basis. Taxpayers may make the election retroactively to tax years 
beginning after December 31, 2017 if certain requirements are met.

The Company has reflected the impact of the Election as well as the impact of the extended net operating loss 

carryback periods provided by the CARES Act on its 2020 income tax provision and continues to assess the future 
implications of these provisions on its consolidated financial statements.

57

 
The provision for income taxes for 2020, 2019, and 2018 consists of the following:

(amounts in thousands)
Domestic and foreign components of income (loss) before
   income taxes are as follows:
Domestic
Foreign

Total income before income taxes

The provision (benefit) for income taxes consists of:
Current tax:

U.S. federal
Foreign
U.S. state and local
Total current tax

Deferred tax:

U.S. federal
Foreign
U.S. state and local

Total deferred tax

Total tax

The effective and statutory income tax rate can be reconciled
   as follows:
Tax at statutory rate
State tax, net of federal benefit
Non-taxable income
Non-deductible expenses
Change in estimate primarily related to foreign taxes
Change in valuation allowance related to U.S. federal taxes
Change in estimate primarily related to U.S. federal taxes
Tax credits
GILTI
Foreign rate differential
Other, net

Total tax

Effective income tax rate

  $

  $

  $

  $

  $

  $

2020

2019

2018

2,497 
8,164 
10,661 

  $

  $

2,306 
3,983 
6,289 

  $

  $

(1,119)
3,388 
2,269 

  $

258 
2,679 
365 
3,302 

— 
(280)    
— 
(280)    
  $

3,022 

  $

2,239 
53 
(393)    
569 
(227)    

1,952 
(1,141)    
(679)    
146 
488 
15 
3,022 

  $
28.3%   

62 
1,947 
107 
2,116 

— 
48 
— 
48 
2,164 

  $

  $

  $

1,321 
121 
(250)    
720 
100 
(629)    
— 
(164)    
376 
531 
38 
2,164 

  $
34.4%   

16 
1,937 
107 
2,060 

3,939 
(784)
(129)
3,026 
5,086 

476 
(12)
(300)
607 
(767)
4,154 
— 
(389)
662 
608 
47 
5,086 
224.2%

The ETR was lower in 2020 primarily resulting from the GILTI High Tax Exclusion election and extended NOL 

carryback periods noted above.

The ETR was higher in 2019 primarily due to non-deductible acquisition costs related to the Tech-IT and Soft 

Company acquisitions. 

The ETR was higher in 2018 primarily due to the recording of a valuation allowance against the Company’s U.S. 
deferred tax assets and GILTI. This additional tax expense was partially offset by a non-taxable life insurance gain, the 
Tax Cuts and Jobs Act which reduced the US federal corporate tax rate to 21%, and tax benefits for the Work Opportunity 
Tax Credit (WOTC) and Research and Development tax credit (R&D).

58

 
 
 
 
 
 
 
   
  
   
  
   
  
   
  
   
  
   
  
   
   
   
   
  
   
  
   
  
   
  
   
  
   
  
   
   
   
   
   
   
   
   
   
   
  
   
  
   
  
   
   
   
   
   
   
   
   
   
   
   
  
   
  
   
  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
The Company’s deferred tax assets and liabilities at December 31, 2020 and 2019 consist of the following:

December 31,
(amounts in thousands)
Assets
Deferred compensation
Loss and credit carryforwards
Accruals deductible for tax purposes when paid
State taxes
Depreciation
Unrealized gain
Leases
Other

Gross deferred tax assets

Deferred tax asset valuation allowance
Gross deferred tax assets less valuation allowance
Liabilities
Amortization
Depreciation
Leases
Deferred compensation

Gross deferred tax liabilities

Net deferred tax liabilities
Net deferred tax assets and liabilities are recorded as follows:
Net non-current assets
Net non-current liabilities

Net deferred tax liabilities

2020

2019

5,475    $
522   
1,551   
836   
52   
12   
5,686   
88   
14,222   
(7,664)  
6,558   

(2,317)  
(312)  
(5,686)  
(24)  
(8,339)  
(1,781)   $

393    $

(2,174)  
(1,781)   $

4,832 
725 
166 
580 
81 
232 
5,444 
23 
12,083 
(5,695)
6,388 

(2,189)
(378)
(5,444)
(25)
(8,036)
(1,648)

453 
(2,101)
(1,648)

  $

  $

  $

  $

In assessing the realizability of deferred tax assets, management considers, within each taxing jurisdiction, whether 
it is more likely than not that all or some portion of the deferred tax assets will be realized, or that a valuation allowance is 
required. Management considers all available evidence, both positive and negative, in assessing realizability of its 
deferred tax assets. A key component of this assessment is management’s critical evaluation of current and future 
impacts of business and economic factors on the Company’s ability to generate future taxable income. Factors that may 
affect the Company’s ability to generate taxable income include, but are not limited to increased competition, a decline in 
revenue or margins, a loss of market share, the availability of qualified professional staff, and a decrease in demand for 
the Company’s services. The Company elected to use the incremental cash tax savings approach when considering 
GILTI in its assessment of the realizability of its U.S. deferred tax assets. The Company generated U.S. book and tax 
income during 2019 and 2020 but incurred significant losses in 2018 resulting in a cumulative near break-even position for 
the three years ended December 31, 2020. The Company believes its financial outlook remains positive; however, the 
COVID-19 pandemic has created a high level of uncertainty. Because of difficulties with forecasting U.S. financial results 
historically, and due to the uncertainties associated with the COVID-19 pandemic, the Company maintained a full 
valuation allowance on its U.S. deferred tax assets totaling $5.2 million at December 31, 2020. The analysis that the 
Company prepared to determine the valuation allowance required significant judgment and assumptions regarding future 
market conditions as well as forecasts for profits, taxable income, and taxable income by jurisdiction. Due to the sensitivity 
of the analysis, changes to the assumptions in subsequent periods could have a material effect on the valuation 
allowance. Additionally, management has determined that a valuation allowance is required against its Netherlands 
deferred taxes. The total valuation allowance recorded against these deferred tax assets is $7.7 million, a net increase of 
$2.0 million during the year, which was recorded as income tax expense in the consolidated statement of operations.

The Company has various U.S. state net operating loss carryforwards of $1.7 million, which begin to expire in 2021.  

The Company has net operating loss carryforwards in the Netherlands and United Kingdom of $0.5 million and $1.1 
million, respectively. The carryforwards in the Netherlands expire between 2021 and 2026, and the carryforwards in the 
United Kingdom have no expiration date.  

At December 31, 2020, the Company believes it has adequately provided for its tax-related liabilities, and that no 
reserve for unrecognized tax benefits is necessary. No significant change in the total amount of unrecognized tax benefits 
is expected within the next twelve months. The Company recognizes accrued interest and penalties related to 

59

 
   
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
unrecognized tax benefits (if any) in tax expense, as applicable. At December 31, 2020 and 2019, the Company had no 
accrual for the payment of interest and penalties.

The Company has not recorded a U.S. deferred tax liability for the excess book basis over the tax basis of its 

investments in foreign subsidiaries as these amounts continue to be indefinitely reinvested in foreign operations. 

Net income tax payments during 2020, 2019, and 2018 totaled $4.2 million, $2.5 million, and $2.1 million, 

respectively. 

6.

Lease Commitments

The Company is obligated under a number of long-term operating leases for office space and office equipment, and 
for automobiles leased in Europe. On January 1, 2019, the Company adopted Topic 842 using the modified retrospective 
transition approach and elected the transition method to apply the new lease standard as of the January 1, 2019 adoption 
date. Results for the reporting periods beginning after January 1, 2019 are presented under Topic 842, while prior period 
amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under Topic 
840.

Most leases contain both lease components (fixed payments for rent) and non-lease components (common-area 

maintenance and other services). The Company has elected the practical expedient to separate lease and non-lease 
components for its office leases and has elected to group lease and non-lease components for its vehicle leases. Some 
leases contain renewal options with escalation clauses commensurate with local market fluctuations, however, generally 
limiting an annual increase to no more than 5.0% of the existing lease payment. The exercise of lease renewal options is 
at the Company’s sole discretion. The Company has excluded renewal options in the measurement of right-of-use assets 
and lease liabilities if they are not reasonably certain of exercise.

Operating leases are included in the right-of-use lease assets, short-term lease liabilities, and long-term lease 

liabilities on the consolidated balance sheet. The Company measures the operating lease liabilities at lease 
commencement date based on the present value of remaining lease payments using the rate implicit in the lease when 
readily determinable, or the Company’s secured incremental borrowing rate. The Company has made an accounting 
policy election not to recognize a lease liability or right-of-use asset for leases with a lease term of twelve months or less 
and do not include an option to purchase the underlying asset. The Company recognizes lease expense on a straight-line 
basis over the lease term and variable lease expense in the period incurred. Variable lease cost consists primarily of 
common-area maintenance, insurance, and taxes, which are paid based on actual costs incurred by the lessor. Operating 
lease cost for 2020 and 2019 was $6.4 million and $6.8 million, respectively. The Company incurred variable lease cost of 
$0.5 million and $0.6 million, and short-term lease cost of $0.6 million and $0.5 million in 2020 and 2019, respectively.

Maturities for the Company’s lease liabilities for all operating leases as of December 31, 2020 are as follows:

Year
(amounts in thousands)
2021
2022
2023
2024
2025
2026 & thereafter
Total undiscounted operating lease payments

Less: Interest

Total present value of operating lease liabilities

Total Operating Leases 

6,501 
5,076 
3,662 
2,240 
1,515 
4,155 
23,149 
(1,158)
21,991  

$

$

Operating lease payments exclude $3.7 million of legally binding lease payment for leases signed, but not yet 
commenced. The weighted average remaining lease term and discount rate for all operating leases as of December 31, 
2020 are as follows:

Weighted average remaining lease term (years)
Weighted average remaining discount rate

60

December 31, 2020

5.91 
2.03%

 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental cash flow information related to the Company’s operating leases for 2020 is as follows:

 (amounts in thousands)
Cash paid for amounts included in the measurement of lease liabilities

Operating cash outflow from operating leases
Right-of-use assets obtained in exchange for new operating lease liabilities

As of December 31, 2019 minimum obligations under operating leases were as follows:

 (amounts in thousands)
2020
2021
2022
2023
2024
Later years
Minimum future obligations

December 31, 2020 

6,450 
5,299  

5,979 
4,696 
3,255 
2,257 
1,485 
4,828 
22,500  

  $

  $

7.

Deferred Compensation Benefits

The Company maintains a non-qualified defined-benefit Executive Supplemental Benefit Plan (ESBP) that provides 

certain former key executives with deferred compensation benefits, based on years of service and base compensation, 
payable during retirement. The plan was amended as of November 30, 1994, to freeze benefits for the participants in the 
plan at that time.

The Company also retained certain potential obligations related to a contributory defined-benefit plan for its previous 

employees located in the Netherlands (NDBP) when the Company disposed of its subsidiary, CTG Nederland, B.V. 
Benefits paid are a function of a percentage of career average pay. This plan was curtailed for additional contributions in 
January 2003.

The Company also maintains a fully funded pension plan related to CTG Belgium and CTG Health Solutions 

(Belgium) employees (BDBP). This is a plan with active employees and the Company expects to make future 
contributions.

As a result of the acquisition of Soft Company on February 15, 2018, the Company maintains an unfunded pension 

plan related to the current Soft Company employees (FDBP). The Company did not make contributions to this plan in 
2019 or 2020 and does not anticipate making contributions to the plan in 2021. No benefit payments were made in 2019 
or 2020 and none are expected to be paid in 2021.

On March 3, 2020, the Company acquired StarDust and now maintains an unfunded pension plan related
to the current StarDust employees (SDBP). The Company does not anticipate contributing to this plan and no benefit 
payments are expected to be paid in 2021.

Net periodic pension cost for the years ended December 31, 2020, 2019, and 2018 for all of the plans is as follows:

Net Periodic Pension Cost
(amounts in thousands)
Service cost
Interest cost
Expected return on assets
Amortization of actuarial loss
Net periodic pension cost

2020

2019

2018

  $

  $

428    $
355     
(657)    
304     
430    $

330    $
583     
(612)    
190     
491    $

340 
581 
(650)
287 
558  

61

 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
 
    
 
    
 
  
   
   
   
The change in benefit obligation and reconciliation of fair value of plan assets for the years ended December 31, 

2020 and 2019 for the ESBP, NDBP, BDBP, FDBP, and SDBP plans are as follows:  

Changes in Benefit Obligation
(amounts in thousands)
Benefit obligation at beginning of period
Service cost
Interest cost
Benefits paid
Acquisition
Actuarial loss (gain)
Effect of exchange rate changes
Benefit obligation at end of period
Reconciliation of Fair Value of Plan Assets
Fair value of plan assets at beginning of period
Actual return on plan assets
Employer contributions
Benefits paid
Effect of exchange rate changes
Fair value of plan assets at end of period
Accrued benefit cost

2020

2019

30,629    $
428   
355   
(996)  
22   
1,733   
2,558   
34,729   

18,079   
603   
1,188   
(968)  
1,754   
20,656   
14,073    $

27,597 
330 
583 
(862)
— 
3,310 
(329)
30,629 

17,403 
610 
1,145 
(855)
(224)
18,079 
12,550  

  $

  $

Accrued benefit cost for the ESBP, NDBP, BDBP, FDBP, and SDBP is included in the consolidated balance sheet 

as follows:

As of December 31, 2020:
Non-current assets
Current liabilities
Non-current liabilities
Discount rates:

Benefit obligation
Net periodic pension cost

Salary increase rate
Expected return on plan assets
As of December 31, 2019:
Non-current assets
Current liabilities
Non-current liabilities
Discount rates:

Benefit obligation
Net periodic pension cost

Salary increase rate
Expected return on plan assets

ESBP

NDBP

BDBP

FDBP

SDBP

 $
 $
 $

— 
512 
4,261 

 $
 $
 $

— 
— 
8,783 

 $
 $
 $

1.56%  
2.60%  
—%  
—%  

0.40%  
0.90%  
—%  
4.00%  

 $
 $
 $

— 
555 
4,635 

 $
 $
 $

— 
— 
7,099 

 $
 $
 $

2.60%  
3.76%  
—%  
—%  

0.90%  
1.90%  
—%  
4.00%  

97 
— 
— 

 $
 $
 $

0.50%  
0.50%  
3.55%  
3.20%  

95 
— 
— 

 $
 $
 $

0.85%  
0.85%  
3.65%  
3.25%  

— 
— 
580 

 $
 $
 $

0.35%  
0.80%  
1.75%  
—%  

— 
— 
356 

 $
 $
 $

0.80%  
1.60%  
1.75%  
—%  

— 
— 
34 

0.35%
0.45%
1.75%
—%

— 
— 
— 

— 
— 
— 
—%

For the ESBP, the accumulated benefit obligation at December 31, 2020 and 2019 was $4.8 million and $5.2 million, 

respectively. The amounts included in other comprehensive loss relating to the pension loss adjustment in 2020 and 
2019, net of tax, was both approximately $(0.2) million and $(0.3) million, respectively. The discount rate used in 2020 
was 1.56%, which is reflective of a series of bonds that are included in the Moody’s AA long-term corporate bond yield 
whose cash flow approximates the payments to participants under the ESBP for the remainder of the plan. This rate was 
a decrease of 104 basis points from the rate used in the prior year and resulted in an increase in the plan’s liabilities of 
$0.4 million. Benefits paid to participants are funded by the Company as needed, and are expected to total approximately 
$0.5 million in 2021. The plan is deemed unfunded as the Company has not specifically identified Company assets to be 
used to discharge the deferred compensation benefit liabilities. The Company has purchased insurance on the lives of 
certain plan participants in amounts considered sufficient to reimburse the Company for the costs associated with the plan 

62

 
   
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
for those participants. The Company does not anticipate making contributions to the plan other than for current year 
benefit payments as required in 2021 or future years.

For the NDBP, the accumulated benefit obligation at December 31, 2020 and 2019 was $16.9 million and $14.5 
million, respectively. The discount rate used in 2020 was 0.40%, which is reflective of a series of corporate bonds whose 
cash flow approximates the payments to participants under the NDBP for the remainder of the plan. This rate was a 
decrease of 50 basis points from the rate used in the prior year. The decrease in the discount rate and foreign currency 
fluctuations resulted in an increase in the plan’s liabilities of $2.4 million in 2020.

The assets for the NDBP are held by Aegon, a financial services firm located in the Netherlands. The Company 
maintains a contract with Aegon to insure future benefit payments of the NDBP; however, due to certain terms of the 
agreement and potential obligations to the Company, the NDBP has not been settled.  The benefit payments to be made 
in 2021 are expected to be paid by Aegon from plan assets. The assets for the plan are included in a general portfolio of 
government bonds, a portion of which is allocated to the NDBP based upon the estimated pension liability associated with 
the plan. The fair market value of the plan’s assets equals the contractual value of the NDBP in any given year. The fair 
value of the assets is determined using a Level 3 methodology (see Note 1 “Summary of Significant Accounting Policies—
Fair Value”). In 2020 and 2019, the plan investments had a targeted minimum return of 4.0%, which is consistent with 
historical returns and the 4.0% return guaranteed to the participants of the plan. Aegon intends to maintain the current 
investment strategy of investing plan assets solely in government bonds in 2021.

For the BDBP, the accumulated benefit obligation at December 31, 2020 and 2019 was $12.4 million and $10.6 
million, respectively. The discount rate used in 2020 was 0.50%, which is reflective of a series of corporate bonds whose 
cash flow approximates the payments to participants under the BDBP for the remainder of the plan. This rate was a 
decrease of 35 basis points from the rate used in the prior year. The decrease in the discount rate and foreign currency 
fluctuations resulted in an increase in the plan’s liabilities of $1.8 million in 2020.

The assets for the BDBP are held by Allianz for the CTG Belgium plan and by Vivium for the CTG Health Solutions 

(Belgium) plan, both financial services firms are located in Belgium. The Company maintains a contract with Allianz to 
insure future benefit payments of the BDBP. Contributions made by the Company to Allianz and Vivium are based on 
employees’ current salaries. The benefit payments to be made in 2021 are expected to be paid by Allianz and Vivium from 
plan assets. The assets for the plan are included in the overall portfolio of assets held by Allianz and Vivium. The fair 
market value of the plan’s assets equals the contractual value of the BDBP in any given year (which is the mathematical 
reserve held by Allianz and Vivium). The fair value of the assets is determined using a Level 3 methodology (see Note 1 
“Summary of Significant Accounting Policies—Fair Value”). Allianz and Vivium do not guarantee a minimum return on the 
plan investments, whereas Belgian law sets a minimum return to be guaranteed to the participants of the plan.

For the FDBP, the accumulated benefit obligation at December 31, 2020 and 2019 was $0.6 million and $0.3 million, 
respectively. The amounts included in other comprehensive loss relating to the pension loss adjustment in 2020 and 2019 
were $0.2 million and less than $(0.1) million, respectively. The discount rate used in 2020 was 0.35%, which is reflective 
of a series of corporate bonds whose cash flows approximates the payments to participants under the FDBP for the 
remainder of the plan. This rate was a decrease of 45 basis points from the rate used in the prior year. The plan is 
deemed unfunded as the Company has not specifically identified Company assets to be used to discharge the deferred 
compensation benefit liabilities.

For the SDBP, the accumulated benefit obligation at December 31, 2020 was less than $0.1 million. The amounts 

included in other comprehensive loss relating to the pension loss adjustment in 2020 was less than $0.1 million. The 
discount rate used in 2020 was 0.35%, which is reflective of a series of corporate bonds whose cash flows approximates 
the payments to participants under the SDBP for the remainder of the plan. The plan is deemed unfunded as the 
Company has not specifically identified Company assets to be used to discharge the deferred compensation benefit 
liabilities.

63

Anticipated benefit payments for the ESBP, NDBP, BDBP, FDBP, and SDBP expected to be paid in future years are 

as follows:

(amounts in thousands)
2021
2022
2023
2024
2025
2026 - 2030
Total

  $

  $

908 
903 
890 
948 
1,518 
5,073 
10,240  

For the ESBP, NDBP, BDBP, FDBP, and SDBP, the amounts included in accumulated other comprehensive loss, 

net of tax, that have not yet been recognized as components of net periodic benefit cost as of December 31, 2020 are 
$1.1 million, $9.3 million, $1.3 million, $0.1 million, and less than $0.1 million, respectively, for unrecognized actuarial 
losses (gains). The amounts included in accumulated other comprehensive loss, net of tax, that had not yet been 
recognized as components of net periodic benefit cost as of December 31, 2019 were $1.2 million, $7.5 million, $0.8 
million, less than $(0.1) million and $0.0 million, respectively, also for unrecognized actuarial losses.

The amounts recognized in other comprehensive income, net of tax, for 2020, 2019, and 2018, which primarily 

consist of an actuarial gain related to year-over-year changes in the discount rate, totaled $2.3 million, $2.8 million, and 
$0.9 million, respectively. Net periodic pension benefit and the amounts recognized in other comprehensive loss, net of 
tax, for the ESBP, NDBP, BDBP, FDBP and SDBP for 2020, 2019, and 2018 totaled $2.7 million, $3.3 million, and $0.3 
million, respectively.

The amounts in accumulated other comprehensive loss expected to be recognized as components of net periodic 

benefit cost during 2020 for the ESBP, NDBP, BDBP, FDBP, and SDBP for unrecognized actuarial losses total $0.5 
million.

The Company also maintains the Key Employee Non-Qualified Deferred Compensation Plan for certain key 
executives. Company contributions to this plan, if any, are based on annually defined financial performance objectives. 
There were no contributions to the plan in 2020 for amounts earned in 2019, no contributions to the plan in 2019 for 
amounts earned in 2018, and no contributions to the plan in 2018 for amounts earned in 2017. The Company does not 
anticipate making contributions in 2021 to this plan for amounts earned in 2020. The investments in the plan are included 
in the total assets of the Company, and are discussed in Note 1, “Investments.” Participants in the plan have the ability to 
purchase stock units from the Company at current market prices using their available investment balances within the plan. 
In return for the funds received, the Company releases shares out of treasury stock equivalent to the number of share 
units purchased by the participants. These shares of common stock are not entitled to any voting rights, but will receive 
dividends in the event any are paid. The shares are being held by the Company, and will be released to the participants 
as prescribed by their payment elections under the plan.

The Company maintains the Non-Employee Director Deferred Compensation Plan for its non-employee directors.  
No cash contributions were made to the plan for the directors during 2020, 2019, or 2018. During 2020, 2019, and 2018, 
the Directors were granted shares out of the Company’s 2010 Equity Award Plan which were deposited into this plan. 
These shares of common stock are not entitled to any voting rights, but will receive dividends in the event any are paid. 
The shares are being held by the Company, and will be released to the participants as prescribed by their payment 
elections under the plan.

8.

Employee Benefits

401(k) Profit-Sharing Retirement Plan

The Company maintains a contributory 401(k) profit-sharing retirement plan covering substantially all U.S. 

employees. Previously, at the Company’s discretion, up to 50% of the first 6% of eligible wages contributed by the 
participants was matched. This match was indefinitely suspended as of January 1, 2017. There were no Company 
contributions in 2020, 2019, and 2018.

64

 
   
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Other Retirement Plans

The Company maintains various other defined contribution retirement plans covering European employees. 
Company contributions charged to operations were $0.2 million in 2020, $0.3 million in 2019, and $0.2 million in 2018.

Employee Health Insurance

The Company provides various health insurance plans for its employees, including a self-insured plan for its salaried 
and hourly employees in the U.S. In 2015, the Company began offering compliant healthcare coverage as required under 
The Patient Protection and Affordable Care Act (PPACA). Where possible, the Company has passed the cost of this 
coverage on to its clients where the employees that elect this coverage are engaged.

9.

Shareholders’ Equity

Employee Stock Purchase Plan

Under the Company’s First Employee Stock Purchase Plan (ESPP), employees may apply up to 10% of their 
compensation to purchase the Company’s common stock. Shares are purchased at the closing market price on the 
business day preceding the date of purchase. As of December 31, 2020, approximately 25,000 shares remain unissued 
under the ESPP. During 2020, 2019, and 2018, approximately 29,000, 32,000, and 21,000 shares, respectively, were 
purchased under the ESPP at an average price of $4.90, $4.57, and $5.87 per share, respectively.

Preferred Stock

At December 31, 2020 and 2019, the Company had 2.5 million shares of par value $0.01 preferred stock authorized 

for issuance, but none outstanding.

10. Equity-Based Compensation

The Company issues stock options and restricted stock in exchange for services of key employees and independent 

directors. In accordance with current accounting standards, the calculated cost of its equity-based compensation awards 
is recognized in the Company’s consolidated statements of operations over the period in which an employee or director is 
required to provide the services for the award. Compensation cost will not be recognized for employees or directors that 
do not render the requisite services. The Company recognizes the expense for equity-based compensation in its 
consolidated statements of operations on a straight-line basis based upon the number of awards that are ultimately 
expected to vest.

Equity-based compensation expense, the corresponding tax benefit and net equity-based compensation expense for 

2020, 2019, and 2018 are as follows:

(amounts in thousands)
Equity-based compensation expense
Tax benefit
Net equity-based compensation expense

2020

2019

2018

  $

  $

2,483    $
—     
2,483    $

1,748    $
—     
1,748    $

2,353 
— 
2,353  

On September 17, 2020, the shareholders approved the Company’s 2020 Equity Award Plan (2020 Plan). Under the 
provisions of the 2020 Plan, stock options, restricted stock, stock appreciation rights, and other awards may be granted or 
awarded to key employees and independent directors of the Company, as well as non-employees. The compensation 
committee of the Board of Directors determines the nature, amount, pricing and vesting of the grants or awards. All 
options and awards remain in effect until the earliest of the expiration, exercise, or surrender date. Options generally 
become exercisable in three or four equal installments, typically beginning one year from the date of grant, and expire no 
more than 15 years from the date of grant. A total of 1,950,000 shares may be granted or awarded under the
2020 plan, all of which are available for grant as of December 31, 2020.

On May 12, 2010, the shareholders approved the Company’s 2010 Equity Award Plan (2010 Plan). Under the 
provisions of the 2010 Plan, stock options, restricted stock, stock appreciation rights, and other awards may be granted or 
awarded to key employees and independent directors of the Company, as well as non-employees. The compensation 

65

 
 
 
 
 
 
 
   
 
 
   
 
 
   
 
 
   
committee of the Board of Directors determines the nature, amount, pricing and vesting of the grants or awards. All 
options and awards remain in effect until the earliest of the expiration, exercise, or surrender date. Options generally 
become exercisable in three or four equal installments, typically beginning one year from the date of grant, and expire no 
more than 15 years from the date of grant. There are no shares or options available for grant under this plan as of 
December 31, 2020.

On April 26, 2000, the shareholders approved the Company’s 2000 Equity Award Plan (Equity Plan). Under the 
provisions of the Equity Plan, stock options, restricted stock, stock appreciation rights, and other awards could previously 
be granted or awarded to key employees and independent directors of the Company. The compensation committee of the 
Board of Directors determined the nature, amount, pricing, and vesting of the grants or awards. All options and awards 
remain in effect until the earlier of the expiration, exercise, or surrender date. Options generally become exercisable in 
three or four equal annual installments, typically beginning one year from the date of grant, and expire no more than 15 
years from the date of grant. In certain limited instances, options granted at fair market value were expected to vest nine 
and one-half years from the date of grant. There are no shares or options available for grant under this plan as of 
December 31, 2020.

Under the Company’s 1991 Restricted Stock Plan, a total of 800,000 shares of restricted stock may be granted to 

certain key employees, 19,866 of which are available for grant as of December 31, 2020.

The Company granted 173,010 stock options during 2020 from the 2010 Equity Award Plan. The options vest 

ratably over three years, and are being expensed over that period. There were no other stock options granted during 
2020. The Company utilizes the Black-Scholes option-pricing model to estimate the fair value of stock options granted on 
the date of grant. The per-option weighted-average fair value on the date of grant of stock options granted in 2020, 2019, 
and 2018 was $1.77, $1.26, and $1.91, respectively.

The fair value of the options at the date of grant was estimated using the following weighted-average assumptions 

for the years ended December 31, 2020, 2019, and 2018:

Expected life (years)
Dividend yield
Risk-free interest rate
Expected volatility

2020

2019

2018

3.7 
0.0%   
2.2%   
36.1%   

3.7 
0.0%   
2.2%   
36.1%   

3.7 
0.0%
2.4%
34.9%

The Company used historical volatility calculated using daily closing prices for its common stock over periods that 

equal the expected term of the options granted to estimate the expected volatility for the grants made in 2020, 2019, and 
2018. The risk-free interest rate assumption was based upon U.S. Treasury yields appropriate for the expected term of 
the Company’s stock options based upon the date of grant. The expected term of the stock options granted was based 
upon the options expected vesting schedule and historical exercise patterns. The Company did not pay a dividend in 
2020, 2019, or 2018, and does not anticipate paying a dividend in the future. 

During 2020, 2019, and 2018, the Company issued restricted stock to certain key employees. The stock vests over a 

period of three or four years, with 33% or 25% of the stock issued vesting one year from the date of grant, and another 
33% or 25% vesting each year thereafter until the stock is fully vested. The Company is recognizing compensation 
expense for these shares ratably over the expected term of the restricted stock, which is three or four years. In the event 
the Company issued stock to its independent directors, the stock vests at retirement. As the independent directors are 
eligible for retirement from the Company’s Board of Directors at any point in time, the Company will recognize the 
expense associated with these shares on the date of grant. The shares of restricted stock issued are considered 
outstanding, can be voted, and are eligible to receive dividends, if any are paid. However, the restricted shares do not 
include a non-forfeitable right for the holder to receive dividends and none will be paid in the event the awards do not vest. 
Accordingly, only vested shares of outstanding restricted stock are included in the calculation of basic earnings per share.

During 2020, the Company granted 115,410 shares with a market condition to senior management from the 2010 

Equity Award Plan. The closing price of the Company’s stock on that day was $5.88 per share. Under these grant 
agreements, the Company’s cumulative three-year non-GAAP earnings per share for the years 2020, 2021, and 2022 
must equal or exceed $1.77 for 100% of the grants to vest. If the combined cumulative three-year non-GAAP earnings per 
share is 80% or more but less than 100% of the earnings per share target, a pro-rata portion of the grants shall vest. If at 
least 80% of the three-year non-GAAP earnings per share target is not met, the grants will expire. The performance share 

66

 
 
 
 
 
 
 
   
   
   
   
   
   
units have a fair value of approximately $0.7 million and the Company is expensing these grants over the derived service 
period. Of the 115,410 performance shares granted during 2020, no shares were cancelled during 2020, and 115,410 
shares were outstanding as of December 31, 2020.

During 2019, the Company granted 217,542 shares with a market condition to senior management from the 2010 

Equity Award Plan. The closing price of the Company’s stock on that day was $4.93 per share. Under these grant 
agreements, the Company’s cumulative three-year non-GAAP earnings per share for the years 2019, 2020, and 2021 
must equal or exceed $1.42 for 100% of the grants to vest. If the combined cumulative three-year non-GAAP earnings per 
share is 80% or more but less than 100% of the earnings per share target, a pro-rata portion of the grants shall vest. If at 
least 80% of the three-year non-GAAP earnings per share target is not met, the grants will expire. The performance share 
units have a fair value of approximately $1.1 million and the Company is expensing these grants over the derived service 
period. Of the 217,542 performance shares granted during 2020, no shares were canceled during 2020, 
and 217,542 shares were outstanding as of December 31, 2020.

During 2018, the Company granted 216,600 shares with a market condition to senior management from the 2010 

Equity Award Plan. The closing price of the Company’s stock on that day was $8.18 per share. Under these grant 
agreements, the Company’s stock price must increase 50% to $12.27 for a 30-day period within a three-year period from 
the date of grant for 50% of the grants to vest. The Company’s stock price must increase 100% to $16.36 for a 30-day 
period within a three-year period from the date of grant for the remaining 50% of the grants to vest.

For these performance grants, the price on the date of grants was $8.18 per share, the expected volatility was 
34.5%, the expected dividend yield is zero, and the risk-free rate of return was 2.47%. Given these assumptions, the 
tranche of the grants that will vest with a 50% increase in the stock price have a value using a binomial model of $2.30 per 
share, and a derived service period of 1.26 years.  For the tranche of the grants that will vest with a 100% increase in the 
stock price, the value of the shares is $1.30 per share and have a derived service period of 1.85 years. The Company is 
expensing these grants over the derived service period as noted for each tranche of a grant. Of the 216,600 performance 
shares granted during 2018, no shares were canceled during 2020, and 128,300 shares were outstanding as of 
December 31, 2020.

As of December 31, 2020, total remaining stock-based compensation expense for non-vested equity-based 
compensation was approximately $3.0 million, which is expected to be recognized on a weighted-average basis over the 
next 14 months. Historically, the Company has issued shares out of treasury stock to fulfill the share requirements from 
stock option exercises and restricted stock grants.

A summary of stock option activity under the 2010 Plan and Equity Plan is as follows:

Outstanding at December 31, 2017

Granted
Exercised
Canceled or forfeited
Expired

Outstanding at December 31, 2018

Granted
Exercised
Canceled or forfeited
Expired

Outstanding at December 31, 2019

Granted
Exercised
Canceled or forfeited
Expired

Outstanding at December 31, 2020
Options Exercisable at December 31, 2020

2010 Plan
Options

Weighted-
Average
Exercise
Price

Equity Plan
Options

Weighted-
Average
Exercise
Price

887,055    $
13,100    $
(100,000)   $
—    $
—    $
800,155    $
26,500    $
(45,096)   $
(50,325)   $
—    $
731,234    $
173,010    $
(45,096)   $
—    $
—    $
859,148    $
662,247    $

11.74     
6.45     
7.52     
—     
—     
12.18     
4.20     
4.95     
6.97     
—     
12.69     
5.88     
4.95     
—     
—     
11.73     
13.51     

734,425    $
—    $
(286,875)   $
—    $
—    $
447,550    $
—    $
(80,000)   $
(72,125)   $
—    $
295,425    $
—    $
—    $
(50,125)   $
—    $
245,300    $
245,300    $

5.13 
— 
4.67 
— 
— 
5.42 
— 
3.57 
5.57 
— 
5.89 
— 
— 
7.18 
— 
5.62 
5.62  

67

 
 
   
   
   
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Under the 2010 Plan, there were 45,096 shares exercised in both 2020 and 2019, and 100,000 shares exercised in 

2018. For 2020, 2019, and 2018, the intrinsic value of the options exercised under the Equity Plan was less than $0.1 
million, $0.1 million, and $1.1 million, respectively. 

A summary of restricted stock activity under the 2010 Plan, the Equity Plan and the 1991 Restricted Stock Plan is as 

follows:

2010 Plan
Restricted
Stock

Weighted-
Average
Fair Value  

Equity Plan
Restricted
Stock

Weighted-
Average
Fair Value  

1991
Restricted
Stock Plan  

Outstanding at Dec. 31, 2017

Granted
Released
Canceled or forfeited

Outstanding at Dec. 31, 2018

Granted
Released
Canceled or forfeited

Outstanding at Dec. 31, 2019

Granted
Released
Canceled or forfeited

Outstanding at Dec. 31, 2020

    507,036    $
    483,800    $
(104,516)   $
(35,393)   $
    850,927    $
    636,268    $
(112,160)   $
(228,151)   $
    1,146,884    $
    599,928    $
(131,949)   $
(129,878)   $
    1,484,985    $

5.40      40,000    $
—     
7.61     
—     
5.52     
—     
5.11     
6.65      40,000    $
—     
4.42     
—     
5.59     
—     
6.80     
5.49      40,000    $
—     
5.02     
—     
5.02     
—     
5.41     
5.35      40,000    $

Weighted-
Average
Fair Value  
6.76 
— 
8.41 
5.75 
5.87 
— 
6.40 
5.15 
5.75 
— 
5.75 
5.75 
5.75  

4.97      90,454    $
—    $
—     
—      (31,937)   $
—     
(2,400)   $
4.97      56,117    $
—    $
—     
—      (20,868)   $
—      (10,874)   $
4.97      24,375    $
—    $
—     
—      (11,470)   $
—     
(1,925)   $
4.97      10,980    $

Options Outstanding at December 31, 2020

A summary of stock options that were outstanding at December 31, 2020 for the 2010 Plan and the Equity Plan is 

as follows:

Range of Exercise Prices:
2010 Plan
$4.20 - $7.48
$12.16 - $13.75
$15.04 - $16.93
$20.68 - $21.41

Equity Plan
$4.15 - $4.78
$5.25 - $7.18

Number of
Options
Outstanding  

Weighted
Average
Exercise Price  

Weighted
Average
Remaining
Contractual
Life in Years  

Aggregate
Intrinsic Value  

373,677    $
232,375    $
105,096    $
148,000    $
859,148    $

105,300    $
140,000    $
245,300    $

5.78     
13.42     
15.83     
21.17     
11.73     

4.65     
6.35     
5.62     

7.4    $
5.1     
2.5     
5.7     
5.9    $

207,140 
— 
— 
— 
207,140 

2.5    $
3.5     
3.1    $

154,841 
52,200 
207,041  

68

 
 
 
 
 
 
 
 
 
   
   
   
   
   
   
 
 
 
 
   
      
      
      
  
   
   
   
   
 
   
   
      
      
      
  
   
   
 
   
Options Exercisable at December 31, 2020

A summary of stock options that are exercisable at December 31, 2020 for the 2010 Plan and the Equity Plan is as 

follows:

Range of Exercise Prices:
2010 Plan
$4.20 - $7.48
$12.16 - $13.75
$15.04 - $16.93
$20.68 - $21.41

Equity Plan
$4.15 - $4.78
$5.25 - $7.18

Number of
Options

Weighted
Average

Exercisable    

Exercise Price    

Weighted
Average
Remaining
Contractual Life
in Years

Aggregate
Intrinsic Value  

176,776    $
232,375    $
105,096    $
148,000    $
662,247    $

105,300    $
140,000    $
245,300    $

5.84     
13.42     
15.83     
21.17     
13.51     

4.65     
6.35     
5.62     

5.6    $
5.1     
2.5     
5.7     
4.9    $

129,396 
— 
— 
— 
129,396 

2.5    $
3.5     
3.1    $

154,841 
52,200 
207,041  

The aggregate intrinsic values as calculated in the above charts detailing options that are outstanding and those that 

are exercisable, respectively, are based upon the Company’s closing stock price on December 31, 2020 of $6.12 per 
share.

11. Significant Clients

In 2020, International Business Machines Corporation (IBM) was the Company’s largest client. The National 
Technical Services Agreement with IBM was renewed and now expires on October 27, 2023. In 2020, 2019, and 2018, 
IBM accounted for $77.5 million or 21.2%, $84.9 million or 21.5%, and $80.6 million or 22.5% of the Company’s 
consolidated revenue, respectively. The Company’s accounts receivable from IBM at December 31, 2020 and 2019 
amounted to $11.3 million and $23.0 million, respectively.

No other client accounted for more than 10% of revenue in 2020, 2019, and 2018.

12. Contingencies

The Company and its subsidiaries are involved from time to time in various legal proceedings and tax audits arising 

in the ordinary course of business. At December 31, 2020 and 2019, the Company was in discussion with various 
governmental agencies relative to tax matters, including income, sales and use, and property and franchise taxes. The 
outcome of these audits and legal proceedings, as applicable, involving the Company and its subsidiaries cannot be 
predicted with certainty, and the amount of any liability that could arise with respect to such audits cannot be accurately 
predicted. However, as none of these matters are individually or in the aggregate significant and as management has not 
recorded an estimate of its potential liability for these audits at December 31, 2020 and 2019. The Company does not 
expect the conclusion of these matters to have a material adverse effect on the financial position, results of operations, or 
cash flows of the Company.

13. Enterprise-Wide Disclosures

The Company operates in one industry segment, providing IT services to its clients. The services provided include 

managed and flexible staffing and the planning, design, implementation, and maintenance of comprehensive IT solutions. 
All of the Company’s revenue is generated from these services.

69

 
   
   
      
      
      
  
   
   
   
   
 
   
   
      
      
      
  
   
   
 
   
CTG’s reportable information is based on geographical areas. The accounting policies of the individual geographical 

areas are the same as those described in Note 1, “Summary of Significant Accounting Policies.”

Financial Information About Geographic Areas

2020

2019

2018

(amounts in thousands)
Revenue from External Customers:

United States
Luxembourg (3)
Belgium (1)
Other countries

Total foreign revenue
Total revenue

Long-lived Assets*:
United States
France (2)
Luxembourg (3)
Other countries

Total long-lived assets*

Deferred Tax Assets, Net of Valuation Allowance:

United States
Europe

Total deferred tax assets, net

*Long-lived Assets exclude goodwill

  $

  $

  $

  $

  $

  $

203,495    $
66,411     
59,851     
36,334     
162,596     
366,091    $

1,710    $
6,841     
3,879     
2,182     
14,612    $

—    $
393     
393    $

241,038    $
64,852     
52,468     
35,812     
153,132     
394,170    $

3,534    $
5,124     
3,965     
2,195     
14,818    $

78    $
375     
453    $

232,178 
44,660 
48,585 
33,346 
126,591 
358,769 

3,715 
6,042 
— 
1,835 
11,592 

— 
767 
767 

(1) Revenue for our Belgium operations has been disclosed separately as it exceeds 10% of consolidated revenue in at 

(2)

least one of the years presented.
Long-lived assets for our France operations have been disclosed separately as they exceed 10% of consolidated 
long-lived assets in at least one of the years presented.

(3) Revenue and long-lived assets for our Luxembourg operations have been disclosed separately as they exceed 10% 

of the consolidated balances in at least one of the years presented.

14. Quarterly Financial Data (Unaudited)

(amounts in thousands, except per-share data)
2020
Revenue
Direct costs
Gross profit
Selling, general, and administrative expenses
Operating income
Interest and other income (expense), net
Income before income taxes
Provision (benefit) for income taxes
Net income
Basic net income per share
Diluted net income per share

First (1)

    Second (2)

Quarters

Third (3)

Fourth

Total

  $

  $
  $
  $

86,949    $
69,903     
17,046     
14,979     
2,067     
(191)    
1,876     
732     
1,144    $
0.08    $
0.08    $

89,146    $
70,408     
18,738     
16,824     
1,914     
1,208     
3,122     
1,363     
1,759    $
0.13    $
0.12    $

88,648    $ 101,348    $ 366,091 
79,721      289,133 
69,101     
76,958 
21,627     
19,547     
67,828 
18,302     
17,723     
9,130 
3,325     
1,824     
1,531 
180     
334     
10,661 
3,505     
2,158     
3,022 
1,600     
(673)    
7,639 
1,905    $
2,831    $
0.56 
0.14    $
0.21    $
0.53  
0.13    $
0.20    $

70

 
   
   
 
 
 
 
   
 
 
   
 
 
 
   
      
      
  
   
   
   
   
   
      
      
  
   
   
   
   
      
      
  
   
     
       
       
 
 
 
       
 
 
 
   
   
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
      
      
      
      
  
   
   
   
   
   
   
   
(amounts in thousands, except per-share data)
2019
Revenue
Direct costs
Gross profit
Selling, general, and administrative expenses
Operating income
Interest and other income (expense), net
Income before income taxes
Provision for income taxes
Net income
Basic net income per share
Diluted net income per share

First (4)

    Second

Third

Fourth

Total

Quarters

  $

  $
  $
  $

97,238    $ 100,408    $
82,072     
79,522     
18,336     
17,716     
16,483     
16,589     
1,853     
1,127     
(366)    
(180)    
1,487     
947     
544     
315     
943    $
632    $
0.07    $
0.05    $
0.07    $
0.05    $

97,204    $
78,462     
18,742     
17,218     
1,524     
(202)    
1,322     
443     
879    $
0.07    $
0.06    $

99,320    $ 394,170 
79,079      319,135 
75,035 
20,241     
68,123 
17,833     
6,912 
2,408     
(623)
125     
6,289 
2,533     
2,164 
862     
4,125 
1,671    $
0.31 
0.12    $
0.29  
0.12    $

(1)  During the 2020 first quarter, the Company acquired StarDust.  The results of operations of StarDust have been 

included in the Company’s consolidated financial results since the date of acquisition.

(2)  During the 2020 second quarter, the Company recorded a $0.4 million non-taxable life insurance gain for a former 

executive that passed away. The non-taxable life insurance gain is included in other income. Also, the Company 
sold its corporate headquarters located in Buffalo, NY for $2.5 million. The book value of the building was 
approximately $1.6 million at the time of sale and the Company recorded a gain on the sale of about $0.8 million, 
after fees.

(3)  During the 2020 third quarter, the Company recorded a $0.6 million non-taxable life insurance gain for a former 

executive that passed away. The non-taxable life insurance gain is included in other income.

(4)  During the 2019 first quarter, the Company acquired Tech-IT.  The results of operations of Tech-IT have been 

included in the Company’s consolidated financial results since the date of acquisition.

71

 
 
       
 
 
 
 
 
 
 
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
      
      
      
      
  
   
   
   
   
   
   
   
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management has evaluated, under the supervision and with the participation of the Company’s 
Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operations of the Company’s 
disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period 
covered by this annual report. Under Rule 13a-15(e) of the Exchange Act, “disclosure controls and procedures” means 
controls and other procedures that are designed to ensure that information required to be disclosed by the Company in 
the reports that it files with the SEC is recorded, processed, summarized and reported, within the time periods specified in 
the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures 
designed to ensure that information required to be disclosed by our Company in the reports that it files or submits under 
the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief 
Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, the 
Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls 
and procedures were effective as of the end of the period covered by this annual report.

(a) Management’s Annual Report on Internal Control Over Financial Reporting

The Company’s management is responsible for establishing and maintaining an adequate system of internal control 

over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance 
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in 
accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes 
those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and 
fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that 
transactions are recorded as necessary to permit preparation of financial statements in accordance with generally 
accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance 
with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding 
prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a 
material effect on the financial statements.

Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable 
assurance and may not prevent or detect misstatements. Therefore, even those systems determined to be effective can 
provide only reasonable assurance with respect to financial statement preparation and presentation. Further, because of 
changes in conditions, effectiveness of internal control over financial reporting may deteriorate.

Management of the Company conducted an evaluation of the effectiveness of the Company’s internal control over 

financial reporting based on the Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring 
Organizations of the Treadway Commission. Based on that evaluation, the Company’s management did not identify any 
control deficiencies it considered to be material weaknesses under the rules specified by the Public Company Accounting 
Oversight Board’s Auditing Standard No. 5, and therefore concluded that its internal control over financial reporting was 
effective as of December 31, 2020.

The Company acquired StarDust on March 3, 2020, and management excluded from its assessment of the 

effectiveness of internal control over financial reporting as of December 31, 2020, StarDust’s internal control over financial 
reporting associated with assets representing $8.1 million of consolidated assets (of which $4.3 million represents 
goodwill and intangible assets included in the scope of the assessment), and revenues representing $5.3 million of 
consolidated revenues included in the consolidated financial statements of the Company as of and for the year ended 
December 31, 2020.

Our independent registered public accounting firm has issued an attestation report on the Company’s effectiveness 
of internal control over financial reporting. Their report appears in Item 9A(b), Attestation Report of the Registered Public 
Accounting Firm.

72

(b) Attestation Report of the Registered Public Accounting Firm

Report of Independent Registered Public Accounting Firm

Board of Directors and Shareholders
Computer Task Group, Incorporated

Opinion on internal control over financial reporting

We have audited the internal control over financial reporting of Computer Task Group, Incorporated (a New York 
corporation) and subsidiaries (the “Company”) as of December 31, 2020, based on criteria established in the 2013 
Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway 
Commission (“COSO”). In our opinion, the Company maintained, in all material respects, effective internal control over 
financial reporting as of December 31, 2020, based on criteria established in the 2013 Internal Control—Integrated 
Framework issued by COSO.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United 
States) (“PCAOB”), the consolidated financial statements of the Company as of and for the year ended December 31, 
2020, and our report dated March 12, 2021 expressed an unqualified opinion on those financial statements.

Basis for opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its 
assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s 
Annual Report on Internal Control Over Financial Reporting (“Management’s Report”). Our responsibility is to express an 
opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm 
registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. 
federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the 
PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and 
perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was 
maintained in all material respects. Our audit included obtaining an understanding of internal control over financial 
reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating 
effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered 
necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Our audit of, and opinion on, the Company’s internal control over financial reporting does not include the internal control 
over financial reporting of StarDust SAS, a wholly-owned subsidiary, whose financial statements reflect total assets and 
revenues constituting 5 and 1 percent, respectively, of the related consolidated financial statement amounts as of and for 
the year ended December 31, 2020. As indicated in Management’s Report, StarDust SAS was acquired during 2020. 
Management’s assertion on the effectiveness of the Company’s internal control over financial reporting excluded internal 
control over financial reporting of StarDust SAS.

Definition and limitations of internal control over financial reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the 
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with 
generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and 
procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the 
transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are 
recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting 
principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of 
management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely 
detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the 
financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, 
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become 
inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may 
deteriorate.

/s/ GRANT THORNTON LLP 

Cleveland, Ohio
March 12, 2021

73

(c) Changes in Internal Control Over Financial Reporting

The Company reviews, revises and improves the effectiveness of the Company’s internal controls on a continuous 

basis. The Company’s management, including its Chief Executive Officer and Chief Financial Officer, evaluated the 
effectiveness of the Company’s internal control over financial reporting as of the end of the period covered by this annual 
report. There were no changes in the Company’s internal control over financial reporting that occurred during the 
Company's last fiscal quarter, which ended on December 31, 2020, that materially affected, or are reasonably likely to 
materially affect, the Company’s internal control over financial reporting.

Item 9B.

Other Information

None

74

PART III

Item 10.

Directors, Executive Officers and Corporate Governance

Except as otherwise set forth below, the information required in response to this item is included in this annual report 

on Form 10-K for the year ended December 31, 2020, except insofar as information with respect to executive officers is 
presented in Part I, Item 1 of this report pursuant to General Instruction G(3) of Form 10-K. Information regarding the 
Company’s Code of Conduct is incorporated herein by reference to the information set forth under “Available Company 
Information” in Part I, Item 1 of this annual report on Form 10-K. The Company maintains a separate standing audit 
committee established in accordance with section 3(a)(58)(A) of the Exchange Act consisting of all independent directors, 
with James R. Helvey III as the designated audit committee financial expert. Mr. Helvey is independent, as independence 
for audit committee members is defined in the listing standard applicable to CTG.

Filip J.L. Gydé. Mr. Gydé, 60, was named Chief Executive Officer of the Company and appointed to the Company’s 
Board of Directors effective March 1, 2019. Mr. Gydé has been with CTG since May 1987 and most recently served as the 
Executive Vice President, General Manager, and President for CTG’s European operations. Mr. Gydé led the Company’s 
European operations from October 2000 through February 2019, and served as Interim Executive Vice President of 
Operations of CTG from October 2014 to April 2015, during which time he was responsible for overall company operating 
activities.

James R. Helvey III. Mr. Helvey, 62, was appointed to CTG’s Board of Directors in November 2015. Mr. Helvey co-

founded Cassia Capital Partners, LLC, a registered investment advisor, in 2011 and has served as a managing partner 
since its formation. From 2005 to 2011, Mr. Helvey was a partner and the Risk Management Officer for CMT Asset 
Management Limited, a private investment firm. From 2003 to 2004, Mr. Helvey was a candidate for the United States 
Congress in the 5th District of North Carolina. Mr. Helvey served as Chairman and Chief Executive Officer of Cygnifi 
Derivatives Services, LLC, an online derivatives services provider, from 2000 to 2002. From 1985 to 2000, Mr. Helvey 
was employed by J.P. Morgan & Co., serving in a variety of capacities, including as Vice Chairman of J.P. Morgan’s Risk 
Management Committee, Chair of J.P. Morgan’s Liquidity Committee, Global Head of Derivative Counterparty Risk 
Management, head of the swap derivative trading business in Asia, and head of short-term interest rate derivatives and 
foreign exchange forward trading in Europe. Mr. Helvey graduated magna cum laude with honors from Wake Forest 
University. Mr. Helvey was also a Fulbright Scholar at the University of Cologne in Germany and received a Master’s 
degree in international finance and banking from Columbia University, School of International and Public Affairs, where he 
was an International Fellow. Mr. Helvey is a director and serves on the Audit Committee of Coca-Cola Consolidated 
Bottling Co. a publicly traded and independent bottler of Coca-Cola Company products, Verger Capital Management LLC, 
Piedmont Federal Savings Bank (Audit Chair), and has also served on the board of trustees of Wake Forest University 
from 1997 to 2017 and the Wake Forest Baptist Medical Center where he continues to serve as a director of Wake Forest 
University Health Sciences.  Mr. Helvey was a director of Pike Corporation, an energy solutions provider, from 2005 to 
2014, where he served as Lead Independent Director, Chairman of the Audit Committee and Chairman of the 
Compensation Committee. 

David H. Klein. Mr. Klein, 72, has been a Director since September 2012. He is the President of Klein Solutions 

Group, LLC, which provides advice on policy, strategy, operations and finance to healthcare delivery and payer 
organizations. Mr. Klein also serves as: a special advisor to the CEO of the University of Rochester (UR) Medical Center, 
a professor of public health sciences in the UR School of Medicine and Dentistry and as an executive professor of 
healthcare management in the UR Simon Business School. Mr. Klein was most recently the Chief Executive Officer of 
The Lifetime Healthcare Companies, which was comprised of Excellus BlueCross BlueShield (BCBS), Univera 
Healthcare, Lifetime Health Medical Group, Lifetime Care (home care agency), EBS-RMSCO Benefit Solutions (benefits 
consulting firm and third party administration) and MedAmerica (long-term care insurance company). Mr. Klein had been a 
senior executive with The Lifetime Healthcare Companies and its predecessor companies since 1986, serving as CEO 
from 2003 until 2012. Mr. Klein previously was an executive with the national BlueCross BlueShield Association and 
Health Care Service Corporation. He served as Director of the national Blue Cross Blue Shield Association (BCBSA) and 
America’s Health Insurance Plans. Mr. Klein currently serves as a Director of the following privately held companies: 
Landmark Health (a General Atlantic and Francisco Partners (private equity fund) company which creates and manages 
home visiting multi-disciplinary medical groups to care for complex, chronically ill patients), Cogito (a Goldman Sachs/ 
Open View Partner/Romulus Capital funded customer engagement/voice analytics company), NextHealth Technologies (a 
Norwest Venture Partners health care cost management optimization company), Excel Venture Partners Fund (a venture 
capital fund that invests in high-tech startups focused on Upstate New York) and Transparent Health Marketplace (a 
provider network management company using spot pricing and patient navigation to create value).  Mr. Klein is also a 
director of CA Healthcare Acquisition Corporation. Mr. Klein is a member of the Cressey & Company private equity fund 

75

Distinguished Executives Council. He serves as an advisor to Health Catalyst Capital Management, LLC and Triple Tree 
Capital Partners venture funds. He is past non-executive chair of the New York eHealth Collaborative which operates New 
York State’s health information exchange and as a Director of Commonwealth Care Alliance (a health plan that serves 
high cost high need patients). Mr. Klein chaired United Way of Greater Rochester and an American Cancer Society 
Capital Campaign to establish a new Rochester Hope Lodge. He has also been president of the local Boy Scout Council 
and Director of Northeast Region, Boy Scouts of America. He is a Boy Scouts’ Distinguished Eagle Scout and a recipient 
of their Silver Beaver and Silver Antelope awards. Mr. Klein received a Bachelor of Science from Rensselaer Polytechnic 
Institute and his Master of Business Administration from the University of Chicago.

Valerie Rahmani. Ms. Rahmani, 63, was appointed to CTG’s Board of Directors in November 2015. Ms. Rahmani is 

a non-executive Director and member of the Nominations and Risk Committees of the London Stock Exchange Group 
plc. She is a non-executive Director and member of the Audit Committee of RenaissanceRe Holdings Ltd, a Bermuda-
based reinsurance company. She is a non-executive Director and member of the Compensation Committee of Entrust 
Corporation, a Minneapolis based provider of identity, payment and data protection. She is also a Board member of a 
social media startup, Rungway, based in London. From November 2017 until August 2019 she was the part-time CEO of 
the Innovation Panel of Standard Life Aberdeen plc, a global investment company based in the UK. From 2010 to 2015, 
Ms. Rahmani was a member of the Board of Directors of Teradici Corporation—a private technology—company where 
she served on the Audit and Compensation Committees. She most recently served as Chief Executive Officer of 
Damballa, Inc. from 2009 to 2012. Damballa was a venture capital funded cyber-security company headquartered in 
Atlanta, Georgia. Prior to her role at Damballa, Ms. Rahmani was with IBM in various managerial capacities for 28 years. 
Her last role with IBM was General Manager of IBM Internet Security Systems. Other IBM roles included General 
Manager of the $2.7 billion Global Technology Services business, head of Sales and Services Strategy unit, General 
Manager of IBM’s $3.5 billon UNIX server business, General Manager of IBM’s Mobile business as well as serving as the 
Executive Assistant to Louis Gerstner, former Chairman and Chief Executive Officer of IBM. Ms. Rahmani holds an MA 
and a Doctor of Philosophy degree in Chemistry from Oxford University, England.

Raj Rajgopal. Mr. Rajgopal, 60, was appointed to CTG’s Board of Directors in December 2020.  Mr. Rajgopal is 
currently the President of RR Advisory Services, LLC, an advisory firm that offers due diligence and consulting services to 
venture capital, private equity, and large enterprises. He also serves as a Board observer at Wevo Conversion, a provider 
of artificial intelligence and machine learning based digital marketing platform.  From 2005-2019, Mr. Rajgopal served in 
various capacities at Virtusa Corporation (VRTU: Consulting & Technology Services), serving as its President from 2013 
to 2019. Mr. Rajgopal successfully led Virtusa’s transformation from an engineering services firm to a leading digital 
consulting, digital solutions and IT services organization.  Mr. Rajgopal also served as an independent consultant to 
Virtusa Corporation from 2003-2005 where he helped set the company’s long-term growth strategy.  From 1991-2003, Mr. 
Rajgopal held global leadership roles in both the U.S. and the U.K. with Capgemini, a global leader in consulting, 
technology services and digital transformation. He was also a Director of Advanced Technologies at BGS Systems, Inc.  
Mr. Rajgopal holds a Masters degree in Business from the MIT Sloan School of Management, and Masters degrees in 
both Computer Science and Operations Research from Virginia Tech. 

Daniel J. Sullivan. Mr. Sullivan, 74, has been a Director of CTG since 2002 and was appointed to serve as the non-

executive Chairman of the Board of Directors in October 2014. He most recently served as the President and Chief 
Executive Officer of FedEx Ground from 1998 until 2007. FedEx Ground is a wholly owned subsidiary of FedEx 
Corporation. From 1996 to 1998, Mr. Sullivan was the Chairman, President and Chief Executive Officer of Caliber System. 
In 1995, Mr. Sullivan was the Chairman, President and Chief Executive Officer of Roadway Services. Mr. Sullivan is 
currently a member of the Board of Directors of Schneider National, Inc. (Green Bay, Wisconsin), where he serves on the 
compensation and governance committees. He serves on the Board of Advisors of Package Solutions, (Atlanta, Georgia) 
from 2015 to the present, the Board of Advisors of Aviation Investment Partners, (Charleston, South Carolina) from 2014 
to the present and is the Principal of Flyway, LLC, (Kiawah Island, South Carolina) from 2009 to the present. Mr. Sullivan 
is also an Emeritus Director of the Board of Directors of The Medical University of South Carolina Foundation. Mr. Sullivan 
previously served as a member of the Board of Directors of Pike Electric, Inc. from 2007 to 2014 (Pike Electric was sold in 
December 2014 to Court Square Capital Partners), GDS Express (Akron, Ohio) from 2004 to 2009; and Gevity, Inc. 
(Bradenton, Florida) from 2008 to 2009. He is a former federal commissioner for the Flight 93 National Memorial project in 
Somerset County, Pennsylvania.

Owen J. Sullivan. Mr. Sullivan, 63, was appointed to the Board of Directors in February 2017. Mr. Sullivan is Chief 

Operating Officer of NCR, a position he has held since July 2018. Before becoming Chief Operating Officer of NCR, 
Mr. Sullivan was an independent consultant, providing strategic planning, consulting and executive mentoring, and 
working with and investing alongside private equity firms and other investor groups. Prior to that, Mr. Sullivan was with 
ManpowerGroup, a workforce and talent management solutions company, from 2003 to 2013. At ManpowerGroup, he 

76

served as President of the Specialty Brands and Experis units from 2010 to 2013, and he served as the Chief Executive 
Officer of the Right Management and Jefferson Wells International, Inc. subsidiaries from 2004 to 2013 and from 2003 to 
2010, respectively. Before joining ManpowerGroup, Mr. Sullivan was with Sullivan Advisors, LLC, a provider of strategic 
planning, consulting and executive mentoring for small to medium-sized businesses from 2001-2003. Prior to that, 
Mr. Sullivan was with Metavante Inc., a bank technology processing company from 1993 to 2001, where he served in 
various management roles including as the President of Metavante’s Financial Services Group and Enterprise Solutions 
Group. Mr. Sullivan is a past Chairman of the Board of Directors at Marquette University but still serves as a trustee of the 
Board.

The Nominating and Corporate Governance Committee and the Board of Directors focuses on the experience, 
qualifications, attributes and skills discussed in each of the director’s biographies set forth above.  In each case, the 
Committee and the Board of Directors considered the achievements throughout the successful careers of each of the 
individuals.  

With regard to Mr. Gydé, the Committee noted that Mr. Gydé has been with the Company since October 1990 and 

had served as the Executive Vice President, General Manager and President for the Company’s European operations. 
Mr. Gydé led the Company’s European operations since October 2000 and served as Interim Executive Vice President of 
Operations of CTG from October 15, 2014 until April 5, 2015, during which time he was responsible for overall company 
operating activities. With regard to Mr. Helvey, the Committee considered his extensive financial experience and prior 
audit committee experience.  With regard to Mr. Klein, the Committee considered his extensive experience managing 
health plan entities and his knowledge of the healthcare industry.  With regard to Ms. Rahmani, the Committee considered 
her experience in cybersecurity and her management experience within the IT Services industry.  With regard to Mr. 
Daniel J. Sullivan, the Committee considered the broad perspective resulting from his diverse experience in managing 
and serving as an officer for a large, public company.  With regard to Mr. Owen J. Sullivan, the Committee considered his 
extensive experience in the staffing solutions and professional resourcing industry, including his roles at ManpowerGroup. 
With regard to Raj Rajgopal, the Committee considered his broad and deep leadership experience in the industry 
throughout the globe, particularly in the implementation of digital strategies and transformation. 

Executive Officers of the Company

The following individuals are executive officers of the Company:

Name
Filip J. L. Gydé

Age
60 President and Chief Executive Officer

Office

Period During
Which Served
as Executive Officer

March 1, 2019 to date

Other Positions
and Offices
with Registrant
Director

Executive Vice President, President and 
General Manager of Europe
Senior Vice President
Interim Executive Vice President of Operations
Senior Vice President

May 8, 2018 to Feb. 28, 2019
April 6, 2015 to May 7, 2018
Oct. 15, 2014 to April 5, 2015
Oct. 1, 2000 to Oct. 14, 2014

John M. Laubacker

54 Executive Vice President, Chief Financial 

April 21, 2017 to date

Treasurer

Officer
Interim Chief Financial Officer

Oct. 15, 2014 to April 5, 2015

Peter P. Radetich

66 Senior Vice President, General Counsel

April 28, 1999 to date

Secretary

Thomas J. Niehaus

59 Executive Vice President, General Manager of 

May 5, 2019 to date

None

North America

Rénald Wauthier        52 Senior Vice President

Vice President

April 1, 2020 to date
January 23, 2019 to March 
31, 2020

None

Mr. Gydé was promoted to President and Chief Executive Officer on March 1, 2019. Previously, Mr. Gydé served as 
an Executive Vice President, and President and General Manager for the Company's European operations. Mr. Gydé was 
Interim Executive Vice President of Operations from October 15, 2014 until April 5, 2015, responsible for operating 
activities of the overall Company. Previously he was Senior Vice President and General Manager of CTG Europe from 
October 1, 2000 through October 14, 2014. Prior to that, Mr. Gydé was Managing Director of the Company’s operations in 
Belgium. Mr. Gydé has been with the Company since May 1987.

77

Mr. Laubacker currently serves as an Executive Vice President, Chief Financial Officer (CFO) and Treasurer.  Mr. 

Laubacker was promoted to CFO on April 21, 2017. Previously, Mr. Laubacker was promoted to Vice President in 
February 2017 and has served as Treasurer since 2006. Prior to that, Mr. Laubacker was the Director of Audit and 
Treasury Services and the Manager of External Reporting. Mr. Laubacker joined the Company in 1996.

Mr. Radetich currently serves as Senior Vice President, General Counsel and Secretary.  Mr. Radetich was 
promoted to General Counsel and Secretary in April 1999, and joined the Company in June 1988 as Associate General 
Counsel.

Mr. Niehaus currently serves as an Executive Vice President, and General Manager of the Company’s North 

American operations. Mr. Niehaus joined the Company in May 2019. Prior to joining CTG, Mr. Niehaus served as the 
managing member of TJN Advisory, a private advisory services consulting firm.  Previously, Mr. Niehaus was the 
President and Chief Operating Officer of Encore Health Resources from 2011 to 2017, and then Chief Executive Officer of 
Encore in 2017.  Mr. Niehaus worked for CTG from 1999 to 2011, including serving as a Senior Vice President.

Mr. Wauthier was promoted to Senior Vice President of our European operations on April 1, 2020.  Previously, Mr. 

Wauthier was a Vice President from January 23, 2019 through March 2020, and prior to that was Managing Director of 
our Luxembourg operation from August 30, 1996 to January 22, 2019.  Mr. Wauthier joined the Company in 1995.

Delinquent Section 16(a) Reports

During the 2020 fiscal year, Company Director, Valerie Rahmani, failed to timely report one transaction consisting of 

the purchase of 2,272 shares of the Company’s common stock that occurred on December 11, 2020.  There were no 
other known delinquent filings for fiscal 2020 and no known delinquent filings from a previous fiscal year that became 
known during the last fiscal year.

Item 11.

Executive Compensation

COMPENSATION DISCUSSION AND ANALYSIS

Compensation Committee Composition and Primary Purposes

The Compensation Committee of the Board of Directors consists of Valerie Rahmani, Chair, James R. Helvey III, 

David H. Klein, Raj, Rajgopal, Daniel J. Sullivan, and Owen J. Sullivan.  The Compensation Committee is responsible for 
overseeing the administration of the Company’s employee stock and benefit plans, establishing policies relating to the 
compensation of employees and setting the terms and conditions of employment for executive officers.  During 2020, the 
Compensation Committee held a total of five meetings.  The Board of Directors has determined that the members of the 
Compensation Committee are independent.

The Compensation Committee has a charter that is available on our Company’s website as described above under 

“Available Company Information” in Part I, Item 1 of this annual report on Form 10-K. The Compensation Committee 
reviews the charter annually and updates the charter as necessary.  

The primary purposes of the Compensation Committee are to: 

(1) review and approve corporate goals and objectives relevant to the Company’s compensation philosophy,

(2) evaluate the CEO’s performance and determine the CEO’s compensation in light of those goals and objectives,

(3) review and approve executive officer compensation, incentive compensation plans and equity-based plans, and

(4) produce an annual report on executive compensation, and approve the Compensation Discussion and Analysis, 
for inclusion in the Company’s annual proxy statement or this annual report on Form 10-K for the year ended 
December 31, 2020.

Effect of Say-on-Pay Vote

At the September 2020 annual meeting, shareholders were asked to approve the Company's fiscal 2019 executive 
compensation programs.  Of those who voted, over 78% voted to approve the proposal.  In light of these results, and in 
consideration of shareholder input obtained from outreach efforts taken in connection with the 2020 meeting, the 
Compensation Committee carefully reviewed the Company's executive compensation practices.  The Committee 

78

concluded that the Company's existing executive compensation programs continue to be the most appropriate for the 
Company and effective in rewarding executives commensurate with business results.  The Committee believes that the 
best way to align the CEO's compensation with shareholder interests is to place the majority of his compensation at-risk in 
the form of long-term performance based equity awards and annual incentive opportunity.

Compensation Philosophy and Executive Compensation Objectives

Given the exceptionally competitive nature of the IT Industry, the Compensation Committee and management 

believe it is strategically critical to attract, retain and motivate the most talented employees possible by providing 
competitive total compensation packages.  This general philosophy on compensation applies to all employees of the 
Company.  With regard to executive officer compensation, the Company seeks to accomplish the following high-level 
objectives:

(cid:129) Offer a Competitive Total Compensation Package. To attract the most talented executive officers possible, the 
Company should tailor each executive officer’s total compensation plan to reflect average total compensation 
offered at similar organizations. This is accomplished by means of routine compensation surveying, the process 
for which is described further below.

(cid:129)

(cid:129)

Tie Total Compensation to Performance in a Meaningful Manner.  To promote the Company’s overall annual 
and long-term financial and operating objectives, a significant portion of total compensation should be based 
upon the accomplishment of specific Company objectives within an executive officer’s purview. This is 
accomplished by means of various performance-based incentive plans described further below.

Encourage Executives to Think Like Shareholders. To promote the best interests of shareholders, executive 
officers should be encouraged to maintain a significant equity interest in the Company. This is accomplished by 
means of various equity award plans described further below. 

How Executive Compensation is Determined

In order to promote the Company’s objective of tying total compensation to performance in a meaningful manner, the 
Company has adopted a uniform approach to compensation planning.  In short, once the Board of Directors has reviewed 
and approved the corporate goals and objectives for the entire Company, the Compensation Committee begins the 
process of setting compensation for the executive officers.  Once compensation has been set for the executive officers, 
they in turn are able to set performance-based objectives for their direct reports.  This approach to compensation planning 
continues throughout the organization.  In this manner, the compensation planning process seeks to optimize shareholder 
value by integrating appropriate employee responsibilities with corporate objectives.

In an effort to accomplish the Company’s objective of offering competitive total compensation packages, the 
Compensation Committee routinely surveys total compensation packages for all executive officers.  In 2020, as has been 
the practice for several years, the Compensation Committee retained the services of Pay Governance LLC (“Pay 
Governance”), a highly regarded independent compensation consulting firm, to undertake an annual compensation review 
for each of the Company’s executive officers. Pay Governance reports to and acts solely at the direction of the 
Compensation Committee. Pay Governance does not provide any other services to the Company or any of the 
Company’s executive officers individually, aside from those services provided to the Compensation Committee. Pay 
Governance has provided the Committee with appropriate assurances and confirmation of its independent status.  
Furthermore, the Committee has considered the factors set forth in 17 C.F.R. §240.10C-1(b) (4) (i)-(vi) and believes that 
Pay Governance has been independent throughout its services to the Committee.  Prior to conducting the study, Pay 
Governance was provided with job descriptions for each of the executive officers and was specifically instructed to provide 
the Compensation Committee with a Competitive Market Analysis, a written report for each executive officer reflecting the 
competitive range of total compensation for comparable positions. 

Surveying Methodology Used.  Pay Governance used a Willis Towers Watson executive compensation database to 

create the report. This database contains compensation data from approximately 700 companies.  From this data, Pay 
Governance performed regression analyses designed to identify a competitive range for jobs in similar companies by 
revenue size, and in similar business units or with similar position-specific revenue responsibilities. Pay Governance’s 
competitive range is based solely on external competitive data and does not take individual performance or internal pay 
equity into account.  The competitive range identified in the Pay Governance report approximates the statistical mean 
within one standard deviation. As such, the competitive range tends to fall within approximately 15% of either side of the 
median. Deviation within this range is usually explained by differences in experience, length of service and/or differences 
in responsibilities.

79

(cid:41)(cid:82)(cid:85)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:51)(cid:68)(cid:92)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:82)(cid:69)(cid:86)(cid:72)(cid:85)(cid:89)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:87)(cid:82)(cid:87)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:81)(cid:68)(cid:80)(cid:72)(cid:71)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)(cid:72)(cid:91)(cid:70)(cid:72)(cid:83)(cid:87)(cid:3)(cid:48)(cid:85)(cid:17)(cid:3)

(cid:42)(cid:92)(cid:71)(cid:112)(cid:15)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:87)(cid:76)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:85)(cid:68)(cid:81)(cid:74)(cid:72)(cid:17)(cid:3)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:87)(cid:82)(cid:87)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:48)(cid:85)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:87)(cid:76)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:85)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:83)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:87)(cid:82)(cid:3)
(cid:75)(cid:76)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:80)(cid:82)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:87)(cid:82)(cid:3)(cid:38)(cid:40)(cid:50)(cid:3)(cid:76)(cid:81)(cid:3)(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:21)(cid:19)(cid:20)(cid:28)(cid:17)

(cid:55)(cid:82)(cid:3)(cid:73)(cid:88)(cid:85)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:68)(cid:86)(cid:86)(cid:72)(cid:86)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:83)(cid:85)(cid:68)(cid:70)(cid:87)(cid:76)(cid:70)(cid:72)(cid:86)(cid:3)(cid:89)(cid:72)(cid:85)(cid:86)(cid:88)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:80)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:15)(cid:3)(cid:51)(cid:68)(cid:92)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:70)(cid:82)(cid:79)(cid:79)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:83)(cid:68)(cid:92)(cid:3)

(cid:71)(cid:68)(cid:87)(cid:68)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:41)(cid:50)(cid:3)(cid:83)(cid:82)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:80)(cid:82)(cid:86)(cid:87)(cid:3)(cid:85)(cid:72)(cid:70)(cid:72)(cid:81)(cid:87)(cid:3)(cid:83)(cid:85)(cid:82)(cid:91)(cid:92)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:68)(cid:3)(cid:81)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:82)(cid:73)(cid:3)(cid:83)(cid:72)(cid:72)(cid:85)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:76)(cid:72)(cid:86)(cid:3)(cid:86)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:76)(cid:72)(cid:86)(cid:3)(cid:86)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:90)(cid:72)(cid:85)(cid:72)(cid:3)(cid:37)(cid:42)(cid:3)(cid:54)(cid:87)(cid:68)(cid:73)(cid:73)(cid:76)(cid:81)(cid:74)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:15)(cid:3)(cid:38)(cid:85)(cid:82)(cid:86)(cid:86)(cid:3)(cid:38)(cid:82)(cid:88)(cid:81)(cid:87)(cid:85)(cid:92)(cid:3)(cid:43)(cid:72)(cid:68)(cid:79)(cid:87)(cid:75)(cid:70)(cid:68)(cid:85)(cid:72)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:15)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:43)(cid:68)(cid:70)(cid:78)(cid:72)(cid:87)(cid:87)(cid:3)
(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:15)(cid:3)(cid:43)(cid:88)(cid:85)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:81)(cid:86)(cid:88)(cid:79)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:15)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:54)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:86)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:15)(cid:3)(cid:48)(cid:68)(cid:86)(cid:87)(cid:72)(cid:70)(cid:75)(cid:3)(cid:39)(cid:76)(cid:74)(cid:76)(cid:87)(cid:68)(cid:79)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:15)(cid:3)(cid:51)(cid:72)(cid:85)(cid:73)(cid:76)(cid:70)(cid:76)(cid:72)(cid:81)(cid:87)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:15)(cid:3)(cid:51)(cid:53)(cid:42)(cid:59)(cid:3)
(cid:42)(cid:79)(cid:82)(cid:69)(cid:68)(cid:79)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:53)(cid:38)(cid:48)(cid:3)(cid:55)(cid:72)(cid:70)(cid:75)(cid:81)(cid:82)(cid:79)(cid:82)(cid:74)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:3)(cid:51)(cid:68)(cid:92)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:86)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:79)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:41)(cid:50)(cid:3)(cid:83)(cid:82)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:69)(cid:72)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)
(cid:85)(cid:72)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:71)(cid:68)(cid:87)(cid:68)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:83)(cid:82)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:88)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:85)(cid:68)(cid:69)(cid:79)(cid:72)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:85)(cid:76)(cid:86)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:71)(cid:76)(cid:70)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)
(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:41)(cid:50)(cid:3)(cid:73)(cid:72)(cid:79)(cid:79)(cid:3)(cid:69)(cid:72)(cid:87)(cid:90)(cid:72)(cid:72)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:21)(cid:24)(cid:87)(cid:75)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:24)(cid:19)(cid:87)(cid:75)(cid:3)(cid:83)(cid:72)(cid:85)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:79)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:72)(cid:85)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:76)(cid:72)(cid:86)(cid:17)(cid:3)

(cid:56)(cid:83)(cid:82)(cid:81)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:79)(cid:72)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:80)(cid:72)(cid:87)(cid:3)(cid:83)(cid:72)(cid:85)(cid:86)(cid:82)(cid:81)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:68)(cid:3)(cid:85)(cid:72)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:68)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:51)(cid:68)(cid:92)(cid:3)

(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:85)(cid:72)(cid:89)(cid:76)(cid:72)(cid:90)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:82)(cid:70)(cid:88)(cid:80)(cid:72)(cid:81)(cid:87)(cid:17)(cid:3)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:88)(cid:86)(cid:72)(cid:71)(cid:3)(cid:68)(cid:3)(cid:86)(cid:72)(cid:83)(cid:68)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:51)(cid:68)(cid:92)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92)(cid:15)(cid:3)(cid:76)(cid:81)(cid:3)
(cid:70)(cid:82)(cid:81)(cid:77)(cid:88)(cid:81)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:3)(cid:79)(cid:82)(cid:81)(cid:74)(cid:16)(cid:87)(cid:72)(cid:85)(cid:80)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:15)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:72)(cid:87)(cid:3)(cid:87)(cid:82)(cid:87)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)
(cid:48)(cid:85)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:38)(cid:40)(cid:50)(cid:17)(cid:3)(cid:3)(cid:48)(cid:85)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112)(cid:3)(cid:71)(cid:76)(cid:71)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:3)(cid:71)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:3)(cid:85)(cid:82)(cid:79)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:72)(cid:86)(cid:87)(cid:68)(cid:69)(cid:79)(cid:76)(cid:86)(cid:75)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:87)(cid:72)(cid:85)(cid:80)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:75)(cid:76)(cid:86)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:88)(cid:86)(cid:86)(cid:72)(cid:71)(cid:3)(cid:69)(cid:72)(cid:79)(cid:82)(cid:90)(cid:17)

(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:40)(cid:50)(cid:3)(cid:88)(cid:86)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:51)(cid:68)(cid:92)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:87)(cid:76)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:48)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:3)(cid:36)(cid:81)(cid:68)(cid:79)(cid:92)(cid:86)(cid:76)(cid:86)(cid:15)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:77)(cid:88)(cid:81)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:3)(cid:79)(cid:82)(cid:81)(cid:74)(cid:16)
(cid:87)(cid:72)(cid:85)(cid:80)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:15)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:68)(cid:78)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:80)(cid:80)(cid:72)(cid:81)(cid:71)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:37)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)
(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:17)(cid:3)(cid:3)(cid:44)(cid:87)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:69)(cid:72)(cid:72)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:68)(cid:70)(cid:87)(cid:76)(cid:70)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:37)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:89)(cid:72)(cid:3)(cid:87)(cid:82)(cid:87)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:83)(cid:68)(cid:70)(cid:78)(cid:68)(cid:74)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:3)(cid:68)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:3)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:87)(cid:68)(cid:76)(cid:79)(cid:82)(cid:85)(cid:72)(cid:71)(cid:15)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:16)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:182)(cid:86)(cid:3)(cid:83)(cid:88)(cid:85)(cid:89)(cid:76)(cid:72)(cid:90)(cid:17)(cid:3)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:81)(cid:82)(cid:3)(cid:71)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:3)(cid:85)(cid:82)(cid:79)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)
(cid:72)(cid:86)(cid:87)(cid:68)(cid:69)(cid:79)(cid:76)(cid:86)(cid:75)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:87)(cid:72)(cid:85)(cid:80)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:76)(cid:85)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:17)(cid:3)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:71)(cid:72)(cid:87)(cid:68)(cid:76)(cid:79)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:81)(cid:68)(cid:80)(cid:72)(cid:71)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:182)(cid:86)(cid:3)(cid:87)(cid:82)(cid:87)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:3)
(cid:68)(cid:85)(cid:72)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:88)(cid:86)(cid:86)(cid:72)(cid:71)(cid:3)(cid:69)(cid:72)(cid:79)(cid:82)(cid:90)(cid:17)

(cid:38)(cid:82)(cid:80)(cid:83)(cid:82)(cid:81)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)

(cid:55)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:83)(cid:68)(cid:76)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)(cid:68)(cid:86)(cid:3)(cid:85)(cid:72)(cid:73)(cid:79)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:87)(cid:68)(cid:69)(cid:79)(cid:72)(cid:86)(cid:3)(cid:86)(cid:72)(cid:87)(cid:3)(cid:73)(cid:82)(cid:85)(cid:87)(cid:75)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)

(cid:82)(cid:81)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:72)(cid:81)(cid:71)(cid:72)(cid:71)(cid:3)(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:22)(cid:20)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:15)(cid:3)(cid:70)(cid:68)(cid:81)(cid:3)(cid:69)(cid:72)(cid:3)(cid:69)(cid:85)(cid:82)(cid:78)(cid:72)(cid:81)(cid:3)(cid:71)(cid:82)(cid:90)(cid:81)(cid:3)(cid:76)(cid:81)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:82)(cid:79)(cid:79)(cid:82)(cid:90)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:85)(cid:72)(cid:72)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:3)(cid:70)(cid:68)(cid:87)(cid:72)(cid:74)(cid:82)(cid:85)(cid:76)(cid:72)(cid:86)(cid:29)(cid:3)
(cid:11)(cid:76)(cid:12)(cid:3)(cid:37)(cid:68)(cid:86)(cid:72)(cid:79)(cid:76)(cid:81)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:11)(cid:76)(cid:76)(cid:12)(cid:3)(cid:51)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:16)(cid:37)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:11)(cid:76)(cid:76)(cid:76)(cid:12)(cid:3)(cid:40)(cid:84)(cid:88)(cid:76)(cid:87)(cid:92)(cid:16)(cid:37)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:17)(cid:3)(cid:3)

(cid:37)(cid:68)(cid:86)(cid:72)(cid:79)(cid:76)(cid:81)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)

(cid:37)(cid:68)(cid:86)(cid:72)(cid:79)(cid:76)(cid:81)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:3)(cid:86)(cid:68)(cid:79)(cid:68)(cid:85)(cid:92)(cid:15)(cid:3)(cid:86)(cid:87)(cid:68)(cid:81)(cid:71)(cid:68)(cid:85)(cid:71)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:68)(cid:89)(cid:68)(cid:76)(cid:79)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)

(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:68)(cid:76)(cid:81)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:16)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:3)(cid:83)(cid:85)(cid:82)(cid:74)(cid:85)(cid:68)(cid:80)(cid:86)(cid:17)(cid:3)(cid:3)(cid:50)(cid:81)(cid:70)(cid:72)(cid:3)(cid:68)(cid:90)(cid:68)(cid:85)(cid:71)(cid:72)(cid:71)(cid:15)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)
(cid:83)(cid:68)(cid:92)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:80)(cid:68)(cid:71)(cid:72)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:82)(cid:81)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:71)(cid:3)(cid:71)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:88)(cid:85)(cid:86)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:82)(cid:88)(cid:87)(cid:3)(cid:85)(cid:72)(cid:74)(cid:68)(cid:85)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:70)(cid:75)(cid:76)(cid:72)(cid:89)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:76)(cid:70)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:16)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:17)(cid:3)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:70)(cid:75)(cid:82)(cid:82)(cid:86)(cid:72)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:68)(cid:92)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:82)(cid:81)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:68)(cid:86)(cid:3)(cid:76)(cid:87)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:85)(cid:76)(cid:86)(cid:72)(cid:86)(cid:3)
(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:82)(cid:88)(cid:81)(cid:71)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:17)(cid:3)(cid:3)(cid:36)(cid:86)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:76)(cid:71)(cid:72)(cid:85)(cid:86)(cid:3)(cid:80)(cid:68)(cid:76)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:87)(cid:76)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:79)(cid:76)(cid:81)(cid:72)(cid:3)
(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:72)(cid:86)(cid:86)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:79)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:87)(cid:87)(cid:85)(cid:68)(cid:70)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:85)(cid:72)(cid:87)(cid:68)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:68)(cid:79)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:83)(cid:72)(cid:85)(cid:86)(cid:82)(cid:81)(cid:81)(cid:72)(cid:79)(cid:17)

Annual Base Salary(cid:3)(cid:178)(cid:44)(cid:81)(cid:3)(cid:68)(cid:81)(cid:3)(cid:72)(cid:73)(cid:73)(cid:82)(cid:85)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:87)(cid:68)(cid:92)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:87)(cid:76)(cid:87)(cid:76)(cid:89)(cid:72)(cid:15)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:86)(cid:68)(cid:79)(cid:68)(cid:85)(cid:76)(cid:72)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:85)(cid:72)(cid:89)(cid:76)(cid:72)(cid:90)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)

(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:82)(cid:81)(cid:3)(cid:68)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:79)(cid:92)(cid:3)(cid:69)(cid:68)(cid:86)(cid:76)(cid:86)(cid:17)(cid:3)(cid:3)(cid:58)(cid:76)(cid:87)(cid:75)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:71)(cid:72)(cid:87)(cid:72)(cid:85)(cid:80)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:3)(cid:86)(cid:68)(cid:79)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:87)(cid:68)(cid:78)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:82)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:76)(cid:71)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:83)(cid:85)(cid:72)(cid:83)(cid:68)(cid:85)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:51)(cid:68)(cid:92)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:182)(cid:86)(cid:3)(cid:76)(cid:81)(cid:71)(cid:76)(cid:89)(cid:76)(cid:71)(cid:88)(cid:68)(cid:79)(cid:3)
(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:68)(cid:86)(cid:3)(cid:90)(cid:72)(cid:79)(cid:79)(cid:3)(cid:68)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:72)(cid:84)(cid:88)(cid:76)(cid:87)(cid:92)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:76)(cid:71)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:17)(cid:3)(cid:3)(cid:50)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:51)(cid:68)(cid:92)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:76)(cid:86)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:74)(cid:76)(cid:89)(cid:72)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:80)(cid:82)(cid:86)(cid:87)(cid:3)(cid:90)(cid:72)(cid:76)(cid:74)(cid:75)(cid:87)(cid:17)(cid:3)(cid:3)(cid:44)(cid:81)(cid:3)(cid:68)(cid:71)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:76)(cid:73)(cid:3)(cid:70)(cid:76)(cid:85)(cid:70)(cid:88)(cid:80)(cid:86)(cid:87)(cid:68)(cid:81)(cid:70)(cid:72)(cid:86)(cid:3)(cid:90)(cid:68)(cid:85)(cid:85)(cid:68)(cid:81)(cid:87)(cid:15)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:68)(cid:86)(cid:3)(cid:68)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:85)(cid:82)(cid:79)(cid:72)(cid:3)(cid:82)(cid:85)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:86)(cid:76)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)
(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:74)(cid:85)(cid:68)(cid:81)(cid:87)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:85)(cid:72)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:85)(cid:92)(cid:3)(cid:69)(cid:82)(cid:81)(cid:88)(cid:86)(cid:72)(cid:86)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:17)(cid:3)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:71)(cid:76)(cid:71)(cid:3)
(cid:81)(cid:82)(cid:87)(cid:3)(cid:74)(cid:85)(cid:68)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:85)(cid:72)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:85)(cid:92)(cid:3)(cid:69)(cid:82)(cid:81)(cid:88)(cid:86)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:17)

Standard Employee Benefits(cid:3)(cid:178)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:72)(cid:81)(cid:87)(cid:76)(cid:87)(cid:79)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:68)(cid:80)(cid:72)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:3)(cid:83)(cid:85)(cid:82)(cid:74)(cid:85)(cid:68)(cid:80)(cid:86)(cid:3)(cid:68)(cid:73)(cid:73)(cid:82)(cid:85)(cid:71)(cid:72)(cid:71)(cid:3)

(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:17)(cid:3)(cid:3)(cid:54)(cid:88)(cid:70)(cid:75)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:3)(cid:68)(cid:3)(cid:23)(cid:19)(cid:20)(cid:11)(cid:78)(cid:12)(cid:3)(cid:83)(cid:85)(cid:82)(cid:74)(cid:85)(cid:68)(cid:80)(cid:15)(cid:3)
(cid:48)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79)(cid:18)(cid:39)(cid:72)(cid:81)(cid:87)(cid:68)(cid:79)(cid:18)(cid:57)(cid:76)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:43)(cid:72)(cid:68)(cid:79)(cid:87)(cid:75)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:86)(cid:15)(cid:3)(cid:40)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:3)(cid:54)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:51)(cid:88)(cid:85)(cid:70)(cid:75)(cid:68)(cid:86)(cid:72)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:15)(cid:3)(cid:54)(cid:75)(cid:82)(cid:85)(cid:87)(cid:16)(cid:55)(cid:72)(cid:85)(cid:80)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:47)(cid:82)(cid:81)(cid:74)(cid:16)(cid:55)(cid:72)(cid:85)(cid:80)(cid:3)(cid:39)(cid:76)(cid:86)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:3)
(cid:41)(cid:79)(cid:72)(cid:91)(cid:76)(cid:69)(cid:79)(cid:72)(cid:3)(cid:54)(cid:83)(cid:72)(cid:81)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:36)(cid:70)(cid:70)(cid:82)(cid:88)(cid:81)(cid:87)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:17)

Executive-Level Benefits(cid:3)(cid:178)(cid:44)(cid:81)(cid:3)(cid:68)(cid:71)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:3)(cid:68)(cid:73)(cid:73)(cid:82)(cid:85)(cid:71)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:15)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:68)(cid:79)(cid:86)(cid:82)(cid:3)
(cid:72)(cid:79)(cid:76)(cid:74)(cid:76)(cid:69)(cid:79)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:82)(cid:85)(cid:3)(cid:85)(cid:72)(cid:70)(cid:72)(cid:76)(cid:89)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:82)(cid:79)(cid:79)(cid:82)(cid:90)(cid:76)(cid:81)(cid:74)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:86)(cid:83)(cid:82)(cid:81)(cid:86)(cid:82)(cid:85)(cid:72)(cid:71)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:16)(cid:47)(cid:72)(cid:89)(cid:72)(cid:79)(cid:3)(cid:37)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:29)(cid:3)(cid:47)(cid:82)(cid:81)(cid:74)(cid:16)(cid:55)(cid:72)(cid:85)(cid:80)(cid:3)
(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:39)(cid:76)(cid:86)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:15)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:47)(cid:76)(cid:73)(cid:72)(cid:3)(cid:44)(cid:81)(cid:86)(cid:88)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:15)(cid:3)(cid:36)(cid:70)(cid:70)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:68)(cid:79)(cid:3)(cid:39)(cid:72)(cid:68)(cid:87)(cid:75)(cid:3)(cid:9)(cid:3)(cid:39)(cid:76)(cid:86)(cid:80)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:55)(cid:85)(cid:68)(cid:89)(cid:72)(cid:79)(cid:3)(cid:36)(cid:70)(cid:70)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:15)(cid:3)
(cid:44)(cid:81)(cid:70)(cid:82)(cid:80)(cid:72)(cid:3)(cid:55)(cid:68)(cid:91)(cid:3)(cid:51)(cid:85)(cid:72)(cid:83)(cid:68)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:36)(cid:71)(cid:89)(cid:76)(cid:70)(cid:72)(cid:3)(cid:83)(cid:85)(cid:82)(cid:74)(cid:85)(cid:68)(cid:80)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:17)(cid:3)(cid:48)(cid:85)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112)(cid:3)(cid:71)(cid:82)(cid:72)(cid:86)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)

(cid:27)(cid:19)

(cid:68)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:86)(cid:3)(cid:37)(cid:72)(cid:79)(cid:74)(cid:76)(cid:68)(cid:81)(cid:3)(cid:79)(cid:68)(cid:90)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:68)(cid:87)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:68)(cid:79)(cid:70)(cid:88)(cid:79)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:86)(cid:72)(cid:83)(cid:68)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:17)(cid:3)(cid:3)(cid:36)(cid:3)(cid:86)(cid:92)(cid:81)(cid:82)(cid:83)(cid:86)(cid:76)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)
(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:16)(cid:47)(cid:72)(cid:89)(cid:72)(cid:79)(cid:3)(cid:37)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:3)(cid:76)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:71)(cid:3)(cid:69)(cid:72)(cid:79)(cid:82)(cid:90)(cid:29)

(cid:129)

(cid:129)

(cid:129)

(cid:129)

(cid:129)

Long-Term Executive Disability Plan(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:83)(cid:68)(cid:92)(cid:15)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:182)(cid:86)(cid:3)(cid:69)(cid:72)(cid:75)(cid:68)(cid:79)(cid:73)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:72)(cid:80)(cid:76)(cid:88)(cid:80)(cid:86)(cid:3)(cid:68)(cid:86)(cid:86)(cid:82)(cid:70)(cid:76)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)
(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:80)(cid:68)(cid:76)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:3)(cid:79)(cid:82)(cid:81)(cid:74)(cid:16)(cid:87)(cid:72)(cid:85)(cid:80)(cid:3)(cid:71)(cid:76)(cid:86)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:83)(cid:82)(cid:79)(cid:76)(cid:70)(cid:92)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:91)(cid:76)(cid:80)(cid:68)(cid:87)(cid:72)(cid:79)(cid:92)(cid:3)(cid:26)(cid:19)(cid:8)(cid:3)(cid:86)(cid:68)(cid:79)(cid:68)(cid:85)(cid:92)(cid:3)(cid:85)(cid:72)(cid:83)(cid:79)(cid:68)(cid:70)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:88)(cid:83)(cid:3)(cid:87)(cid:82)(cid:3)(cid:7)(cid:21)(cid:24)(cid:15)(cid:19)(cid:19)(cid:19)(cid:3)(cid:83)(cid:72)(cid:85)(cid:3)
(cid:80)(cid:82)(cid:81)(cid:87)(cid:75)(cid:17)(cid:3)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:71)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:47)(cid:82)(cid:81)(cid:74)(cid:16)(cid:55)(cid:72)(cid:85)(cid:80)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:39)(cid:76)(cid:86)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:79)(cid:76)(cid:72)(cid:88)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:47)(cid:82)(cid:81)(cid:74)(cid:16)
(cid:55)(cid:72)(cid:85)(cid:80)(cid:3)(cid:39)(cid:76)(cid:86)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:3)(cid:68)(cid:73)(cid:73)(cid:82)(cid:85)(cid:71)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:17)

Executive Life Insurance Plan(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:83)(cid:68)(cid:92)(cid:15)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:182)(cid:86)(cid:3)(cid:69)(cid:72)(cid:75)(cid:68)(cid:79)(cid:73)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:72)(cid:80)(cid:76)(cid:88)(cid:80)(cid:86)(cid:3)(cid:68)(cid:86)(cid:86)(cid:82)(cid:70)(cid:76)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)
(cid:80)(cid:68)(cid:76)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:3)(cid:79)(cid:76)(cid:73)(cid:72)(cid:3)(cid:76)(cid:81)(cid:86)(cid:88)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:83)(cid:82)(cid:79)(cid:76)(cid:70)(cid:92)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:74)(cid:72)(cid:3)(cid:72)(cid:84)(cid:88)(cid:68)(cid:79)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:85)(cid:72)(cid:72)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:86)(cid:3)(cid:70)(cid:88)(cid:85)(cid:85)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:3)(cid:86)(cid:68)(cid:79)(cid:68)(cid:85)(cid:92)(cid:17)

Accidental Death & Dismemberment & Travel Accident Plan.(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:83)(cid:68)(cid:92)(cid:15)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:182)(cid:86)(cid:3)(cid:69)(cid:72)(cid:75)(cid:68)(cid:79)(cid:73)(cid:15)(cid:3)
(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:72)(cid:80)(cid:76)(cid:88)(cid:80)(cid:86)(cid:3)(cid:68)(cid:86)(cid:86)(cid:82)(cid:70)(cid:76)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:80)(cid:68)(cid:76)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:3)(cid:68)(cid:70)(cid:70)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:68)(cid:79)(cid:3)(cid:71)(cid:72)(cid:68)(cid:87)(cid:75)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:71)(cid:76)(cid:86)(cid:80)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:83)(cid:82)(cid:79)(cid:76)(cid:70)(cid:92)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:74)(cid:72)(cid:3)(cid:72)(cid:84)(cid:88)(cid:68)(cid:79)(cid:3)
(cid:87)(cid:82)(cid:3)(cid:73)(cid:82)(cid:88)(cid:85)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:86)(cid:3)(cid:70)(cid:88)(cid:85)(cid:85)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:3)(cid:86)(cid:68)(cid:79)(cid:68)(cid:85)(cid:92)(cid:17)

Income Tax Preparation and Advice Program.(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:85)(cid:72)(cid:76)(cid:80)(cid:69)(cid:88)(cid:85)(cid:86)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:82)(cid:88)(cid:87)(cid:16)(cid:82)(cid:73)(cid:16)
(cid:83)(cid:82)(cid:70)(cid:78)(cid:72)(cid:87)(cid:3)(cid:73)(cid:72)(cid:72)(cid:86)(cid:3)(cid:72)(cid:91)(cid:83)(cid:72)(cid:81)(cid:71)(cid:72)(cid:71)(cid:15)(cid:3)(cid:88)(cid:83)(cid:3)(cid:87)(cid:82)(cid:3)(cid:7)(cid:21)(cid:15)(cid:19)(cid:19)(cid:19)(cid:3)(cid:11)(cid:25)(cid:15)(cid:19)(cid:19)(cid:19)(cid:3)(cid:40)(cid:88)(cid:85)(cid:82)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:48)(cid:85)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112)(cid:12)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:68)(cid:91)(cid:3)(cid:83)(cid:85)(cid:72)(cid:83)(cid:68)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:85)(cid:3)(cid:68)(cid:71)(cid:89)(cid:76)(cid:70)(cid:72)(cid:17)

Change in Control Agreements.(cid:3)(cid:36)(cid:79)(cid:79)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:182)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:3)(cid:71)(cid:82)(cid:88)(cid:69)(cid:79)(cid:72)(cid:3)(cid:87)(cid:85)(cid:76)(cid:74)(cid:74)(cid:72)(cid:85)(cid:3)
(cid:80)(cid:72)(cid:70)(cid:75)(cid:68)(cid:81)(cid:76)(cid:86)(cid:80)(cid:86)(cid:17)(cid:3)(cid:3)(cid:51)(cid:88)(cid:85)(cid:86)(cid:88)(cid:68)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:87)(cid:72)(cid:85)(cid:80)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:72)(cid:81)(cid:87)(cid:76)(cid:87)(cid:79)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:82)(cid:79)(cid:79)(cid:82)(cid:90)(cid:76)(cid:81)(cid:74)(cid:3)
(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:89)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:11)(cid:68)(cid:86)(cid:3)(cid:71)(cid:72)(cid:73)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:12)(cid:29)(cid:3)(cid:11)(cid:68)(cid:12)(cid:3)(cid:76)(cid:80)(cid:80)(cid:72)(cid:71)(cid:76)(cid:68)(cid:87)(cid:72)(cid:3)(cid:89)(cid:72)(cid:86)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:16)
(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:90)(cid:68)(cid:85)(cid:71)(cid:86)(cid:3)(cid:74)(cid:85)(cid:68)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:21)(cid:19)(cid:20)(cid:19)(cid:3)(cid:40)(cid:84)(cid:88)(cid:76)(cid:87)(cid:92)(cid:3)(cid:36)(cid:90)(cid:68)(cid:85)(cid:71)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:21)(cid:19)(cid:19)(cid:19)(cid:3)(cid:40)(cid:84)(cid:88)(cid:76)(cid:87)(cid:92)(cid:3)(cid:36)(cid:90)(cid:68)(cid:85)(cid:71)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:20)(cid:28)(cid:28)(cid:20)(cid:3)(cid:53)(cid:72)(cid:86)(cid:87)(cid:85)(cid:76)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)
(cid:54)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:30)(cid:3)(cid:11)(cid:69)(cid:12)(cid:3)(cid:76)(cid:80)(cid:80)(cid:72)(cid:71)(cid:76)(cid:68)(cid:87)(cid:72)(cid:3)(cid:89)(cid:72)(cid:86)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:83)(cid:68)(cid:92)(cid:82)(cid:88)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:71)(cid:72)(cid:73)(cid:72)(cid:85)(cid:85)(cid:72)(cid:71)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:68)(cid:70)(cid:70)(cid:85)(cid:88)(cid:76)(cid:81)(cid:74)(cid:3)(cid:83)(cid:88)(cid:85)(cid:86)(cid:88)(cid:68)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:49)(cid:82)(cid:81)(cid:84)(cid:88)(cid:68)(cid:79)(cid:76)(cid:73)(cid:76)(cid:72)(cid:71)(cid:3)(cid:46)(cid:72)(cid:92)(cid:3)(cid:40)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:3)(cid:39)(cid:72)(cid:73)(cid:72)(cid:85)(cid:85)(cid:72)(cid:71)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:51)(cid:79)(cid:68)(cid:81)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:11)(cid:70)(cid:12)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:87)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:182)(cid:86)(cid:3)
(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:82)(cid:83)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:85)(cid:76)(cid:74)(cid:75)(cid:87)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:76)(cid:80)(cid:83)(cid:72)(cid:71)(cid:72)(cid:71)(cid:3)(cid:82)(cid:85)(cid:3)(cid:68)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:11)(cid:76)(cid:17)(cid:72)(cid:17)(cid:15)(cid:3)(cid:81)(cid:82)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:85)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)
(cid:70)(cid:82)(cid:81)(cid:89)(cid:72)(cid:85)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:83)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:82)(cid:73)(cid:73)(cid:72)(cid:85)(cid:72)(cid:71)(cid:12)(cid:15)(cid:3)(cid:68)(cid:81)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:76)(cid:86)(cid:3)(cid:72)(cid:81)(cid:87)(cid:76)(cid:87)(cid:79)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:81)(cid:3)(cid:76)(cid:80)(cid:80)(cid:72)(cid:71)(cid:76)(cid:68)(cid:87)(cid:72)(cid:3)(cid:79)(cid:88)(cid:80)(cid:83)(cid:3)(cid:86)(cid:88)(cid:80)(cid:3)(cid:83)(cid:68)(cid:92)(cid:82)(cid:88)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:88)(cid:76)(cid:79)(cid:87)(cid:16)(cid:76)(cid:81)(cid:3)(cid:74)(cid:68)(cid:76)(cid:81)(cid:3)(cid:82)(cid:81)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)
(cid:88)(cid:81)(cid:72)(cid:91)(cid:72)(cid:85)(cid:70)(cid:76)(cid:86)(cid:72)(cid:71)(cid:3)(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:82)(cid:83)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:70)(cid:68)(cid:79)(cid:70)(cid:88)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:17)(cid:3)(cid:3)(cid:41)(cid:88)(cid:85)(cid:87)(cid:75)(cid:72)(cid:85)(cid:15)(cid:3)(cid:68)(cid:71)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:86)(cid:72)(cid:89)(cid:72)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)
(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:3)(cid:68)(cid:83)(cid:83)(cid:79)(cid:92)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:89)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:182)(cid:86)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:76)(cid:86)(cid:3)(cid:87)(cid:72)(cid:85)(cid:80)(cid:76)(cid:81)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:42)(cid:82)(cid:82)(cid:71)(cid:3)(cid:53)(cid:72)(cid:68)(cid:86)(cid:82)(cid:81)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:85)(cid:3)
(cid:90)(cid:76)(cid:87)(cid:75)(cid:82)(cid:88)(cid:87)(cid:3)(cid:38)(cid:68)(cid:88)(cid:86)(cid:72)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:76)(cid:81)(cid:3)(cid:86)(cid:76)(cid:91)(cid:3)(cid:11)(cid:25)(cid:12)(cid:3)(cid:80)(cid:82)(cid:81)(cid:87)(cid:75)(cid:86)(cid:3)(cid:69)(cid:72)(cid:73)(cid:82)(cid:85)(cid:72)(cid:3)(cid:82)(cid:85)(cid:3)(cid:87)(cid:90)(cid:72)(cid:81)(cid:87)(cid:92)(cid:16)(cid:73)(cid:82)(cid:88)(cid:85)(cid:3)(cid:11)(cid:21)(cid:23)(cid:12)(cid:3)(cid:80)(cid:82)(cid:81)(cid:87)(cid:75)(cid:86)(cid:3)(cid:68)(cid:73)(cid:87)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)
(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:68)(cid:71)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:86)(cid:72)(cid:89)(cid:72)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:69)(cid:72)(cid:81)(cid:72)(cid:73)(cid:76)(cid:87)(cid:86)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:29)(cid:3)(cid:68)(cid:3)(cid:79)(cid:88)(cid:80)(cid:83)(cid:3)(cid:86)(cid:88)(cid:80)(cid:3)(cid:83)(cid:68)(cid:92)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:90)(cid:82)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:182)(cid:86)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)
(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:86)(cid:68)(cid:79)(cid:68)(cid:85)(cid:92)(cid:15)(cid:3)(cid:68)(cid:3)(cid:79)(cid:88)(cid:80)(cid:83)(cid:3)(cid:86)(cid:88)(cid:80)(cid:3)(cid:83)(cid:68)(cid:92)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:90)(cid:82)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:182)(cid:86)(cid:3)(cid:68)(cid:89)(cid:72)(cid:85)(cid:68)(cid:74)(cid:72)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:11)(cid:70)(cid:68)(cid:79)(cid:70)(cid:88)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:83)(cid:85)(cid:72)(cid:70)(cid:72)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:85)(cid:72)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:86)(cid:12)(cid:15)(cid:3)(cid:68)(cid:3)(cid:79)(cid:88)(cid:80)(cid:83)(cid:3)(cid:86)(cid:88)(cid:80)(cid:3)(cid:83)(cid:68)(cid:92)(cid:82)(cid:88)(cid:87)(cid:3)(cid:11)(cid:76)(cid:81)(cid:3)(cid:79)(cid:76)(cid:72)(cid:88)(cid:3)(cid:82)(cid:73)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:76)(cid:81)(cid:88)(cid:72)(cid:71)(cid:3)(cid:75)(cid:72)(cid:68)(cid:79)(cid:87)(cid:75)(cid:70)(cid:68)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:74)(cid:72)(cid:12)(cid:3)(cid:72)(cid:84)(cid:88)(cid:68)(cid:79)(cid:3)(cid:87)(cid:82)(cid:3)(cid:21)(cid:24)(cid:8)(cid:3)(cid:82)(cid:73)(cid:3)(cid:70)(cid:88)(cid:85)(cid:85)(cid:72)(cid:81)(cid:87)(cid:3)
(cid:86)(cid:68)(cid:79)(cid:68)(cid:85)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:75)(cid:76)(cid:74)(cid:75)(cid:72)(cid:86)(cid:87)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:11)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:72)(cid:70)(cid:72)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:85)(cid:72)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:86)(cid:12)(cid:15)(cid:3)(cid:76)(cid:81)(cid:71)(cid:72)(cid:80)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:74)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:68)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:86)(cid:76)(cid:91)(cid:87)(cid:92)(cid:3)(cid:11)(cid:25)(cid:19)(cid:12)(cid:3)(cid:80)(cid:82)(cid:81)(cid:87)(cid:75)(cid:86)(cid:15)(cid:3)(cid:68)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:16)(cid:82)(cid:88)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:72)(cid:84)(cid:88)(cid:76)(cid:87)(cid:92)(cid:16)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:68)(cid:92)(cid:82)(cid:88)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:71)(cid:72)(cid:73)(cid:72)(cid:85)(cid:85)(cid:72)(cid:71)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)
(cid:68)(cid:70)(cid:70)(cid:85)(cid:88)(cid:76)(cid:81)(cid:74)(cid:3)(cid:88)(cid:83)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:72)(cid:85)(cid:80)(cid:76)(cid:81)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:17)(cid:3)(cid:41)(cid:82)(cid:85)(cid:3)(cid:80)(cid:82)(cid:85)(cid:72)(cid:3)(cid:76)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:81)(cid:3)(cid:51)(cid:82)(cid:87)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:79)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:83)(cid:68)(cid:92)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)
(cid:86)(cid:72)(cid:72)(cid:3)(cid:179)(cid:51)(cid:82)(cid:87)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:79)(cid:3)(cid:51)(cid:68)(cid:92)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:88)(cid:83)(cid:82)(cid:81)(cid:3)(cid:55)(cid:72)(cid:85)(cid:80)(cid:76)(cid:81)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:85)(cid:3)(cid:38)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:38)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:17)(cid:180)(cid:3)(cid:3)

(cid:3)

(cid:51)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:16)(cid:37)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)

(cid:51)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:16)(cid:37)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:3)(cid:68)(cid:81)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:76)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:11)(cid:179)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:180)(cid:12)(cid:17)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:83)(cid:68)(cid:92)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:71)(cid:3)

(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:74)(cid:85)(cid:68)(cid:80)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:88)(cid:83)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:70)(cid:70)(cid:82)(cid:80)(cid:83)(cid:79)(cid:76)(cid:86)(cid:75)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:76)(cid:70)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:16)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:74)(cid:82)(cid:68)(cid:79)(cid:86)(cid:17)(cid:3)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)
(cid:70)(cid:75)(cid:82)(cid:82)(cid:86)(cid:72)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:68)(cid:92)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:82)(cid:81)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:69)(cid:72)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:3)(cid:76)(cid:87)(cid:3)(cid:69)(cid:72)(cid:79)(cid:76)(cid:72)(cid:89)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:83)(cid:85)(cid:82)(cid:74)(cid:85)(cid:68)(cid:80)(cid:3)(cid:76)(cid:86)(cid:3)(cid:70)(cid:85)(cid:76)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:82)(cid:87)(cid:76)(cid:89)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)
(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:3)(cid:80)(cid:68)(cid:81)(cid:81)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:71)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:86)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:89)(cid:68)(cid:79)(cid:88)(cid:72)(cid:17)

Annual Cash Incentive Compensation(cid:3)(cid:178)(cid:40)(cid:68)(cid:70)(cid:75)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:182)(cid:86)(cid:3)(cid:87)(cid:82)(cid:87)(cid:68)(cid:79)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:86)(cid:3)(cid:68)(cid:3)(cid:83)(cid:82)(cid:87)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:79)(cid:3)

(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:68)(cid:90)(cid:68)(cid:85)(cid:71)(cid:17)(cid:3)(cid:3)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:83)(cid:68)(cid:92)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:76)(cid:81)(cid:74)(cid:72)(cid:81)(cid:87)(cid:3)(cid:88)(cid:83)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:70)(cid:70)(cid:82)(cid:80)(cid:83)(cid:79)(cid:76)(cid:86)(cid:75)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:68)(cid:76)(cid:81)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:16)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)
(cid:86)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:79)(cid:92)(cid:17)(cid:3)(cid:3)(cid:44)(cid:81)(cid:3)(cid:86)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:86)(cid:72)(cid:72)(cid:78)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)
(cid:76)(cid:81)(cid:71)(cid:76)(cid:89)(cid:76)(cid:71)(cid:88)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:87)(cid:68)(cid:76)(cid:79)(cid:82)(cid:85)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:70)(cid:85)(cid:76)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:68)(cid:80)(cid:82)(cid:88)(cid:81)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:80)(cid:88)(cid:79)(cid:68)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)
(cid:70)(cid:68)(cid:79)(cid:70)(cid:88)(cid:79)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:70)(cid:87)(cid:88)(cid:68)(cid:79)(cid:3)(cid:83)(cid:68)(cid:92)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:88)(cid:79)(cid:68)(cid:85)(cid:79)(cid:92)(cid:3)(cid:85)(cid:72)(cid:89)(cid:76)(cid:72)(cid:90)(cid:72)(cid:71)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:86)(cid:88)(cid:85)(cid:89)(cid:72)(cid:92)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:77)(cid:88)(cid:81)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:51)(cid:68)(cid:92)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:86)(cid:87)(cid:88)(cid:71)(cid:92)(cid:3)
(cid:71)(cid:76)(cid:86)(cid:70)(cid:88)(cid:86)(cid:86)(cid:72)(cid:71)(cid:3)(cid:72)(cid:68)(cid:85)(cid:79)(cid:76)(cid:72)(cid:85)(cid:17)(cid:3)(cid:3)(cid:44)(cid:81)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:72)(cid:81)(cid:86)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:72)(cid:86)(cid:87)(cid:68)(cid:69)(cid:79)(cid:76)(cid:86)(cid:75)(cid:72)(cid:71)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)
(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:68)(cid:85)(cid:74)(cid:72)(cid:87)(cid:72)(cid:71)(cid:3)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:81)(cid:82)(cid:81)(cid:16)(cid:42)(cid:36)(cid:36)(cid:51)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)(cid:70)(cid:82)(cid:80)(cid:72)(cid:17)(cid:3)(cid:55)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:87)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:73)(cid:76)(cid:70)(cid:3)
(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:86)(cid:76)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:90)(cid:72)(cid:85)(cid:72)(cid:3)(cid:86)(cid:83)(cid:79)(cid:76)(cid:87)(cid:3)(cid:69)(cid:72)(cid:87)(cid:90)(cid:72)(cid:72)(cid:81)(cid:29)(cid:3)(cid:11)(cid:76)(cid:12)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:81)(cid:82)(cid:81)(cid:16)(cid:42)(cid:36)(cid:36)(cid:51)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)
(cid:76)(cid:81)(cid:70)(cid:82)(cid:80)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:81)(cid:87)(cid:76)(cid:85)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:11)(cid:76)(cid:76)(cid:12)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:88)(cid:81)(cid:76)(cid:87)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:74)(cid:85)(cid:82)(cid:86)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:73)(cid:76)(cid:87)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:182)(cid:86)(cid:3)(cid:73)(cid:82)(cid:70)(cid:88)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:17)(cid:3)(cid:3)(cid:55)(cid:68)(cid:85)(cid:74)(cid:72)(cid:87)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:81)(cid:82)(cid:81)(cid:16)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:40)(cid:50)(cid:15)(cid:3)(cid:90)(cid:72)(cid:85)(cid:72)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:86)(cid:82)(cid:79)(cid:72)(cid:79)(cid:92)(cid:3)(cid:82)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:81)(cid:82)(cid:81)(cid:16)(cid:42)(cid:36)(cid:36)(cid:51)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)(cid:70)(cid:82)(cid:80)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:81)(cid:87)(cid:76)(cid:85)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:17)(cid:3)(cid:3)(cid:44)(cid:81)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:81)(cid:72)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)
(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)(cid:70)(cid:82)(cid:80)(cid:72)(cid:3)(cid:87)(cid:68)(cid:85)(cid:74)(cid:72)(cid:87)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:3)(cid:76)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:86)(cid:3)(cid:90)(cid:72)(cid:85)(cid:72)(cid:3)(cid:7)(cid:23)(cid:19)(cid:25)(cid:15)(cid:22)(cid:20)(cid:25)(cid:15)(cid:19)(cid:19)(cid:19)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:7)(cid:20)(cid:19)(cid:15)(cid:26)(cid:20)(cid:21)(cid:15)(cid:19)(cid:19)(cid:19)(cid:15)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:79)(cid:92)(cid:17)

(cid:55)(cid:75)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:80)(cid:88)(cid:79)(cid:68)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:70)(cid:68)(cid:79)(cid:70)(cid:88)(cid:79)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:182)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:72)(cid:81)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:68)(cid:87)(cid:3)(cid:79)(cid:72)(cid:68)(cid:86)(cid:87)(cid:3)(cid:27)(cid:19)(cid:8)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:87)(cid:76)(cid:83)(cid:88)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:3)(cid:87)(cid:68)(cid:85)(cid:74)(cid:72)(cid:87)(cid:3)

(cid:11)(cid:179)(cid:55)(cid:75)(cid:85)(cid:72)(cid:86)(cid:75)(cid:82)(cid:79)(cid:71)(cid:180)(cid:12)(cid:3)(cid:80)(cid:88)(cid:86)(cid:87)(cid:3)(cid:69)(cid:72)(cid:3)(cid:68)(cid:70)(cid:75)(cid:76)(cid:72)(cid:89)(cid:72)(cid:71)(cid:3)(cid:69)(cid:72)(cid:73)(cid:82)(cid:85)(cid:72)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:85)(cid:72)(cid:80)(cid:88)(cid:81)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:86)(cid:3)(cid:68)(cid:90)(cid:68)(cid:85)(cid:71)(cid:72)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:17)(cid:3)(cid:3)(cid:44)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:55)(cid:75)(cid:85)(cid:72)(cid:86)(cid:75)(cid:82)(cid:79)(cid:71)(cid:3)(cid:76)(cid:86)(cid:3)(cid:68)(cid:70)(cid:75)(cid:76)(cid:72)(cid:89)(cid:72)(cid:71)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:3)(cid:85)(cid:72)(cid:70)(cid:72)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:24)(cid:19)(cid:8)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:3)(cid:68)(cid:90)(cid:68)(cid:85)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:81)(cid:15)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:68)(cid:71)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:20)(cid:8)(cid:3)(cid:68)(cid:70)(cid:75)(cid:76)(cid:72)(cid:89)(cid:72)(cid:71)(cid:3)
(cid:68)(cid:69)(cid:82)(cid:89)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:55)(cid:75)(cid:85)(cid:72)(cid:86)(cid:75)(cid:82)(cid:79)(cid:71)(cid:15)(cid:3)(cid:88)(cid:83)(cid:3)(cid:87)(cid:82)(cid:3)(cid:20)(cid:19)(cid:19)(cid:8)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:3)(cid:87)(cid:68)(cid:85)(cid:74)(cid:72)(cid:87)(cid:3)(cid:11)(cid:179)(cid:50)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:42)(cid:82)(cid:68)(cid:79)(cid:180)(cid:12)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:3)(cid:85)(cid:72)(cid:70)(cid:72)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:21)(cid:17)(cid:24)(cid:8)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:3)(cid:68)(cid:90)(cid:68)(cid:85)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:17)(cid:3)(cid:41)(cid:82)(cid:85)(cid:3)(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:68)(cid:71)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:20)(cid:8)(cid:3)(cid:68)(cid:70)(cid:75)(cid:76)(cid:72)(cid:89)(cid:72)(cid:71)(cid:3)(cid:68)(cid:69)(cid:82)(cid:89)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:50)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:42)(cid:82)(cid:68)(cid:79)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:3)
(cid:85)(cid:72)(cid:70)(cid:72)(cid:76)(cid:89)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:24)(cid:8)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:3)(cid:68)(cid:90)(cid:68)(cid:85)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:17)(cid:3)(cid:3)(cid:40)(cid:68)(cid:70)(cid:75)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:3)(cid:83)(cid:85)(cid:82)(cid:75)(cid:76)(cid:69)(cid:76)(cid:87)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:70)(cid:72)(cid:76)(cid:83)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:80)(cid:82)(cid:88)(cid:81)(cid:87)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:72)(cid:91)(cid:70)(cid:72)(cid:86)(cid:86)(cid:3)
(cid:82)(cid:73)(cid:3)(cid:87)(cid:90)(cid:82)(cid:3)(cid:75)(cid:88)(cid:81)(cid:71)(cid:85)(cid:72)(cid:71)(cid:3)(cid:83)(cid:72)(cid:85)(cid:70)(cid:72)(cid:81)(cid:87)(cid:3)(cid:21)(cid:19)(cid:19)(cid:8)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:3)(cid:68)(cid:90)(cid:68)(cid:85)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:82)(cid:69)(cid:77)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:17)(cid:3)(cid:3)

(cid:27)(cid:20)

The plan award is generally calculated as a percentage of annual base salary.  In 2020, the plan awards were: 

(i)
(ii)
(iii)
(iv)
(v)

For Mr. Gydé, 100% of base salary actually paid.
For Mr. Laubacker, CFO, approximately 58% of base salary actually paid, 
For Mr. Niehaus, EVP, approximately 65% of base salary actually paid,
For Mr. Radetich, SVP, approximately 69% of base salary actually paid, and
For Mr. Wauthier, SVP, approximately 48% of base salary actually paid (pro-rated for his appointment to 
SVP on April 1, 2020).

The Compensation Committee believes that each executive officer’s Incentive plan targets for 2020 involved a 
reasonably challenging degree of difficulty that considers current economic challenges and reflects the Board’s desire to 
maintain flexibility in enhancing the executive officer’s focus, motivation and enthusiasm.  In exceptional circumstances, 
the Compensation Committee exercises discretion to award Incentive compensation absent achievement of the specified 
thresholds or to reduce or increase the size of any award or payout.  In this manner, the Compensation Committee 
believes that each executive officer’s Incentive plan targets are reasonably tailored to promote the Company’s overall 
annual and long-term financial goals.

Equity-Based Incentives

This component of executive compensation consists of grants of restricted stock and stock options under the 
Company’s 2010 Equity Award Plan.  In making such grants, the Compensation Committee considers an executive’s past 
contributions and expected future contributions towards Company performance.  Grants are made to key employees of 
the Company who, in the opinion of the Compensation Committee, have had and are expected to continue to have a 
significant impact on the long-term performance of the Company.  The awards are designed to reward individuals who 
remain with the Company and to further align employee interests with those of the Company’s shareholders.  The 
Company chooses to pay this component of compensation because it believes that stock ownership by management is 
beneficial in aligning management’s activities and decisions with shareholders’ interests of maximizing share value.

Except in circumstances of new or recently promoted executive officers, the Compensation Committee generally 
grants equity compensation on a set date each year.  The Company does not time or plan the release of material non-
public information for the purpose of affecting the value of compensation.  Equity awards may also be granted at other 
meetings of the Compensation Committee to individuals who become executive officers, are given increased 
responsibilities during the year or in recognition of special accomplishments.  The Company has adopted stock ownership 
guidelines for senior executive officers requiring: (i) the CEO to own Company shares valued at five (5) times his or her 
own base salary, and (ii) the CFO, Executive Vice Presidents, and Senior Vice Presidents with oversight of operating 
segments, to own Company shares valued at three (3) times his or her own base salary. 

Restricted Stock Grants During 2020 —The Compensation Committee granted restricted stock awards under the 

2010 Equity Award Plan to various executive officers as identified in the tables below.  In general, recipients of restricted 
stock awards receive a specified number of non-transferable restricted shares to be held by the Company, in the name of 
the grantee, until satisfaction of stipulated vesting requirements.  Upon satisfaction of such vesting requirements, 
restrictions prohibiting transferability will be removed from the vested shares.  In determining whether to grant an 
individual restricted stock, the Compensation Committee considers an executive’s contribution toward Company 
performance, expected future contribution and the number of options and shares of common stock presently held by the 
executive.  For awards of restricted stock granted in 2020 to the executive officers, the shares vest at the end of a three-
year period. If the Company’s cumulative three-year non-GAAP earnings per share for the years 2020, 2021, and 2022 
equals or exceeds $1.77, then 100% of the grants will vest. If the combined cumulative three-year non-GAAP earnings 
per share is 80% or more, but less than 100% of the earnings per share target, a pro-rata portion of the grants shall vest. 
If at least 80% of the three-year non-GAAP earnings per share target is not met, the grants will expire.

Compensation Committee Report

The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis required by 

Item 402(b) of Regulation S-K with management and, based on such review and discussions, the Compensation 
Committee recommended to the Board that the Compensation Discussion and Analysis be included in this annual report 
on Form 10-K for the year ended December 31, 2020.

82

Submitted by the Compensation Committee

Valerie Rahmani, Chair
James R. Helvey III
David H. Klein
Raj Rajgopal
Daniel J. Sullivan
Owen J. Sullivan

Compensation Committee Interlocks and Insider Participation

During the last completed fiscal year, the Compensation Committee was comprised entirely of independent 
directors.  The Compensation Committee of the Board of Directors is composed of Valerie Rahmani, Chair, James R. 
Helvey III, David H. Klein, Raj Rajgopal, Daniel J. Sullivan, and Owen J. Sullivan. 

Name and
Principal Position
(a)

  Year
(b)

2020 SUMMARY COMPENSATION TABLE

    Non-Equity    
    Option     Incentive Plan  
    Awards     Awards     Compensation 

Stock

Salary

  (c)  ($) (10)     (e)  ($)  (1)     (f)  ($)  (2)    

(g)  ($)

All Other
  Compensation 
(i)  ($)  (4)

Total
(j)  ($)

Filip J.L. Gydé

President and CEO (March 2019 to 
present)

2020

  $

465,481     $

386,198    $

128,743     $

758,850   (3) $

65,742   (5) $ 1,805,014  

EVP, President and GM, CTG Europe

2018

  $

356,971     $

45,000    $

2019

  $

395,508     $

449,995    $

—     $

—     $

497,303   (3) $

70,945   (5) $ 1,413,751  

229,406   (3) $

113,268   (5) $ 744,645  

John M. Laubacker

EVP, CFO and Treasurer

2020

  $

343,462     $

187,396    $

62,498     $

324,169   (3) $

41,902   (6) $ 959,427  

2019

  $

355,000     $

209,998    $

2018

  $

320,000     $

71,640    $

—     $

—     $

302,333   (3) $

34,578   (6) $ 901,909  

106,152   (3) $

30,323   (6) $ 528,115  

Thomas J. Niehaus

EVP and GM, CTG North America

2020

  $

298,269     $

201,155    $

33,740     $

224,856   (3) $

70,033   (7) $ 828,053  

(from May 5, 2019 to present)

Peter P. Radetich

2019

  $

215,000     $

101,097    $

33,518     $

145,193   (3) $

47,681   (7) $ 542,489  

SVP and General Counsel

2020

  $

266,635     $

108,662    $

36,232     $

299,339   (3) $

22,073   (8) $ 732,941  

2019

  $

283,000     $

144,996    $

2018

  $

283,000     $

50,400    $

—     $

—     $

285,669   (3) $

19,964   (8) $ 733,629  

102,689   (3) $

20,018   (8) $ 456,107  

Rénald Wauthier

SVP

2020

  $

289,389     $

197,333    $

28,189     $

200,415   (3) $

28,048   (9) $ 743,374  

(1)

(2)

(3)

(4)

The amounts in column (e) reflect the aggregate grant date fair value for the awards granted in the fiscal years ended December 31, 2020, 2019, and 2018 as 
applicable, as computed in accordance with FASB ASC Topic 718.  The assumptions used in the calculation of these amounts are included in footnote 10 to the 
Company’s audited financial statements for the fiscal year ended December 31, 2020 included in Item 8, “Financial Statements and Supplementary Data.”

The amounts in column (f) reflect the aggregate grant date fair value for the options granted in the fiscal years ended December 31, 2020, 2019, and 2018 as 
applicable, as computed in accordance with FASB ASC Topic 718. The assumptions used in the calculation of these amounts are included in footnote 10 to the 
Company’s audited financial statements for the fiscal year ended December 31, 2020 included in Item 8, “Financial Statements and Supplementary Data.”

Represents cash payments earned under the respective executive’s annual cash incentive plan.

Life Insurance.  During 2020, 2019, and 2018, the Company provided life insurance benefits for Messrs. Gydé, Laubacker, Niehaus and Radetich. The premiums 
paid by the Company in 2020 for this benefit totaled $45,169, $19,579, $47,575 and $0, respectively. The premiums paid by the Company for this benefit in 2019 for 
Messrs. Gydé, Laubacker, Niehaus and Radetich totaled $38,151, $15,969, $32,452, and $0, respectively.  The premiums paid by the Company for this benefit in 
2018 for Messrs. Gydé, Laubacker and Radetich totaled $30,773, $13,268, and $0, respectively.

401(k) Contributions.  The Company may match up to 3% of the contributions made by Messrs. Laubacker, Niehaus, and Radetich to the Computer Task Group, 
Incorporated 401(k) Retirement Plan.  Contributions made by the Company to Messrs. Laubacker, Niehaus and Radetich in 2020 totaled $2,495, $207, and $1,054, 
respectively.  No contributions were made in 2019. In 2018, the Company contributed $375 to Mr. Laubacker’s account. 

83

 
   
   
 
       
      
 
 
   
   
 
 
 
   
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
       
      
     
 
   
 
 
   
   
 
 
 
   
 
 
 
       
      
     
 
   
 
 
   
   
 
 
 
 
   
 
 
 
       
      
     
 
 
 
 
 
   
   
 
 
 
   
 
 
 
       
      
     
 
 
 
 
 
   
   
 
   
 
 
 
       
      
     
 
   
 
 
   
   
 
 
 
   
 
 
 
       
      
     
 
   
 
 
   
   
 
 
 
 
 
 
 
 
 
       
      
     
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
       
      
     
 
 
 
 
 
 
 
   
 
   
 
 
 
       
      
     
 
   
 
 
   
   
 
 
   
 
 
 
       
      
     
 
   
 
 
   
   
 
 
 
 
   
 
 
 
       
      
     
 
 
 
 
 
   
   
 
   
 
 
 
       
      
     
 
   
 
 
   
   
 
 
 
   
 
 
 
       
      
     
 
   
 
 
   
   
 
 
 
 
 
 
 
 
 
       
      
     
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
       
      
     
 
 
 
 
 
 
 
   
 
   
 
 
 
       
      
     
 
   
 
 
   
   
 
 
 
   
 
 
 
       
      
     
 
 
 
 
 
   
   
 
(5)

 (6)

(7)

(8)

(9)

Previously, the Company paid Mr. Gydé: (i) 92% of one month’s pay as vacation pay and (ii) a year-end premium equal to one month’s base salary. Together, these 
legal obligations totaled $14,321 in 2019, and $63,005 in 2018.  The Company also contributes towards Mr. Gydé’s cafeteria plan account, which is a plan generally 
available to all Belgium employees. Contributions to Mr. Gydé’s cafeteria plan totaled $45,169 in 2020, $38,151 in 2019, and $30,773 in 2018. The Company also 
leases an automobile for Mr. Gydé’s use, which is an option provided to all Belgium employees with a likelihood of traveling.  The cost to the Company for leasing Mr. 
Gydé’s automobile was $15,904 in 2020, $16,234 in 2019, and $17,128 in 2018. Mr. Gydé also received $4,669, $2,239 and $2,362 for the Income Tax Preparation 
and Financial Advice Program in 2020, 2019, and 2018, respectively. For the amounts paid to Mr. Gydé in Euros, the amounts were converted to United States 
Dollars based on the average foreign currency exchange rates for 2020, 2019, and 2018.

In addition to life insurance premiums (as further disclosed in footnote 4), during 2020, 2019, and 2018, Mr. Laubacker received a total value of $19,828, $18,609, and 
$17,055, respectively, in Other Compensation for the following Benefits (which are further described in this Item 11, Executive Compensation):  Long-Term Executive 
Disability Plan, Accidental Death & Dismemberment & Travel Accident Plan, 401(k) match, and the Company’s Medical and Dental Plan.

In addition to life insurance premiums (as further disclosed in footnote 4), during 2020 and 2019 Mr. Niehaus received a total value of $20,251 and $15,229 for the 
following Benefits (which are further described in this Item 11, Executive Compensation): Long-Term Executive Disability Plan, Accidental Death & Dismemberment & 
Travel Accident Plan, 401(k) match, the Company’s Medical and Dental Plan, and the Income Tax Preparation and Advice Program.

In addition to life insurance premiums (as further disclosed in footnote 4), during 2020, 2019, and 2018, Mr. Radetich received a total value of $20,910, $19,964, and 
$20,817 for the following Benefits (which are further described in this Item 11, Executive Compensation): Long-Term Executive Disability Plan, Accidental Death & 
Dismemberment & Travel Accident Plan, 401(k) match, the Company’s Medical and Dental Plan, and the Income Tax Preparation and Advice Program. 

Mr. Wauthier, who was promoted to SVP on April 1, 2020, received $21,233 in 2020 for the Company leasing an automobile for the benefit of Mr. Wauthier, which is 
an option provided to all Luxembourg employees with a likelihood of traveling.  Mr. Wauthier also received a total of $6,815 in 2020 for other statutory benefits.

(10)

During 2020, all of the names executive officers took a reduction in pay equaling 20% of their base compensation for 25 weeks during the year. Mr. Wauthier was 
reimbursed for his reduction in pay under a program administered by the Luxembourg government. 

Specific Executive Officer Compensation Plans and Employment Agreements

Filip J.L. Gydé, CEO.   In 2020, Mr. Gydé’s total compensation included annual base salary payments of $465,481, 
an Incentive of $758,850, grants of 65,680 restricted shares with a value of $386,198 (of which approximately 67% of the 
grants have a performance condition), and a grant of 65,630 stock options with a value of $128,743.  In setting baseline 
compensation and the performance standards for Mr. Gydé, the Compensation Committee considered the Pay 
Governance report.  The total amount of compensation that Mr. Gydé received was based on a combination of his 
baseline compensation, and the extent to which the thresholds for compensation were achieved under his performance 
based incentives.  Pursuant to Belgian law, the Company is required to pay Mr. Gydé certain additional benefits that are 
generally afforded to all Belgian employees.  These benefits totaled $65,742 (see the “2020 Summary Compensation 
Table”).

John M. Laubacker, CFO.  In 2020, Mr. Laubacker’s total compensation included annual salary payments of 
$343,462, an Incentive of $324,169, grants of 31,870 restricted shares with a value of $187,396 (of which approximately 
67% of the grants have a performance condition), and a grant of 31,860 stock options with a value of $62,498.  In setting 
baseline compensation and the performance standards for Mr. Laubacker’s compensation, the Compensation Committee 
considered the Pay Governance report.  The total amount of compensation that Mr. Laubacker received was based on a 
combination of his baseline compensation, and the extent to which the thresholds for compensation were achieved under 
his performance based incentives. Mr. Laubacker also received additional benefits totaling $41,902 (see the “2020 
Summary Compensation Table”). 

Thomas J. Niehaus, EVP.  In 2020, Mr. Niehaus’ total compensation included annual base salary payments of 
$298,269, an Incentive of $224,856, grants of 34,210 restricted shares with a value of $201,155 (of which approximately 
34% of the grants have a performance condition), and a grant of 17,200 stock options with a value of $33,740. In setting 
baseline compensation and the performance standards for Mr. Niehaus’ compensation, the Compensation Committee 
considered the Pay Governance report.  The total amount of compensation that Mr. Niehaus received was based on a 
combination of his baseline compensation, and the extent to which the thresholds for compensation were achieved under 
his performance-based incentives. Mr. Niehaus also received additional benefits totaling $70,033 (see the “2020 
Summary Compensation Table”).

Peter P. Radetich, SVP.   In 2020, Mr. Radetich’s total compensation included annual base salary payments of 

$266,635, an Incentive of $299,339, grants of 18,480 restricted shares with a value of $108,662 (of which approximately 
67% of the grants have a performance condition), and a grant of 18,470 stock options with a value of $36,232. In setting 
baseline compensation and the performance standards for Mr. Radetich’s compensation, the Compensation Committee 
considered the Pay Governance report and his past performance.  The total amount of compensation that Mr. Radetich 
received was based on a combination of his baseline compensation, and the extent to which the thresholds for 
compensation were achieved under his performance-based incentives. Mr. Radetich also received additional benefits 
totaling $22,073 (see the “2020 Summary Compensation Table”).

Rénald Wauthier, SVP.   Mr. Wauthier’s was promoted to Senior Vice President on April 1, 2020. Mr. Wauthier’s 
total compensation included annual base salary payments (including payments made under a program administered by 

84

the Luxembourg government) of $289,389, an Incentive of $200,415, grants of 33,560 restricted shares with a value of 
$197,333 (of which approximately 29% of the grants have a performance condition), and a grant of 14,370 stock options 
with a value of $28,189. In setting baseline compensation and the performance standards for Mr. Wauthier’s 
compensation, the Compensation Committee considered the Pay Governance report and his past performance.  The total 
amount of compensation that Mr. Wauthier received was based on a combination of his baseline compensation, and the 
extent to which the thresholds for compensation were achieved under his performance-based incentives. Mr. Wauthier 
also received additional benefits totaling $28,048 (see the “2020 Summary Compensation Table”).

We believe executive pay must be internally consistent and equitable to motivate our employees to create 

shareholder value. We are committed to internal pay equity, and the Compensation Committee monitors the relationship 
between the pay our executive officers receive and the pay our non-managerial employees receive. The compensation for 
our CEO in 2020 was approximately 35 times the median pay of our employees.

Our CEO to median employee pay ratio is calculated in accordance with the SEC’s rules and regulations under item 

402(u) of Regulation S-K. We identified the median employee by examining the 2020 total cash compensation for all 
individuals, excluding our CEO, who were actively employed by us on December 31, 2020, the last day of our fiscal year. 
We included full-time, part-time, and seasonal employees. For employees that were not located in the US, we converted 
their total cash compensation from local currencies to US dollars by using the 2020 average currency exchange rates per 
www.irs.gov (https://www.irs.gov/individuals/international-taxpayers/yearly-average-currency-exchange-rates). We did not 
make any other assumptions, adjustments, or estimates with respect to the total cash compensation, and we did not 
annualize the compensation for any employees that were not employed by us for all of 2020. We believe the use of total 
cash compensation for all employees is a consistently applied compensation measure because we do not widely 
distribute annual equity awards to employees.

After identifying the median employee based on total cash compensation, we calculated the annual total 

compensation for such employee using the same methodology we use for our named executive officers as set forth in the 
2020 Summary Compensation Table in our Proxy Statement.

As illustrated in the table below, our 2020 CEO to median employee pay ratio is 35:1:

Salary
Overtime Pay
Stock Awards
Non-Equity Incentive
All Other Compensation

Ratio

Filip J.L. Gydé, 

President and CEO     Median CTG Employee  
51,999 
— 
— 
— 
— 
51,999 

465,481    $
—   
514,941   
758,850   
65,742   
1,805,014    $

  $

  $

34.71   

1.00  

2020 GRANTS OF PLAN-BASED AWARDS

Estimated Future Payouts
Under Non-Equity Incentive
Plan Awards (1)

Estimated Future Payouts
Under Equity Incentive
Plan Awards

Name
(a)

Grant 
Date
(b)

 Threshold     Target
    (d)  ($)

(c)  ($)

(e)  ($)

Filip J.L. Gydé
  3/6/2020  $ 257,500    $ 515,000   $1,030,000    
John M. Laubacker   3/6/2020  $ 110,000    $ 220,000   $ 440,000    
Thomas J. Niehaus   3/6/2020  $ 107,500    $ 215,000   $ 430,000    
  3/6/2020  $ 101,575    $ 203,149   $ 406,298    
Peter P. Radetich
Rénald Wauthier
53,511    $ 107,023   $ 214,045    
  3/6/2020  $

    Maximum    Threshold    Target    Maximum    

    (g)  #    
(f)  #
21,895      43,790     
10,625      21,250     
5,735      11,470     
6,160      12,320     
4,795      9,590     

(i)  #

(h)  #
43,790      21,890     
21,250      10,620     
11,470      22,740     
6,160     
12,320     
9,590      23,970     

85

All 
Other 
Stock 
Awards: 
Number 
of 
Shares 
of Stock 
or Units    

All Other 
Option 
Awards: 
Number of 
Securities 
Underlying 

Options    

(j)  #

Exercise 
or Base 
Price of 
Option 
Awards    
   (k)  ($/sh)    

Grant 
Date 
Fair 
Value of 
Stock 
and 
Option 
Awards  
(l)  ($)

65,630   $
31,860   $
17,200   $
18,470   $
14,370   $

5.88   $ 514,941 
5.88   $ 249,894 
5.88   $ 234,895 
5.88   $ 144,894 
5.88   $ 225,522  

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
 
   
    
 
    
 
    
 
    
 
 
 
 
 
   
   
   
   
 
(1)

The amounts shown in column (c) reflect Incentives that would be paid for achieving 80% of the plan target. The amounts shown in column (d) reflect Incentives that 
would be paid for achieving 100% of all stipulated plan targets. For Mr. Wauthier, his annual incentive as SVP for 2020 was $142,697, but this amount was prorated to 
$107,023 as his promotion was effective April 1, 2020. Additionally, Mr. Wauthier earned $29,906 of incentives as his role as a VP between January 1, 2020 and 
March 31, 2020. The amounts shown in column (e) reflect the maximum Incentives that would be paid under the stipulated plan.  The number of shares shown in 
column (f) reflect the number of shares that will be awarded for achieving 80% of the plan target. The number of shares showed in columns (g) and (h) reflect the 
number of shares that will be awarded for achieving 100% or more of the plan target. Further discussion of Incentive plan calculations is provided under the section 
entitled “Annual Cash Incentive Compensation,” found earlier in this annual report on Form 10-K for the year ended December 31, 2020 under the heading 
“Performance-Based Incentives.”

Grants of Plan-Based Awards

Each of the Non-Equity Incentive Plan Awards represented in the table above were Incentive awards granted to the 

named executive officers during 2020.  Such Incentive awards are described earlier in this report under the heading 
“Performance-Based Incentives.”  The formula for calculating each executive officer’s Incentive provides that at least 
80% of the stipulated plan target (“Threshold”) must be achieved before any remuneration is awarded for that objective.  If 
the Threshold is achieved, the executive officer receives 50% of the designated plan award1 for that objective.  Then, for 
each 1% point achieved above the Threshold, up to 100% of the plan target (“Objective Goal”), the executive officer 
receives another 2.5% of the designated plan award for that objective.  For each 1% point achieved above the Objective 
Goal, the executive officer receives another 5% of the designated plan award for that objective.  Each plan prohibits the 
receipt of amounts in excess of 200% of the designated plan award for that objective.

Pursuant to Company policies, an Incentive is only earned by and payable to an individual who remains in the 
Company’s employ on the date of Incentive distribution.  Incentive payments for 2020 were made on February 26, 2021. 

Each of the equity awards represented in the table above were granted pursuant to the 2010 Equity Award Plan. 
The restricted stock awards represented in the table above were granted by the Board to the named executive officers on 
March 6, 2020 and certain of those grants include a performance condition. For the performance awards of restricted 
stock granted in 2020 to the executive officers, the shares vest at the end of a three-year period. If the Company’s 
cumulative three-year non-GAAP earnings per share for the years 2020, 2021, and 2022 equals or exceeds $1.77, then 
100% of the grants will vest. If the combined cumulative three-year non-GAAP earnings per share is 80% or more, but 
less than 100% of the earnings per share target, a pro-rata portion of the grants shall vest. If at least 80% of the three-
year non-GAAP earnings per share target is not met, the grants will expire.  For the remaining restricted stock awards that 
were granted to the named executive officers, those awards vest ratably over three years, beginning one year from the 
date of grant.

For the stock option awards that were granted to the named executive officers, these options are non-qualified stock 

options with a grant price of $5.88 per option, vest ratably over three years, and expire 10 years from the date of grant.

Recipients of restricted stock awards and stock option awards were required to enter into agreements with the 
Company governing the vesting, exercise and/or transferability (as applicable) of such awards.  Vesting requirements for 
restricted stock awards are based solely on continued employment.

1 The designated plan award is generally calculated as a percentage of annual base salary.  In 2020, the designated plan awards were: (i) for Mr. Gydé, CEO, 
100% of base salary actually paid, (ii) for Mr. Laubacker, CFO, approximately 58% of base salary actually paid, (iii) for Mr. Niehaus, EVP, approximately 65% of 
base salary actually paid, (iv) for Mr. Radetich, SVP, approximately 69% of base salary actually paid, and (v) for Mr. Wauthier, SVP, 48% of base salary actually 
paid.

86

2020 OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END

Option Awards

Stock Awards

Number of 
Securities 
Underlying 
Unexercised 
Options 
Exercisable 
(#)
(b)

Number of 
Securities 
Underlying 
Unexercised 
Options 
Unexercisable 
(#)
(c)

Equity 
Incentive 
Plan 
Awards: 
Number of 
Securities 
Underlying 
Unexercised 
Unearned 
Options (#)  
(d)

Option 
Exercise 
Price ($)  
(e)

Option 
Expiration 
Date
(f)

Number of 
Shares or 
Units of 
Stock That 
Have Not 
Vested (#)
(g)

Market Value 
of Shares or 
Units of 
Stock That 
Have Not 
Vested ($)
(h)

Equity 
Incentive 
Plan 
Awards: 
Number of 
Unearned 
Shares, 
Units or 
Other Rights 
That Have 
Not Vested 
(#)
(i)

Equity 
Incentive 
Plan Awards: 
Market or 
Payout Value 
of Unearned 
Shares, 
Units or 
Other Rights 
That Have 
Not Vested 
($)
(j)

10,000      
9,000      
9,000      
9,000      
13,600      
—      
—      

7,500      
7,000      
7,000      
7,000      
10,400      
18,675      
—      
—      

8,834      
—      
—      

10,000      
9,000      
9,000      
9,000      
14,500      
—      
—      

—      
—      

—  
—  
—  
—  
—  
65,630   (ga)  
—  

—  
—  
—  
—  
—  
6,225   (la)  
31,860   (lb)  
—  

17,666   (na)  
17,200   (nb)  
—  

—  
—  
—  
—  
—  
18,470   (ra)  
—  

14,370   (wa)  
—  

—     $ 12.16     2/15/2021      
—     $ 15.04     2/14/2022      
—     $ 20.68     2/12/2023      
—     $ 16.93     2/19/2024      
—     $
7.48     11/10/2025      
—     $
5.88     3/6/2030      
—      
—      

—      

—     $ 12.16     2/15/2021      
—     $ 15.04     2/14/2022      
—     $ 20.68     2/12/2023      
—     $ 16.93     2/19/2024      
—     $
7.48     11/10/2025      
—     $
5.75     5/15/2027      
—     $
5.88     3/6/2030      
—      
—      

—      

—     $
—     $
—      

4.20     5/31/2029      
5.88     3/6/2030      
—      

—      

—     $ 12.16     2/15/2021      
—     $ 15.04     2/14/2022      
—     $ 20.68     2/12/2023      
—     $ 16.93     2/19/2024      
—     $
7.48     11/10/2025      
—     $
5.88     3/6/2030      
—      
—      

—      

—      
—      
—      
—      
—      
—      
181,957     $

—      
—      
—      
—      
—      
—      
—      
116,266     $

—      
—      
53,234     $

—      
—      
—      
—      
—      
—      
75,891     $

—      
—      
—      
—      
—      
—      
1,113,577      

—      
—      
—      
—      
—      
—      
—      
711,548      

—      
—      
325,792      

—      
—      
—      
—      
—      
—      
464,453      

—     $
—     $

5.88     3/6/2030      
—      

—      

—      
55,160     $

—      
337,579      

—      
—      
—      
—      
—      
—      
—      

—      
—      
—      
—      
—      
—      
—      
—      

—      
—      
—      

—      
—      
—      
—      
—      
—      
—      

—      
—      

—  
—  
—  
—  
—  
—  
—  

—  
—  
—  
—  
—  
—  
—  
—  

—  
—  
—  

—  
—  
—  
—  
—  
—  
—  

—  
—  

Name
(a)

Filip J.L. Gydé

John M. Laubacker

Thomas J. Niehaus  

Peter P. Radetich

Rénald Wauthier

(ga)
(la)
(lb)
(na)
(nb)
(ra)
(wa)

21,877, 21,876, and 21,877 vest on 3/6/2021, 3/6/2022, and 3/6/2023, respectively
6,225 vest on 5/15/2021
10,620 vest on each of 3/6/2021, 3/6/2022, and 3/6/2023
8,833 vest on each of 5/31/2021 and 5/31/2022
5,734, 5,733, and 5,733 vest on 3/6/2021, 3/6/2022, and 3/6/2023, respectively
6,157, 6,156, and 6,157 vest on 3/6/2021, 3/6/2022, and 3/6/2023, respectively
4,790 vest on each of 3/6/2021, 3/6/2022, and 3/6/2023

87

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
       
   
   
     
 
     
 
       
       
       
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
       
 
 
   
     
 
     
 
       
       
       
       
 
 
 
 
 
 
 
 
 
 
 
 
   
       
 
 
   
     
 
     
 
       
       
       
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
       
 
 
   
     
 
     
 
       
       
       
       
 
 
 
 
 
 
 
 
 
 
   
       
 
 
   
     
 
     
 
       
       
       
       
 
 The following table provides information for each of the Company’s named executive officers regarding stock option 
exercises and vesting of stock awards during 2020. 

2020 OPTION EXERCISES AND STOCK VESTED

Name of Executive Officer
Filip J.L. Gydé
John M. Laubacker
Thomas J. Niehaus
Peter P. Radetich
Rénald Wauthier

Option Awards

Stock Awards

Number of 
Shares 
Acquired on 

Exercise (#) (1)    

Value Realized 
on Exercise ($)
(1)

Number of 
Shares 
Acquired on 

Vesting  (#) (1)    

Value Realized 
on Vesting ($)
(1)

— 
— 
— 
— 
— 

 $
 $
 $
 $
 $

— 
— 
— 
— 
— 

6,788 
6,913 
2,667 
6,838 
14,213 

 $
 $
 $
 $
 $

39,710 
36,861 
10,935 
40,002 
64,816  

(1)

For Option Awards, the value realized is the difference between the fair market value of the underlying stock at the time of exercise and the exercise price.  For Stock 
Awards, the value realized is based on the fair market value of the underlying stock on the vest date. 

Pension Benefits

The Company maintains an Executive Supplemental Benefit Plan (Supplemental Plan) which provides certain 
former executives with deferred compensation benefits.  The Supplemental Plan was amended as of December 1, 1994 in 
order to freeze the then-current benefits, provide no additional benefit accruals for participants and to admit no new 
participants.  None of the named executive officers participates in the Supplemental Plan.  

Generally, the Supplemental Plan provides for retirement benefits of up to 50% of a participating employee’s base 

compensation at termination or as of December 1, 1994, whichever is earlier, and pre-retirement death benefits calculated 
using the same formula that is used to calculate normal and early retirement benefits.  Benefits are based on service 
credits earned each year of employment prior to and subsequent to admission to the Supplemental Plan through 
December 1, 1994.  Retirement benefits and pre-retirement death benefits are paid during the 180 months following 
retirement or death, respectively, while disability benefits are paid until normal retirement age.  Normal retirement is age 
60. For any participant who is also a participant in the Deferred Compensation Plan, the normal retirement age was 
increased to 65.

2020 NONQUALIFIED DEFERRED COMPENSATION

Executive 
Contributions 
in Last FY ($)
(b) (1)

Registrant 
Contributions 
in Last FY ($)
(c)

Aggregate 
Earnings in 
Last FY ($)
(d)

Aggregate 
Withdrawals / 
Distributions 
($)
(e)

Aggregate 
Balance at 
Last FYE ($)
(f)

— 
— 
26,948 
— 
— 

— 
— 
— 
— 
— 

 $
 $
 $
 $
 $

— 
28,482 
6,113 
57,475 
— 

—    $
—    $
—    $
—    $
—    $

— 
179,096 
37,190 
316,041 
—  

Name of Executive Officer
(a)
Filip J.L. Gydé
John M. Laubacker
Thomas J. Niehaus
Peter P. Radetich
Rénald Wauthier
(1)

During 2017, the Company discontinued contributions under the Deferred Compensation Plan. Mr. Gydé and Mr. Wauthier do not have an account under the Deferred 
Compensation Plan as they are not eligible to participate in the plan. 

On February 2, 1995, the Compensation Committee approved the creation of a Nonqualified Key Employee 
Deferred Compensation Plan (“Deferred Compensation Plan”).  The Deferred Compensation Plan is a successor plan to 
the Supplemental Plan. Participants in the Deferred Compensation Plan are eligible to elect to defer a percentage of their 
annual cash compensation.  Prior to 2017, participants were eligible to receive a Company contribution of a percentage of 
their base compensation and annual Incentive if the Company attained annual defined performance objectives for the 
year.  These performance objectives were on an annual basis for the upcoming year.  The contribution to the Deferred 
Compensation Plan by the Company was discontinued during 2017.

Plan participants have a 100% non-forfeitable right to the value of their corporate contribution account after the fifth 
anniversary of employment with the Company.  If a participant terminates employment due to death, disability, retirement 
at age 65, or upon the occurrence of a Change in Control Event (as defined in the plan), the participant or his or her 
estate will be entitled to receive the benefits accrued for the participant as of the date of such event. The Company 
contributions will be forfeited in the event a participant incurs a separation from service for cause. Participants are 100% 

88

 
 
   
 
 
   
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
   
   
   
 
 
 
 
 
  
  
 
 
  
  
 
 
  
  
 
 
  
  
 
 
  
  
vested in their own contributions.  All amounts in the Deferred Compensation Plan, including elective deferrals, are held 
as general assets of the Company and are subject to the claims of creditors of the Company.

Potential Payments upon Termination or Change in Control

Agreement with Mr. Gydé—Employment Agreement.  Effective as of March 1, 2019 the Company and Mr. Gydé 

entered into an employment agreement that provides that each party may terminate the employment agreement in 
accordance with the provisions of the Belgian law of July 3, 1978 relating to employment contracts. Any termination 
indemnities that may be due and owing to Mr. Gydé will take into account the co-employment between the Company and 
the Company’s Belgian subsidiary and will be done according to the transitional provisions as included in the articles 67, 
68 and 69 of the Belgian Law of December 26, 2013 regarding the introduction of a unified statute, with the period May 1, 
1987 until December 31, 2013 fully to be taken into account and severance payments to be calculated under the scheme 
of article 68 of said legislation. Prior to his appointment as Chief Executive Officer in March 2019, Mr. Gydé had not 
entered into an employment agreement with the Company itself since Belgian law mandates certain separation benefits.

Under Belgian law, Mr. Gydé is entitled to notice prior to a termination of his employment by the Company, 
expressed as a period of months for service prior to January 1, 2014 plus a period of weeks for service after January 1, 
2014. As of December 31, 2020, Mr. Gydé would have been entitled to 27 months plus 18 weeks of notice. Alternatively, 
in lieu of providing notice, the Company may elect to pay a termination indemnity to Mr. Gydé. The amount of the 
termination indemnity is determined pursuant to Belgian law and is based on the duration of Mr. Gydé’s employment with 
the Company and the amount of his gross annual compensation package. If Mr. Gydé’s employment with the Company 
and the Company’s Belgian subsidiary had been terminated without notice on December 31, 2020, Mr. Gydé would have 
been entitled to a termination indemnity totaling $3,730,234. In the event of a termination of Mr. Gydé’s employment, his 
equity awards would be subject to the terms of the 2010 Equity Award Plan, as discussed below in the section entitled 
“2010 Equity Award Plan.”

Agreement with Mr. Gydé—Change in Control. In connection with his promotion to Chief Executive Officer, 

Mr. Gydé’s stock option and restricted stock awards granted under the Company’s 2010 Equity Award Plan were 
amended pursuant to a letter agreement in May 2019 (the “Letter Agreement”) to provide for immediate vesting in the 
event his employment is terminated for any reason other than Cause, death or Disability within 6 months before or 24 
months after a change in control. Mr. Gydé does not otherwise have a change in control agreement.

Pursuant to the Letter Agreement, upon a termination of his employment for any reason other than Cause, death or 
Disability within 6 months before or 24 months after a change in control, Mr. Gydé would have immediately become fully 
vested in any stock option or restricted stock awards previously granted. These awards are more fully described in the 
table entitled “Outstanding Equity Awards at Fiscal Year-end.” If the stock price of the Company was $6.12, which was the 
closing price of the stock on December 31, 2020, then Mr. Gydé could potentially have realized gains, before tax, from the 
sale of vested securities in the following amounts:

Name of Executive Officer
Filip J.L. Gydé

Restricted Stock     
1,113,577     
$

Stock Options 
—   
$

In addition, pursuant to the Letter Agreement, in the event of a change in control, Mr. Gydé’s stock-based award with 

performance-based vesting conditions would, immediately prior to the change in control, be deemed to have satisfied the 
performance-based vesting conditions at the greater of the target level or the pro rata portion of the level of achievement 
of the performance goals that the Compensation Committee determines he likely would have received for the 
performance period during which his employment was terminated, had his employment not terminated. Such 
performance-based equity awards would then vest, unless sooner accelerated, monthly in equal installments over the 
remaining performance period (a “Modified Award”), and the Board would cause any successor to assume the Modified 
Awards.

With respect to any stock-based award with performance-based vesting conditions, in the event of a change in 
control in which the Company’s common stock ceases to be listed on the New York Stock Exchange or the NASDAQ 
Global Select Market or the Company’s common stock is converted into any consideration other than shares of common 
stock listed on the New York Stock Exchange or the NASDAQ Global Select Market, then immediately prior to such 
change in control, the Board in its reasonable discretion must take one of the following actions:

(cid:129)

  terminate such awards as of immediately prior to the consummation of the change in control in exchange for a 

89

 
 
  
  
 
 
payment equal the excess of the fair market value of such award,

  accelerate all vesting conditions in such award so that the award is fully exercisable immediately prior to the 

consummation of the change in control, with such vesting and notice of exercise contingent upon 
consummation of the change in control;

  issue substitute awards that will substantially preserve the realizable value and otherwise applicable terms of 

any affected awards previously granted to Mr. Gydé; or

  any combination of the foregoing.

(cid:129)

(cid:129)

(cid:129)

Because Mr. Gydé does not have a change in control agreement and Belgian law does not provide for payments 
upon a change in control, so long as his compensation, duties and responsibilities are not reduced as a result of a change 
in control, a change in control alone would not trigger any payments to Mr. Gydé, other than with respect to his equity 
awards, as described above. If Mr. Gydé’s employment were terminated or constructively terminated in connection with a 
change in control, however, he would be entitled to notice or the termination indemnity described in the section entitled 
“Agreement with Mr. Gydé—Employment Agreement.”

Agreements with Mr. Laubacker.  Mr. Laubacker has an employment agreement affording severance benefits 

upon termination.  Pursuant to the terms of such agreement, in the event of termination by Mr. Laubacker for Good 
Reason (as that term is defined in the agreement), or by the Company other than for Cause (as that term is defined in the 
agreement), Mr. Laubacker would receive a lump-sum cash payment equal to his current base salary plus an amount 
equal to the average annual Incentive paid to Mr. Laubacker during the most recent three-year period.  Mr. Laubacker 
would also continue to receive medical and dental benefits for a period of twelve (12) months.  Had Mr. Laubacker’s 
employment been terminated on December 31, 2020, he would have been eligible to receive an initial lump-sum cash 
payment equal to $624,218.  Mr. Laubacker would also receive, for a period of twelve months, continuing medical and 
dental coverage under any plans he participates in as of the effective date of such termination.  The value of continued 
medical and dental benefits would likely total approximately $4,852.

Agreements with Other Executive Officers.  Each of the other named executive officers, except Mr. Gydé, have 

entered into a change in control agreement with the Company.  All executive officers Change in Control agreements 
contain double trigger mechanisms.

If a change in control occurred on December 31, 2020, then each of the named executive officers (excluding Mr. 
Gydé) would have immediately become fully vested in any stock option or restricted stock awards previously granted. 
These awards are more fully described in the table entitled “Outstanding Equity Awards at Fiscal Year-end.” If the stock 
price of the Company was $6.12, which was the closing price of the stock on December 31, 2020, then the named 
executive officers could potentially have realized gains, before tax, from the sale of vested securities in the following 
amounts:

Name of Executive Officer
John M. Laubacker
Thomas J. Niehaus
Peter P. Radetich
Rénald Wauthier

Restricted Stock

Stock Options

  $
  $
  $
  $

711,548 
325,792 
464,453 
337,579 

 $
 $
 $
 $

6,910 
16,961 
— 
—  

Had the abovementioned executive officers’ employment been terminated without cause by the Company or by 

themselves with good reason within 6 months prior to or 24 months following such a change in control, they would also 
have been entitled to receive, by the tenth day following their termination, lump-sum cash payments from the Company in 
the following amounts: 

(cid:129) Mr. Laubacker would have received a lump-sum payment of $1,424,478; 

(cid:129) Mr. Niehaus would have received a lump-sum payment of $1,168,763;

(cid:129) Mr. Radetich would have received a lump-sum payment of $1,197,049; and

(cid:129) Mr. Wauthier would have received a lump-sum payment of $1,102,059.

90

 
 
 
 
 
 
 
   
 
These payments equal two (2) times the sum of each individual’s current annual salary, which as of December 31, 

2020 were $380,000 for Mr. Laubacker, $330,000 for Mr. Niehaus, $295,000 for Mr. Radetich, and $318,881 for Mr. 
Wauthier. It also includes two (2) times their average annual Incentive payment from the last three years and an amount 
equal to 25% of each individual’s current base salary and the highest annual Incentive payment from the last three years. 
This amount is intended to cover fringe benefits such as 401(k), health, medical, dental, disability and similar benefits for a 
period of twenty-four months.   

2020 DIRECTOR COMPENSATION

Fees 
Earned or 
Paid in 
Cash ($)
(b)

Stock 
Awards 
($)
(c) (1)
—   $ 165,000   $
—   $ 160,000   $
—   $ 160,000   $
—   $
—   $
—   $ 250,000   $
—   $ 150,000   $

  $
  $
  $
  $
  $
  $

Option 
Awards 
($)
(d)

Non-Equity 
Incentive Plan 
Compensation 
($)
(e)

Change in 
Pension Value 
and 
Nonqualified 
Deferred 
Compensation 
Earnings ($)
(f)

All Other 
Compensation 
($)
(g)

Total ($)
(h)

—   $
—   $
—   $
—   $
—   $
—   $

—    $
—    $
—    $
—    $
—    $
—    $

—    $
—    $
—    $
—    $
—    $
—    $

—    $ 165,000 
—    $ 160,000 
—    $ 160,000 
— 
—    $
—    $ 250,000 
—    $ 150,000  

Name of Director
(a)
 James R. Helvey III
 David H. Klein
 Valerie Rahmani
 Raj Rajgopal
 Daniel J. Sullivan
 Owen J. Sullivan
(1)

At the election of the directors, the director fees for 2020 were paid in the form of deferred stock units granted under the 2010 Equity Award Plan and deposited into 
the Director Deferred Compensation Plan. Awards vest ratably throughout the year and were fully vested at December 31, 2020. 

As of December 31, 2020, Mr. Daniel J. Sullivan had been granted 40,000 shares of Company restricted stock. This 
restricted stock vests upon retirement from the Board. Mr. Klein, who was appointed to the Board in September 2012, Mr. 
Helvey and Ms. Rahmani, who were appointed to the board in November 2015, Mr. Owen Sullivan, who was appointed in 
February 2017, and Mr. Rajgopal, who was appointed in December 2020, have not received any grants of restricted 
shares.

As of December 31, 2020, the directors had the following number of stock options outstanding: Helvey (0), Klein 

(33,096), Rahmani (0), Daniel J. Sullivan (140,000), Owen J. Sullivan (0), and Raj Rajgopal (0).  

In 2010, the Company’s shareholders approved the Non-Employee Director Deferred Compensation Plan (“Director 

Deferred Compensation Plan”).  Although no set benefits or amounts were granted under this Plan in 2020, the Director 
Deferred Compensation Plan allows non-employee directors the ability to defer up to 100% of their total director 
compensation.  Beginning January 1, 2018, the Board elected to eliminate cash payments and take their compensation 
wholly in deferred stock units, which are granted under the 2010 Equity Award Plan and deposited into the Director 
Deferred Compensation Plan.  Grants were made at the beginning of 2020, and vested quarterly throughout the year, 
each equal to one-quarter of the total fees due to each director.  

For 2020, base compensation for each board member totaled $150,000. The chairman of the Board of Directors (Mr. 

Daniel J. Sullivan) also received a $100,000 annual fee.  The chairman of the Audit Committee (Mr. Helvey) received a 
$15,000 annual fee, and the Chairman of the Compensation Committee (Ms. Rahmani) received a $10,000 annual fee, 
while the Chairman of the Nominating and Governance Committee (Mr. Klein) received an annual fee of $10,000.  
Directors are reimbursed for expenses they incur while attending Board and committee meetings.  As previously noted, all 
fees for 2020 were paid in the form of deferred stock units. Mr. Gydé did not receive any additional compensation for his 
services as a director.  

The Company has adopted stock ownership guidelines requiring each independent director to own Company shares 

valued at five (5) times the director’s base annual fee.   

The Director Deferred Compensation Plan is administered by the Compensation Committee in accordance with 
Section 409A of the Internal Revenue Code.  All amounts credited to the participant are invested, as approved by the 
Compensation Committee, and the participant is credited with the actual earnings of the investments. Company 
contributions, including investment earnings, may be in cash or the stock of the Company.  Plan participants have an 
immediate 100% non-forfeitable right to the value of their contributions.  If a participant does not make an election in the 
time and manner specified in the Plan, payment of the vested value of his or her account will be paid in shares for share 

91

 
   
   
   
   
   
   
 
units owned, and in cash for the cash balance in their account.  A participant’s eligibility terminates upon retirement or 
resignation from service.

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners

As of March 12, 2021, the following persons were beneficial owners of more than 5% of the Company’s common 

stock.  The beneficial ownership information presented is based upon information furnished by each person or contained 
in filings made with the Securities and Exchange Commission.  Except as otherwise indicated, each holder has sole 
voting and investment power with respect to the shares indicated.  The following table shows the nature and amount of 
their beneficial ownership. 

Title of Class

Name and Address of Beneficial Owner

Common Stock

  Minerva Advisors LLC, and related parties
  50 Monument Road, Suite 201
  Bala Cynwyd, PA 19004

Amount and Nature of 
Ownership
1,180,231 (1)

Percent of Class
7.8%

Common Stock

  Renaissance Technologies LLC, and

1,169,436 (2)

7.7%

Common Stock

Common Stock

related parties
  800 Third Avenue
  New York, NY 10022

  Dimensional Fund Advisors LP
  Building One
  6300 Bee Cave Road
  Austin, TX 78746

  The Vanguard Group
  100 Vanguard Blvd.
  Malvern, PA 19355

954,086 (3)

6.3%

808,641 (4)

5.3%

(1)

(2)

(3)

(4)

Based solely on information contained in a Schedule 13G filed on February 9, 2021, indicating that Minerva Advisors LLC, Minerva Group, LP, 
Minerva GP, LP, Minerva GP, Inc. and David P. Cohen have sole voting power and sole dispositive power over 933,526 shares; and that 
Minerva Advisors LLC and David P. Cohen have shared voting power and share dispositive power over 246,705 shares.
Based solely on information contained in a Schedule 13G filed February 11, 2021, indicating that Renaissance Technologies LLC and 
Renaissance Technologies Holdings Corporation have sole voting power over 1,016,225 shares and sole dispositive power over 1,169,436 
shares.
Based solely on information contained in a Schedule 13G filed February 12, 2021, indicating that Dimensional Fund Advisors LP has sole 
voting power over 905,284 shares and sole dispositive power over 954,086 shares.
Based solely on information contained in a Schedule 13G filed February 10, 2021, indicating that The Vanguard Group has shared voting 
power over 2,786 shares, sole dispositive power over 803,679 shares, and shared dispositive power over 4,962 shares.

Security Ownership by Management

The table below sets forth, as of March 12, 2021, the beneficial ownership of the Company’s common stock by (i) 

each director and nominee for director individually, (ii) each executive officer named in the summary compensation table 
individually, and (iii) all directors and executive officers of the Company as a group.

Name of Individual or Number in Group
Filip J.L. Gydé
James R. Helvey III
David H. Klein
Valerie Rahmani
Raj Rajgopal
Daniel J. Sullivan
Owen J. Sullivan
John M. Laubacker
Thomas J. Niehaus
Peter P. Radetich
Rénald Wauthier
All directors and executive officers as a group (11 persons)

  Shares Owned    

Shares 
Beneficially 
Owned (1)

287,640 
140,280 
148,507 
129,703 
- 
346,804 
110,078 
162,474 
55,901 
148,353 
36,492 
1,566,232 

62,477 
- 
33,096 
- 
- 
140,000 
- 
60,695 
14,568 
47,657 
4,790 
363,283 

Total 
Ownership 
(2)
350,117 
140,280 
181,603 
129,703 
- 
486,804 
110,078 
223,169 
70,469 
196,010 
41,282 
1,929,515 

Percent of 
Class

2.3%
0.9%
1.2%
0.9%
0.0%
3.2%
0.7%
1.5%
0.5%
1.3%
0.3%
12.8%

(1)

Amounts represent number of shares available to purchase through the exercise of options that were exercisable on or within 60 days after March 12, 2020.

92

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
   
   
 
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
(2)

The beneficial ownership information presented is based upon information furnished by each person or contained in filings made with the Securities and Exchange 
Commission.  Except as otherwise indicated, each holder has sole voting and investment power with respect to the shares indicated.

The following table sets forth, as of December 31, 2020, certain information related to the Company’s compensation 

plans under which shares of its common stock are authorized for issuance:

Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights (a)    

Weighted-average
exercise price of
outstanding options,
warrants and rights (b)   

Number of securities
remaining available
for future issuance
under equity
compensation plans
(excluding securities listed
in column (a) (c)

—   $
859,148   $
245,300   $
—   $

—   
11.73   
5.62   
—   

1,950,000 
— 
— 
19,866 

Equity compensation plans approved by security
   holders:

2020 Equity Award Plan
2010 Equity Award Plan
2000 Equity Award Plan
1991 Restricted Stock Plan

Equity compensation plans not approved by security
   holders:
None

Total

1,104,448    

1,969,866  

At December 31, 2020, the Company did not have any outstanding rights or warrants. All outstanding awards are 

either stock options or restricted stock.

Item 13.

Certain Relationships and Related Transactions, and Director Independence

The Board of Directors affirmatively determined in February 2021 that each of the Company’s six non-management 
directors, which include James R. Helvey III, David H. Klein, Valerie Rahmani, Raj Rajgopal, Daniel J. Sullivan, and Owen 
J. Sullivan, is an independent director in accordance with our corporate governance policies and the standards of the 
NASDAQ Stock Market (“NASDAQ”).  Messrs. Daniel J. Sullivan and Owen J. Sullivan are not related.  As these six 
directors are independent, a majority of our Company’s Board of Directors is currently independent as so defined. The 
Board of Directors has determined that there are no relationships between the Company and the directors classified as 
independent other than service on our Company’s Board of Directors.

The foregoing independence determination also included the conclusions of the Board of Directors that:

(cid:129)

(cid:129)

each member of the Audit Committee, Nominating and Corporate Governance Committee, and Compensation 
Committee described in this annual report on Form 10-K is respectively independent under the standards listed 
above for purposes of membership on each of these committees; and

each of the members of the Audit Committee also meets the additional independence requirements under Rule 
10A-3(b) of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”).

Mr. Daniel J. Sullivan serves as the Chairman of the Board of Directors and is responsible for scheduling and setting 

the agenda for the executive sessions of the independent directors.  Such executive sessions are expected to occur at 
regularly scheduled times during the fiscal year ending December 31, 2021, typically in conjunction with a regularly 
scheduled Board meeting, in addition to the separate meetings of the standing committees of the Board of Directors.

In accordance with the charter of the Audit Committee, the Audit Committee reviews related person transactions.  It 

is the Company’s policy that it will not enter into transactions that are considered related person transactions that are 
required to be disclosed under Item 404 of Regulation S-K unless the Audit Committee or another independent body of 
the Board of Directors first reviews and approves the transactions.

Item 14.

Principal Accounting Fees and Services

Appointment of Auditors and Fees

The Audit Committee appointed Grant Thornton LLP as the independent registered public accounting firm to audit 

the Company’s financial statements for fiscal 2020 and 2019.

93

 
 
 
  
     
    
  
  
  
  
  
  
     
    
  
  
     
    
  
  
    
To the best of the Company’s knowledge, no member of that firm has any past or present interest, financial or 
otherwise, direct or indirect, in the Company or any of its subsidiaries.  Matters involving auditing and related functions are 
considered and acted upon by the Audit Committee.

Audit Fees —The aggregate fees billed for professional services rendered by Grant Thornton LLP for the audit of the 

Company’s annual financial statements for the last fiscal year, including the Company’s foreign subsidiaries, the reviews 
of the financial statements included in the Company’s Form 10-K and 10-Qs, and services rendered in connection with the 
Company’s obligations under Section 404 of the Sarbanes-Oxley Act of 2002 and related regulations were approximately 
$694,885 in 2020 and $640,326 in 2019.

Audit-Related Fees —There were no fees billed for assurance and related services rendered by Grant Thornton LLP 

in 2020 and 2019, respectively, that are reasonably related to the performance of the audit or review of the Company’s 
financial statements.

Tax Fees — There were a total of $15,700 and $20,315 of tax fees for compliance, tax advice and tax planning 

provided by Grant Thornton LLP in 2020 and 2019, respectively.

All Other Fees — No other fees were paid to Grant Thornton LLP in 2020 or 2019.

The Audit Committee pre-approves all fees paid to and all services performed by the Company’s independent 
registered public accounting firm, including the nature, type and scope of service to be performed during the year.  Any 
services to be performed during the year that are outside the scope of the initial services and fees approved by the Audit 
Committee must be approved prior to being performed.  In addition, the independent registered public accounting firm is 
required to confirm that such services does not impair its independence.

94

PART IV

Item 15.

Exhibits, Financial Statement Schedules

(a)
(1)

Index to Consolidated Financial Statements and Financial Statement Schedule
Financial Statements:

Consolidated Statements of Operations
Consolidated Statements of Comprehensive Income (Loss)
Consolidated Balance Sheets
Consolidated Statements of Cash Flows
Consolidated Statements of Shareholders’ Equity
Notes to Consolidated Financial Statements
Index to Consolidated Financial Statement Schedule
Financial statement schedule:
Schedule II—Valuation and Qualifying Accounts
Exhibits
The Exhibits to this annual report on Form 10-K are listed on the attached Exhibit Index

(2)

(b)

36
37
38
39
40
42

98

95

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit
2.

3.

4.

10.

  Description

EXHIBIT INDEX

(a) Share Purchase Agreement, dated as of February 15, 2018, by and between Computer 

Task Group IT Solutions S.A. and Soft Company SAS

Reference
(7)

(c)

(b)

(a)
(b)
(a)
(b)
(c)
(a)

(b) Share Purchase Agreement, dated as of January 3, 2019, by and between Computer 
Task Group PSF S.A. and Mr. Hamid Kaddour and Karp-Kneip Participations S.A.
  Restated Certificate of Incorporation of Registrant
  Restated By-laws of Registrant
  Restated Certificate of Incorporation of Registrant
  Restated By-laws of Registrant
  Specimen Common Stock Certificate
Computer Task Group, Incorporated Non-Qualified Key Employee Deferred 
Compensation Plan 2007 Restatement 
Computer Task Group, Incorporated Executive Supplemental Benefit Plan 1997 
Restatement
First Amendment to the Computer Task Group, Incorporated Executive Supplemental 
Benefit Plan 1997 Restatement
  Compensation Arrangements for the Named Executive Officers
Employment Agreement, signed March 12, 2020, between the Registrant and John M. 
Laubacker
Computer Task Group, Incorporated First Employee Stock Purchase Plan (Ninth 
Amendment and Restatement)
  Restated Computer Task Group, Incorporated 2010 Equity Award Plan
Computer Task Group, Incorporated Non-Employee Director Deferred Compensation 
Plan
  Computer Task Group, Incorporated Indemnification Agreement (Directors)
  Computer Task Group, Incorporated Indemnification Agreement (Executive Officers)
  Officer Change in Control Agreement 

(i)
(j)
(k)
(l) Credit Agreement, dated as of December 21, 2017, among Computer Task Group, 

(g)
(h)

(d)
(e)

(f)

Incorporated as Borrower, with KeyBank National Association as Administrative Agent, 
Swing Line Lender and Issuing Lender and KeyBanc Capital Markets Inc. as Lead 
Arranger and Sole Book Runner

(m) First Amendment Agreement dated as of April 13, 2018 to the Credit Agreement dated as 
of December  21, 2017 by and among Computer Task Group, Incorporated as Borrower, 
with KeyBank National Association as Administrative Agent, Swing Line Lender and 
Issuing Lender and KeyBanc Capital Markets Inc. as Lead Arranger and Sole Book 
Runner

(n) Second Amendment Agreement dated as of October 10, 2018 to the Credit Agreement 
dated as of December  21, 2017 by and among Computer Task Group, Incorporated as 
Borrower, with KeyBank National Association as Administrative Agent, Swing Line Lender 
and Issuing Lender and KeyBanc Capital Markets Inc. as Lead Arranger and Sole Book 
Runner

(10)

(2)
(14)
(2)
(14)
(2)
(1) +

(2) +

(2) +

(15) +
(13) +

(4) +

(5) +
(3) +

(16) +
(16) +
(14) +
(6)

(8)

(9)

(o) Employment Agreement, dated March 1, 2019, between Computer Task Group, 

(11) +

Incorporated, Computer Task Group Belgium NV and Filip J.L. Gydé

(p) Annex to Employment Agreement dated March 1, 2019, between Computer Task Group, 

(11) +

Incorporated, Computer Task Group Belgium NV and Filip J.L. Gydé

(q) Third Amendment Agreement dated as of December 23, 2019 to the Credit Agreement 
dated as of December  21, 2017 by and among Computer Task Group, Incorporated as 
Borrower, with KeyBank National Association as Administrative Agent, Swing Line Lender 
and Issuing Lender and KeyBanc Capital Markets Inc. as Lead Arranger and Sole Book 
Runner

(r) Computer Task Group, Incorporated 2020 Equity Award Plan

21.
23.

31.

32.

Subsidiaries of the Registrant

(a) Consent of Experts and Counsel
(b) Consent of Experts and Counsel
(a)
(b)

  Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(12)

(15) + 
#
#
#
#
#
##

96

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101.INS

101.SCH
101.CAL
101.LAB
101.PRE
101.DEF
104

Inline XBRL Instance Document - the instance document does not appear in the 
Interactive Data File because its XBRL tags are embedded within the Inline XBRL 
document.
  Inline XBRL Taxonomy Extension Schema Document
  Inline XBRL Taxonomy Extension Calculation Linkbase
  Inline XBRL Taxonomy Extension Label Linkbase
  Inline XBRL Taxonomy Extension Presentation Linkbase
  Inline XBRL Taxonomy Extension Definition Linkbase Document
  Cover Page Interactive Data File (embedded within the Inline XBRL document)

#

#
#
#
#
#

References

#
  Filed herewith
##   Furnished herewith
+   Management contract or compensatory plan or arrangement
(1)

Filed as an Exhibit to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2006, and 
incorporated herein by reference (file No. 001-09410 filed on March 7, 2007)
Filed as an Exhibit to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2007, and 
incorporated herein by reference (file No. 001-09410 filed on March 10, 2008)
Filed as Exhibit A to the Registrant's Proxy Statement on Schedule 14A, dated April 2, 2010, for its Annual 
Meeting of Shareholders held on May 12, 2010 (file No. 001-09410 filed on March 31, 2010)
Filed as Exhibit A to the Registrant's Proxy Statement on Schedule 14A dated April 4, 2012, for its Annual Meeting 
of Shareholders held on May 9, 2012 (file No. 001-09410 filed on April 4, 2012)
Filed as an Exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended September 
29, 2017, and incorporated herein by reference (file No. 001-09410 filed on October 26, 2017)
Filed as an Exhibit to the Registrant’s Form 8-K on December 26, 2017, and incorporated herein by reference (file 
No. 001-09410)
Filed as an Exhibit to the Registrant’s Form 8-K on February 15, 2018, and incorporated herein by reference (file 
No. 001-09410)
Filed as an Exhibit to the Registrant’s Form 8-K on April 13, 2018, and incorporated herein by reference (file No. 
001-09410)
Filed as an Exhibit to the Registrant’s Form 8-K on October 15, 2018, and incorporated herein by reference (file 
No. 001-09410)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

(10) Filed as an Exhibit to the Registrant’s Form 8-K on January 3, 2019, and incorporated herein by reference (file No. 

001-09410)

(11) Filed as an Exhibit to the Registrant’s Form 8-K on March 4, 2019, and incorporated herein by reference (file No. 

001-09410)

(12) Filed as an Exhibit to the Registrant’s Form 8-K on December 26, 2019, and incorporated herein by reference (file 

No. 001-09410)

(13) Filed as an Exhibit to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2019, and 

incorporated herein by reference (file No. 001-09410 filed on March 13, 2020)

(14) Filed as an Exhibit to the Registrant’s Form 8-K on August 12, 2020, and incorporated herein by reference (file No. 

001-09410)

(15) Filed as an Exhibit to the Registrant's Proxy Statement on Schedule 14A dated August 13, 2020, for its Annual 

Meeting of Shareholders held on September 17, 2020 (file No. 001-09410 filed on August 13, 2020)

(16) Filed as an Exhibit to the Registrant’s Form 8-K on November 12, 2020, and incorporated herein by reference (file 

No. 001-09410)

Item 16.

Form 10-K Summary

None.

97

 
 
 
 
 
 
 
COMPUTER TASK GROUP, INCORPORATED
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
(amounts in thousands)

2020
Accounts deducted from accounts receivable -

Allowance for doubtful accounts

Accounts deducted from deferred tax assets -
Deferred tax asset valuation allowance

2019
Accounts deducted from accounts receivable -

Allowance for doubtful accounts

Accounts deducted from deferred tax assets -
Deferred tax asset valuation allowance

2018
Accounts deducted from accounts receivable -

Allowance for doubtful accounts

Accounts deducted from deferred tax assets -
Deferred tax asset valuation allowance

Balance at
January 1

Additions       Deductions  

Balance at
December 31  

84     

595  A    

(118) A   $

561 

5,695     

2,389  B    

(420) B   $

7,664 

104     

15  A    

(35) A   $

84 

5,590     

886  B    

(781) B   $

5,695 

133     

91  A    

(120) A   $

104 

2,505     

4,118  B    

(1,033) B   $

5,590  

  $

  $

  $

  $

  $

  $

A

B

These balances primarily reflect additions to the allowance charged to expense resulting from the normal course of 
business, less deductions for recovery of accounts that were previously reserved, and additions and deductions for 
foreign currency translation

These balances primarily reflect additions or deductions to the valuation allowance associated with the U.S. deferred 
tax assets, reversal of the valuation allowance against the U.K. and India deferred tax assets, changes in foreign 
currency exchange rates, and deductions for expiring net operating loss carryforwards

98

 
 
   
   
   
      
        
  
    
  
   
      
        
  
    
  
   
      
        
  
    
  
 
   
      
        
  
    
  
   
      
        
  
    
  
   
      
        
  
    
  
   
      
        
  
    
  
 
   
      
        
  
    
  
   
      
        
  
    
  
   
      
        
  
    
  
   
      
        
  
    
  
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly 

caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIGNATURES

COMPUTER TASK GROUP, INCORPORATED

By

/s/ Filip J.L. Gydé
Filip J.L. Gydé
President and Chief Executive Officer

Dated: March 12, 2021

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the 

following persons on behalf of the registrant and in the capacities and on the dates indicated.

(i) Principal Executive Officer

Signature

Title
President and Chief Executive Officer

Date
March 12, 2021

/s/ Filip J.L. Gydé

Filip J.L. Gydé

(ii) Principal Accounting and Principal Financial Officer

Chief Financial Officer

March 12, 2021

(iii) Directors

/s/ John M. Laubacker

John M. Laubacker

/s/ Filip J.L. Gydé
Filip J.L. Gydé

/s/ James R. Helvey III
James R. Helvey III

/s/ David H. Klein
David H. Klein

/s/ Valerie Rahmani
Valerie Rahmani

/s/ Raj Rajgopal
Raj Rajgopal

/s/ Daniel J. Sullivan
Daniel J. Sullivan

/s/ Owen J. Sullivan
Owen J. Sullivan

Director

Director

Director

Director

Director

March 12, 2021

March 12, 2021

March 12, 2021

March 12, 2021

March 12, 2021

Chairman of the Board of Directors

March 12, 2021

Director

March 12, 2021

99

 
 
 
 
 
 
(cid:38)(cid:50)(cid:48)(cid:51)(cid:56)(cid:55)(cid:40)(cid:53)(cid:3)(cid:55)(cid:36)(cid:54)(cid:46)(cid:3)(cid:42)(cid:53)(cid:50)(cid:56)(cid:51)(cid:15)(cid:3)(cid:44)(cid:49)(cid:38)(cid:50)(cid:53)(cid:51)(cid:50)(cid:53)(cid:36)(cid:55)(cid:40)(cid:39)

(cid:54)(cid:56)(cid:37)(cid:54)(cid:44)(cid:39)(cid:44)(cid:36)(cid:53)(cid:44)(cid:40)(cid:54)(cid:3)(cid:50)(cid:41)(cid:3)(cid:38)(cid:50)(cid:48)(cid:51)(cid:56)(cid:55)(cid:40)(cid:53)(cid:3)(cid:55)(cid:36)(cid:54)(cid:46)(cid:3)(cid:42)(cid:53)(cid:50)(cid:56)(cid:51)(cid:15)(cid:3)(cid:44)(cid:49)(cid:38)(cid:50)(cid:53)(cid:51)(cid:50)(cid:53)(cid:36)(cid:55)(cid:40)(cid:39)

(cid:40)(cid:91)(cid:75)(cid:76)(cid:69)(cid:76)(cid:87)(cid:3)(cid:21)(cid:20)

(cid:55)(cid:75)(cid:72)(cid:3)(cid:73)(cid:82)(cid:79)(cid:79)(cid:82)(cid:90)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:86)(cid:3)(cid:68)(cid:3)(cid:79)(cid:76)(cid:86)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:76)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:53)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:3)(cid:68)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:22)(cid:20)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:17)(cid:3)(cid:36)(cid:79)(cid:79)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:53)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:89)(cid:82)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:86)(cid:72)(cid:70)(cid:88)(cid:85)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:90)(cid:75)(cid:82)(cid:79)(cid:79)(cid:92)(cid:3)(cid:82)(cid:90)(cid:81)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:53)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:29)

(cid:54)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)

(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:82)(cid:73)(cid:3)(cid:39)(cid:72)(cid:79)(cid:68)(cid:90)(cid:68)(cid:85)(cid:72)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)
(cid:38)(cid:55)(cid:42)(cid:3)(cid:82)(cid:73)(cid:3)(cid:37)(cid:88)(cid:73)(cid:73)(cid:68)(cid:79)(cid:82)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:11)(cid:43)(cid:82)(cid:79)(cid:71)(cid:76)(cid:81)(cid:74)(cid:86)(cid:12)(cid:3)(cid:47)(cid:76)(cid:80)(cid:76)(cid:87)(cid:72)(cid:71)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:68)(cid:81)(cid:68)(cid:71)(cid:68)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:44)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:40)(cid:88)(cid:85)(cid:82)(cid:83)(cid:72)(cid:3)(cid:37)(cid:17)(cid:57)(cid:17)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:44)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:12)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:11)(cid:56)(cid:46)(cid:12)(cid:3)(cid:47)(cid:76)(cid:80)(cid:76)(cid:87)(cid:72)(cid:71)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:40)(cid:88)(cid:85)(cid:82)(cid:83)(cid:72)(cid:3)(cid:37)(cid:17)(cid:57)(cid:17)(cid:12)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:37)(cid:72)(cid:79)(cid:74)(cid:76)(cid:88)(cid:80)(cid:3)(cid:49)(cid:57)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:40)(cid:88)(cid:85)(cid:82)(cid:83)(cid:72)(cid:3)(cid:37)(cid:17)(cid:57)(cid:17)(cid:12)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:55)(cid:72)(cid:70)(cid:75)(cid:81)(cid:82)(cid:79)(cid:82)(cid:74)(cid:92)(cid:3)(cid:54)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:86)(cid:3)(cid:51)(cid:85)(cid:76)(cid:89)(cid:68)(cid:87)(cid:72)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)
(cid:3)(cid:3)(cid:3)(cid:3)(cid:44)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:12)
(cid:38)(cid:55)(cid:42)(cid:3)(cid:44)(cid:55)(cid:54)(cid:3)(cid:54)(cid:17)(cid:36)(cid:17)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:44)(cid:55)(cid:3)(cid:54)(cid:82)(cid:79)(cid:88)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:54)(cid:17)(cid:36)(cid:17)(cid:12)
(cid:54)(cid:82)(cid:73)(cid:87)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:54)(cid:36)(cid:54)(cid:3)(cid:11)(cid:38)(cid:55)(cid:42)(cid:3)(cid:41)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)(cid:12)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:44)(cid:55)(cid:3)(cid:54)(cid:82)(cid:79)(cid:88)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:54)(cid:17)(cid:36)(cid:17)(cid:12)
(cid:54)(cid:87)(cid:68)(cid:85)(cid:39)(cid:88)(cid:86)(cid:87)(cid:3)(cid:54)(cid:36)(cid:54)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:54)(cid:82)(cid:73)(cid:87)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:54)(cid:36)(cid:54)(cid:12)
(cid:47)(cid:68)(cid:3)(cid:54)(cid:82)(cid:70)(cid:76)(cid:72)(cid:87)(cid:112)(cid:3)(cid:71)(cid:72)(cid:3)(cid:55)(cid:72)(cid:86)(cid:87)(cid:86)(cid:3)(cid:54)(cid:87)(cid:68)(cid:85)(cid:39)(cid:88)(cid:86)(cid:87)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:54)(cid:87)(cid:68)(cid:85)(cid:39)(cid:88)(cid:86)(cid:87)(cid:3)(cid:54)(cid:36)(cid:54)(cid:12)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:82)(cid:73)(cid:3)(cid:47)(cid:88)(cid:91)(cid:72)(cid:80)(cid:69)(cid:82)(cid:88)(cid:85)(cid:74)(cid:3)(cid:51)(cid:54)(cid:41)(cid:15)(cid:3)(cid:54)(cid:17)(cid:36)(cid:17)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)
(cid:3)(cid:3)(cid:3)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:12)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:44)(cid:55)(cid:3)(cid:54)(cid:82)(cid:79)(cid:88)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:54)(cid:17)(cid:36)(cid:17)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:47)(cid:88)(cid:91)(cid:72)(cid:80)(cid:69)(cid:82)(cid:88)(cid:85)(cid:74)(cid:3)
(cid:3)(cid:3)(cid:3)(cid:3)(cid:51)(cid:54)(cid:41)(cid:15)(cid:3)(cid:54)(cid:17)(cid:36)(cid:17)(cid:12)
(cid:38)(cid:55)(cid:42)(cid:3)(cid:43)(cid:72)(cid:68)(cid:79)(cid:87)(cid:75)(cid:3)(cid:54)(cid:82)(cid:79)(cid:88)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:49)(cid:57)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:37)(cid:72)(cid:79)(cid:74)(cid:76)(cid:88)(cid:80)(cid:3)(cid:49)(cid:57)(cid:12)
(cid:38)(cid:55)(cid:42)(cid:3)(cid:41)(cid:72)(cid:71)(cid:72)(cid:85)(cid:68)(cid:79)(cid:3)(cid:54)(cid:92)(cid:86)(cid:87)(cid:72)(cid:80)(cid:86)(cid:15)(cid:3)(cid:47)(cid:47)(cid:38)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:12)
(cid:38)(cid:55)(cid:42)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:54)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:86)(cid:15)(cid:3)(cid:47)(cid:47)(cid:38)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:44)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:12)
(cid:38)(cid:55)(cid:42)(cid:3)(cid:47)(cid:36)(cid:55)(cid:36)(cid:48)(cid:15)(cid:3)(cid:54)(cid:36)(cid:54)(cid:3)(cid:11)(cid:68)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:44)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:12)

(cid:54)(cid:87)(cid:68)(cid:87)(cid:72)(cid:18)(cid:38)(cid:82)(cid:88)(cid:81)(cid:87)(cid:85)(cid:92)
(cid:82)(cid:85)(cid:3)(cid:45)(cid:88)(cid:85)(cid:76)(cid:86)(cid:71)(cid:76)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)
(cid:82)(cid:73)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)

(cid:39)(cid:72)(cid:79)(cid:68)(cid:90)(cid:68)(cid:85)(cid:72)
(cid:49)(cid:72)(cid:90)(cid:3)(cid:60)(cid:82)(cid:85)(cid:78)
(cid:56)(cid:81)(cid:76)(cid:87)(cid:72)(cid:71)(cid:3)(cid:46)(cid:76)(cid:81)(cid:74)(cid:71)(cid:82)(cid:80)
(cid:38)(cid:68)(cid:81)(cid:68)(cid:71)(cid:68)
(cid:39)(cid:72)(cid:79)(cid:68)(cid:90)(cid:68)(cid:85)(cid:72)
(cid:55)(cid:75)(cid:72)(cid:3)(cid:49)(cid:72)(cid:87)(cid:75)(cid:72)(cid:85)(cid:79)(cid:68)(cid:81)(cid:71)(cid:86)
(cid:56)(cid:81)(cid:76)(cid:87)(cid:72)(cid:71)(cid:3)(cid:46)(cid:76)(cid:81)(cid:74)(cid:71)(cid:82)(cid:80)
(cid:37)(cid:72)(cid:79)(cid:74)(cid:76)(cid:88)(cid:80)

(cid:44)(cid:81)(cid:71)(cid:76)(cid:68)
(cid:37)(cid:72)(cid:79)(cid:74)(cid:76)(cid:88)(cid:80)
(cid:41)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)
(cid:41)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)
(cid:38)(cid:68)(cid:81)(cid:68)(cid:71)(cid:68)

(cid:47)(cid:88)(cid:91)(cid:72)(cid:80)(cid:69)(cid:82)(cid:88)(cid:85)(cid:74)

(cid:47)(cid:88)(cid:91)(cid:72)(cid:80)(cid:69)(cid:82)(cid:88)(cid:85)(cid:74)
(cid:37)(cid:72)(cid:79)(cid:74)(cid:76)(cid:88)(cid:80)
(cid:49)(cid:72)(cid:90)(cid:3)(cid:60)(cid:82)(cid:85)(cid:78)
(cid:49)(cid:72)(cid:90)(cid:3)(cid:60)(cid:82)(cid:85)(cid:78)
(cid:38)(cid:82)(cid:79)(cid:82)(cid:80)(cid:69)(cid:76)(cid:68)

(cid:40)(cid:91)(cid:75)(cid:76)(cid:69)(cid:76)(cid:87)(cid:3)(cid:21)(cid:22)(cid:3)(cid:11)(cid:68)(cid:12)

(cid:38)(cid:50)(cid:49)(cid:54)(cid:40)(cid:49)(cid:55)(cid:3)(cid:50)(cid:41)(cid:3)(cid:44)(cid:49)(cid:39)(cid:40)(cid:51)(cid:40)(cid:49)(cid:39)(cid:40)(cid:49)(cid:55)(cid:3)(cid:53)(cid:40)(cid:42)(cid:44)(cid:54)(cid:55)(cid:40)(cid:53)(cid:40)(cid:39)(cid:3)(cid:51)(cid:56)(cid:37)(cid:47)(cid:44)(cid:38)(cid:3)(cid:36)(cid:38)(cid:38)(cid:50)(cid:56)(cid:49)(cid:55)(cid:44)(cid:49)(cid:42)(cid:3)(cid:41)(cid:44)(cid:53)(cid:48)(cid:3)

(cid:58)(cid:72)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:76)(cid:86)(cid:86)(cid:88)(cid:72)(cid:71)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:86)(cid:3)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:20)(cid:21)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:15)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)
(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:36)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)
(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:72)(cid:81)(cid:71)(cid:72)(cid:71)(cid:3)(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:22)(cid:20)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:17)(cid:3)(cid:58)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:76)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:69)(cid:92)(cid:3)
(cid:85)(cid:72)(cid:73)(cid:72)(cid:85)(cid:72)(cid:81)(cid:70)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:86)(cid:68)(cid:76)(cid:71)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:53)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:86)(cid:3)(cid:54)(cid:16)(cid:27)(cid:3)
(cid:11)(cid:41)(cid:76)(cid:79)(cid:72)(cid:3)(cid:49)(cid:82)(cid:17)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:24)(cid:20)(cid:20)(cid:25)(cid:21)(cid:15)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:20)(cid:23)(cid:22)(cid:19)(cid:27)(cid:19)(cid:15)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:20)(cid:25)(cid:26)(cid:23)(cid:25)(cid:20)(cid:15)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:20)(cid:27)(cid:22)(cid:21)(cid:19)(cid:25)(cid:15)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:21)(cid:19)(cid:25)(cid:21)(cid:20)(cid:28)(cid:15)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:21)(cid:20)(cid:28)(cid:28)(cid:20)(cid:20)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:21)(cid:24)(cid:20)(cid:23)(cid:22)(cid:19)(cid:12)(cid:17)(cid:3)

(cid:18)(cid:86)(cid:18)(cid:3)(cid:42)(cid:53)(cid:36)(cid:49)(cid:55)(cid:3)(cid:55)(cid:43)(cid:50)(cid:53)(cid:49)(cid:55)(cid:50)(cid:49)(cid:3)(cid:47)(cid:47)(cid:51)(cid:3)

(cid:38)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:68)(cid:81)(cid:71)(cid:15)(cid:3)(cid:50)(cid:75)(cid:76)(cid:82)(cid:3)
(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:20)(cid:21)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)

(cid:40)(cid:91)(cid:75)(cid:76)(cid:69)(cid:76)(cid:87)(cid:3)(cid:21)(cid:22)(cid:3)(cid:11)(cid:69)(cid:12)

(cid:38)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:44)(cid:81)(cid:71)(cid:72)(cid:83)(cid:72)(cid:81)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:53)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:51)(cid:88)(cid:69)(cid:79)(cid:76)(cid:70)(cid:3)(cid:36)(cid:70)(cid:70)(cid:82)(cid:88)(cid:81)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:41)(cid:76)(cid:85)(cid:80)

(cid:55)(cid:75)(cid:72)(cid:3)(cid:37)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)(cid:39)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)

(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:29)

(cid:58)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:76)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:69)(cid:92)(cid:3)(cid:85)(cid:72)(cid:73)(cid:72)(cid:85)(cid:72)(cid:81)(cid:70)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:49)(cid:82)(cid:17)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:24)(cid:20)(cid:20)(cid:25)(cid:21)(cid:15)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:20)(cid:23)(cid:22)(cid:19)(cid:27)(cid:19)(cid:15)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:20)(cid:25)(cid:26)(cid:23)(cid:25)(cid:20)(cid:15)(cid:3)
(cid:22)(cid:22)(cid:22)(cid:16)(cid:20)(cid:27)(cid:22)(cid:21)(cid:19)(cid:25)(cid:15)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:21)(cid:19)(cid:25)(cid:21)(cid:20)(cid:28)(cid:15)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:21)(cid:20)(cid:28)(cid:28)(cid:20)(cid:20)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:22)(cid:22)(cid:22)(cid:16)(cid:21)(cid:24)(cid:20)(cid:23)(cid:22)(cid:19)(cid:3)(cid:82)(cid:81)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:54)(cid:16)(cid:27)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)
(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:20)(cid:24)(cid:15)(cid:3)(cid:21)(cid:19)(cid:20)(cid:28)(cid:15)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:85)(cid:72)(cid:75)(cid:72)(cid:81)(cid:86)(cid:76)(cid:89)(cid:72)(cid:3)(cid:76)(cid:81)(cid:70)(cid:82)(cid:80)(cid:72)(cid:3)(cid:11)(cid:79)(cid:82)(cid:86)(cid:86)(cid:12)(cid:15)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)
(cid:73)(cid:79)(cid:82)(cid:90)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:182)(cid:3)(cid:72)(cid:84)(cid:88)(cid:76)(cid:87)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:72)(cid:81)(cid:71)(cid:72)(cid:71)(cid:3)(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:22)(cid:20)(cid:15)(cid:3)(cid:21)(cid:19)(cid:20)(cid:27)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:81)(cid:82)(cid:87)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:86)(cid:70)(cid:75)(cid:72)(cid:71)(cid:88)(cid:79)(cid:72)(cid:3)(cid:11)(cid:70)(cid:82)(cid:79)(cid:79)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:79)(cid:92)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:12)(cid:15)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:68)(cid:83)(cid:83)(cid:72)(cid:68)(cid:85)(cid:86)(cid:3)
(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:22)(cid:20)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:82)(cid:81)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:17)

(cid:18)(cid:86)(cid:18)(cid:3)(cid:46)(cid:51)(cid:48)(cid:42)(cid:3)(cid:47)(cid:47)(cid:51)

(cid:53)(cid:82)(cid:70)(cid:75)(cid:72)(cid:86)(cid:87)(cid:72)(cid:85)(cid:15)(cid:3)(cid:49)(cid:72)(cid:90)(cid:3)(cid:60)(cid:82)(cid:85)(cid:78)
(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:20)(cid:21)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)

(cid:40)(cid:91)(cid:75)(cid:76)(cid:69)(cid:76)(cid:87)(cid:3)(cid:22)(cid:20)(cid:3)(cid:11)(cid:68)(cid:12)

(cid:44)(cid:15)(cid:3)(cid:41)(cid:76)(cid:79)(cid:76)(cid:83)(cid:3)(cid:45)(cid:17)(cid:47)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112)(cid:15)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:92)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:29)

(cid:38)(cid:40)(cid:53)(cid:55)(cid:44)(cid:41)(cid:44)(cid:38)(cid:36)(cid:55)(cid:44)(cid:50)(cid:49)

(cid:20)(cid:17)

(cid:21)(cid:17)

(cid:22)(cid:17)

(cid:23)(cid:17)

(cid:44)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:85)(cid:72)(cid:89)(cid:76)(cid:72)(cid:90)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:82)(cid:81)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:30)

(cid:37)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:80)(cid:92)(cid:3)(cid:78)(cid:81)(cid:82)(cid:90)(cid:79)(cid:72)(cid:71)(cid:74)(cid:72)(cid:15)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:71)(cid:82)(cid:72)(cid:86)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:88)(cid:81)(cid:87)(cid:85)(cid:88)(cid:72)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:80)(cid:76)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:3)(cid:68)(cid:3)
(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:3)(cid:81)(cid:72)(cid:70)(cid:72)(cid:86)(cid:86)(cid:68)(cid:85)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:68)(cid:78)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:80)(cid:68)(cid:71)(cid:72)(cid:15)(cid:3)(cid:76)(cid:81)(cid:3)(cid:79)(cid:76)(cid:74)(cid:75)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:76)(cid:85)(cid:70)(cid:88)(cid:80)(cid:86)(cid:87)(cid:68)(cid:81)(cid:70)(cid:72)(cid:86)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)
(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:90)(cid:72)(cid:85)(cid:72)(cid:3)(cid:80)(cid:68)(cid:71)(cid:72)(cid:15)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:80)(cid:76)(cid:86)(cid:79)(cid:72)(cid:68)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:30)

(cid:37)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:80)(cid:92)(cid:3)(cid:78)(cid:81)(cid:82)(cid:90)(cid:79)(cid:72)(cid:71)(cid:74)(cid:72)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:76)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:15)(cid:3)(cid:73)(cid:68)(cid:76)(cid:85)(cid:79)(cid:92)(cid:3)
(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:73)(cid:79)(cid:82)(cid:90)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:3)(cid:68)(cid:86)(cid:3)
(cid:82)(cid:73)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:86)(cid:3)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:30)

(cid:55)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:92)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:44)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:86)(cid:76)(cid:69)(cid:79)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:72)(cid:86)(cid:87)(cid:68)(cid:69)(cid:79)(cid:76)(cid:86)(cid:75)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:80)(cid:68)(cid:76)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)
(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:3)(cid:11)(cid:68)(cid:86)(cid:3)(cid:71)(cid:72)(cid:73)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:36)(cid:70)(cid:87)(cid:3)(cid:53)(cid:88)(cid:79)(cid:72)(cid:86)(cid:3)(cid:20)(cid:22)(cid:68)(cid:16)(cid:20)(cid:24)(cid:11)(cid:72)(cid:12)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:20)(cid:24)(cid:71)(cid:16)(cid:20)(cid:24)(cid:11)(cid:72)(cid:12)(cid:12)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)
(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:11)(cid:68)(cid:86)(cid:3)(cid:71)(cid:72)(cid:73)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:36)(cid:70)(cid:87)(cid:3)(cid:53)(cid:88)(cid:79)(cid:72)(cid:86)(cid:3)(cid:20)(cid:22)(cid:68)(cid:16)(cid:20)(cid:24)(cid:11)(cid:73)(cid:12)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:20)(cid:24)(cid:71)(cid:16)(cid:20)(cid:24)(cid:11)(cid:73)(cid:12)(cid:12)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:29)

(cid:68)(cid:17)

(cid:69)(cid:17)

(cid:70)(cid:17)

(cid:71)(cid:17)

(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)
(cid:69)(cid:72)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:88)(cid:83)(cid:72)(cid:85)(cid:89)(cid:76)(cid:86)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:81)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:76)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:15)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)
(cid:76)(cid:87)(cid:86)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:76)(cid:86)(cid:3)(cid:80)(cid:68)(cid:71)(cid:72)(cid:3)(cid:78)(cid:81)(cid:82)(cid:90)(cid:81)(cid:3)(cid:87)(cid:82)(cid:3)(cid:88)(cid:86)(cid:3)(cid:69)(cid:92)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:82)(cid:86)(cid:72)(cid:3)(cid:72)(cid:81)(cid:87)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85)(cid:79)(cid:92)(cid:3)(cid:71)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:76)(cid:86)(cid:3)(cid:69)(cid:72)(cid:76)(cid:81)(cid:74)(cid:3)(cid:83)(cid:85)(cid:72)(cid:83)(cid:68)(cid:85)(cid:72)(cid:71)(cid:30)

(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)
(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:69)(cid:72)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:88)(cid:83)(cid:72)(cid:85)(cid:89)(cid:76)(cid:86)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:3)(cid:85)(cid:72)(cid:68)(cid:86)(cid:82)(cid:81)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)(cid:68)(cid:86)(cid:86)(cid:88)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:68)(cid:85)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:79)(cid:76)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)
(cid:82)(cid:73)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:72)(cid:83)(cid:68)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:72)(cid:91)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:83)(cid:88)(cid:85)(cid:83)(cid:82)(cid:86)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:70)(cid:70)(cid:82)(cid:85)(cid:71)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)
(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:68)(cid:70)(cid:70)(cid:72)(cid:83)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:70)(cid:70)(cid:82)(cid:88)(cid:81)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:83)(cid:85)(cid:76)(cid:81)(cid:70)(cid:76)(cid:83)(cid:79)(cid:72)(cid:86)(cid:30)

(cid:72)(cid:89)(cid:68)(cid:79)(cid:88)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)
(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:82)(cid:81)(cid:70)(cid:79)(cid:88)(cid:86)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:68)(cid:69)(cid:82)(cid:88)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:15)(cid:3)(cid:68)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:81)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:72)(cid:89)(cid:68)(cid:79)(cid:88)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)

(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:82)(cid:70)(cid:70)(cid:88)(cid:85)(cid:85)(cid:72)(cid:71)(cid:3)
(cid:71)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:80)(cid:82)(cid:86)(cid:87)(cid:3)(cid:85)(cid:72)(cid:70)(cid:72)(cid:81)(cid:87)(cid:3)(cid:73)(cid:76)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:3)(cid:11)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:73)(cid:82)(cid:88)(cid:85)(cid:87)(cid:75)(cid:3)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:68)(cid:86)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:81)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)
(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:12)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:68)(cid:86)(cid:82)(cid:81)(cid:68)(cid:69)(cid:79)(cid:92)(cid:3)(cid:79)(cid:76)(cid:78)(cid:72)(cid:79)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)
(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)

(cid:24)(cid:17)

(cid:55)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:92)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:44)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:72)(cid:71)(cid:15)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:80)(cid:82)(cid:86)(cid:87)(cid:3)(cid:85)(cid:72)(cid:70)(cid:72)(cid:81)(cid:87)(cid:3)(cid:72)(cid:89)(cid:68)(cid:79)(cid:88)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:15)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:68)(cid:88)(cid:71)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:88)(cid:71)(cid:76)(cid:87)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:69)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)
(cid:82)(cid:73)(cid:3)(cid:71)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:11)(cid:82)(cid:85)(cid:3)(cid:83)(cid:72)(cid:85)(cid:86)(cid:82)(cid:81)(cid:86)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:84)(cid:88)(cid:76)(cid:89)(cid:68)(cid:79)(cid:72)(cid:81)(cid:87)(cid:3)(cid:73)(cid:88)(cid:81)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:12)(cid:29)

(cid:68)(cid:17)

(cid:69)(cid:17)

(cid:68)(cid:79)(cid:79)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:3)(cid:71)(cid:72)(cid:73)(cid:76)(cid:70)(cid:76)(cid:72)(cid:81)(cid:70)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:90)(cid:72)(cid:68)(cid:78)(cid:81)(cid:72)(cid:86)(cid:86)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)
(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:85)(cid:72)(cid:68)(cid:86)(cid:82)(cid:81)(cid:68)(cid:69)(cid:79)(cid:92)(cid:3)(cid:79)(cid:76)(cid:78)(cid:72)(cid:79)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:15)(cid:3)
(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:86)(cid:86)(cid:15)(cid:3)(cid:86)(cid:88)(cid:80)(cid:80)(cid:68)(cid:85)(cid:76)(cid:93)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:76)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)

(cid:68)(cid:81)(cid:92)(cid:3)(cid:73)(cid:85)(cid:68)(cid:88)(cid:71)(cid:15)(cid:3)(cid:90)(cid:75)(cid:72)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:82)(cid:85)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:15)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:76)(cid:81)(cid:89)(cid:82)(cid:79)(cid:89)(cid:72)(cid:86)(cid:3)(cid:80)(cid:68)(cid:81)(cid:68)(cid:74)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:3)(cid:90)(cid:75)(cid:82)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:3)
(cid:85)(cid:82)(cid:79)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:17)

(cid:39)(cid:68)(cid:87)(cid:72)(cid:29)(cid:3)(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:20)(cid:21)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)

(cid:3)

/s/ Filip J.L. Gydé
(cid:41)(cid:76)(cid:79)(cid:76)(cid:83)(cid:3)(cid:45)(cid:17)(cid:47)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112)
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:50)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)

(cid:40)(cid:91)(cid:75)(cid:76)(cid:69)(cid:76)(cid:87)(cid:3)(cid:22)(cid:20)(cid:3)(cid:11)(cid:69)(cid:12)

(cid:44)(cid:15)(cid:3)(cid:45)(cid:82)(cid:75)(cid:81)(cid:3)(cid:48)(cid:17)(cid:3)(cid:47)(cid:68)(cid:88)(cid:69)(cid:68)(cid:70)(cid:78)(cid:72)(cid:85)(cid:15)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:92)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:29)

(cid:38)(cid:40)(cid:53)(cid:55)(cid:44)(cid:41)(cid:44)(cid:38)(cid:36)(cid:55)(cid:44)(cid:50)(cid:49)

(cid:20)(cid:17)

(cid:21)(cid:17)

(cid:22)(cid:17)

(cid:23)(cid:17)

(cid:44)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:85)(cid:72)(cid:89)(cid:76)(cid:72)(cid:90)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:82)(cid:81)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:30)

(cid:37)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:80)(cid:92)(cid:3)(cid:78)(cid:81)(cid:82)(cid:90)(cid:79)(cid:72)(cid:71)(cid:74)(cid:72)(cid:15)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:71)(cid:82)(cid:72)(cid:86)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:88)(cid:81)(cid:87)(cid:85)(cid:88)(cid:72)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:80)(cid:76)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:3)(cid:68)(cid:3)
(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:73)(cid:68)(cid:70)(cid:87)(cid:3)(cid:81)(cid:72)(cid:70)(cid:72)(cid:86)(cid:86)(cid:68)(cid:85)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:68)(cid:78)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:80)(cid:68)(cid:71)(cid:72)(cid:15)(cid:3)(cid:76)(cid:81)(cid:3)(cid:79)(cid:76)(cid:74)(cid:75)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:76)(cid:85)(cid:70)(cid:88)(cid:80)(cid:86)(cid:87)(cid:68)(cid:81)(cid:70)(cid:72)(cid:86)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)
(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:90)(cid:72)(cid:85)(cid:72)(cid:3)(cid:80)(cid:68)(cid:71)(cid:72)(cid:15)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:80)(cid:76)(cid:86)(cid:79)(cid:72)(cid:68)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:30)

(cid:37)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:80)(cid:92)(cid:3)(cid:78)(cid:81)(cid:82)(cid:90)(cid:79)(cid:72)(cid:71)(cid:74)(cid:72)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:76)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:15)(cid:3)(cid:73)(cid:68)(cid:76)(cid:85)(cid:79)(cid:92)(cid:3)
(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:86)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:73)(cid:79)(cid:82)(cid:90)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:3)(cid:68)(cid:86)(cid:3)
(cid:82)(cid:73)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:86)(cid:3)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:30)

(cid:55)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:92)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:44)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:86)(cid:76)(cid:69)(cid:79)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:72)(cid:86)(cid:87)(cid:68)(cid:69)(cid:79)(cid:76)(cid:86)(cid:75)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:80)(cid:68)(cid:76)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)
(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:3)(cid:11)(cid:68)(cid:86)(cid:3)(cid:71)(cid:72)(cid:73)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:36)(cid:70)(cid:87)(cid:3)(cid:53)(cid:88)(cid:79)(cid:72)(cid:86)(cid:3)(cid:20)(cid:22)(cid:68)(cid:16)(cid:20)(cid:24)(cid:11)(cid:72)(cid:12)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:20)(cid:24)(cid:71)(cid:16)(cid:20)(cid:24)(cid:11)(cid:72)(cid:12)(cid:12)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)
(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:11)(cid:68)(cid:86)(cid:3)(cid:71)(cid:72)(cid:73)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:36)(cid:70)(cid:87)(cid:3)(cid:53)(cid:88)(cid:79)(cid:72)(cid:86)(cid:3)(cid:20)(cid:22)(cid:68)(cid:16)(cid:20)(cid:24)(cid:11)(cid:73)(cid:12)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:20)(cid:24)(cid:71)(cid:16)(cid:20)(cid:24)(cid:11)(cid:73)(cid:12)(cid:12)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:29)

(cid:68)(cid:17)

(cid:69)(cid:17)

(cid:70)(cid:17)

(cid:71)(cid:17)

(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)
(cid:69)(cid:72)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:88)(cid:83)(cid:72)(cid:85)(cid:89)(cid:76)(cid:86)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:81)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:76)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:15)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)
(cid:76)(cid:87)(cid:86)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:69)(cid:86)(cid:76)(cid:71)(cid:76)(cid:68)(cid:85)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:76)(cid:86)(cid:3)(cid:80)(cid:68)(cid:71)(cid:72)(cid:3)(cid:78)(cid:81)(cid:82)(cid:90)(cid:81)(cid:3)(cid:87)(cid:82)(cid:3)(cid:88)(cid:86)(cid:3)(cid:69)(cid:92)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:82)(cid:86)(cid:72)(cid:3)(cid:72)(cid:81)(cid:87)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:76)(cid:70)(cid:88)(cid:79)(cid:68)(cid:85)(cid:79)(cid:92)(cid:3)(cid:71)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:76)(cid:86)(cid:3)(cid:69)(cid:72)(cid:76)(cid:81)(cid:74)(cid:3)(cid:83)(cid:85)(cid:72)(cid:83)(cid:68)(cid:85)(cid:72)(cid:71)(cid:30)

(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:71)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)
(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:69)(cid:72)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:88)(cid:83)(cid:72)(cid:85)(cid:89)(cid:76)(cid:86)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:3)(cid:85)(cid:72)(cid:68)(cid:86)(cid:82)(cid:81)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)(cid:68)(cid:86)(cid:86)(cid:88)(cid:85)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:68)(cid:85)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:79)(cid:76)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)
(cid:82)(cid:73)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:72)(cid:83)(cid:68)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:72)(cid:91)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:83)(cid:88)(cid:85)(cid:83)(cid:82)(cid:86)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:70)(cid:70)(cid:82)(cid:85)(cid:71)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)
(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:68)(cid:70)(cid:70)(cid:72)(cid:83)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:70)(cid:70)(cid:82)(cid:88)(cid:81)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:83)(cid:85)(cid:76)(cid:81)(cid:70)(cid:76)(cid:83)(cid:79)(cid:72)(cid:86)(cid:30)

(cid:72)(cid:89)(cid:68)(cid:79)(cid:88)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)
(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:82)(cid:81)(cid:70)(cid:79)(cid:88)(cid:86)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:68)(cid:69)(cid:82)(cid:88)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:76)(cid:89)(cid:72)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:88)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:71)(cid:88)(cid:85)(cid:72)(cid:86)(cid:15)(cid:3)(cid:68)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:81)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:3)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:72)(cid:89)(cid:68)(cid:79)(cid:88)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)

(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:82)(cid:70)(cid:70)(cid:88)(cid:85)(cid:85)(cid:72)(cid:71)(cid:3)
(cid:71)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:80)(cid:82)(cid:86)(cid:87)(cid:3)(cid:85)(cid:72)(cid:70)(cid:72)(cid:81)(cid:87)(cid:3)(cid:73)(cid:76)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:3)(cid:11)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:73)(cid:82)(cid:88)(cid:85)(cid:87)(cid:75)(cid:3)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:68)(cid:86)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:81)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)
(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:12)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:15)(cid:3)(cid:82)(cid:85)(cid:3)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:68)(cid:86)(cid:82)(cid:81)(cid:68)(cid:69)(cid:79)(cid:92)(cid:3)(cid:79)(cid:76)(cid:78)(cid:72)(cid:79)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)
(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)

(cid:24)(cid:17)

(cid:55)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:92)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:44)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:79)(cid:82)(cid:86)(cid:72)(cid:71)(cid:15)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:80)(cid:82)(cid:86)(cid:87)(cid:3)(cid:85)(cid:72)(cid:70)(cid:72)(cid:81)(cid:87)(cid:3)(cid:72)(cid:89)(cid:68)(cid:79)(cid:88)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:15)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:68)(cid:88)(cid:71)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:88)(cid:71)(cid:76)(cid:87)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:69)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)
(cid:82)(cid:73)(cid:3)(cid:71)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:11)(cid:82)(cid:85)(cid:3)(cid:83)(cid:72)(cid:85)(cid:86)(cid:82)(cid:81)(cid:86)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:84)(cid:88)(cid:76)(cid:89)(cid:68)(cid:79)(cid:72)(cid:81)(cid:87)(cid:3)(cid:73)(cid:88)(cid:81)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:12)(cid:29)

(cid:68)(cid:17)

(cid:69)(cid:17)

(cid:68)(cid:79)(cid:79)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:3)(cid:71)(cid:72)(cid:73)(cid:76)(cid:70)(cid:76)(cid:72)(cid:81)(cid:70)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:90)(cid:72)(cid:68)(cid:78)(cid:81)(cid:72)(cid:86)(cid:86)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)
(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:85)(cid:72)(cid:68)(cid:86)(cid:82)(cid:81)(cid:68)(cid:69)(cid:79)(cid:92)(cid:3)(cid:79)(cid:76)(cid:78)(cid:72)(cid:79)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:68)(cid:71)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:79)(cid:92)(cid:3)(cid:68)(cid:73)(cid:73)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:15)(cid:3)
(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:86)(cid:86)(cid:15)(cid:3)(cid:86)(cid:88)(cid:80)(cid:80)(cid:68)(cid:85)(cid:76)(cid:93)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:76)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)

(cid:68)(cid:81)(cid:92)(cid:3)(cid:73)(cid:85)(cid:68)(cid:88)(cid:71)(cid:15)(cid:3)(cid:90)(cid:75)(cid:72)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:82)(cid:85)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:15)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:76)(cid:81)(cid:89)(cid:82)(cid:79)(cid:89)(cid:72)(cid:86)(cid:3)(cid:80)(cid:68)(cid:81)(cid:68)(cid:74)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:82)(cid:85)(cid:3)(cid:82)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:3)(cid:90)(cid:75)(cid:82)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:81)(cid:87)(cid:3)
(cid:85)(cid:82)(cid:79)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:81)(cid:87)(cid:182)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:81)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:76)(cid:81)(cid:74)(cid:17)

(cid:39)(cid:68)(cid:87)(cid:72)(cid:29)(cid:3)(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:20)(cid:21)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)

(cid:3)

/s/ John M. Laubacker
(cid:45)(cid:82)(cid:75)(cid:81)(cid:3)(cid:48)(cid:17)(cid:3)(cid:47)(cid:68)(cid:88)(cid:69)(cid:68)(cid:70)(cid:78)(cid:72)(cid:85)
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:50)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)

(cid:40)(cid:91)(cid:75)(cid:76)(cid:69)(cid:76)(cid:87)(cid:3)(cid:22)(cid:21)

(cid:51)(cid:56)(cid:53)(cid:54)(cid:56)(cid:36)(cid:49)(cid:55)(cid:3)(cid:55)(cid:50)(cid:3)(cid:54)(cid:40)(cid:38)(cid:55)(cid:44)(cid:50)(cid:49)(cid:3)(cid:28)(cid:19)(cid:25)(cid:3)(cid:50)(cid:41)(cid:3)(cid:55)(cid:43)(cid:40)(cid:3)(cid:54)(cid:36)(cid:53)(cid:37)(cid:36)(cid:49)(cid:40)(cid:54)(cid:16)(cid:50)(cid:59)(cid:47)(cid:40)(cid:60)(cid:3)(cid:36)(cid:38)(cid:55)(cid:3)(cid:50)(cid:41)(cid:3)(cid:21)(cid:19)(cid:19)(cid:21)

(cid:11)(cid:54)(cid:88)(cid:69)(cid:86)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:11)(cid:68)(cid:12)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:11)(cid:69)(cid:12)(cid:3)(cid:82)(cid:73)(cid:3)(cid:54)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:20)(cid:22)(cid:24)(cid:19)(cid:15)(cid:3)(cid:38)(cid:75)(cid:68)(cid:83)(cid:87)(cid:72)(cid:85)(cid:3)(cid:25)(cid:22)(cid:3)(cid:82)(cid:73)(cid:3)(cid:55)(cid:76)(cid:87)(cid:79)(cid:72)(cid:3)(cid:20)(cid:27)(cid:15)(cid:3)(cid:56)(cid:81)(cid:76)(cid:87)(cid:72)(cid:71)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:72)(cid:86)(cid:3)(cid:38)(cid:82)(cid:71)(cid:72)(cid:12)

(cid:38)(cid:40)(cid:53)(cid:55)(cid:44)(cid:41)(cid:44)(cid:38)(cid:36)(cid:55)(cid:44)(cid:50)(cid:49)

(cid:51)(cid:88)(cid:85)(cid:86)(cid:88)(cid:68)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:54)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:28)(cid:19)(cid:25)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:54)(cid:68)(cid:85)(cid:69)(cid:68)(cid:81)(cid:72)(cid:86)(cid:16)(cid:50)(cid:91)(cid:79)(cid:72)(cid:92)(cid:3)(cid:36)(cid:70)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:21)(cid:19)(cid:19)(cid:21)(cid:3)(cid:11)(cid:86)(cid:88)(cid:69)(cid:86)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:11)(cid:68)(cid:12)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:11)(cid:69)(cid:12)(cid:3)(cid:82)(cid:73)(cid:3)(cid:54)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:20)(cid:22)(cid:24)(cid:19)(cid:15)(cid:3)(cid:38)(cid:75)(cid:68)(cid:83)(cid:87)(cid:72)(cid:85)(cid:3)(cid:25)(cid:22)(cid:3)(cid:82)(cid:73)(cid:3)(cid:55)(cid:76)(cid:87)(cid:79)(cid:72)(cid:3)
(cid:20)(cid:27)(cid:15)(cid:3)(cid:56)(cid:81)(cid:76)(cid:87)(cid:72)(cid:71)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:72)(cid:86)(cid:3)(cid:38)(cid:82)(cid:71)(cid:72)(cid:12)(cid:15)(cid:3)(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:15)(cid:3)(cid:68)(cid:3)(cid:49)(cid:72)(cid:90)(cid:3)(cid:60)(cid:82)(cid:85)(cid:78)(cid:3)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)
(cid:11)(cid:87)(cid:75)(cid:72)(cid:3)(cid:179)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:180)(cid:12)(cid:15)(cid:3)(cid:71)(cid:82)(cid:72)(cid:86)(cid:3)(cid:75)(cid:72)(cid:85)(cid:72)(cid:69)(cid:92)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:92)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:36)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:82)(cid:81)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:72)(cid:81)(cid:71)(cid:72)(cid:71)(cid:3)
(cid:39)(cid:72)(cid:70)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:22)(cid:20)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:19)(cid:3)(cid:68)(cid:86)(cid:3)(cid:73)(cid:76)(cid:79)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:54)(cid:72)(cid:70)(cid:88)(cid:85)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:86)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:11)(cid:87)(cid:75)(cid:72)(cid:3)(cid:179)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:180)(cid:12)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:29)

(cid:11)(cid:20)(cid:12)

(cid:11)(cid:21)(cid:12)

(cid:87)(cid:75)(cid:72)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:73)(cid:88)(cid:79)(cid:79)(cid:92)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:79)(cid:76)(cid:72)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:54)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:20)(cid:22)(cid:11)(cid:68)(cid:12)(cid:3)(cid:82)(cid:85)(cid:3)(cid:20)(cid:24)(cid:11)(cid:71)(cid:12)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:54)(cid:72)(cid:70)(cid:88)(cid:85)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:36)(cid:70)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:20)(cid:28)(cid:22)(cid:23)(cid:30)(cid:3)(cid:68)(cid:81)(cid:71)

(cid:87)(cid:75)(cid:72)(cid:3)(cid:76)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:68)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:73)(cid:68)(cid:76)(cid:85)(cid:79)(cid:92)(cid:3)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:72)(cid:70)(cid:87)(cid:86)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:70)(cid:82)(cid:81)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)
(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:17)

(cid:36)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:72)(cid:71)(cid:3)(cid:82)(cid:85)(cid:76)(cid:74)(cid:76)(cid:81)(cid:68)(cid:79)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:90)(cid:85)(cid:76)(cid:87)(cid:87)(cid:72)(cid:81)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:85)(cid:72)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:54)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:28)(cid:19)(cid:25)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:69)(cid:72)(cid:72)(cid:81)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)
(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:69)(cid:72)(cid:3)(cid:85)(cid:72)(cid:87)(cid:68)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:73)(cid:88)(cid:85)(cid:81)(cid:76)(cid:86)(cid:75)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:54)(cid:72)(cid:70)(cid:88)(cid:85)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)
(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:86)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:85)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:86)(cid:87)(cid:68)(cid:73)(cid:73)(cid:3)(cid:88)(cid:83)(cid:82)(cid:81)(cid:3)(cid:85)(cid:72)(cid:84)(cid:88)(cid:72)(cid:86)(cid:87)(cid:17)

(cid:39)(cid:68)(cid:87)(cid:72)(cid:29)(cid:3)(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:20)(cid:21)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)

(cid:3)

(cid:39)(cid:68)(cid:87)(cid:72)(cid:29)(cid:3)(cid:48)(cid:68)(cid:85)(cid:70)(cid:75)(cid:3)(cid:20)(cid:21)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)

(cid:3)

/s/ Filip J.L. Gydé
(cid:41)(cid:76)(cid:79)(cid:76)(cid:83)(cid:3)(cid:45)(cid:17)(cid:47)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112)
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:50)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)

/s/ John M. Laubacker
(cid:45)(cid:82)(cid:75)(cid:81)(cid:3)(cid:48)(cid:17)(cid:3)(cid:47)(cid:68)(cid:88)(cid:69)(cid:68)(cid:70)(cid:78)(cid:72)(cid:85)
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:50)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)

(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)

(cid:3)

(cid:54)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:48)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:3)(cid:44)(cid:81)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:3)
(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:82)(cid:81)(cid:3)(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:76)(cid:86)(cid:3)(cid:87)(cid:85)(cid:68)(cid:71)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)
(cid:49)(cid:36)(cid:54)(cid:39)(cid:36)(cid:52)(cid:3)(cid:54)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:48)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:3)(cid:47)(cid:47)(cid:38)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:92)(cid:80)(cid:69)(cid:82)(cid:79)(cid:3)(cid:38)(cid:55)(cid:42)(cid:17)(cid:3)

(cid:36)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:48)(cid:72)(cid:72)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:3)
(cid:55)(cid:75)(cid:72)(cid:3)(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:80)(cid:72)(cid:72)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:3)(cid:76)(cid:86)(cid:3)(cid:89)(cid:76)(cid:85)(cid:87)(cid:88)(cid:68)(cid:79)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)
(cid:69)(cid:72)(cid:72)(cid:81)(cid:3)(cid:86)(cid:70)(cid:75)(cid:72)(cid:71)(cid:88)(cid:79)(cid:72)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:54)(cid:72)(cid:83)(cid:87)(cid:72)(cid:80)(cid:69)(cid:72)(cid:85)(cid:3)(cid:20)(cid:25)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:15)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)
(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:36)(cid:88)(cid:74)(cid:88)(cid:86)(cid:87)(cid:3)(cid:25)(cid:15)(cid:3)(cid:21)(cid:19)(cid:21)(cid:20)(cid:17)(cid:3)

(cid:60)(cid:82)(cid:88)(cid:85)(cid:3)(cid:85)(cid:72)(cid:84)(cid:88)(cid:72)(cid:86)(cid:87)(cid:86)(cid:15)(cid:3)(cid:68)(cid:86)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)(cid:70)(cid:82)(cid:81)(cid:70)(cid:72)(cid:85)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)
(cid:80)(cid:68)(cid:87)(cid:87)(cid:72)(cid:85)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:80)(cid:82)(cid:86)(cid:87)(cid:3)(cid:72)(cid:73)(cid:73)(cid:76)(cid:70)(cid:76)(cid:72)(cid:81)(cid:87)(cid:79)(cid:92)(cid:3)(cid:68)(cid:81)(cid:86)(cid:90)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)
(cid:70)(cid:82)(cid:85)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:71)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:79)(cid:92)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:29)(cid:3)(cid:3)

(cid:54)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:54)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:86)(cid:3)(cid:49)(cid:88)(cid:80)(cid:69)(cid:72)(cid:85)(cid:29)(cid:3)(cid:11)(cid:27)(cid:19)(cid:19)(cid:12)(cid:3)(cid:26)(cid:22)(cid:19)(cid:16)(cid:23)(cid:19)(cid:19)(cid:20)(cid:3)(cid:3)
(cid:44)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:82)(cid:85)(cid:3)(cid:38)(cid:72)(cid:81)(cid:87)(cid:72)(cid:85)(cid:3)(cid:83)(cid:82)(cid:85)(cid:87)(cid:68)(cid:79)(cid:29)(cid:3)
(cid:90)(cid:90)(cid:90)(cid:17)(cid:70)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:17)(cid:70)(cid:82)(cid:80)(cid:18)(cid:76)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:82)(cid:85)(cid:3)

(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:43)(cid:72)(cid:68)(cid:71)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:86)(cid:3)(cid:3)
(cid:38)(cid:55)(cid:42)(cid:3)
(cid:22)(cid:19)(cid:19)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:51)(cid:68)(cid:85)(cid:78)(cid:90)(cid:68)(cid:92)(cid:15)(cid:3)(cid:54)(cid:88)(cid:76)(cid:87)(cid:72)(cid:3)(cid:21)(cid:20)(cid:23)(cid:49)(cid:3)
(cid:36)(cid:80)(cid:75)(cid:72)(cid:85)(cid:86)(cid:87)(cid:15)(cid:3)(cid:49)(cid:60)(cid:3)(cid:20)(cid:23)(cid:21)(cid:21)(cid:25)(cid:3)
(cid:11)(cid:26)(cid:20)(cid:25)(cid:12)(cid:3)(cid:27)(cid:27)(cid:21)(cid:16)(cid:27)(cid:19)(cid:19)(cid:19)(cid:3)
(cid:11)(cid:27)(cid:19)(cid:19)(cid:12)(cid:3)(cid:28)(cid:28)(cid:21)(cid:16)(cid:24)(cid:22)(cid:24)(cid:19)(cid:3)

(cid:38)(cid:55)(cid:42)(cid:3)(cid:40)(cid:88)(cid:85)(cid:82)(cid:83)(cid:72)(cid:3)(cid:43)(cid:72)(cid:68)(cid:71)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:86)(cid:3)(cid:3)
(cid:38)(cid:55)(cid:42)(cid:3)(cid:40)(cid:88)(cid:85)(cid:82)(cid:83)(cid:72)(cid:3)(cid:37)(cid:57)(cid:3)
(cid:70)(cid:18)(cid:82)(cid:3)(cid:38)(cid:88)(cid:79)(cid:79)(cid:76)(cid:74)(cid:68)(cid:81)(cid:79)(cid:68)(cid:68)(cid:81)(cid:20)(cid:39)(cid:3)
(cid:20)(cid:27)(cid:22)(cid:20)(cid:3)(cid:39)(cid:76)(cid:72)(cid:74)(cid:72)(cid:80)(cid:15)(cid:3)(cid:37)(cid:72)(cid:79)(cid:74)(cid:76)(cid:88)(cid:80)(cid:3)
(cid:14)(cid:22)(cid:21)(cid:3)(cid:11)(cid:19)(cid:12)(cid:21)(cid:3)(cid:26)(cid:21)(cid:19)(cid:3)(cid:24)(cid:20)(cid:3)(cid:26)(cid:19)(cid:3)

(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:38)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)
(cid:55)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:82)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:73)(cid:76)(cid:79)(cid:72)(cid:71)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)
(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:85)(cid:72)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:54)(cid:68)(cid:85)(cid:69)(cid:68)(cid:81)(cid:72)(cid:86)(cid:16)(cid:50)(cid:91)(cid:79)(cid:72)(cid:92)(cid:3)(cid:36)(cid:70)(cid:87)(cid:3)(cid:3)
(cid:82)(cid:73)(cid:3)(cid:21)(cid:19)(cid:19)(cid:21)(cid:17)(cid:3)

(cid:44)(cid:81)(cid:71)(cid:72)(cid:83)(cid:72)(cid:81)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:53)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:51)(cid:88)(cid:69)(cid:79)(cid:76)(cid:70)(cid:3)(cid:36)(cid:70)(cid:70)(cid:82)(cid:88)(cid:81)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:41)(cid:76)(cid:85)(cid:80)(cid:3)
(cid:42)(cid:85)(cid:68)(cid:81)(cid:87)(cid:3)(cid:55)(cid:75)(cid:82)(cid:85)(cid:81)(cid:87)(cid:82)(cid:81)(cid:3)(cid:47)(cid:47)(cid:51)(cid:3)
(cid:20)(cid:22)(cid:26)(cid:24)(cid:3)(cid:40)(cid:17)(cid:3)(cid:49)(cid:76)(cid:81)(cid:87)(cid:75)(cid:3)(cid:54)(cid:87)(cid:85)(cid:72)(cid:72)(cid:87)(cid:15)(cid:3)(cid:54)(cid:88)(cid:76)(cid:87)(cid:72)(cid:3)(cid:20)(cid:24)(cid:19)(cid:19)(cid:3)
(cid:38)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:68)(cid:81)(cid:71)(cid:15)(cid:3)(cid:50)(cid:43)(cid:3)(cid:23)(cid:23)(cid:20)(cid:20)(cid:23)(cid:3)

(cid:55)(cid:85)(cid:68)(cid:81)(cid:86)(cid:73)(cid:72)(cid:85)(cid:3)(cid:36)(cid:74)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:53)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:85)(cid:3)
(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:3)(cid:76)(cid:86)(cid:3)(cid:38)(cid:55)(cid:42)(cid:182)(cid:86)(cid:3)(cid:87)(cid:85)(cid:68)(cid:81)(cid:86)(cid:73)(cid:72)(cid:85)(cid:3)(cid:68)(cid:74)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:85)(cid:68)(cid:85)(cid:15)(cid:3)
(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:86)(cid:76)(cid:69)(cid:79)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:86)(cid:15)(cid:3)
(cid:76)(cid:86)(cid:86)(cid:88)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:86)(cid:87)(cid:82)(cid:70)(cid:78)(cid:3)(cid:70)(cid:72)(cid:85)(cid:87)(cid:76)(cid:73)(cid:76)(cid:70)(cid:68)(cid:87)(cid:72)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:71)(cid:76)(cid:86)(cid:87)(cid:85)(cid:76)(cid:69)(cid:88)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:71)(cid:76)(cid:89)(cid:76)(cid:71)(cid:72)(cid:81)(cid:71)(cid:86)(cid:15)(cid:3)(cid:76)(cid:73)(cid:3)(cid:68)(cid:81)(cid:92)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:83)(cid:68)(cid:76)(cid:71)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:44)(cid:53)(cid:54)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:28)(cid:28)(cid:17)(cid:3)(cid:3)

(cid:3)

(cid:3)

U.S. mail:(cid:3)

Overnight delivery:(cid:3)

(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:3)
(cid:44)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:82)(cid:85)(cid:3)(cid:54)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:86)(cid:3)
(cid:51)(cid:17)(cid:50)(cid:17)(cid:3)(cid:37)(cid:82)(cid:91)(cid:3)(cid:24)(cid:19)(cid:24)(cid:19)(cid:19)(cid:19)(cid:3)
(cid:47)(cid:82)(cid:88)(cid:76)(cid:86)(cid:89)(cid:76)(cid:79)(cid:79)(cid:72)(cid:15)(cid:3)(cid:46)(cid:60)(cid:3)(cid:3)
(cid:23)(cid:19)(cid:21)(cid:22)(cid:22)(cid:16)(cid:24)(cid:19)(cid:19)(cid:19)(cid:3)

(cid:3)

(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:3)
(cid:44)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:82)(cid:85)(cid:3)(cid:54)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:86)(cid:3)
(cid:23)(cid:25)(cid:21)(cid:3)(cid:54)(cid:82)(cid:88)(cid:87)(cid:75)(cid:3)(cid:23)(cid:87)(cid:75)(cid:3)(cid:54)(cid:87)(cid:85)(cid:72)(cid:72)(cid:87)(cid:3)
(cid:54)(cid:88)(cid:76)(cid:87)(cid:72)(cid:3)(cid:20)(cid:25)(cid:19)(cid:19)(cid:3)
(cid:47)(cid:82)(cid:88)(cid:76)(cid:86)(cid:89)(cid:76)(cid:79)(cid:79)(cid:72)(cid:15)(cid:3)(cid:46)(cid:60)(cid:3)(cid:23)(cid:19)(cid:21)(cid:19)(cid:21)(cid:3)

(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:38)(cid:82)(cid:71)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:40)(cid:87)(cid:75)(cid:76)(cid:70)(cid:86)(cid:15)(cid:3)
(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)(cid:38)(cid:75)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:42)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:51)(cid:82)(cid:79)(cid:76)(cid:70)(cid:76)(cid:72)(cid:86)(cid:3)
(cid:36)(cid:89)(cid:68)(cid:76)(cid:79)(cid:68)(cid:69)(cid:79)(cid:72)(cid:3)
(cid:3)
(cid:38)(cid:82)(cid:83)(cid:76)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:3)(cid:36)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:15)(cid:3)
(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:79)(cid:92)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:86)(cid:3)(cid:82)(cid:81)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:52)(cid:15)(cid:3)(cid:70)(cid:88)(cid:85)(cid:85)(cid:72)(cid:81)(cid:87)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:86)(cid:3)(cid:82)(cid:81)(cid:3)
(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:27)(cid:16)(cid:46)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:68)(cid:80)(cid:72)(cid:81)(cid:71)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:82)(cid:86)(cid:72)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:86)(cid:3)
(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:70)(cid:82)(cid:71)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:72)(cid:87)(cid:75)(cid:76)(cid:70)(cid:86)(cid:15)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:72)(cid:3)
(cid:70)(cid:75)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:74)(cid:82)(cid:89)(cid:72)(cid:85)(cid:81)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:83)(cid:82)(cid:79)(cid:76)(cid:70)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:73)(cid:76)(cid:79)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)
(cid:87)(cid:75)(cid:72)(cid:3)(cid:54)(cid:72)(cid:70)(cid:88)(cid:85)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:40)(cid:91)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:38)(cid:82)(cid:80)(cid:80)(cid:76)(cid:86)(cid:86)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:69)(cid:72)(cid:3)
(cid:82)(cid:69)(cid:87)(cid:68)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:82)(cid:88)(cid:87)(cid:3)(cid:70)(cid:75)(cid:68)(cid:85)(cid:74)(cid:72)(cid:3)(cid:72)(cid:76)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:85)(cid:82)(cid:88)(cid:74)(cid:75)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:90)(cid:72)(cid:69)(cid:86)(cid:76)(cid:87)(cid:72)(cid:3)(cid:68)(cid:87)(cid:3)
(cid:90)(cid:90)(cid:90)(cid:17)(cid:70)(cid:87)(cid:74)(cid:17)(cid:70)(cid:82)(cid:80)(cid:18)(cid:76)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:82)(cid:85)(cid:3)(cid:88)(cid:83)(cid:82)(cid:81)(cid:3)(cid:90)(cid:85)(cid:76)(cid:87)(cid:87)(cid:72)(cid:81)(cid:3)(cid:82)(cid:85)(cid:3)(cid:89)(cid:72)(cid:85)(cid:69)(cid:68)(cid:79)(cid:3)
(cid:85)(cid:72)(cid:84)(cid:88)(cid:72)(cid:86)(cid:87)(cid:3)(cid:87)(cid:82)(cid:29)(cid:3)(cid:3)

(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:3)
(cid:44)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:82)(cid:85)(cid:3)(cid:53)(cid:72)(cid:79)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:39)(cid:72)(cid:83)(cid:68)(cid:85)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:3)
(cid:22)(cid:19)(cid:19)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:51)(cid:68)(cid:85)(cid:78)(cid:90)(cid:68)(cid:92)(cid:15)(cid:3)(cid:54)(cid:88)(cid:76)(cid:87)(cid:72)(cid:3)(cid:21)(cid:20)(cid:23)(cid:49)(cid:3)(cid:3)
(cid:36)(cid:80)(cid:75)(cid:72)(cid:85)(cid:86)(cid:87)(cid:15)(cid:3)(cid:49)(cid:60)(cid:3)(cid:20)(cid:23)(cid:21)(cid:21)(cid:25)(cid:3)
(cid:11)(cid:26)(cid:20)(cid:25)(cid:12)(cid:3)(cid:27)(cid:27)(cid:21)(cid:16)(cid:27)(cid:19)(cid:19)(cid:19)

(cid:37)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)(cid:39)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:50)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)(cid:3)

(cid:3)

(cid:39)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)

(cid:39)(cid:68)(cid:81)(cid:76)(cid:72)(cid:79)(cid:3)(cid:45)(cid:17)(cid:3)(cid:54)(cid:88)(cid:79)(cid:79)(cid:76)(cid:89)(cid:68)(cid:81)(cid:3)(cid:3)
Chairman and Independent Director 

(cid:41)(cid:76)(cid:79)(cid:76)(cid:83)(cid:3)(cid:45)(cid:17)(cid:47)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112)(cid:3)(cid:3)
President and Chief Executive Officer, CTG 

(cid:45)(cid:68)(cid:80)(cid:72)(cid:86)(cid:3)(cid:53)(cid:17)(cid:3)(cid:43)(cid:72)(cid:79)(cid:89)(cid:72)(cid:92)(cid:15)(cid:3)(cid:44)(cid:44)(cid:44)(cid:3)
Independent Director 

(cid:39)(cid:68)(cid:89)(cid:76)(cid:71)(cid:3)(cid:43)(cid:17)(cid:3)(cid:46)(cid:79)(cid:72)(cid:76)(cid:81)(cid:3)
Independent Director 

(cid:57)(cid:68)(cid:79)(cid:72)(cid:85)(cid:76)(cid:72)(cid:3)(cid:53)(cid:68)(cid:75)(cid:80)(cid:68)(cid:81)(cid:76)(cid:3)
Independent Director 

(cid:53)(cid:68)(cid:77)(cid:3)(cid:53)(cid:68)(cid:77)(cid:74)(cid:82)(cid:83)(cid:68)(cid:79)(cid:3)
Independent Director 

(cid:46)(cid:68)(cid:87)(cid:75)(cid:85)(cid:92)(cid:81)(cid:3)(cid:36)(cid:17)(cid:3)(cid:54)(cid:87)(cid:72)(cid:76)(cid:81)(cid:3)
Independent Director(cid:3)

(cid:3)

(cid:3)

(cid:3)
(cid:3)
(cid:50)(cid:73)(cid:73)(cid:76)(cid:70)(cid:72)(cid:85)(cid:86)(cid:3)

(cid:41)(cid:76)(cid:79)(cid:76)(cid:83)(cid:3)(cid:45)(cid:17)(cid:47)(cid:17)(cid:3)(cid:42)(cid:92)(cid:71)(cid:112) 
President and Chief Executive Officer 

(cid:45)(cid:82)(cid:75)(cid:81)(cid:3)(cid:48)(cid:17)(cid:3)(cid:47)(cid:68)(cid:88)(cid:69)(cid:68)(cid:70)(cid:78)(cid:72)(cid:85) 
Executive Vice President, Chief Financial Officer  
and Treasurer 

(cid:55)(cid:75)(cid:82)(cid:80)(cid:68)(cid:86)(cid:3)(cid:45)(cid:17)(cid:3)(cid:49)(cid:76)(cid:72)(cid:75)(cid:68)(cid:88)(cid:86)(cid:3)
Executive Vice President Operations, North America(cid:3)

(cid:51)(cid:72)(cid:87)(cid:72)(cid:85)(cid:3)(cid:51)(cid:17)(cid:3)(cid:53)(cid:68)(cid:71)(cid:72)(cid:87)(cid:76)(cid:70)(cid:75) 
Senior Vice President, Secretary  
and General Counsel 

(cid:53)(cid:112)(cid:81)(cid:68)(cid:79)(cid:71)(cid:3)(cid:58)(cid:68)(cid:88)(cid:87)(cid:75)(cid:76)(cid:72)(cid:85)(cid:3)
Senior Vice President, Europe 

(cid:53)(cid:82)(cid:69)(cid:72)(cid:85)(cid:87)(cid:3)(cid:37)(cid:68)(cid:85)(cid:85)(cid:68)(cid:86) 
Vice President, Sales, North America 

(cid:37)(cid:82)(cid:69)(cid:3)(cid:39)(cid:68)(cid:72)(cid:79)(cid:80)(cid:68)(cid:81) 
Vice President, Belgium and U.K., Europe  

(cid:42)(cid:88)(cid:76)(cid:71)(cid:82)(cid:3)(cid:43)(cid:72)(cid:79)(cid:86)(cid:79)(cid:82)(cid:82)(cid:87) 
Vice President, Finance, Administration and Compliance, 
Europe  

(cid:36)(cid:80)(cid:68)(cid:81)(cid:71)(cid:68)(cid:3)(cid:47)(cid:72)(cid:37)(cid:79)(cid:68)(cid:81)(cid:70) 
Vice President and Chief Marketing Officer, Global 
Marketing and Communications 

(cid:50)(cid:79)(cid:76)(cid:89)(cid:76)(cid:72)(cid:85)(cid:3)(cid:54)(cid:68)(cid:88)(cid:70)(cid:76)(cid:81) 
Vice President, Global Solutions 

(cid:40)(cid:79)(cid:76)(cid:93)(cid:68)(cid:69)(cid:72)(cid:87)(cid:75)(cid:3)(cid:48)(cid:68)(cid:85)(cid:87)(cid:76)(cid:81)(cid:3)(cid:54)(cid:68)(cid:89)(cid:76)(cid:81)(cid:82) 
Vice President, Human Resources 

 
 
 
(cid:41)(cid:82)(cid:85)(cid:90)(cid:68)(cid:85)(cid:71)(cid:16)(cid:79)(cid:82)(cid:82)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)

(cid:3)
This document contains certain forward-looking statements concerning the Company's current expectations as to 
future growth, financial outlook, business strategy and performance expectations for 2021 and beyond and 
statements related to cost control, new business opportunities, financial performance, market demand, and other 
attributes of the Company, which are protected as forward-looking statements under the Private Securities Litigation 
Reform Act of 1995. Generally, the words “anticipates”, “believes”, “expects”, “plans”, “may”, “will”, “would”, “should”, 
“seeks”, “estimates”, “project”, “predict”, “potential”, “currently”, “continue”, “intends”, “outlook”, and other similar 
words identify forward-looking statements. These statements are based upon the Company's current expectations 
and assumptions, a review of industry reports, current business conditions in the areas where the Company does 
business, feedback from existing and potential new clients, a review of current and proposed legislation and 
governmental regulations that may affect the Company and/or its clients, and other future events or circumstances. 
Actual results could differ materially from the outlook guidance, expectations, and other forward-looking statements 
as a result of a number of factors and risks, including among others, the effects of the COVID-19 pandemic and the 
regulatory, social and business responses thereto on the Company’s business, operations, employees, contractors 
and clients, the availability to the Company of qualified professional staff, domestic and foreign industry competition 
for clients and talent, increased bargaining power of large clients, the Company's ability to protect confidential client 
data, the partial or complete loss of the revenue the Company generates from International Business Machines 
Corporation (IBM), the ability to integrate businesses when acquired and retain their clients while achieving cost 
reduction targets, the uncertainty of clients' implementations of cost reduction projects, the effect of healthcare reform 
and initiatives, the mix of work between solutions and staffing, currency exchange risks, risks associated with 
operating in foreign jurisdictions, renegotiations, nullification, or breaches of contracts with clients, vendors, 
subcontractors or other parties, the change in valuation of capitalized software balances, the impact of current and 
future laws and government regulation, as well as repeal or modification of such, affecting the information technology 
(IT) solutions and staffing industry, taxes and the Company's operations in particular, industry and economic 
conditions, including fluctuations in demand for IT services, consolidation among the Company's competitors or 
clients, the need to supplement or change our IT services in response to new offerings in the industry or changes in 
client requirements for IT products and solutions, actions of activist shareholders, and other factors that involve risk 
and uncertainty including those listed in the Company's reports filed with the Securities and Exchange Commission. 
Such forward-looking statements should be read in conjunction with the Company's disclosures set forth in the 
Company's Form 10-K for the year ended December 31, 2020,(cid:3)including the uncertainties described in the "Risk 
Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections and 
other reports, including but not limited to subsequent quarterly reports on Form 10-Q, that may be filed from time to 
time with the Securities and Exchange Commission and may be obtained through the Securities and Exchange 
Commission's Electronic Data Gathering and Analysis Retrieval System ("EDGAR") at www.sec.gov. 

(cid:38)(cid:82)(cid:80)(cid:83)(cid:88)(cid:87)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:86)(cid:78)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:15)(cid:3)(cid:44)(cid:81)(cid:70)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)
(cid:22)(cid:19)(cid:19)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:51)(cid:68)(cid:85)(cid:78)(cid:90)(cid:68)(cid:92)(cid:15)(cid:3)(cid:54)(cid:88)(cid:76)(cid:87)(cid:72)(cid:3)(cid:21)(cid:20)(cid:23)(cid:49)(cid:3)
(cid:36)(cid:80)(cid:75)(cid:72)(cid:85)(cid:86)(cid:87)(cid:15)(cid:3)(cid:49)(cid:72)(cid:90)(cid:3)(cid:60)(cid:82)(cid:85)(cid:78)(cid:3)(cid:20)(cid:23)(cid:21)(cid:21)(cid:25)(cid:3)

(cid:11)(cid:26)(cid:20)(cid:25)(cid:12)(cid:3)(cid:27)(cid:27)(cid:21)(cid:16)(cid:27)(cid:19)(cid:19)(cid:19)(cid:3)(cid:79)(cid:3)(cid:11)(cid:27)(cid:19)(cid:19)(cid:12)(cid:3)(cid:28)(cid:28)(cid:21)(cid:16)(cid:24)(cid:22)(cid:24)(cid:19)(cid:3)
(cid:90)(cid:90)(cid:90)(cid:17)(cid:70)(cid:87)(cid:74)(cid:17)(cid:70)(cid:82)(cid:80)(cid:3)(cid:3)
(cid:3)

(cid:49)(cid:36)(cid:54)(cid:39)(cid:36)(cid:52)(cid:29)(cid:3)(cid:38)(cid:55)(cid:42)(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:3)

(cid:19)(cid:19)(cid:21)(cid:38)(cid:54)(cid:49)(cid:38)(cid:21)(cid:19)(cid:21)(cid:3)